-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 RZe4rgewDq2l+jz9nOCIgVUT2xM3wMHyGZqyt+lgvwllZmee3pfVvh6feuxb5WlA
 LKyBoRrivYMngtrw/NmySA==

<SEC-DOCUMENT>0001144204-08-006297.txt : 20080205
<SEC-HEADER>0001144204-08-006297.hdr.sgml : 20080205
<ACCEPTANCE-DATETIME>20080205171624
ACCESSION NUMBER:		0001144204-08-006297
CONFORMED SUBMISSION TYPE:	DEFR14A
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20080205
DATE AS OF CHANGE:		20080205
EFFECTIVENESS DATE:		20080205

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOANALYTICAL SYSTEMS INC
		CENTRAL INDEX KEY:			0000720154
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				351345024
		STATE OF INCORPORATION:			IN
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		DEFR14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23357
		FILM NUMBER:		08577955

	BUSINESS ADDRESS:	
		STREET 1:		2701 KENT AVE
		CITY:			WEST LAFAYETT
		STATE:			IN
		ZIP:			47906-1382
		BUSINESS PHONE:		3174634527

	MAIL ADDRESS:	
		STREET 1:		2701 KENT AVENUE
		CITY:			WEST LAFAYETTE
		STATE:			IN
		ZIP:			47906-1382
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFR14A
<SEQUENCE>1
<FILENAME>v102090_defr14a.htm
<TEXT>
<html>
  <head>
    <title>
      </title>
</head>
  <body bgcolor="#ffffff">
    <div>&#160;</div>
    <div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>UNITED
        STATES</strong></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>SECURITIES
        AND EXCHANGE COMMISSION</strong></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Washington,
        D.C. 20549</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>SCHEDULE
        14A</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Proxy
        Statement Pursuant to Section 14(a) of the Securities</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Exchange
        Act of 1934</font></div>

        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font size="2">Amendment
          No. 1</font></div>

      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Filed
        by
        the Registrant &#160;&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">&#254;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Filed
        by
        a Party other than the Registrant &#160;&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">o</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Check
        the
        appropriate box:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td align="left" style="width: 18pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">o</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Preliminary
                  Proxy Statement</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td align="left" style="width: 18pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">o</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Confidential,
                  for Use of the Commission Only (as permitted by
                  Rule&#160;14a-6(e)(2))</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td align="left" style="width: 18pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">&#254;</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Definitive
                  Proxy Statement</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td align="left" style="width: 18pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">o</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Definitive
                  Additional Materials</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td align="left" style="width: 18pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">o</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Soliciting
                  Material Pursuant to &#167;240.14a-12</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Bioanalytical
        Systems, Inc.</strong></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">
        <div>
          <hr style="COLOR: gray" align="left" noshade size="1" width="100%">
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Name
        of
        Registrant as Specified In Its Charter)</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">
        <hr style="COLOR: gray" align="left" noshade size="1" width="100%">
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Name
        of
        Person(s) Filing Proxy Statement, if other than the Registrant)</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Payment
        of Filing Fee (Check the appropriate box):</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td align="left" style="width: 18pt;">
                <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">&#254;</font></div>
              </td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">No
                  fee required.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td align="left" style="width: 18pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">o</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Fee
                  computed on table below per Exchange Act Rules&#160;14a-6(i)(4) and
                  0-11.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 18pt;">
              </td>
              <td align="left" style="width: 18pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1)</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Title
                  of each class of securities to which transaction
                  applies:</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 18pt;">
              </td>
              <td align="left" style="width: 18pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2)</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Aggregate
                  number of securities to which transaction
                  applies:</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 18pt;">
              </td>
              <td align="left" style="width: 18pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3)</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Per
                  unit price or other underlying value of transaction computed pursuant
                  to
                  Exchange Act Rule&#160;0-11 (set forth the amount on which the filing fee
                  is calculated and state how it was
                  determined):</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 18pt;">
              </td>
              <td align="left" style="width: 18pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4)</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Proposed
                  maximum aggregate value of
                  transaction:</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 18pt;">
              </td>
              <td align="left" style="width: 18pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5)</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Total
                  fee paid:</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td align="left" style="width: 18pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">o</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Fee
                  paid previously with preliminary
                  materials.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td align="left" style="width: 18pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">o</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Check
                  box if any part of the fee is offset as provided by Exchange Act
                  Rule&#160;0-11(a)(2) and identify the filing for which the offsetting fee
                  was paid previously. Identify the previous filing by registration
                  statement number, or the Form or Schedule and the date of its
                  filing.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 18pt;">
              </td>
              <td align="left" style="width: 18pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1)</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Amount
                  Previously Paid:</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 18pt;">
              </td>
              <td align="left" style="width: 18pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2)</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Form,
                  Schedule or Registration Statement
                  No.:</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 18pt;">
              </td>
              <td align="left" style="width: 18pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3)</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Filing
                  Party:</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 18pt;">
              </td>
              <td align="left" style="width: 18pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4)</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Date
                  Filed:</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
        <hr style="COLOR: black" align="left" noshade size="1" width="100%">
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

        <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
          amendment is being filed to correct the percentage ownership of our common
          shares outstanding for two of our principal shareholders.&#160;</font></div>

      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
          </div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font size="2">January
        29, 2008</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dear
        BASi
        Shareholders:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">You
        are
        invited to attend the Annual Meeting of Shareholders of Bioanalytical Systems,
        Inc. (&#8220;BASi&#8221;) to be held Thursday, March 20, 2008, at 10:00 a.m. (EST) at BASi
        headquarters located at 2701 Kent Avenue, West Lafayette, Indiana,
        47906.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At
        the
        meeting, we are asking the shareholders to:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 54pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif">&#183;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Elect
                  five directors of BASi to serve for a one-year
                  term;</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 54pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif">&#183;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Approve
                  a grant of non-qualified stock options to Mr. Richard M. Shepperd
                  in
                  connection with his extended employment agreement, dated May,
                  2007;</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 54pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif">&#183;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Approve
                  a grant of non-qualified stock options to Mr. Michael R. Cox in
                  connection
                  with his new employment agreement, dated November,
                  2007;</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 54pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif">&#183;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Approve
                  a grant of non-qualified stock options to Mr. Edward M. Chait in
                  connection with his new employment agreement, dated November, 2007;
                  and,</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 54pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif">&#183;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Approve
                  the adoption of the Bioanalytical Systems, Inc. 2008 Stock Option
                  Plan as
                  a replacement for a previous stock option plan that expired in
                  2007.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Details
        can be found in the accompanying Notice of Annual Meeting and Proxy
        Statement.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We
        hope
        you are able to attend the Annual Meeting personally, and we look forward
        to
        meeting with you. Whether or not you currently plan to attend, please complete,
        date and return the proxy card in the enclosed envelope. The vote of each
        shareholder is very important. You may revoke your proxy at any time before
        it
        is voted by giving written notice to the Secretary of BASi, by filing a properly
        executed proxy bearing a later date or by attending the Annual Meeting and
        voting in person.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On
        behalf
        of the Board of Directors and management of BASi, I sincerely thank you for
        your
        continued support.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Sincerely,</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><img src="sigx1x1.jpg" alt=""></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Richard
        M. Shepperd</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>President
        and Chief Executive Officer</em></font></div><br>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
          </div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div><br>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>NOTICE
        OF ANNUAL MEETING OF SHAREHOLDERS</strong></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">DATE:
        March 20, 2008</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">TIME:
        10:00 a.m.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PLACE:
        Bioanalytical Systems, Inc. Headquarters</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2701
        Kent
        Avenue</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">West
        Lafayette, IN 47906</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MATTERS
        TO BE VOTED UPON:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To
                  elect five directors of BASi to serve for a one-year term;
                  </font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To
                  approve the grant of non-qualified stock options to Mr. Richard
                  M.
                  Shepperd in connection with his extended employment agreement,
                  dated May
                  2007;</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To
                  approve the grant of non-qualified stock options to Mr. Michael
                  R. Cox in
                  connection with his new employment agreement, dated November
                  2007;</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To
                  approve the grant of non-qualified stock options to Mr. Edward
                  M. Chait in
                  connection with his new employment agreement, dated November
                  2007;</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To
                  approve and adopt the Bioanalytical Systems, Inc. 2008 Stock Option
                  Plan
                  as a replacement for a previous stock option plan that expired
                  in
                  2007.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">OUR
        BOARD
        OF DIRECTORS RECOMMENDS THAT YOU VOTE </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>FOR
        </strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">EACH
        OF
        THE NOMINEES NAMED IN THE PROXY STATEMENT AND </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>FOR</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
        EACH
        PROPOSAL. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Holders
        of BASi common shares of record at the close of business on January 31, 2008
        are
        entitled to notice of, and to vote at, the Annual Meeting.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">By
        Order
        of the Board of Directors,</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><img src="sigx1x1.jpg" alt=""></div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Richard
        M. Shepperd</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>President
        and Chief Executive Officer</em></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">YOUR
        VOTE
        IS IMPORTANT. IF YOU DO NOT EXPECT TO ATTEND THE ANNUAL MEETING, OR IF YOU
        DO
        PLAN TO ATTEND BUT WISH TO VOTE BY PROXY, PLEASE DATE, SIGN AND PROMPTLY
        MAIL
        THE ENCLOSED PROXY. A POSTAGE-PAID RETURN ENVELOPE IS PROVIDED FOR THIS
        PURPOSE.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>TABLE
        OF CONTENTS</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div>
        <table cellpadding="0" cellspacing="0" id="ftable" width="100%">

            <tr>
              <td align="left" valign="bottom" width="85%" style="border-bottom: #ffffff solid;">&#160;</td>
              <td width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
              <td colspan="2" valign="bottom" width="11%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Page</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: black thin solid;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="85%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PROXY
                  STATEMENT</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">1</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="85%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">HOW
                  TO VOTE YOUR SHARES</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: white;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">1</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="85%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">COMMONLY
                  ASKED QUESTIONS AND ANSWERS</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">1</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="85%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PROPOSAL
                  1 - ELECTION OF DIRECTORS</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: white;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">4</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="85%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Required
                  Vote and Board of Directors&#8217; Recommendation</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">4</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="85%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Business
                  Experience of Nominated Directors</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: white;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">4</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="85%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Committees
                  and Meetings of the Board of Directors</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">5</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="85%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Family
                  Relationships</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: white;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">6</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="85%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Certain
                  Relationships and Transactions</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">7</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="85%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Communications
                  with the Board of Directors</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: white;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">7</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="85%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Communications
                  with the Audit Committee</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">7</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="85%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Non-employee
                  Director Compensation and Benefits</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: white;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">7</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="85%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PROPOSAL
                  2 - APPROVAL OF THE GRANT OF NON-QUALIFIED STOCK OPTIONS TO </font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">RICHARD
                  M. SHEPPERD</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">8</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="85%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PROPOSAL
                  3 - APPROVAL OF THE GRANT OF NON-QUALIFIED STOCK OPTIONS TO </font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MICHAEL
                  R. COX</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: white;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">9</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="85%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PROPOSAL
                  4 - APPROVAL OF THE GRANT OF NON-QUALIFIED STOCK OPTIONS TO </font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">EDWARD
                  M. CHAIT</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">9</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="85%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PROPOSAL
                  5 - APPROVAL AND ADOPTION OF THE 2008 STOCK OPTION PLAN</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: white;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">9</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="85%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SELECTION
                  OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTING FIRM</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">11</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="85%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">REPORT
                  OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: white;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">12</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="85%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PRINCIPAL
                  SHAREHOLDERS</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">14</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="85%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">COMPENSATION
                  OF EXECUTIVE OFFICERS</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: white;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">14</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="85%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Compensation
                  Discussion and Analysis</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">14</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="85%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Compensation
                  Committee Report</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: white;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">23</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="85%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Fiscal
                  2007 Summary Compensation Table</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">24</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="85%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Fiscal
                  2007 Grants of Plan-Based Awards Table</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: white;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">25</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="85%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Outstanding
                  Equity Awards at Fiscal Year-End Table</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">25</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="85%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Fiscal
                  2007 Option Exercises</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: white;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">26</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="85%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">EQUITY
                  COMPENSATION PLAN INFORMATION</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">26</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="85%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SECTION
                  16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: white;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">26</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="85%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SHAREHOLDER
                  PROPOSALS FOR 2009 ANNUAL MEETING</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">26</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="85%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">OTHER
                  BUSINESS</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: white;"><font style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" size="2">27</font></td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="85%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">APPENDIX
                  A - 2008 STOCK OPTION PLAN</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="85%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">APPENDIX
                  B - NOMINATING COMMITTEE CHARTER</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="85%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">APPENDIX
                  C - COMPENSATION COMMITTEE CHARTER</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="85%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">APPENDIX
                  D - AUDIT COMMITTEE CHARTER</font></div>
              </td>
              <td width="2%">&#160;</td>
              <td align="left" valign="bottom" width="1%">&#160;</td>
              <td align="right" valign="bottom" width="11%">&#160;</td>
              <td align="left" valign="bottom" width="1%">&#160;</td>
            </tr>

        </table>
      </div><br>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
          </div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BIOANALYTICAL
        SYSTEMS, INC., PROXY STATEMENT</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ANNUAL
        MEETING OF MARCH 20, 2008</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>PROXY
        STATEMENT</u></strong></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
        proxy statement is furnished by Bioanalytical Systems, Inc. (&#8220;BASi&#8221; or the
&#8220;Company&#8221;) in connection with the solicitation by the Board of Directors of BASi
        of proxies to be voted at the Annual Meeting of Shareholders to be held at
        10:00
        a.m. (EST) on Thursday, March 20, 2008, and at any adjournment thereof. The
        meeting will be held at the principal executive offices of BASi, 2701 Kent
        Avenue, West Lafayette, Indiana 47906. This proxy statement and the accompanying
        form of proxy were first mailed to shareholders on or about February 1,
        2008.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A
        shareholder signing and returning the enclosed proxy may revoke it at any
        time
        before it is exercised by delivering written notice to the Secretary of BASi,
        by
        filing a properly executed proxy bearing a later date or by attending the
        Annual
        Meeting and voting in person. The signing of a proxy does not preclude a
        shareholder from attending the Annual Meeting in person. All proxies returned
        prior to the Annual Meeting, and not revoked, will be voted in accordance
        with
        the instructions contained therein. Any proxy not specifying to the contrary
        will be voted FOR the election of each of the nominees for director named
        below.
        Abstentions and broker non-votes are not counted for purposes of determining
        whether a proposal has been approved, but will be counted for purposes of
        determining whether a quorum is present.</font></div>
      <div>&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As
        of the
        close of business on January 31, 2008, the record date for the Annual Meeting,
        there were outstanding and entitled to vote 4,912,568 common shares of BASi.
        Each outstanding common share is entitled to one vote. BASi has no other
        voting
        securities outstanding. Shareholders do not have cumulative voting
        rights.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A
        quorum
        will be present if a majority of the outstanding common shares are present,
        in
        person or by proxy, at the Annual Meeting. If a quorum is present, the proposals
        will be decided by a plurality of the votes cast.</font></div>
      <div>&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A
        copy of
        the BASi Annual Report and Form 10-K, including audited financial statements
        and
        a description of operations for the fiscal year ended September 30, 2007,
        accompanies this proxy statement. The financial statements contained in the
        Annual Report and Form 10-K are not incorporated by reference in this proxy
        statement. The solicitation of proxies is being made by BASi, and all expenses
        in connection with the solicitation of proxies will be borne by BASi. BASi
        expects to solicit proxies primarily by mail, but directors, officers and
        other
        employees of BASi may also solicit proxies in person or by telephone. BASi
        will
        pay any costs so incurred, and the directors, officers and other employees
        involved in such solicitations will not receive any additional compensation
        for
        such actions.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>HOW
        TO VOTE YOUR SHARES</strong></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We
        are
        pleased to offer you two options for designating the proxies and indicating
        your
        voting preferences: </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div>
        <table cellpadding="0" cellspacing="0" width="100%">

            <tr>
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              </td>
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1)&#160;
                  </font></div>
              </td>
              <td align="left" valign="top" width="72%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">You
                  can attend the Annual Meeting and cast your vote in person; or
                  </font></div>
              </td>
            </tr>
            <tr>
              <td align="left" valign="top" width="3%">&#160;</td>
              <td align="left" valign="top" width="3%">&#160;</td>
              <td align="left" valign="top" width="72%">&#160;</td>
            </tr>
            <tr>
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              </td>
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(2)&#160;
                  </font></div>
              </td>
              <td align="left" valign="top" width="72%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">You
                  may complete, sign, date and return by mail the proxy card.
                  </font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>COMMONLY
        ASKED QUESTIONS AND ANSWERS</strong></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>Why
        am I receiving this proxy statement and proxy card?</em></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
        proxy statement describes proposals on which you, as a shareholder, are being
        asked to vote. It also gives you information on these proposals, as well
        as
        other information so that you can make an informed decision. You are invited
        to
        attend the Annual Meeting to vote on the proposals, but you do not need to
        attend in person in order to vote. You may, instead, follow the
        instructions&#160;above to vote by mail using the enclosed proxy card. Even if
        you currently plan to attend the meeting, it is a good idea to complete and
        return your proxy card before the meeting date just in case your plans change.
        </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">1</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>Who
        can vote at the Annual Meeting?</em></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Shareholders
        who owned common stock on January 31, 2008&#160;may attend and vote at the
        Annual Meeting. Each common share is entitled to one vote. There were
        4,912,568&#160;common shares outstanding on January 31, 2008.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>What
        am I voting on?</em></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We
        are
        asking you to: </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div>
        <table cellpadding="0" cellspacing="0" width="100%">

            <tr>
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              </td>
              <td align="left" valign="top" width="2%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.&#160;
                  </font></div>
              </td>
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Elect
                  five directors; </font></div>
              </td>
            </tr>
            <tr>
              <td align="left" valign="middle" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              </td>
              <td align="left" valign="middle" width="2%">&#160;</td>
              <td align="left" valign="middle" width="73%">&#160;</td>
            </tr>
            <tr>
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              </td>
              <td align="left" valign="top" width="2%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.
                  </font></div>
              </td>
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Approve
                  a grant of non-qualified stock options to Mr. Richard M. Shepperd
                  in
                  connection with his extended employment agreement, dated May
                  2007;</font></div>
              </td>
            </tr>
            <tr>
              <td align="left" valign="middle" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              </td>
              <td align="left" valign="middle" width="2%">&#160;</td>
              <td align="left" valign="middle" width="73%">&#160;</td>
            </tr>
            <tr>
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              </td>
              <td align="left" valign="top" width="2%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.
                  </font></div>
              </td>
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Approve
                  a grant of non-qualified stock options to Mr. Michael R. Cox in
                  connection
                  with his new employment agreement, dated November 2007;</font></div>
              </td>
            </tr>
            <tr>
              <td align="left" valign="middle" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              </td>
              <td align="left" valign="middle" width="2%">&#160;</td>
              <td align="left" valign="middle" width="73%">&#160;</td>
            </tr>
            <tr>
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              </td>
              <td align="left" valign="top" width="2%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.
                  </font></div>
              </td>
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Approve
                  a grant of non-qualified stock options to Mr. Edward M. Chait in
                  connection with his new employment agreement, dated November
                  2007;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;and
                  </font></div>
              </td>
            </tr>
            <tr>
              <td align="left" valign="middle" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              </td>
              <td align="left" valign="middle" width="2%">&#160;</td>
              <td align="left" valign="middle" width="73%">&#160;</td>
            </tr>
            <tr>
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              </td>
              <td align="left" valign="top" width="2%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.
                  </font></div>
              </td>
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Approve
                  and adopt the Bioanalytical Systems, Inc. 2008 Stock Option Plan
                  as a
                  replacement for a previous stock option plan that expired in
                  2007.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>What
        if I change my mind after I give my proxy?</em></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">You
        may
        revoke your proxy and change your vote at any time before the polls close
        at the
        meeting. You may do this by: </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div>
        <table cellpadding="0" cellspacing="0" width="100%">

            <tr>
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              </td>
              <td align="left" valign="top" width="2%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;&#160;
                  </font></div>
              </td>
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Sending
                  a signed statement to the Company that the proxy is revoked (you
                  may send
                  such a statement to the Company&#8217;s Secretary at our corporate headquarters
                  address listed on the Notice of Meeting); </font></div>
              </td>
            </tr>
            <tr>
              <td align="left" valign="middle" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              </td>
              <td align="left" valign="middle" width="2%">&#160;</td>
              <td align="left" valign="middle" width="73%">&#160;</td>
            </tr>
            <tr>
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              </td>
              <td align="left" valign="top" width="2%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;&#160;
                  </font></div>
              </td>
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Signing
                  another proxy with a later date; or</font></div>
              </td>
            </tr>
            <tr>
              <td align="left" valign="middle" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              </td>
              <td align="left" valign="middle" width="2%">&#160;</td>
              <td align="left" valign="middle" width="73%">&#160;</td>
            </tr>
            <tr>
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              </td>
              <td align="left" valign="top" width="2%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;&#160;
                  </font></div>
              </td>
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Voting
                  in person at the meeting. </font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Your
        proxy will not be revoked if you attend the meeting but do not vote.
</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>How
        many shares must be present to hold the meeting?</em></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To
        hold
        the meeting and conduct business, a majority of BASi&#8217;s outstanding voting shares
        as of January 31, 2008 must be present or represented by proxies at the meeting.
        On this date, a total of 4,912,568&#160;common shares were outstanding and
        entitled to vote. Shares representing a majority number of these votes, or
        2,456,285&#160;shares, must be present. This is called a quorum. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Shares
        are counted as present at the meeting if: </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div>
        <table cellpadding="0" cellspacing="0" width="100%">

            <tr>
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              </td>
              <td align="left" valign="top" width="2%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;&#160;
                  </font></div>
              </td>
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">They
                  are voted in person at the meeting,&#160;or </font></div>
              </td>
            </tr>
            <tr>
              <td align="left" valign="middle" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              </td>
              <td align="left" valign="middle" width="2%">&#160;</td>
              <td align="left" valign="middle" width="73%">&#160;</td>
            </tr>
            <tr>
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              </td>
              <td align="left" valign="top" width="2%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;&#160;
                  </font></div>
              </td>
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
                  shareholder has voted by properly submitting a proxy card via mail.
                  </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Abstentions
                  and broker non-votes are not counted for purposes of determining
                  whether a
                  proposal has been approved, but will be counted for purposes of
                  determining whether a quorum is
                  present.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>Will
        my shares be voted if I do not sign and return my proxy
        card?</em></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If
        your
        shares are registered in your name, they will not be voted unless you vote
        by
        submitting your proxy card via mail, or vote in person at the meeting.
</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">2</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>How
        will my shares be voted if they are held in &#8220;street
        name&#8221;?</em></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If
        your
        shares are held in &#8220;street name,&#8221; you should have received voting instructions
        with these materials from your broker or other nominee. We urge you to instruct
        your broker or other nominee how to vote your shares by following those
        instructions. If you do not give your broker or nominee instructions as to
        how
        to vote your shares, they may be voted only on matters for which the broker
        or
        nominee has discretionary authority under applicable rules. These &#8220;broker
        non-votes&#8221; will be counted for purposes of determining whether a quorum is
        present but will not be counted for any other purpose with respect to
        Proposals&#160;1, 2, 3, 4 and 5. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>How
        many votes must the nominees have to be elected as
        directors?</em></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Directors
        will be elected by a plurality of the votes cast, meaning that the persons
        receiving the highest number of &#8220;for&#8221; votes, up to the total number of directors
        to be elected at the Annual Meeting, will be elected. We expect that the
        election to be held at the 2008 Annual Meeting will be an uncontested election.
        </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Shares
        represented by your proxy will be voted by BASi&#8217;s management &#8220;for&#8221; the election
        of the five nominees recommended by BASi&#8217;s Board of Directors unless
        you&#160;withhold authority for&#160;any or all of such nominees or you mark
        your proxy to &#8220;abstain&#8221; from so voting. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>How
        many votes are required to pass the adoption of the 2008 Stock Option Plan,
        the
        approval of the grant of non-qualified stock options to Mr. Shepperd, and
        the
        approval of the grants of non-qualified stock options to Mr. Cox and Mr.
        Chait?</em></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        adoption of the Stock Option Plan, the approval of Mr. Shepperd&#8217;s stock option
        grant and the approval of both Mr. Cox&#8217;s and Mr. Chait&#8217;s non-qualified stock
        option grants must receive a &#8220;for&#8221; vote of a majority of the voting shares
        present at the meeting in person or by proxy and voting for or against these
        proposals. Abstentions and broker non-votes will have no effect on the outcome
        of these proposals. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>Why
        do the Shareholders have to approve the grant of non-qualified stock options
        to
        Mr. Shepperd and the grants of non-qualified stock options to both Mr. Cox
        and
        Mr. Chait?</em></strong></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">It
        is a
        rule of NASDAQ that options granted to employees be approved by shareholders.
        This is generally accomplished by granting options under a shareholder approved
        option plan. The existing shareholder plan does not allow us to issue
        non-qualified options; therefore, these non-qualified option grants must
        be
        approved by shareholders. In the case of Mr. Shepperd, his options represent
        options on 6% of our outstanding common shares of the Company. These options
        replace his original bonus plan, which provided for cash bonuses equal to
        10% of
        EBITDA. In addition to conserving our cash, the Board of Directors believes
        the
        option grant better aligns Mr. Shepperd&#8217;s economic interests with your interests
        as a shareholder and is less economically dilutive than his cash bonus. Mr.
        Chait and Mr. Cox have assumed positions of increased responsibility in the
        Company, and were each tentatively awarded 75,000 additional options, of
        which,
        in each case, 30,000 were issued under our stock option plan, and 45,000
        are
        non-qualified and must be approved by shareholders.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>Why
        are you adopting a new Stock Option Plan?</em></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        purpose of the 2008 Stock Option Plan is to attract and to encourage the
        continued employment and service of, and maximum efforts by, officers,
        directors, key employees and other key individuals by offering those persons
        an
        opportunity to acquire or increase a direct proprietary interest in the
        operations and future success of the Company. In the judgment of the Board
        of
        Directors, an initial or increased grant under the 2008 Stock Option Plan
        will
        be a valuable incentive and will ultimately benefit our shareholders by aligning
        more closely the interest of 2008 Stock Option Plan participants with those
        of
        our shareholders. We are asking that the 2008 Stock Option Plan be approved
        as
        the replacement for our former stock option plans, 1997 Employee Stock Option
        Plan and 1997 Director Stock Option Plan (which has expired).</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>Who
        will pay for this proxy solicitation?</em></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We
        will
        bear the costs of soliciting proxies from our shareholders. These costs include
        preparing, assembling, printing, mailing and distributing the proxy statements,
        proxy cards and annual reports. We will also reimburse brokerage houses and
        other custodians for their reasonable out-of-pocket expenses for forwarding
        proxy and solicitation materials to the beneficial owners of common shares.
        </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">3</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>PROPOSALS
        TO BE VOTED UPON</u></strong></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>PROPOSAL
        1 - ELECTION OF DIRECTORS</em></strong></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Required
        Vote and Board of Directors&#8217; Recommendation</u></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Bylaws of BASi provide for no fewer than seven and no more than nine directors.
        Five directors will be elected at the Annual Meeting, leaving two vacancies.
        Vacancies on the Board of Directors may be filled by the Board of Directors.
        When the Board has fewer than the required minimum directors, there still
        must
        be a quorum of the required minimum present (i.e. four directors) in order
        for
        the Board to conduct business. Each director is elected for a one-year term.
        The
        terms of all incumbent directors will expire at the Annual Meeting. The
        Nominating Committee of the Board of Directors has nominated the following
        current directors for re-election at the Annual Meeting. The directors nominated
        for election are: William E. Baitinger, David W. Crabb, Leslie B. Daniels,
        Larry
        S. Boulet and Richard M. Shepperd (collectively, the &#8220;Nominated Directors&#8221;). The
        Board of Directors has determined that each of the Nominated Directors, other
        than Richard M. Shepperd, is an &#8220;independent director&#8221; as defined in the
        applicable rules of the NASDAQ Stock Market. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Board
        of Directors recommends that shareholders vote FOR the election of all of
        the
        Nominated Directors and, unless authority to vote for any Nominated Director
        is
        withheld, the accompanying proxy will be voted FOR the election of all the
        Nominated Directors. However, the persons designated as proxies reserve the
        right to cast votes for another person designated by the Board of Directors
        in
        the event any Nominated Director becomes unable to serve or for good cause
        will
        not serve. Proxies will not be voted for more than five nominees. If a quorum
        is
        present, those nominees receiving a plurality of the votes cast will be elected
        to the Board of Directors.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        following table shows certain information about the Nominated
        Directors:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br></font>
        <div align="left">
          <table cellpadding="0" cellspacing="0" width="100%">

              <tr>
                <td align="left" valign="bottom" width="25%" style="border-bottom: medium none;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Name</u></font></div>
                </td>
                <td align="left" valign="bottom" width="10%" style="border-bottom: medium none;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Age</u></font></div>
                </td>
                <td align="left" valign="bottom" width="52%" style="border-bottom: medium none;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Position</u></font></div>
                </td>
                <td valign="bottom" width="13%" style="border-bottom: medium none;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Served
                    as</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Director
                    Since</u></font></div>
                </td>
              </tr>
              <tr>
                <td align="left" valign="top" width="25%">&#160;</td>
                <td align="left" valign="top" width="10%">&#160;</td>
                <td align="left" valign="top" width="52%">&#160;</td>
                <td align="left" valign="top" width="13%">&#160;</td>
              </tr>
              <tr bgcolor="#ccffcc">
                <td align="left" valign="top" width="25%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">William
                    E. Baitinger</font></div>
                </td>
                <td align="left" valign="top" width="10%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">72</font></div>
                </td>
                <td align="left" valign="top" width="52%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Director,
                    Chairman of the Board</font></div>
                </td>
                <td valign="top" width="13%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1979</font></div>
                </td>
              </tr>
              <tr bgcolor="white">
                <td align="left" valign="top" width="25%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">David
                    W. Crabb</font></div>
                </td>
                <td align="left" valign="top" width="10%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">54</font></div>
                </td>
                <td align="left" valign="top" width="52%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Director</font></div>
                </td>
                <td valign="top" width="13%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2004</font></div>
                </td>
              </tr>
              <tr bgcolor="#ccffcc">
                <td align="left" valign="top" width="25%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Leslie
                    B. Daniels</font></div>
                </td>
                <td align="left" valign="top" width="10%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">60</font></div>
                </td>
                <td align="left" valign="top" width="52%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Director</font></div>
                </td>
                <td valign="top" width="13%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2003</font></div>
                </td>
              </tr>
              <tr bgcolor="white">
                <td align="left" valign="top" width="25%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Larry
                    S. Boulet</font></div>
                </td>
                <td align="left" valign="top" width="10%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">61</font></div>
                </td>
                <td align="left" valign="top" width="52%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Director</font></div>
                </td>
                <td valign="top" width="13%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2007</font></div>
                </td>
              </tr>
              <tr bgcolor="#ccffcc">
                <td align="justify" valign="top" width="25%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Richard
                    M. Shepperd </font></div>
                </td>
                <td align="justify" valign="top" width="10%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">67</font></div>
                </td>
                <td align="left" valign="top" width="52%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Director,
                    President and Chief Executive Officer</font></div>
                </td>
                <td align="justify" valign="top" width="13%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2007</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Business
        Experience of Nominated Directors</u></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">William
        E. Baitinger has served as a director of BASi since 1979. Mr. Baitinger was
        Director of Technology Transfer for the Purdue Research Foundation from 1988
        until 2000. In this capacity he was responsible for all licensing and
        commercialization activities from Purdue University. He currently serves
        as
        Special Assistant to the Vice President for Research at Purdue University.
        Mr.
        Baitinger has a Bachelor of Science degree in Chemistry and Physics from
        Marietta College and a Master of Science degree in Chemistry from Purdue
        University.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">David
        W.
        Crabb, M.D. has served as a director of the Company since February 2004.
        He has
        been Chairman of the Indiana University Department of Medicine since 2001.
        Previously he had served as Chief Resident of Internal Medicine and on the
        Medicine and Biochemistry faculty of Indiana University. He was appointed
        Vice
        Chairman for Research for the department and later Assistant Dean for Research.
        Dr. Crabb serves on several editorial boards. He is Director of the Indiana
        Alcohol Research Center funded by NIAAA. He was a recipient of an NIH Merit
        Award and numerous other research and teaching awards. He currently serves
        on
        the Board of Directors of Polymer Technology Sciences, Inc., a privately
        owned
        corporation, and the Board of Trustees of Health and Hospital Corporation
        of
        Marion County, a public agency.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Leslie
        B.
        Daniels joined the BASi Board of Directors in July 2003. Mr. Daniels is a
        founding partner of CAI, a private equity fund in New York City. He previously
        was President of Burdge, Daniels &amp; Co., Inc., a principal in venture capital
        and buyout investments as well as trading of private placement securities,
        and
        before that, a Senior Vice President of Blyth, Eastman, Dillon &amp; Co. where
        he had responsibility for the corporate fixed income sales and trading
        departments. Mr. Daniels is a former Director of Aster-Cephac SA, IVAX
        Corporation, MIM Corporation, Mylan Laboratories, Inc., NBS Technologies
        Inc.
        and MIST Inc. He was also Chairman of Zenith Laboratories, Inc. and currently
        serves as Chairman of Turbo Combustor Technology Inc. and as a Director of
        SafeGuard Health Enterprises, Inc. and Aerosat, Inc.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">4</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Larry
        S.
        Boulet</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">has
        served as a director of the Company since May 2007. Mr. Boulet was a Senior
        Audit Partner with PriceWaterhouseCoopers (PWC) and a National Financial
        Services Industry Specialist. For the last five years of his career with
        PWC,
        Mr. Boulet served as Partner-in-charge of the Indianapolis office&#8217;s Private
        Client Group. Prior to serving on our Board, he served on the Board of Directors
        of Century Realty Trust, an Indiana based, real estate investment trust.
        He also
        served as Audit Committee Chairman until the Trust&#8217;s sale and liquidation in
        2007. Currently, Mr. Boulet also serves on the Indiana State University
        Foundation Board of Directors, where he is the immediate past Chairman of
        the
        Board. He holds a Bachelor of Science degree in Accounting from Indiana State
        University.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Richard
        M. Shepperd</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">was
        elected President and Chief Executive Officer of the Company in September
        2006,
        and in May, 2007 agreed to extend his term until December 2009. Mr. Shepperd
        served for two years prior to joining the Company with Able Laboratories,
        Inc.,
        of Cranbury, New Jersey ("Able") as its Chief Restructuring Officer and Director
        of Restructuring. Able was formerly a generic pharmaceutical manufacturing
        company which filed a voluntary petition for bankruptcy on July 18, 2005
        following the loss of FDA approval for its product line. Mr. Shepperd's duties
        for Able included exercising executive authority over all operational and
        restructuring activities of Able, which included advising its Board, creditors
        committee and courts regarding strategies to maintain and realize the most
        value
        from the company's assets. Able was not affiliated with the Company. For
        the two
        years prior to serving with Able, Mr. Shepperd served as an independent
        management consultant for various businesses. In that capacity, he advised
        these
        businesses on developing strategies to improve their financial health and
        maximize the assets of those organizations.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Committees
        and Meetings of the Board of Directors</u></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Board
        of Directors has established Compensation, Audit and Nominating Committees.
        Scheduled meetings are supplemented by frequent informal exchange of information
        and actions taken by unanimous votes without meetings.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">No
        member
        of the Board of Directors attended fewer than 75% of the meetings of the
        Board
        of Directors and meetings of any committee of the Board of Directors of which
        he
        or she was a member. Three out of five members of the Board of Directors
        attended the 2007 Annual Meeting of shareholders. All of the members of the
        Board of Directors are encouraged, but not required, to attend BASi&#8217;s annual
        meetings. The following chart shows the number of meetings of each of the
        committees of the Board of Directors and meetings of the Board of Directors
        at
        which a quorum was present:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div align="left">
        <table cellpadding="0" cellspacing="0" width="75%">

            <tr>
              <td valign="bottom" width="30%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Committee</font></div>
              </td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td valign="bottom" width="30%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Members</font></div>
              </td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td valign="bottom" width="20%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Meetings
                  in 2007</font></div>
              </td>
            </tr>
            <tr>
              <td align="left" valign="bottom" width="30%">&#160;</td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td align="left" valign="bottom" width="30%">&#160;</td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td align="left" valign="bottom" width="20%">&#160;</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" width="30%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Compensation
                  </font></div>
              </td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td align="left" valign="bottom" width="30%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">William
                  E. Baitinger</font></div>
              </td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td valign="bottom" width="20%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4</font></div>
              </td>
            </tr>
            <tr>
              <td align="left" valign="bottom" width="30%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              </td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td align="left" valign="bottom" width="30%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Leslie
                  B. Daniels</font></div>
              </td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td valign="bottom" width="20%">&#160;</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" width="30%">&#160;</td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td align="left" valign="bottom" width="30%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">David
                  W. Crabb</font></div>
              </td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td valign="bottom" width="20%">&#160;</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" width="30%">&#160;</td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td align="left" valign="bottom" width="30%">&#160;</td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td valign="bottom" width="20%">&#160;</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" width="30%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Audit</font></div>
              </td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td align="left" valign="bottom" width="30%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Larry
                  S. Boulet</font></div>
              </td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td valign="bottom" width="20%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1
                  (a)</font></div>
              </td>
            </tr>
            <tr>
              <td align="left" valign="bottom" width="30%">&#160;</td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td align="left" valign="bottom" width="30%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">William
                  E. Baitinger</font></div>
              </td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td valign="bottom" width="20%">&#160;</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" width="30%">&#160;</td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td align="left" valign="bottom" width="30%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Leslie
                  B. Daniels</font></div>
              </td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td valign="bottom" width="20%">&#160;</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" width="30%">&#160;</td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td align="left" valign="bottom" width="30%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">David
                  W. Crabb</font></div>
              </td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td valign="bottom" width="20%">&#160;</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" width="30%">&#160;</td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td align="left" valign="bottom" width="30%">&#160;</td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td valign="bottom" width="20%">&#160;</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" width="30%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Nominating</font></div>
              </td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td align="left" valign="bottom" width="30%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">William
                  E. Baitinger</font></div>
              </td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td valign="bottom" width="20%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1</font></div>
              </td>
            </tr>
            <tr>
              <td align="left" valign="bottom" width="30%">&#160;</td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td align="left" valign="bottom" width="30%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Leslie
                  B. Daniels</font></div>
              </td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td valign="bottom" width="20%">&#160;</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" width="30%">&#160;</td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td align="left" valign="bottom" width="30%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">David
                  W. Crabb</font></div>
              </td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td valign="bottom" width="20%">&#160;</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" width="30%">&#160;</td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td align="left" valign="bottom" width="30%">&#160;</td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td valign="bottom" width="20%">&#160;</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" width="30%">&#160;</td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td align="left" valign="bottom" width="30%">&#160;</td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td valign="bottom" width="20%">&#160;</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" width="30%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Board
                  of Directors</font></div>
              </td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td align="left" valign="bottom" width="30%">&#160;</td>
              <td align="left" valign="bottom" width="5%">&#160;</td>
              <td valign="bottom" width="20%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)
        Mr.
        Baitinger, as Chairman of the Audit Committee, met either in person or by
        phone
        with the auditors prior to each quarterly earnings release.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">5</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Compensation Committee makes recommendations to the Board of Directors with
        respect to:</font></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 36pt;">
              </td>
              <td align="left" style="width: 9pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">compensation
                  arrangements for the executive officers of
                  BASi,</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 36pt;">
              </td>
              <td align="left" style="width: 9pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">policies
                  relating to salaries and job
                  descriptions,</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 36pt;">
              </td>
              <td align="left" style="width: 9pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">insurance
                  programs,</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 36pt;">
              </td>
              <td align="left" style="width: 9pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">benefit
                  programs, including retirement
                  plans,</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 36pt;">
              </td>
              <td align="left" style="width: 9pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">administration
                  of the 1997 Employee Incentive Stock Option Plan, the 1997
                  Director</font></div>
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Stock
                  Option Plan and the 2008 Stock Option Plan if approved by
                  shareholders.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Audit
        Committee is responsible for:</font></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 36pt;">
              </td>
              <td align="left" style="width: 9pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">reviewing
                  with the auditors the scope of the audit work
                  performed,</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 36pt;">
              </td>
              <td align="left" style="width: 9pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">establishing
                  audit practices,</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 36pt;">
              </td>
              <td align="left" style="width: 9pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">overseeing
                  internal accounting controls,</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 36pt;">
              </td>
              <td align="left" style="width: 9pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">reviewing
                  financial reporting, and</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 36pt;">
              </td>
              <td align="left" style="width: 9pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></td>
              <td align="left">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">accounting
                  personnel staffing.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Board
        of Directors has adopted a written charter for the Audit Committee, a copy
        of
        which is included as Appendix D to this Proxy Statement. Audit Committee
        members
        are not employees of BASi and, in the opinion of the Board of Directors,
        are
&#8220;independent&#8221; (as defined by Rule 4200(a)(15) of the NASD listing standards).
        The Board of Directors has determined that Larry S. Boulet and Leslie B.
        Daniels
        are &#8220;audit committee financial experts&#8221; (as defined by Item 401(h) of Regulation
        S-K) and &#8220;independent&#8221; (as defined by Item 7(d)(3)(iv) of Schedule 14A).
</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Nominating Committee is responsible for receiving and reviewing recommendations
        for nominations to the Board of Directors and recommending individuals as
        nominees for election to the Board of Directors. Nominating Committee members
        are not employees of BASi and, in the opinion of the Board of Directors,
        are
&#8220;independent&#8221; (as defined by rule 4200 (a)(15) of the NASD listing standards).
        The Board of Directors adopted a written charter for the Nominating Committee
        on
        February 21, 2007, a copy of which is included as Appendix B to this Proxy
        Statement.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Board
        of Directors will consider for nomination as directors persons recommended
        by
        shareholders. Such recommendations must be made to the Board of Directors
        or to
        an individual director in writing and delivered to Bioanalytical Systems,
        Inc.,
        Attention: Corporate Secretary, 2701 Kent Avenue, West Lafayette, Indiana
        47906.
        The Secretary will forward all such communications to the
        addressee.</font></div>
      <div>&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There
        is
        no fixed process for identifying and evaluating potential candidates to be
        nominees for directors, and there is no fixed set of qualifications that
        must be
        satisfied before a candidate will be considered. Rather, the Nominating
        Committee has the flexibility to consider such factors as it deems appropriate.
        These factors may include education, diversity, experience with business
        and
        other organizations comparable with BASi, the interplay of the candidate&#8217;s
        experience with that of other members of the Board of Directors, and the
        extent
        to which the candidate would be a desirable addition to the Board of Directors
        and to any of the committees of the Board of Directors. The Nominating Committee
        will evaluate nominees for directors submitted by shareholders in the same
        manner in which it evaluates other director nominees. No shareholder has
        properly nominated anyone for election as a director at the Annual
        Meeting.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Family
        Relationships</u></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There&#160;are
        no family relationships among the directors and executive officers of
        BASi.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">6</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Certain
        Relationships and Transactions</u></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As
        part
        of the acquisition of PharmaKinetics Laboratories, Inc. (&#8220;PKLB&#8221;) by the Company
        in fiscal 2003, Leslie B. Daniels, a director of the Company nominated for
        reelection, exchanged preferred stock of PKLB for 6% convertible subordinated
        debt of the Company in the amount of $498,648. The total of $4,000,000 of
        such
        debt issued in the acquisition was repaid in December, 2007.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As
        part
        of their separation agreements, Peter T. Kissinger, Ph.D. and Candice B.
        Kissinger received benefits and the grant of a license to certain technologies
        described elsewhere herein.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Board
        reviews transactions with related parties, but has no formal policies in
        place
<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">with
        respect to such review or the approval of such transactions.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Communications
        with the Board of Directors</u></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any
        shareholder who desires to contact members of the Board of Directors, including
        non-management members as a group, may do so by writing to:</font></div>
      <div>&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Corporate
        Secretary, Bioanalytical Systems, Inc.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2701
        Kent
        Avenue</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">West
        Lafayette, IN 47906</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">corporatesecretary@bioanalytical.com</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        corporate secretary will collect all such communications and organize them
        by
        subject matter. Thereafter, each communication will be promptly forwarded
        to the
        appropriate board committee chairperson according to the subject matter of
        the
        communication. Communications addressed to the non-management members as
        a group
        will be forwarded to each non-management member of the board.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Communications
        with the Audit Committee</u></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any
        person who would like to contact the Company for the purpose of submitting
        a
        complaint regarding accounting, internal accounting controls, or auditing
        matters may do so via email, by writing to: </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Chairman
        of the Audit Committee, </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Larry
        S.
        Boulet</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">auditcommittee@bioanalytical.com</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Upon
        receipt of a complaint, the Chairman of the Audit Committee will follow a
        review
        process and actions dictated in the Company&#8217;s Code of Business Conduct and
        Ethics.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Non-Employee
        Director Compensation and Benefits</u></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BASi's
        compensation package for non-employee directors is generally comprised of
        cash
        (annual retainers and committee meeting fees) and stock option awards. The
        annual pay package is designed to attract and retain highly-qualified,
        independent professionals to represent BASi's shareholders and reflect BASi's
        position in the industry. If the shareholders approve the 2008 Stock Option
        Plan
        at the March Annual Meeting, BASi will have the ability to align director
        and
        shareholder interests through the use of stock option awards to directors.
        Actual annual pay varies among directors based on Board committee memberships,
        committee chair responsibilities and meetings attended. BASi has not adopted
        guidelines with respect to non-employee director ownership of common shares.
        Directors who are employees receive no additional compensation for their
        service
        on the Board.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Compensation
        for non-employee directors during the 2007 fiscal year consisted of the
        following:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div>
        <table cellpadding="0" cellspacing="0" id="ftable" width="100%">

            <tr>
              <td align="left" valign="bottom" width="85%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Type
                  of Compensation</strong></font></div>
              </td>
              <td width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
              <td colspan="2" valign="bottom" width="11%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Amount&#160;($)</strong></font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: black thin solid;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="85%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Annual
                  retainer for Board membership </font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">2,500</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="85%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Annual
                  retainer for director serving as Chair of the Audit
                  Committee</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">2,000</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="85%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Annual
                  retainer for director serving as Chair of the Compensation
                  Committee</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">1,000</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="85%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Annual
                  retainer for director serving as Chair of the Nominating
                  Committee</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">500</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="85%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Meeting
                  fee for Board meeting, in person</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">1,000</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="85%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Meeting
                  fee for Board meeting, by phone</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">500</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="85%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Committee
                  meetings, non-Board meeting days, in person</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">500</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="85%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Committee
                  meetings, non-Board meeting days, by phone</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">250</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="85%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Daily
                  fee for consultation with management</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">1,000</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">7</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For
        meetings of the standing Board committees held in conjunction with a meeting
        of
        the Board, no additional fees are paid.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Business
        Expenses</em></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        directors are reimbursed for their business expenses related to their attendance
        at BASi meetings, including room, meals and transportation to and from Board
        and
        committee meetings. </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Directors
        are also encouraged to attend educational programs related to Board issues
        and
        corporate governance, which are reimbursed by the Company.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Non-Employee
        Directors' Compensation Table</em></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        following table shows information regarding the compensation of BASi's
        non-employee directors for the 2007 fiscal year. </font></div>
      <div>&#160;</div>
      <div align="left">
        <table border="0" cellpadding="0" cellspacing="0" id="ftable" width="100%">

            <tr>
              <td colspan="5" valign="bottom" width="100%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>DIRECTOR
                  COMPENSATION </strong></font></div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" width="76%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Name</font></div>
              </td>
              <td width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
              <td colspan="2" valign="bottom" width="21%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Total
                  fees paid, all paid in cash</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">($)</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: black thin solid;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="76%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">William
                  E. Baitinger</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="20%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">7,325</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="76%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Larry
                  S. Boulet</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="20%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">3,825</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="76%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dr.
                  David W. Crabb</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="20%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">5,325</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="76%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Leslie
                  B. Daniels</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="20%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">4,825</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>PROPOSAL
        2 - APPROVAL OF GRANT OF NON-QUALIFIED STOCK OPTIONS TO RICHARD M. SHEPPERD,
        PRESIDENT AND CHIEF EXECUTIVE OFFICER</em></strong></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On
        May
        18, 2007, as part of the negotiations to extend his employment contract,
        Mr.
        Shepperd was granted options, subject to shareholder approval, to purchase
        275,000 shares at a purchase price of $7.15 per share, the closing price
        of
        BASi&#8217;s common shares on May 18, 2007. The options are intended to replace his
        cash bonus provision under his interim employment contract. Under that contract,
        Mr. Shepperd was to receive 10% of EBITDA of the Company, computed on a
        quarterly basis. Prior to this revision, Mr. Shepperd had earned $295,000
        in
        bonus for the first six months of fiscal 2007. The replacement of his bonus
        with
        this amount of shares under option is intended to create the opportunity
        for Mr.
        Shepperd to earn similar gains, but are dependent on the Company creating
        significant value for shareholders.&#160;<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
        better aligns Mr. Shepperd&#8217;s financial rewards with the creation of value for
        shareholders and to conserve cash flow.&#160;</font></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If
        the
        shareholders do not approve this option grant, Mr. Shepperd will be entitled
        to
        receive a bonus, as described under Compensation of Executive
        Officers.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mr.
        Shepperd's options vest and become exercisable in 3 installments: options
        to
        purchase 75,000 shares will vest at 5:00 p.m. on the day the options grant
        is
        approved by the Company's shareholders, followed by two installments of 100,000
        shares each, on December&#160;1, 2008 and 2009. The option grant expires as to
        all un-exercised shares on May&#160;18, 2017, but may be terminated in
        connection with the termination of Mr. Shepperd's employment within 30 days
        of
        such termination. In the event of his death while employed by the Company,
        Mr.
        Shepperd's personal representative may also exercise the option within six
        months of his death. The option may be terminated by BASi on 30 days' notice
        from BASi in the event of a merger, consolidation or a sale of all or
        substantially all of BASi's assets. In the event of a change in control,
        as
        defined in the agreement, these shares will vest immediately. <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As
        of the
        close of trading on January 25, 2008, the market value of the shares underlying
        </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
        option grant </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">was
        $7.49
        per share, or $2,059,750. This value does not take account of the </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">exercise
        price of $7.15 per </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">share
        required to be paid by Mr. Shepperd to exercise the option. </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Under
        current tax law, the exercise of </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">these
        options will create a taxable gain to the recipient of the amount by which
        the
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">then
        current market price </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">exceeds
        the exercise price, when exercised, and a tax deduction to the Company
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">of
        the
        same amount.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">8</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        number of shares covered by the option and the option price each will be
        proportionally adjusted for any increase or decrease in the number of issued
        common shares resulting from a subdivision or consolidation of shares of
        BASi,
        the payment of a share dividend, a share split or other increase or decrease
        in
        the outstanding common shares effected without receipt of consideration by
        BASi
        (including an increase or decrease effected as a part of the Recapitalization
        of
        BASi, as described below). If there is a recapitalization or reorganization
        of
        BASi or a reclassification of its outstanding shares, as a result of which
        new
        shares are issued in exchange for common shares, then new shares will be
        substituted for the option shares then issuable. In that case, the number
        of new
        shares that will be issued will be the number into which those option shares
        would have been converted had they been outstanding at the effective date
        of the
        recapitalization.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As
        with
        other grants of stock options, the primary purpose of stock options is to
        provide executive officers and other team members with a personal and financial
        interest in BASi's success through common share ownership, thereby aligning
        the
        interests of executive officers and other team members with those of BASi's
        shareholders.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">THE
        BOARD
        OF DIRECTORS RECOMMENDS THAT SHAREHOLDERS VOTE "FOR" THE APPROVAL OF THE
        GRANT
        OF STOCK OPTIONS TO MR. SHEPPERD.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>PROPOSALS
        3 and 4 - APPROVAL OF GRANTS OF NON-QUALIFIED STOCK OPTIONS TO MICHAEL R.
        COX,
        VICE PRESIDENT, FINANCE AND CHIEF FINANCIAL OFFICER, AND EDWARD M. CHAIT,
        CHIEF
        BUSINESS OFFICER</em></strong></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subsequent
        to fiscal 2007, on November 6, 2007, the Company granted options to purchase
        45,000 common shares, at a purchase price of $8.60 per share, the closing
        price
        of BASi&#8217;s common shares on November 6, 2007, subject to shareholder approval, to
        Mr. Chait and Mr. Cox. These grants were made simultaneously with new employment
        contracts entered into with these executives, which reflect their expanded
        responsibilities and the Compensation Committee&#8217;s desire to establish incentives
        for these executives which are aligned with creation of shareholder
        value.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        non-qualified options granted to Mr. Chait and Mr. Cox on November 6, 2007
        to
        purchase 45,000 common shares each vest in three equal installments on November
        30, 2008, 2009 and 2010. The options expire by their own terms on November
        6,
        2017, but may be terminated in connection with the termination of either
        Mr.
        Chait's or Mr. Cox's employment respectively, within 30 days of such
        termination. The options may also be terminated by BASi on 30 days' notice
        from
        BASi in the event of a merger, consolidation or sale of all or substantially
        all
        of BASi's assets. In the event of a change in control, as defined in the
        agreement, these shares will vest immediately. <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As
        of the
        close of trading on January 25, 2008, the market value of the shares underlying
        </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
        option grant </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">was
        $7.49
        per share, or $337,050 each. This value does not take account of the exercise
        </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">price
        of
        $8.60 per </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">share
        required to be paid by Mr. Chait or Mr. Cox to exercise his respective option.
        </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Under
        current tax law, </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
        exercise of these options will create a taxable gain to the recipient of
        the
        amount </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">by
        which
        the then </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">current
        market price exceeds the exercise price, when exercised, and a tax deduction
        </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">to
        the
        Company of the </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">same
        amount.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        number of shares covered by the option and the option price each will be
        proportionally adjusted for any increase or decrease in the number of issued
        common shares resulting from a subdivision or consolidation of shares of
        BASi,
        the payment of a share dividend, a share split or other increase or decrease
        in
        the outstanding common shares effected without receipt of consideration by
        BASi
        (including an increase or decrease effected as a part of the Recapitalization
        of
        BASi, as described below). If there is a recapitalization or reorganization
        of
        BASi or a reclassification of its outstanding shares, as a result of which
        new
        shares are issued in exchange for common shares, then new shares will be
        substituted for the option shares then issuable. In that case, the number
        of new
        shares that will be issued will be the number into which those option shares
        would have been converted had they been outstanding at the effective date
        of the
        recapitalization.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As
        with
        other grants of stock options, the primary purpose of stock options is to
        provide executive officers and other team members with a personal and financial
        interest in BASi's success through common share ownership, thereby aligning
        the
        interests of executive officers and other team members with those of BASi's
        shareholders.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">THE
        BOARD
        OF DIRECTORS RECOMMENDS THAT SHAREHOLDERS VOTE "FOR" THE APPROVAL OF THE
        GRANTS
        OF STOCK OPTIONS TO MR. COX AND MR. CHAIT.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>PROPOSAL
        5 - APPROVAL AND ADOPTION OF 2008 STOCK OPTION PLAN</em></strong></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
        section provides a summary of the terms of the BASi 2008 Stock Option Plan
        and
        the proposal to approve the plan.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">9</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Board
        of Directors approved the 2008 Stock Option Plan on January 21, 2008, subject
        to
        approval from our shareholders. Shareholder approval of the plan is necessary
        to
        make sure that the plan meets the requirements of the Internal Revenue Code,
        including the section 162(m) limitation on the deductibility of executive
        compensation, as well as the NASDAQ shareholder approval requirements for
        equity
        compensation plans. The Company intends to grant awards under the 2008 Stock
        Option Plan across a wide base of its employees and considers the ability
        to
        grant equity-based awards to be an important part of its strategy for recruiting
        and retaining key employees.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        purpose of the 2008 Stock Option Plan is to attract and to encourage the
        continued employment and service of, and maximum efforts by, officers,
        directors, key employees and other key individuals by offering those persons
        an
        opportunity to acquire or increase a direct proprietary interest in the
        operations and future success of the Company. In the judgment of the Board
        of
        Directors, an initial or increased grant under the 2008 Stock Option Plan
        will
        be a valuable incentive and will ultimately benefit our shareholders by aligning
        more closely the interest of 2008 Stock Option Plan participants with those
        of
        our shareholders.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subject
        to shareholder approval, the number of common shares reserved for issuance
        under
        the 2008 Stock Option Plan is equal to a maximum of 500,000 common shares.
<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">These
        shares had a market value of $7.49 per share as of the close of trading on
        January </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">25,
        2008,
        for a </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">total
        of
        $3,745,000. This value does not take account of the exercise price required
        to
        be paid by optionees to exercise any options granted under the 2008 Stock
        Option
        Plan, which exercise price will be equal to the </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">closing
        price of the common shares on the date of grant. </font>As of January 31, 2008
        there were no common shares available for grant under the 1997 Outside Director
        Stock Option Plan because the plan has expired. </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There
        were 287,000 Common Shares reserved for issuance for which options had not
        been
        granted under the 1997 Employee Stock Option Plan, which will not be issued
        as
        that plan will be replaced for future grants by the 2008 Stock Option
        Plan.</font></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;There
        are currently no participants in the 2008 Stock Option Plan. Because
        participation and the types of awards under the 2008 Stock Option Plan are
        subject to the discretion of the Compensation Committee, the benefits or
        amounts
        that will be received by any participant or groups of participants if the
        2008
        Stock Option Plan is approved are not currently determinable.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        affirmative vote of a majority of the common shares voted affirmatively or
        negatively at the Annual Meeting is required to approve the Stock Option
        Plan.
        Unless otherwise indicated, properly executed proxies will be voted FOR approval
        of Proposal 5 to approve the 2008 Stock Option Plan.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>SUMMARY
        DESCRIPTION OF THE PLAN</u></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A
        description of the provisions of the 2008 Stock Option Plan is set forth
        below.
        This summary is qualified in its entirety by the detailed provisions of the
        2008
        Stock Option Plan, a copy of which is attached as Exhibit A to this proxy
        statement.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Purpose.
        </em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        purpose of the Plan is to promote the long-term interests of the Company
        and its
        shareholders by providing a means for attracting and retaining officers,
        directors and key employees of the Company and its affiliates. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Eligibility.
        </em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Only
        those persons who are employees or directors of the Company shall be eligible
        to
        participate in the Plan. The Compensation Committee shall determine from
        time to
        time the particular employees or directors of the Company who shall be eligible
        to participate in the Plan and the extent of their participation
        therein.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Administration.</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>&#160;</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        2008
        Stock Option Plan will be administered by our Compensation Committee (or
        a
        subcommittee thereof), which is comprised of at least three Directors. Subject
        to the terms of the plan, the Committee may approve participants to receive
        awards, determine the types of awards and terms and conditions of awards,
        and
        interpret the provisions of the plan. All determinations and decisions made
        by
        the Committee, the Board, and any delegate of the Committee shall be final,
        conclusive, and binding on all persons, including the Company and
        participants.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Amendment
        or Termination of the Plan. </em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Board
        of Directors may terminate or amend the plan at any time and for any reason.
        The
        2008 Stock Option Plan shall terminate in any event ten years after its
        effective date. Amendments will be submitted for shareholder approval to
        the
        extent required by the Internal Revenue Code or other applicable laws, rules
        or
        regulations.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Options.
        </em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        2008
        Stock Option Plan permits the granting of options to purchase common shares
        intended to qualify as incentive stock options under the Internal Revenue
        Code
        and options that do not qualify as incentive stock options.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 3.6pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Federal
          Income Tax Consequences. </em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
          exercise of qualified incentive stock options does not create </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">taxable
          income to the grantee or a tax deduction for the Company if holding period
          </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">requirements
          are met. </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
          exercise of non-qualified options creates taxable income to the grantee
          </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">and
          a tax
          deduction to the C</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ompany
          equal to the amount by which the market price exceeds the exercise price
          </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">on
          the
          date of exercise.</font></div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">10</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        exercise price of each stock option may not be less than 100% of the fair
        market
        value of our common shares on the date of grant. The fair market value is
        generally determined as the closing price of the common shares on the grant
        date. No participant may be granted incentive stock options under the Plan
        that
        would result in shares with an aggregate fair market value (determined as
        of the
        date the option is granted) of more than $100,000 first becoming exercisable
        in
        any one calendar year. To the extent that a purported incentive stock option
        would violate any limitation specified in the preceding sentence, the portion
        of
        the option in excess of such limitation will be deemed a non-qualified stock
        option.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        term
        of each stock option is fixed by the Committee and may not exceed 10 years
        from
        the date of grant. The Committee determines at what time or times each option
        may be exercised and the period of time, if any, after retirement, death,
        disability or termination of employment during which options may be
        exercised.&#160;<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Typically,
        incentive stock options vested evenly over a four year period commencing
        one
        year from date of grant.&#160;</font></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Options
        may be made exercisable in installments. The Committee may accelerate the
        exercisability of options.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
        general, an optionee may pay the exercise price of an option by cash, certified
        check, by tendering common shares (which if acquired from the Company have
        been
        held by the optionee for at least six months), relinquishing options with
        sufficient &#8220;in-the-money&#8221; value to settle the strike price of the options, or by
        means of a broker-assisted cashless exercise. In the event that optionee
        relinquishes options to acquire shares under option, such options relinquished
        will not be available for future grant.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Stock
        options granted under the 2008 Stock Option Plan may not be sold, transferred,
        pledged or assigned other than by will or under applicable laws of descent
        and
        distribution. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There
        are
        500,000 shares to be reserved for issuance under this plan. No grants have
        as
        yet been made.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
        <div>
          <table cellpadding="0" cellspacing="0" id="ftable" width="100%">

              <tr>
                <td colspan="7" valign="bottom" width="98%">&#160;</td>
                <td align="left" valign="bottom" width="1%">&#160;</td>
              </tr>
              <tr>
                <td colspan="7" valign="bottom" width="98%" style="border-bottom: black thin solid;">
                  <div align="center">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Non-Qualified
                      Option Awards for Shareholder Approval</strong></font></div>
                  </div>
                </td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff solid;">&#160;</td>
              </tr>
              <tr>
                <td valign="bottom" width="71%" style="border-bottom: medium none;">&#160;</td>
                <td width="2%" style="border-bottom: medium none;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
                <td align="right" valign="bottom" width="11%" style="border-bottom: medium none;">&#160;</td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: medium none;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
                <td align="right" valign="bottom" width="11%" style="border-bottom: medium none;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
              </tr>
              <tr>
                <td valign="bottom" width="71%" style="border-bottom: black thin solid;">
                  <div align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><strong>Name
                    and Position</strong></font></div>
                </td>
                <td width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: black thin solid;">&#160;</td>
                <td align="right" valign="bottom" width="11%" style="border-bottom: black thin solid;">
                  <div style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; COLOR: #000000; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman"><strong>Exercise
                    Price</strong></font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: black thin solid;">&#160;</td>
                <td align="right" valign="bottom" width="11%" style="border-bottom: black thin solid;">
                  <div style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; COLOR: #000000; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman"><strong>Number
                    of Units</strong></font></div>
                </td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff thin solid;">&#160;</td>
              </tr>
              <tr bgcolor="#ccffcc">
                <td align="left" valign="bottom" width="71%" style="border-bottom: #ccffcc;">
                  <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">Richard
                    M. Shepperd, President &amp; Chief Executive Officer,
                    Director</font></div>
                </td>
                <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">
                  <div style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; COLOR: #000000; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">$</font></div>
                </td>
                <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;">
                  <div style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; COLOR: #000000; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">7.15</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;">
                  <div style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; COLOR: #000000; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">275,000</font></div>
                </td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              </tr>
              <tr bgcolor="white">
                <td align="left" valign="bottom" width="71%" style="border-bottom: white;">
                  <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">Michael
                    R. Cox, Chief Financial Officer</font></div>
                </td>
                <td width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">
                  <div style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; COLOR: #000000; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">$</font></div>
                </td>
                <td align="right" valign="bottom" width="11%" style="border-bottom: white;">
                  <div style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; COLOR: #000000; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">8.60</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="11%" style="border-bottom: white;">
                  <div style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; COLOR: #000000; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">45,000</font></div>
                </td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              </tr>
              <tr bgcolor="#ccffcc">
                <td align="left" valign="bottom" width="71%" style="border-bottom: #ccffcc;">
                  <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">Edward
                    M. Chait, Ph.D., Chief Business Officer</font></div>
                </td>
                <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">
                  <div style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; COLOR: #000000; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">$</font></div>
                </td>
                <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;">
                  <div style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; COLOR: #000000; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">8.60</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;">
                  <div style="MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; COLOR: #000000; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">45,000</font></div>
                </td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              </tr>
              <tr bgcolor="white">
                <td align="left" valign="bottom" width="71%" style="border-bottom: white;">&#160;</td>
                <td width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="11%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="11%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              </tr>
              <tr bgcolor="#ccffcc">
                <td align="left" valign="bottom" width="71%" style="border-bottom: #ccffcc;">
                  <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">There
                    were no other awards subject to shareholder approval.</font></div>
                </td>
                <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Adjustments
        upon Changes in Capitalization. </em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Compensation Committee will make appropriate adjustments in outstanding awards
        and the number of shares available for issuance under the 2008 Stock Option
        Plan, including the individual limitations on awards, to reflect common share
        dividends, stock splits and other similar events.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">THE
        BOARD
        OF DIRECTORS RECOMMENDS THAT SHAREHOLDERS VOTE "FOR" THE APPROVAL OF THE
        2008
        STOCK OPTION PLAN.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>SELECTION
        OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</strong></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Company&#8217;s Audit Committee engaged Crowe Chizek and Company LLC (&#8220;Crowe&#8221;) as the
        Company&#8217;s independent registered public accounting firm for the audit of the
        consolidated financial statements for the fiscal years ended September 30,
        2007
        and 2006. As previously reported by the Company on a Form 8-K filed with
        the
        Securities and Exchange Commission (&#8220;SEC&#8221;) on September 14, 2006, the Company&#8217;s
        prior independent accountants, KPMG LLP, resigned effective September 14,
        2006.
        As reported on a Form 8-K filed with the SEC on November 1, 2006, the Audit
        Committee engaged Crowe on October 30, 2006.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        reports of KPMG for the fiscal years ended September 30, 2005 and 2004,
        contained no adverse opinion or disclaimer of opinion and were not qualified
        or
        modified as to uncertainty, audit scope, or accounting principles. In connection
        with its audits for the fiscal years ended September 30, 2005 and 2004 and
        through September 15, 2006, there were no disagreements with KPMG on any
        matter
        of accounting principles or practices, financial statement disclosure, or
        auditing scope or procedure, which disagreements, if not resolved to the
        satisfaction of KPMG, would have caused them to make reference to the subject
        matter of the disagreement in connection with their report on the financial
        statements for such period.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During
        the fiscal years ended September 30, 2005 and 2004, and through September
        15,
        2006, there were no reportable events (as defined in Regulation S-K, Item
        304(a)(1)(v)), except for a material weakness in the Company&#8217;s internal control
        at June 30, 2006 which was identified by KPMG and disclosed in Item 9 in
        the
        Company&#8217;s Annual Report on Form 10-K for the year ended September 30, 2006. KPMG
        noted certain conditions involving the Company&#8217;s internal control and its
        operation that KPMG considered to be &#8220;material weaknesses.&#8221; &#8220;Material weakness&#8221;
was defined as &#8220;a control deficiency, or combination of control deficiencies,
        that result in more than a remote likelihood that a material misstatement
        of the
        annual or interim financial statements will not be prevented or detected
        by the
        entity's internal control.&#8221; The material weaknesses noted by KPMG consisted of a
        failure to set an appropriate "tone at the top" to instill a company-wide
        attitude of control consciousness; failure to maintain adequate procedures
        for
        anticipating and identifying financial reporting risks and for reacting to
        changes in its operating environment that could have a material effect on
        financial reporting; failure to maintain adequately trained personnel to
        perform
        effective review of accounting procedures critical to financial reporting;
        and a
        lack of adequately trained finance and accounting personnel with the ability
        to
        apply U.S. generally accepted accounting principles associated with the
        impairment of certain long-lived assets in accordance with Statement of
        Financial Accounting Standards No. 144, Accounting for the Impairment or
        Disposal of Long-Lived Assets. Management concurred with the assessment of
        KPMG.
        KPMG discussed the matters described in this paragraph with the Audit Committee
        of the Company. The Company authorized KPMG to respond fully to the inquiries
        of
        its successor accountant concerning these matters.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">11</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">KPMG
        also
        communicated to the Audit Committee in the Letter that the Company had filed
        its
        Report on Form 10-Q for the three and nine month periods ended June 30, 2006,
        prior to the completion of its interim review. KPMG subsequently completed
        its
        interim review and the Company filed an amended report on Form 10-Q/A for
        the
        three and nine month periods ended June 30, 2006.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Company engaged Crowe as its principal independent registered public accountants
        effective as of October 30, 2006. At no time prior to October 30, 2006 had
        the
        Company consulted with Crowe regarding either: (i) the application of accounting
        principles to a specified transaction, either completed or proposed; or the
        type
        of audit opinion that might be rendered on the Company&#8217;s financial statements;
        or (ii) any matter that was either the subject of a disagreement (as that
        term
        is defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions
        to that Item) or a reportable event (as that term is defined in Item
        304(a)(1)(v) of Regulation S-K). </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Representatives
        of Crowe are expected to be present at the Annual Meeting. They will have
        the
        opportunity to make a statement if they desire to do so and will be available
        to
        answer appropriate questions concerning the audit of the Company&#8217;s financial
        statements.</font></div>
      <div>&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Fees
        of Independent Registered Public Accountants</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>&#160;</u></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        aggregate fees billed for the last two fiscal years for each of the following
        categories of services are set forth below: </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br>
        <div>
          <table cellpadding="0" cellspacing="0" id="ftable" width="100%">

              <tr>
                <td align="left" valign="bottom" width="71%" style="border-bottom: #ffffff solid;">&#160;</td>
                <td width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
                <td colspan="2" valign="bottom" width="12%" style="border-bottom: black thin solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2007</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
                <td colspan="2" valign="bottom" width="11%" style="border-bottom: black thin solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2006</font></div>
                </td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff thin solid;">&#160;</td>
              </tr>
              <tr>
                <td align="left" valign="bottom" width="71%" style="border-bottom: medium none;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Audit
                    Fees - </font></div>
                </td>
                <td width="2%" style="border-bottom: medium none;">&#160;</td>
                <td align="right" colspan="2" valign="bottom" width="12%" style="border-bottom: medium none;">&#160;</td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: medium none;">&#160;</td>
                <td align="right" colspan="2" valign="bottom" width="11%" style="border-bottom: medium none;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
              </tr>
              <tr bgcolor="#ccffcc">
                <td align="left" valign="bottom" width="71%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Aggregate
                    fees for annual audit, quarterly reviews</font></div>
                </td>
                <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">$</font></div>
                </td>
                <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">280,000</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">$</font></div>
                </td>
                <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">398,000</font></div>
                </td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              </tr>
              <tr bgcolor="white">
                <td align="left" valign="bottom" width="71%" style="border-bottom: white;">&#160;</td>
                <td width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="11%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="11%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              </tr>
              <tr bgcolor="white">
                <td align="left" valign="bottom" width="71%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Tax
                    Fees - </font></div>
                </td>
                <td width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="11%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="11%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              </tr>
              <tr bgcolor="#ccffcc">
                <td align="left" valign="bottom" width="71%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Income
                    tax services related to compliance with tax laws</font></div>
                </td>
                <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">$</font></div>
                </td>
                <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">66,000</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">$</font></div>
                </td>
                <td align="right" valign="bottom" width="11%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">55,000</font></div>
                </td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There
          were no fees for services other than the above paid to the Company&#8217;s Independent
          Registered Public Accountants.</font></div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BASi&#8217;s
        policies require that the scope and cost of all work to be performed for
        BASi by
        its independent registered public accountants must be approved by the Audit
        Committee. Prior to the commencement of any work by the independent registered
        public accountants on behalf of BASi, the independent registered public
        accountants provide an engagement letter describing the scope of the work
        to be
        performed and an estimate of the fees. The Audit Committee and the Chief
        Financial Officer must review and approve the engagement letter and the estimate
        before authorizing the engagement&#160;and all fees were reviewed and approved
        during fiscal 2006 and 2007. Where fees charged by the independent registered
        public accountants exceed the estimate, the Audit Committee must review and
        approve the excess fees prior to their payment. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>REPORT
        OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>The
        following Report of the Audit Committee shall not be deemed to be &#8221;soliciting
        material&#8221; or to be &#8220;filed&#8221; with the Securities and Exchange Commission nor shall
        this information be incorporated by reference into any future filing under
        the
        Securities Act of 1933, as amended, or the Securities Exchange Act of 1934,
        as
        amended, except to the extent that BASi specifically incorporates it by
        reference into a filing.</em></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">12</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Audit
        Committee of the Board operates under a written charter, which is reviewed
        on an
        annual basis and was most recently amended in February, 2004. The Audit
        Committee is comprised of four non-employee directors, each of whom in the
        opinion of the Board of Directors meets the current independence requirements
        and financial literacy standards of the NASDAQ Marketplace Rules, as well
        as the
        independence requirements of the Securities and Exchange Commission (&#8220;SEC&#8221;).
        From October 1, 2006 through August 21, 2007, the Audit Committee consisted
        of
        William E. Baitinger, Leslie B. Daniels and David W. Crabb. On August 21,
        2007,
        the Board elected Larry S. Boulet to be Chairman of the Audit Committee,
        serving
        with the other three members of the Committee through the remainder of our
        fiscal year ended September 30, 2007. In the opinion of the Board of Directors,
        Mr. Boulet and Mr. Daniels each meet the criteria for a &#8220;financial expert&#8221; as
        set forth in applicable SEC rules.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BASi&#8217;s
        management is primarily responsible for the preparation, presentation and
        integrity of the Company&#8217;s financial statements. BASi&#8217;s independent registered
        public accounting firm, Crowe Chizek and Company LLC (&#8216;independent auditors&#8217;),
        is responsible for performing an independent audit of the Company&#8217;s financial
        statements and expressing an opinion as to the conformity of the financial
        statements with generally accepted accounting principles.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        function of the Audit Committee is to assist the Board of Directors in its
        oversight responsibilities relating to the integrity of BASi&#8217;s accounting
        policies, internal controls and financial reporting. The Audit Committee
        reviews
        BASi&#8217;s quarterly and annual financial statements prior to public earnings
        releases and submission to the SEC; reviews and evaluates the performance
        of our
        independent auditors; consults with the independent auditors regarding internal
        controls and the integrity of the Company&#8217;s financial statements; assesses the
        independence of the independent auditors: and is responsible for the selection
        of the independent auditors. In this context, the Audit Committee has met
        and
        held discussions with members of management and the independent auditors.
        Management has represented to the Audit Committee that the Company&#8217;s
        consolidated financial statements were prepared in accordance with accounting
        principles generally accepted in the United States, and the Audit Committee
        has
        reviewed and discussed the consolidated financial statements with management
        and
        the independent auditors. Management has also represented to the Audit Committee
        that the Company&#8217;s internal control over financial reporting was effective as of
        the end of the Company&#8217;s most recently-completed fiscal year. The Audit
        Committee also discussed with the independent auditors matters required to
        be
        discussed by Statement on Auditing Standards No. 61 (Communications with
        Audit
        Committees), as amended, including the quality and acceptability of the
        Company&#8217;s financial reporting process and internal controls. The Audit Committee
        has also discussed with the Company&#8217;s independent auditors the overall scope and
        plans for their annual audit and reviewed the results of the audit with
        management and the independent auditors.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
        addition, the Audit Committee has discussed the independent auditors&#8217;
independence from the Company and its management, including the matters in
        the
        written disclosures required by Independence Standards Board Standard No.
        1
        (Independence Discussions with Audit Committees). The Audit Committee has
        also
        considered whether the provision of any non-audit services (as discussed
        under
&#8220;Fees of Independent Auditors&#8221;) would impact the independence of the
        auditors.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        members of the Audit Committee are not engaged in the practice of auditing
        or
        accounting. In performing its functions, the Audit Committee necessarily
        relies
        on the work and assurances of the Company&#8217;s management and independent
        auditors.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
        reliance on the reviews and discussions referred to in this report and in
        light
        of it role and responsibilities, the Audit Committee recommended to the Board
        of
        Directors that the audited financial statements of the Company included in
        the
        Company&#8217;s Annual Report on Form 10-K for the year ended September 30, 2007 be
        filed with the SEC.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>AUDIT
        COMMITTEE</u></strong></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Larry
        S.
        Boulet (Chairman)</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">William
        E. Baitinger</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">David
        W.
        Crabb</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Leslie
        B.
        Daniels</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">13</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>PRINCIPAL
        SHAREHOLDERS</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>Common
        Stock</em></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        following table shows, as of January 31, 2008, the number of common shares
        owned
        by our directors, executive officers named in the Summary Compensation Table
        below, our current directors and executive officers as a group, and beneficial
        owners known to us holding more than 5% of our outstanding common shares.
        As of
        January 31, 2008, there were 4,912,568&#160;common shares outstanding.
</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>

        <div align="left">
          <table border="0" cellpadding="0" cellspacing="0" id="ftable" width="100%">

              <tr>
                <td align="left" valign="bottom" width="27%" style="border-bottom: black thin solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NAME(4)</font></div>
                </td>
                <td width="2%" style="border-bottom: #ffffff solid;">&#160;</td>
                <td colspan="2" valign="bottom" width="10%" style="border-bottom: black thin solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Shares</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Owned</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff solid;">&#160;</td>
                <td colspan="2" valign="bottom" width="10%" style="border-bottom: black thin solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Shares</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Owned</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Jointly</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff solid;">&#160;</td>
                <td colspan="2" valign="bottom" width="10%" style="border-bottom: black thin solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Shares
                    /</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Options</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Owned</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Beneficially</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff solid;">&#160;</td>
                <td colspan="2" valign="bottom" width="14%" style="border-bottom: black thin solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Options</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Exercisable</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">within
                    60 days of January 31, 2008</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff solid;">&#160;</td>
                <td colspan="2" valign="bottom" width="10%" style="border-bottom: black thin solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Total</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff solid;">&#160;</td>
                <td colspan="2" valign="bottom" width="6%" style="border-bottom: black thin solid;"><font size="2">%</font></td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff solid;">&#160;</td>
              </tr>
              <tr bgcolor="#ccffcc">
                <td align="left" valign="bottom" width="27%" style="border-bottom: #ccffcc solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Peter
                    T. Kissinger (1)</font></div>
                </td>
                <td width="2%" style="border-bottom: #ccffcc solid;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc solid;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: #ccffcc solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">430,947</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc solid;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc solid;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: #ccffcc solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">595,910</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc solid;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc solid;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: #ccffcc solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">252,310</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc solid;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc solid;">&#160;</td>
                <td align="right" valign="bottom" width="13%" style="border-bottom: #ccffcc solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">&#8212;</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc solid;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc solid;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: #ccffcc solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">1,279,167</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc solid;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: black thin solid;">&#160;</td>
                <td align="right" valign="bottom" width="5%" style="border-bottom: black thin solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">26.0</font></div>
                </td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc solid;">&#160;</td>
              </tr>
              <tr bgcolor="white">
                <td align="left" valign="bottom" width="27%" style="border-bottom: #ffffff solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Candice
                    B. Kissinger (1)</font></div>
                </td>
                <td width="2%" style="border-bottom: #ffffff solid;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff solid;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: #ffffff solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">250,956</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff solid;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff solid;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: #ffffff solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">595,910</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff solid;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff solid;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: #ffffff solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">432,301</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff solid;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff solid;">&#160;</td>
                <td align="right" valign="bottom" width="13%" style="border-bottom: #ffffff solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">&#8212;</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff solid;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff solid;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: #ffffff solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">1,279,167</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff solid;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: black thin solid;">&#160;</td>
                <td align="right" valign="bottom" width="5%" style="border-bottom: black thin solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">26.0</font></div>
                </td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff solid;">&#160;</td>
              </tr>
              <tr bgcolor="#ccffcc">
                <td align="left" valign="bottom" width="27%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">William
                    B. Baitinger(2)</font></div>
                </td>
                <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">&#8212;</font></div>
                    </div>
                  </div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">146,512</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">&#8212;</font></div>
                  </div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="13%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">9,000</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">155,412</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="5%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">3.2</font></div>
                </td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              </tr>
              <tr bgcolor="white">
                <td align="left" valign="bottom" width="27%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Ronald
                    E. Shoup(2)</font></div>
                </td>
                <td width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">361</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">89,760</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">&#8212;</font></div>
                  </div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="13%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">30,000</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">120,121</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="5%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">2.4</font></div>
                </td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              </tr>
              <tr bgcolor="#ccffcc">
                <td align="left" valign="bottom" width="27%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Leslie
                    B. Daniels</font></div>
                </td>
                <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">38,042</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">&#8212;</font></div>
                  </div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">&#8212;</font></div>
                  </div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="13%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">&#8212;</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">38,042</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="5%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">0.8</font></div>
                </td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              </tr>
              <tr bgcolor="white">
                <td align="left" valign="bottom" width="27%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Michael
                    R. Cox</font></div>
                </td>
                <td width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">&#8212;</font></div>
                    </div>
                  </div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">&#8212;</font></div>
                  </div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">&#8212;</font></div>
                  </div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="13%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">50,000</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">50,000</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="5%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">1.0</font></div>
                </td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              </tr>
              <tr bgcolor="#ccffcc">
                <td align="left" valign="bottom" width="27%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Edward
                    M. Chait</font></div>
                </td>
                <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">&#8212;</font></div>
                    </div>
                  </div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">&#8212;</font></div>
                  </div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">&#8212;</font></div>
                  </div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="13%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">37,500</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">37,500</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="5%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">0.7</font></div>
                </td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              </tr>
              <tr bgcolor="white">
                <td align="left" valign="bottom" width="27%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Richard
                    M. Shepperd</font></div>
                </td>
                <td width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">10,750</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">&#8212;</font></div>
                  </div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">&#8212;</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="13%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">(3</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">)</font></div>
                </td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">10,750</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="5%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">0.2</font></div>
                </td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              </tr>
              <tr bgcolor="#ccffcc">
                <td align="left" valign="bottom" width="27%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Larry
                    S. Boulet</font></div>
                </td>
                <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">3,500</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">&#8212;</font></div>
                  </div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">&#8212;</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="13%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">&#8212;</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">3,500</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="5%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">0.1</font></div>
                </td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              </tr>
              <tr bgcolor="white">
                <td align="left" valign="bottom" width="27%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9
                    Executive Officers and Directors as a group</font></div>
                </td>
                <td width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
                  </div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">110,135</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
                  </div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">236,955</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
                  </div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">&#8212;</font></div>
                  </div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="13%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
                  </div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">381,772</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="9%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
                  </div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">728,862</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="5%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px">
                  </div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">14.8</font></div>
                </td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              </tr>

          </table>
        </div>

      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1)
        Dr.
        and Mrs. Kissinger&#8217;s shares owned beneficially include the shares owned
        individually by the other </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">spouse
        and 1,354 shares jointly owned with their children.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(2)
        Shares owned jointly by Mr. Baitinger and Dr. Shoup, with their wives,
        respectively.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(3)
        Does
        not included options to purchase 75,000 shares that will vest upon approval
        of
        shareholders which is a proposal of this proxy.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(4)
        All
        addresses are in care of BASi at 2701 Kent Avenue, West Lafayette, Indiana
        47906.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Compensation
        Interlocks and Insider Participation</u></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During
        the most recent fiscal year, no Company insiders were on the Compensation
        Committee. Also, during the same period, no officers served as directors
        of any
        companies of which our directors are affiliated.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>COMPENSATION
        OF EXECUTIVE OFFICERS</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div><a name="226"/>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>Compensation
        Discussion and Analysis</em></strong></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
        section includes information regarding, among other things, the overall
        objectives of BASi's compensation program and each element of compensation
        that
        BASi provides. The goal of this section is to provide a summary of BASi's
        executive compensation practices and the decisions that BASi made during
        the
        2007 fiscal year concerning the compensation package payable to its executive
        officers, including the six executives in the Summary Compensation Table.
        Each
        of the six executives listed in the Summary Compensation Table is referred
        to
        herein as a "named executive officer" or "NEO." This "Compensation Discussion
        and Analysis" should be read in conjunction with the detailed tables and
        narrative descriptions under "Executive Compensation Tables" below.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">14</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Compensation
        Committee and Compensation Methodology</u></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During
        the 2007 fiscal year, the Compensation Committee of the Board was responsible
        for administering the compensation and benefit programs for BASi's team members,
        including the executive officers. Historically, the Compensation Committee
        annually reviewed and evaluated cash compensation and stock option award
        recommendations along with the rationale for such recommendations, as well
        as
        summary information regarding the aggregate compensation, provided to BASi's
        executive officers. The Compensation Committee examined these recommendations
        in
        relation to BASi's overall objectives and made compensation recommendations
        to
        the Board for final approval. The Compensation Committee also historically
        sent
        to the Board for approval its recommendations on compensation for the Chairman
        of the Board and the President and Chief Executive Officer, who do not
        participate in the decisions of the Board as to their compensation packages.
        Neither the Chairman of the Board nor the President and Chief Executive Officer
        was a member of the Compensation Committee during the 2007 fiscal
        year.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BASi
        has
        not hired a compensation consultant to review its compensation practices.
        The
        compensation of BASi's executives who were employees as of September 30,
        2006
        (the end of our last fiscal year) was frozen by the Compensation Committee
        at
        the last fiscal year&#8217;s compensation level through fiscal 2007 as part of the
        effort to return the Company to profitability. The compensation of the CEO
        was
        determined by the Compensation Committee through arms' length negotiation
        during
        the recruitment process, and was subsequently modified when the CEO was retained
        on a long-term basis to provide equity participation rather than cash bonuses
        in
        order to conserve the Company&#8217;s cash and better align the interests of the CEO
        with those of the shareholders.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BASi's
        executive compensation practices are also affected by the highly competitive
        nature of the biotechnology industry and the location of BASi's executive
        offices in West Lafayette, Indiana. The fact that West Lafayette, Indiana
        is a
        small city in a predominantly rural area can present challenges to attracting
        executive talent from other industries and parts of the country; however,
        the
        favorable cost of living in this area and the small number of competitive
        employers in this market, enable the Company to pay generally lower salaries
        for
        comparable positions to others in its industry. The Company has also recruited
        a
        number of key employees from Purdue University, particularly for scientific
        and
        technical responsibilities.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Compensation Committee, in collaboration with management, is in the process
        of
        reviewing the compensation structure of the Company in order to provide the
        proper incentives and necessary retention of key employees, including the
        named
        executive officers, to achieve financial success and an appropriate return
        to
        shareholders. These efforts will be ongoing in the current fiscal
        year.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Company intends to develop compensation packages for BASi's executive officers
        that meet each of the following three criteria: (1)&#160;market
        competitive&#160;-&#160;levels competitive with companies of similar size and
        performance to BASi; (2)&#160;performance-based "at risk" pay that is based on
        both short- and long-term goals; and (3)&#160;shareholder-aligned incentives
        that are structured to create alignment between the shareholders and executives
        with respect to short- and long-term objectives.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>The
        Elements of BASi's Compensation Program</u></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As
        a
        result of BASi's compensation objectives, it is intended that the compensation
        package of BASi's executive officers will consist of five primary elements:
        (1)&#160;base salary; (2)&#160;stock options; (3)&#160;discretionary annual cash
        bonuses; (4)&#160;participation in employee benefit plans; and
        (5)&#160;severance and change-in-control arrangements. BASi's executive
        compensation program has been designed to implement the objectives described
        above and is comprised of the following fundamental elements:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 36pt;">&#160;</td>
              <td style="width: 36pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings 2, serif">&#8211;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A
                  base salary that will be determined by individual contributions
                  and
                  sustained performance in the Company's competitive marketplace
                  </font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 36pt;">&#160;</td>
              <td style="width: 36pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings 2, serif">&#8211;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Grants
                  of options under BASi's option plans that will reward executives
                  when
                  shareholder value is created through increase in the market value
                  of
                  BASi's common shares. Stock option grants focus executives on managing
                  BASi from the perspective of an owner with an equity position in
                  the
                  business.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">15</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 36pt;">&#160;</td>
              <td style="width: 36pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings 2, serif">&#8211;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Bonus
                  payments determined and awarded in the Board of Directors' and
                  Compensation Committee's discretion, based on individual contributions
                  and
                  profitability of the Company. </font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 36pt;">&#160;</td>
              <td style="width: 36pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings 2, serif">&#8211;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Competitive
                  benefits available on substantially the same terms to all
                  employees.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 36pt;">&#160;</td>
              <td style="width: 36pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings 2, serif">&#8211;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Severance
                  and change-in-control benefits payable to key executive officers,
                  determined in amount and availability by the Compensation Committee
                  for
                  executive officers that the Company has the most essential need
                  to retain
                  in connection with a change in
                  control.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Base
        Salary</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.&#160;&#160;Generally,
        the base salary, and any periodic increase thereof, of the Named Executive
        Officers were and are determined by the Board of Directors of BASi, with
        input
        from the Chief Executive Officer. The level of base salary compensation for
        officers and key executives is determined by both the scope of their
        responsibility and the salary ranges for officers and key executives of BASi
        established by the Board of Directors and the Compensation Committee. There
        has
        been one increase for a Named Executive Officer (&#8220;NEO&#8221;) in the past three fiscal
        years, which was intended to more closely align that salary with salaries
        paid
        to executives recruited from outside the Company. As a result of losses
        sustained by the Company, no other increases were granted to NEO&#8217;s in that
        period. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mr.
        Shepperd's annual base salary for the period of <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">September
        25</font>, 2006 to May 17, 2007, when he served as Interim President and Chief
        Executive Officer, was $420,000, which rate was continued in his Employment
        Agreement, dated May&#160;18, 2007. No additional increases occurred in the
        fiscal year ended September&#160;30, 2007. Mr. Shepperd's interim contract was
        weighted toward cash and short-term, EBITDA- based bonus compensation to
        reflect
        what BASi then understood to be a short-term engagement. EBITDA, as used
        in Mr.
        Shepperd's interim arrangements, can be calculated from BASi's audited financial
        statements by adding to Net Income the interest, income taxes, depreciation
        and
        amortization recorded for that period. This approach aligned Mr. Shepperd's
        short-term interests with the Company's short-term interests. When the Company
        retained Mr. Shepperd on a long-term basis, the Company adopted compensation
        composed of a cash base salary and a grant of stock options to reflect the
        Company's desire, consistent with its other employees and officers, to align
        Mr.
        Shepperd's interests with the Company's long-term interests and to conserve
        cash
        flow by compensation through a stock option agreement, which requires
        shareholder approval to implement. Moreover, it selected a compensation level
        that was consistent with the compensation agreed between the Company and
        Mr.
        Shepperd for his short-term engagement. Mr. Shepperd and the Compensation
        Committee negotiated the cash/stock mix and the nature of the option
        arrangement.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Compensation Committee determined its recommended base salary for Mr. Shepperd
        under his employment agreement through negotiations with him initially to
        obtain
        his services on an interim basis and through subsequent revision of the terms
        of
        his agreement to reflect his retention on a long-term basis as President
        and
        Chief Executive Officer. The Compensation Committee then recommended to the
        Board that this Employment Agreement be approved, and the Board accepted
        this
        recommendation. The Compensation Committee did not act with reference to
        any
        specific corporate or individual financial performance measure in recommending
        Mr. Shepperd's 2006 and continuing base salary. The Compensation Committee
        approved the negotiated compensation in order to expeditiously obtain the
        services of Mr. Shepperd as an expert in turn-around situations to improve
        the
        operations of the Company and increase cash flow in order to repay significant
        debt maturing in December, 2007. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Company also negotiated new employment agreements with Mr. Chait and Mr.
        Cox in
        November of 2007. This was done as a result of the expiration of their
        employment contracts earlier in the fiscal year, the significant expansion
        of
        their responsibilities and to recognize their contribution to the Company&#8217;s
        return to profitability in fiscal 2007. The new contracts contain provisions
        to
        maintain their salaries for a two-year period after a change of control in
        order
        to secure their services, should such an event occur, through the period
        of
        change. Both Mr. Chait and Mr. Cox were granted additional stock options,
        a
        significant portion of which are dependent on shareholder approval, in order
        to
        align their interests more closely with those of the stockholders</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">16</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Stock
        Options</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>.
        </em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Stock
        options have always been an element of BASi's long-term incentive program.
        The
        primary purpose of stock options is to provide executive officers and other
        team
        members with a personal and financial interest in BASi's success through
        common
        share ownership, thereby aligning the interests of executive officers and
        other
        team members with those of BASi's shareholders. BASi's broad-based stock
        option
        program was intended to further BASi's goal of motivating outstanding long-term
        contributions by team members within all levels of BASi. BASi's compensation
        methodology was based upon the belief that stock options help to create an
        entrepreneurial environment within BASi and instill the spirit of ownership
        participation. The Company is evaluating the mix of cash compensation, incentive
        cash bonuses and equity participation that it will utilize in determining
        its
        future compensation methodologies. Stock option awards have been based on
        an
        individual&#8217;s level of responsibility, contribution, length of service or equity
        participation required to recruit new employees. Management and employees
        in key
        positions participate in the stock option plans. The Compensation Committee
        of
        the Board of Directors must approve all option grants.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Under
        the
        stock option plans, options may also be granted to key employees and
        non-employee directors, at the discretion of the Compensation Committee,
        and
        generally become exercisable in annual increments beginning two years after
        the
        date of grant. The term of each option granted expires within the period
        prescribed by the Compensation Committee, but shall not be more than five
        years
        from the date the option is granted if the optionee is a 10% or more
        shareholder, and not more than ten years for all other optionees, in the
        case of
        employee plan options, or no more than ten years for Outside Directors. All
        rights under the options automatically terminate upon the optionee's separation
        from service with BASi, unless such separation results from retirement,
        disability or death.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We
        have
        maintained two option plans: the 1997 Employee Stock Option Plan and the
        1997
        Outside Director Stock Option Plan. Additionally, we have made individual
        non-qualifying stock option grants to Messrs. Shepperd, Chait and Cox, as
        well
        as employees of our United Kingdom subsidiary who are not eligible for our
        qualified option plans. All options granted under the 1997 Employee Stock
        Option
        Plan and the 1997 Outside Director Stock Option Plan are valued at or above
        fair
        market value at the date of grant. Options granted vest and become exercisable
        in four equal installments, beginning two years after the date of grant,
        and
        expire upon the earlier of the employee's or director's termination of service
        with the Company or ten years from the date of grant. The Outside Director
        Plan
        terminates in fiscal 2008. The Company is proposing in this Proxy Statement
        the
        adoption of a new stock option plan to enable grants to both employees and
        outside directors, which would replace both existing plans.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
        May
        2007, as part of the negotiations to extend his employment contract, Mr.
        Shepperd was granted options, subject to shareholder approval, to purchase
        275,000 shares at a purchase price of $7.10 per share, the closing price
        of
        BASi&#8217;s common shares on May 18, 2007. These options are intended to replace his
        cash bonus provision under his interim contract. Under that contract, Mr.
        Shepperd was to receive 10% of EBITDA of the Company, computed on a quarterly
        basis. Prior to this revision, Mr. Shepperd had earned $295,000 in bonus
        for the
        first six months of fiscal 2007. The replacement of his bonus with this option
        is intended to provide economic rewards for Mr. Shepperd that are dependent
        on
        the Company creating value for shareholders. Whereas previously Mr. Shepperd
        would have received, based on fiscal 2007 results, approximately 60% of net
        earnings as a bonus, through his option grant, he will now earn approximately
        6%
        of the increase in shareholder value over the value on the date of his grant.
        If
        the shareholders do not approve this option grant, Mr. Shepperd will be entitled
        to receive a bonus, as described below.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mr.
        Shepperd's options vest and become exercisable in 3 installments: options
        to
        purchase 75,000 shares will vest at 5:00 p.m. on the day the options grant
        is
        approved by the Company's shareholders, followed by two installments of 100,000
        shares each, on December&#160;1, 2008 and 2009. The option grant expires as to
        all un-exercised shares on May&#160;18, 2017, but may be terminated in
        connection with the termination of Mr. Shepperd's employment within 30 days
        of
        such termination. In the event of his death while employed by the Company,
        Mr.
        Shepperd's personal representative may also exercise the option within six
        months of his death. The option may be terminated by BASi on 30 days' notice
        from BASi in the event of a merger, consolidation or a sale of all or
        substantially all of BASi's assets. In the event of a change in control,
        as
        defined in the agreement, these shares will vest immediately.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        number of shares covered by the option and the option price each will be
        proportionally adjusted for any increase or decrease in the number of issued
        common shares resulting from a subdivision or consolidation of shares of
        BASi,
        the payment of a share dividend, a share split or other increase or decrease
        in
        the outstanding common shares effected without receipt of consideration by
        BASi
        (including an increase or decrease effected as a part of the Recapitalization
        of
        BASi, as described below). If there is a recapitalization or reorganization
        of
        BASi or a reclassification of its outstanding shares, as a result of which
        new
        shares are issued in exchange for common shares, then new shares will be
        substituted for the option shares then issuable. In that case, the number
        of new
        shares that will be issued will be the number into which those option shares
        would have been converted had they been outstanding at the effective date
        of the
        recapitalization.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">17</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subsequent
        to fiscal 2007, on November 6, 2007, the Company granted options to purchase
        30,000 common shares at a purchase price of $8.60 per share, the closing
        price
        of BASi&#8217;s common shares on November 6, 2007, under its employee stock plan and,
        subject to shareholder approval, non-qualified options to purchase 45,000
        shares
        of common stock to each of Mr. Chait and Mr. Cox. These grants were made
        simultaneously with new employment contracts entered into with these executives,
        which reflect their expanded responsibilities and the Compensation Committee&#8217;s
        desire to establish incentives for these executives which are aligned with
        creation of shareholder value.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        non-qualified options granted to Mr. Chait and Mr. Cox on November 6, 2007
        to
        purchase 45,000 common shares each vest in three equal installments on November
        30, 2008, 2009 and 2010. The options expire by their own terms on November
        6,
        2017, but may be terminated in connection with the termination of either
        Mr.
        Chait's or Mr. Cox's employment respectively, within 30 days of such
        termination. The options may also be terminated by BASi on 30 days' notice
        from
        BASi in the event of a merger, consolidation or sale of all or substantially
        all
        of BASi's assets. In the event of a change in control, as defined in the
        agreement, these shares will vest immediately.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        number of shares covered by the option and the option price each will be
        proportionally adjusted for any increase or decrease in the number of issued
        common shares resulting from a subdivision or consolidation of shares of
        BASi,
        the payment of a share dividend, a share split or other increase or decrease
        in
        the outstanding common shares effected without receipt of consideration by
        BASi
        (including an increase or decrease effected as a part of the Recapitalization
        of
        BASi, as described below). If there is a recapitalization or reorganization
        of
        BASi or a reclassification of its outstanding shares, as a result of which
        new
        shares are issued in exchange for common shares, then new shares will be
        substituted for the option shares then issuable. In that case, the number
        of new
        shares that will be issued will be the number into which those option shares
        would have been converted had they been outstanding at the effective date
        of the
        recapitalization.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        grant
        of options to Mr. Shepperd, and the grant in fiscal 2008 of non-qualified
        option
        grants to Mr. Chait and Mr. Cox, are each contingent upon shareholder approval
        to ensure compliance with NASDAQ rules. BASi has undertaken to seek shareholder
        approval for the option grants to Messrs. Shepperd, Chait and Cox at the
        annual
        shareholder meeting to be held in March 2008 in connection with this proxy
        statement. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
        the
        event that the shareholders do not approve the grant of options to Mr. Shepperd,
        BASi has agreed to pay Mr. Shepperd a cash bonus in three installments, on
        the
        day the shareholders fail to approve the grant of options to Mr. Shepperd,
        on
        December&#160;1, 2008 and December&#160;1, 2009. The amount of each bonus
        installment is determined by subtracting $7.10 from the closing price of
        BASi
        common shares on the date before each bonus payment date. If the difference
        is
        positive, the difference is then multiplied by (i) 75,000, for the bonus
        paid on
        the date the shareholders fail to approve the option grant, or (ii) 100,000,
        on
        each of December&#160;31, 2008 and 2009. If the difference is negative, no bonus
        is paid. The bonus is designed to be approximately economically equivalent
        to
        the stock option. For further information on the terms of the contingent
        bonus
        to Mr. Shepperd, refer to "Bonus" below. Mr. Chait and Mr. Cox did not receive
        the additional bonus element to their November 2007 non-qualified options.
        </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">No
        options were granted to NEO&#8217;s during the fiscal year ended September&#160;30,
        2007 except to Mr. Shepperd. Options were granted to Mr. Chait and Mr. Cox
        in
        November of 2007, as described above. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Bonus</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.&#160;&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Prior
        to
        fiscal 2007, the Company had not paid any significant bonuses since fiscal
        2001.
        Bonuses to key management and other key employees were recommended by the
        CEO
        and approved by the Compensation Committee. The bonuses for fiscal 2007 were
        decided by a subjective evaluation by the Company of the appropriate level
        of
        bonus for the efforts made by the key people in returning the Company to
        profitability. The Company is considering a plan for the current and future
        years whereby bonus opportunities as a percentage of base compensation will
        be
        defined by levels of responsibility, then adjusted by factors which include
        personal performance, profit center performance and overall Company performance.
        It is the Company&#8217;s intention to develop a plan providing substantial incentive
        for positive performance that will place a meaningful portion of the
        compensation of key employees &#8220;at risk.&#8221; <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mr.
        Shepperd received cash bonuses of $295,000 representing 10% of defined EBITDA
        for the period prior to the extension of his employment
        agreement.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">18</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Perquisites.
        </em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BASi</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">does
        not
        provide perquisites to NEOs.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Health
        and Welfare Benefits</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        The
        NEOs receive the same opportunity for benefits as those provided to all other
        salaried U.S. employees, such as medical, dental, vision, life insurance
        and
        disability coverage. Certain of these benefits are funded by and at the election
        of the employee, and therefore vary from individual to individual.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Post-Termination
        Compensation and Change in Control Agreements</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>.
        </em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As
        described in further detail below, four of our NEOs, Messrs. Chait, Cox,
        Shepperd and Shoup, have arrangements which provide for payments in the event
        the executive's employment is terminated under certain circumstances. Only
        Mr.
        Shepperd's arrangement was entered into during the fiscal year ended September
        30, 2007. The type and amount of payments vary by the NEO and the nature
        of the
        termination. These severance benefits are payable if and only if the executive's
        employment terminates as specified in the applicable employment or severance
        agreement. Change-in-control provisions are intended to provide for continuity
        of management in the context of a prospective change in control of BASi.
        These
        provisions are necessary to reinforce and encourage the continued attention
        and
        dedication of management to their assigned duties without distraction in
        the
        face of potentially disturbing circumstances arising from the possibility
        of a
        change in control.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Role
        of Management in Compensation Decisions. </em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Compensation Committee has historically annually reviewed and adjusted
        compensation recommendations made by the President and Chief Executive Officer
        for the executive officers other than himself, along with the rationale for
        such
        recommendations. Neither the Chairman of the Board nor the President and
        Chief
        Executive Officer was a member of the Compensation Committee during the fiscal
        year ended September&#160;30, 2007. In November, 2007 the Board of Directors
        elected William E. Baitinger as non-executive Chairman of the Board to replace
        the Company&#8217;s founder and prior Chairman of the Board, who resigned in
        September, 2007. Mr. Baitinger is a member of the Compensation Committee,
        and is
        receiving no additional compensation for serving as the Chairman of the Board.
        The Board will consider whether Mr. Baitinger should receive additional
        compensation for this service at its next regular meeting. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">19</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Common
        Share Ownership Guidelines. </em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BASi
        has
        not adopted guidelines with respect to its directors or senior management
        team's
        ownership of its common shares. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Accounting
        for Stock-Based Compensation</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        Since
        October 1, 2005, the Company has expensed a cost associated with the vesting
        of
        stock options in accordance with Statement of Financial Accounting Standard
        No.
        123R. See the Notes to the Consolidated Financial Statements included in
        the
        Company&#8217;s annual report for fiscal 2007 for details underlying the computation
        of the amounts expensed.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Changes
        in Senior Management During the 2007 Fiscal Year</u></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During
        the 2007 fiscal year, there were significant changes in BASi's executive
        management team. Among other changes, the following events
        occurred:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 36pt;">&#160;</td>
              <td style="width: 36pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings 2, serif">&#8211;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">on
                  May 18, 2007, Mr.&#160;Shepperd began his service as President and Chief
                  Executive Officer, after serving as Interim President and Chief
                  Executive
                  Officer from October 1, 2006 through May 17, 2007;
                  </font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 36pt;">&#160;</td>
              <td style="width: 36pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings 2, serif">&#8211;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">on
                  October 1, 2006, Dr.&#160;Kissinger became Chief Science Officer, after
                  serving as President and Chief Executive Officer since the Company's
                  formation; and</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 36pt;">&#160;</td>
              <td style="width: 36pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings 2, serif">&#8211;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On
                  September 28, 2007, Dr. and Mrs. Kissinger resigned from the Board
                  of
                  Directors and from their positions as executive officers and employees
                  of
                  the Company.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On
        September 28, 2007, Dr. and Mrs. Kissinger each entered into a Severance
        Agreement and Release of All Claims with respect to the termination of their
        employment with BASi and service as officers and directors of BASi. As part
        of
        the negotiated separation of the Kissingers from the Company, BASi also entered
        into a License Agreement with Phlebotics, Inc., a corporation&#160;owned
        by&#160;Dr. and Mrs. Kissinger, with respect to a license of technology from
        BASi to the Kissingers. The Severance Agreements require that BASi pay $175,000,
        less taxes and deductions required by law, to each of Dr. and Mrs. Kissinger.
        The amount is payable in a lump sum of $87,500 to each of Dr. and Mrs. Kissinger
        on October 15, 2007, with the remainder payable in twelve equal semi-monthly
        installments of $7,292 beginning November 15, 2007 and ending April 30, 2008.
        Dr. and Mrs. Kissinger are also entitled to receive payment equal to the
        monthly
        cost of maintaining their health insurance for themselves and their dependents
        for 12 months, which BASi estimates to be a total cost of $13,592. The Severance
        Agreements release all claims Dr. and Mrs. Kissinger may have against the
        Company. Under the Severance Agreements, Dr. and Mrs. Kissinger may also
        convert
        Company paid life insurance policies on their lives to individual policies,
        with
        Company assistance, but not at Company expense. All of Mrs. Kissinger's stock
        options were terminated in the Severance Agreements. The License Agreement
        grants licenses to two of BASi's patent applications and their related know-how
        for technology designed for use in portable sampling and drug delivery devices.
        The License Agreement applies only to uses in human applications. No amounts
        are
        payable to Dr. or Mrs. Kissinger under the License Agreement. The License
        Agreement grants use of the technology in human applications which may require
        approval as either a medical device or a diagnostic methodology. These approvals
        require extensive testing and other procedures in the approval process, which
        in
        turn is likely to require extensive funding for completion. The Board of
        Directors of the Company did not believe that pursuit of these applications,
        with their potentially substantial costs, was appropriate for&#160;the Company
        to pursue directly. The total amount payable under the Severance Agreements
        together during the fiscal year ended September 30, 2008 will be $363,592,
        not
        including the Company&#8217;s portion of payroll taxes. BASi reached these payment
        terms during the course of their negotiation between the President of BASi
        (with
        the assistance of the Company&#8217;s Board of Directors) and Dr. and Mrs. Kissinger.
        The Severance Agreements contain non-disclosure and non-disparagement
        provisions. The non-disparagement provisions and the confidentiality provisions
        do not have stated end dates. Dr. Kissinger has been named Chairman Emeritus
        of
        the Board of Directors, a non-voting, uncompensated position that provides
        for
        his continued input into matters coming before the Board.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">20</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>Employment
        Agreements and Potential Post-Termination Payments</em></strong></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BASi
        has
        Employment Agreements with Messrs. Shepperd, Chait, Cox and Shoup.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Employment
        Agreement with Richard M. Shepperd</u></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On
        May&#160;18, 2007, BASi entered into an Employment Agreement with
        Mr.&#160;Shepperd to become President and Chief Executive Officer of BASi.
        Pursuant to the terms of the agreement between BASi and Mr.&#160;Shepperd, the
        agreement has an initial twenty-nine month term that provides for automatic
        three-month extensions, beginning on January&#160;1, 2010, unless either BASi or
        Mr.&#160;Shepperd gives prior notice of termination. Mr.&#160;Shepperd will
        receive a base salary at a rate not less than $420,000 per year.
        Mr.&#160;Shepperd will also have the opportunity to earn an annual cash bonus at
        the discretion of the Board of Directors.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        agreement provides that Mr.&#160;Shepperd could be entitled to certain severance
        benefits following termination of employment. If he is terminated by BASi
        without "cause," or if Mr.&#160;Shepperd terminates his employment for "good
        reason," he would be entitled to the following:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 36pt;">&#160;</td>
              <td style="width: 36pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings 2, serif">&#8211;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mr.&#160;Shepperd's
                  base salary through December&#160;31, 2009, to be paid
                  monthly;</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 36pt;">&#160;</td>
              <td style="width: 36pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings 2, serif">&#8211;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
                  vacation accrued as of the date of
                  termination;</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 36pt;">&#160;</td>
              <td style="width: 36pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings 2, serif">&#8211;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
                  bonus amounts earned but not paid as of the date of termination;
                  and</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 36pt;">&#160;</td>
              <td style="width: 36pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings 2, serif">&#8211;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
                  salary earned but not paid through the date of
                  termination.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
        addition, the non-solicitation provisions of Mr.&#160;Shepperd's employment
        contract will not apply in the event of termination without cause or resignation
        with good reason.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        agreement further provides that if Mr.&#160;Shepperd's employment ends for any
        reason other than termination without cause or resignation with &#8220;good reason,&#8221;
Mr.&#160;Shepperd shall receive his earned but unpaid salary through the date of
        termination, all bonus amounts earned but not paid as of the date of termination
        and all vacation accrued through the date of such termination or
        resignation.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Employment
        Agreement with Edward M. Chait</u></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On
        November 6, 2007, BASi entered into an Employment Agreement with Mr. Chait
        to
        serve as Chief Business Officer of BASi. Pursuant to the terms of the agreement
        between BASi and Mr. Chait, the agreement has an initial term that ends on
        December 30, 2010, but this employment term can be extended for successive
        one
        year periods unless either BASi or Mr. Chait gives the other party written
        notice at least 90 days before the end of the term. Mr. Chait will receive
        a
        base salary of $165,000 per year in the first year, which may be increased
        by
        the Company in the future. Mr. Chait will also be eligible for any bonus
        plans
        adopted by the Company at the discretion of the Compensation Committee of
        the
        Board of Directors.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Agreement provides that Mr. Chait could be entitled to severance benefits
        following the termination of his employment, as is further described above.
        If
        he is terminated by BASi without "cause," or if Mr. Chait terminates his
        employment for "good reason" he would be entitled to the following:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 54pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif">&#183;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mr.
                  Chait's base salary payable monthly for 12 months following
                  termination;</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 54pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif">&#183;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                  vacation accrued as of the date of termination;
</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 54pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif">&#183;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                  bonus amounts earned but not paid as of the date of termination;
                  and</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 54pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif">&#183;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                  salary earned but not paid through the date of
                  termination.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">21</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
        addition, the non-solicitation provision of Mr. Chait's employment contract
        will
        not apply in the event of termination without cause or resignation with good
        reason. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Employment
        Agreement with Michael R. Cox</u></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On
        November 6, 2007 BASi entered into an Employment Agreement with Mr. Cox to
        serve
        as Vice President, Finance and Administration and Chief Financial Officer
        of
        BASi. Pursuant to the terms of the agreement between BASi and Mr. Cox, the
        agreement has an initial term that ends on December 30, 2010, but this
        employment term can be extended for successive one year periods unless either
        BASi or Mr. Cox gives the other party written notice at least 90 days before
        the
        end of the term. Mr. Cox will receive a base salary of $165,000 per year
        in the
        first year, which may be increased by the Company in the future. Mr. Cox
        will
        also be eligible for any bonus plans adopted by the Company at the discretion
        of
        the Compensation Committee of the Board of Directors.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Agreement provides that Mr. Cox could be entitled to severance benefits
        following the termination of his employment, as is further described above.
        If
        he is terminated by BASi without "cause", or if Mr. Cox terminates his
        employment for "good reason" he would be entitled to the following:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 54pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif">&#183;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mr.
                  Cox's base salary, payable monthly for 12 months following
                  termination;</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 54pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif">&#183;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                  vacation accrued as of the date of termination;
</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 54pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif">&#183;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                  bonus amounts earned but not paid as of the date of termination;
                  and</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 54pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif">&#183;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                  salary earned but not paid through the date of
                  termination.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
        addition, the non-solicitation provision of Mr. Cox's employment contract
        will
        not apply in the event of termination without cause or resignation with good
        reason. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Change-in-Control
        Agreements</u></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mr.
        Shepperd's Employment Agreement contains a change-in-control feature. Under
        Mr.
        Shepperd's Employment Agreement, if Mr. Shepperd is "involuntary terminated"
        within one year following a "change in control," Mr. Shepperd will receive
        $8,333.34 per month for each month remaining in his employment term. Mr.
        Shepperd's ordinary severance compensation under the Employment Agreement
        will
        not apply, and he will be eligible for any special bonus program. A "change
        in
        control" is defined in the Employment Agreement as (1) approval by shareholders
        of the Company of (a) any consolidation or merger of the Company in which
        the
        Company is not the continuing or surviving corporation or pursuant to which
        shares of stock of the Company would be converted into cash, securities or
        other
        property, other than a consolidation or merger of the Company in which holders
        of its common shares immediately prior to the consolidation or merger have
        substantially the same proportionate ownership of voting common stock of
        the
        surviving corporation immediately after the consolidation or merger as
        immediately before, or (b) a sale, lease, exchange or other transfer (in
        one
        transaction or a series of related transactions) of all or substantially
        all the
        assets of the Company; (2) a change in the majority of members of the Board
        of
        Directors of the Company within a twenty-four (24) month period unless the
        election, or nomination for election by the Company shareholders, of each
        new
        director was approved by a vote of two-thirds (2/3) of the directors then
        still
        in office who were in office at the beginning of the twenty-four (24) month
        period; or (3) the Company combines with another company and is the surviving
        corporation but, immediately after the combination, the shareholders of the
        Company immediately prior to the combination do not hold, directly or
        indirectly, more than fifty percent (50%) of the share of voting common stock
        of
        the combined company (there being excluded from the number of shares held
        by
        such shareholders, but not from the shares of voting common stock of the
        combined company, any shares received by affiliates (as defined in the rules
        of
        the SEC) of such other company in exchange for stock of such other
        company).</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mr.
        Chait&#8217;s and Mr. Cox's Employment Agreements contain a change in control feature.
        Under these Employment Agreements, if Mr. Chait or Mr. Cox has their employment
        terminated for any reason following a change in control, Mr. Chait or Mr.
        Cox
        would receive their monthly base salary for the 12 months prior to termination
        payable for at least 2 years. Each would also be eligible for any special
        bonus
        program. A "change in control" is defined in the Employment Agreement in
        the
        same manner as in Mr. Shepperd's Employment Agreement.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">22</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On
        June&#160;19, 2003, Ronald E. Shoup entered into a Severance Agreement with
        BASi. Under the terms of this Severance Agreement, Mr. Shoup is entitled
        to
        receive a continuation of his base salary for one month per year of service
        with
        BASi if he is terminated other than for "just cause" following a "significant
        transaction" or a "change of board composition." "Just Cause" is defined
        as a
        good faith determination by the Company's Board of personal dishonesty, breach
        of fiduciary duty involving personal profit, willful failure to perform stated
        duties, or willful violation of any law, rule or regulation (other than traffic
        violation or similar offenses). "Significant Transaction" is defined as any
        of:
        (a) the sale of a block of stock representing greater than 50% or more of
        the
        combined voting power of the Company's then outstanding securities; (b) upon
        the
        first purchase of the Company's common stock pursuant to a tender or exchange
        offer; and (c) upon the approval by the Company's shareholders of (i) a merger
        with or into another corporation; (ii) a sale or disposition of all or
        substantially all of the Company's assets; or (iii) a plan of liquidation
        or
        dissolution of the Company. "Change of Board Composition" means any change
        in
        the composition of the Board of Directors of the Company in connection with
        any
        transaction in which stock of the Company is sold by the Company, such that
        a
        majority of the non-employee directors of the Company at the time of the
        stock
        sale transaction no longer constitute a majority of the Board. If this Agreement
        had been triggered on September 30, 2007, Mr. Shoup would have been entitled
        to
        monthly payments by BASi of $11,204, payable for 28 months. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>COMPENSATION
        COMMITTEE REPORT</u></strong></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Compensation Committee has reviewed and discussed with management the above
        "Compensation Discussion and Analysis," and, based on such review and
        discussion, the Compensation Committee recommended to the Board that the
        "Compensation Discussion and Analysis" be included in this Proxy
        Statement.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Leslie
        B.
        Daniels, Chairman</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dr.
        David
        Crabb</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">William
        Baitinger</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>Executive
        Compensation Tables</em></strong></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Fiscal
        2007 Summary Compensation Table</u></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        following narrative, tables and footnotes describe the "total compensation"
        earned during BASi's 2007 fiscal year by BASi's NEOs. The total compensation
        presented below does not reflect the actual compensation received by BASi's
        NEOs
        or the target compensation of BASi's NEOs during its 2007 fiscal year. There
        was
        no value realized by BASi's NEOs during its 2007 fiscal year from long-term
        incentives (exercise of options).</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        individual components of the total compensation calculation reflected in
        the
        Summary Compensation Table are broken out below:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Salary.
        </em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Base
        salary earned during BASi's 2007 fiscal year. The terms of his Employment
        Agreement governs the base salary for Mr. Shepperd.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Bonus</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        The
        amounts presented as bonuses for NEO&#8217;s below represent amounts both paid and
        accrued in regards to fiscal 2007. Annual bonuses were paid in January, 2008
        for
        fiscal 2007. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Option
        Awards. </em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">awards
        disclosed under the heading "Option Awards" consist of the expense recognized
        in
        fiscal 2007 for grants of stock options awarded under the 1997 Employee Stock
        Option Plan and the non-qualifying option agreement of Mr. Shepperd, which
        is
        subject to shareholder approval. Details about Mr. Shepperd&#8217;s option award made
        during BASi's 2007 fiscal year are included in the Grant of Plan-Based Awards
        Table below. The recognized compensation expense of the option awards for
        financial reporting purposes will likely vary from the actual amount ultimately
        realized by the NEO based on a number of factors. The factors include BASi's
        actual operating performance, Common Share price fluctuations, differences
        from
        the valuation assumptions used, the restricted nature of shares acquired
        under
        non-qualified stock option grants, the limited liquidity in the trading of
        the
        Company&#8217;s shares and the timing of exercise or applicable vesting.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">23</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>All
        Other Compensation. </em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        amounts included under the All Other Compensation are described in the footnotes
        to the table.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div align="left">
        <table border="0" cellpadding="0" cellspacing="0" id="ftable" width="100%">

            <tr>
              <td colspan="22" valign="bottom" width="99%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>SUMMARY
                  COMPENSATION TABLE</strong></font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff thin solid;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" width="26%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Name
                  and principal position</font></div>
              </td>
              <td width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
              <td colspan="2" valign="bottom" width="6%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Year</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
              <td colspan="2" valign="bottom" width="8%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Salary
                  ($)</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
              <td colspan="2" valign="bottom" width="8%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Bonus
                  ($)</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
              <td colspan="2" valign="bottom" width="10%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Option
                  Awards (1) ($)</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
              <td colspan="2" valign="bottom" width="11%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Company
                  Contributions to 401(k)</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">($)</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
              <td colspan="2" valign="bottom" width="8%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
                  Other Compensation ($)</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
              <td colspan="2" valign="bottom" width="8%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Total
                  ($)</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff thin solid;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="26%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Peter
                  T. Kissinger, Ph.D, Chairman of the Board and Chief Scientific
                  Officer
                  (2)</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="5%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">2007</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="7%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">117,330</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="7%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">--</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="9%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">--</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="10%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">2,581</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="7%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">210,207(3</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">)</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="7%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">330,118</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="26%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Richard
                  M. Shepperd, President &amp; Chief Executive Officer;
                  Director</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="5%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">2007</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="7%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">420,000</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="7%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">295,000(4</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">)</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="9%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">141,282(5</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">)</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="10%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">--</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="7%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">8,774(6</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">)</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="7%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">865,056</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="26%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Michael
                  R. Cox, Vice President, Finance and Chief Financial Officer
                  (7)</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="5%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">2007</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="7%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">153,000</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="7%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">40,000</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="9%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">6,241</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="10%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">1,530</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="7%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">--</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="7%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">200,771</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="26%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Ronald
                  E. Shoup, Ph.D., Chief Operating Officer, BASi Contract Research
                  Services
                  (8)</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="5%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">2007</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="7%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">135,408</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="7%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">--</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="9%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">25,558</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="10%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">3,902</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="7%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">--</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="7%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">164,868</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="26%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Edward
                  M. Chait, Ph.D., Vice President (9)</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="5%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">2007</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="7%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">150,000</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="7%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">35,000</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="9%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">15,493</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="10%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">3,480</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="7%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">--</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="7%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">203,973</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="26%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Candice
                  B. Kissinger, Senior Vice President, Research; Secretary and Director
                  (2)</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="5%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">2007</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="7%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">120,358</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="7%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">--</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="9%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">(10</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">)</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="10%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">2,240</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="7%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">(11</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">)</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="7%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">122,598</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1)
        Amount expensed in financial statements for fiscal 2007.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(2)
        Dr.
        and Mrs. Kissinger resigned as officers and directors of the Company on
        September 28, 2007. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(3)
        Includes $175,000 of severance and $13,592 of employee benefits programs
        accrued
        at September 30, 2007; and $21,615 of premiums on life insurance payable
        to a
        trust created by the Kissingers, which amount is added to Dr. Kissinger&#8217;s
        taxable income.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(4)
        Includes $150,000 paid in fiscal 2007 and $145,000 accrued in regards to
        2007
        before renegotiation of Mr. Shepperd&#8217;s employment agreement.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(5)
        Mr.
        Shepperd&#8217;s stock option award is contingent on shareholder approval; however,
        since the Company must pay cash compensation in the event the award is not
        approved, the Company has accrued the stock option expense.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(6)
        Housing allowance and travel expenses during period as interim CEO.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(7)
        Effective October 4, 2007, Mr. Cox also assumed the responsibilities of Chief
        Administrative Officer. In November, 2007, as discussed above, Mr. Cox entered
        into a new employment agreement and was awarded additional stock option
        grants.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(8)
        Effective October, 2007, Dr. Shoup became Chief Scientific Officer and
        relinquished his title of Chief Operating Officer.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(9)
        Effective October 4, 2007, Dr. Chait assumed the responsibilities of Chief
        Business Officer. In November, 2007, as discussed above, Dr. Chait entered
        into
        a new employment agreement and was awarded additional stock option
        grants.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(10)
        As
        part of the Severance Agreement with the Company, Mrs. Kissinger relinquished
        all rights to unexercised options on September 28, 2007. All expenses for
        non-vested options for the year were accordingly reversed, and the value
        of
        vested options surrendered, calculated as $38,718, was used to reduce severance
        expense.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(11)
        Mrs.
        Kissinger was also insured under the life insurance policy included in Dr.
        Kissinger&#8217;s other compensation as detailed in note 3.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">24</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Fiscal
        2007 Grant of Plan-Based Awards Table</u></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During
        fiscal 2007, BASi granted stock options only to Mr. Shepperd. Information
        with
        respect to this award, which is subject to shareholder approval at the Annual
        Meeting, is set forth in the table below. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div align="left">
        <table border="0" cellpadding="0" cellspacing="0" id="ftable" width="100%">

            <tr>
              <td valign="bottom" width="33%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Name</font></div>
              </td>
              <td width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
              <td colspan="2" valign="bottom" width="16%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Grant
                  Date</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
              <td colspan="2" valign="bottom" width="14%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Number
                  of Securities Underlying Options</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
              <td colspan="2" valign="bottom" width="14%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Exercise
                  Price of Option Awards (1)</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
              <td colspan="2" valign="bottom" width="14%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Grant
                  Date Fair Value of Option Awards (2)</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff thin solid;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="33%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Richard
                  M. Shepperd</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="15%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">May
                  18, 2007</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="13%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">275,000</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">$</font></div>
              </td>
              <td align="right" valign="bottom" width="13%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">7.10</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">$</font></div>
              </td>
              <td align="right" valign="bottom" width="13%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">985,628</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1)
        The
        exercise price of the options is 100% of the fair market value on the date
        of
        grant (based on the closing price on the day prior to the grant).</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(2)
        Represents the value estimated for reporting purposes in accordance with
        SFAS
        No. 123R.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Outstanding
        Equity Awards at Fiscal Year-End Table</u></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BASi
        has
        awarded stock options to members of its senior management and other BASi
        team
        members. The terms of these awards typically provide for vesting over a defined
        period of time. Option awards generally have a four-part vesting schedule
        in
        which the first of the four installments vests on the second anniversary
        of the
        grant date. Each subsequent one-fourth installment thereafter vests on the
        anniversary of the grant date for the next three years: however, the
        Compensation Committee and the Board has to ability to alter, and occasionally
        does alter, the vesting schedule to meet specific objectives, such as the
        matching of the period of Mr. Shepperd&#8217;s option grant in the current fiscal year
        to match the period of his employment contract. The options expire if not
        exercised within ten years from the date of grant. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        following table shows the equity awards granted to BASi's NEOs that were
        outstanding as of the end of BASi's 2007 fiscal year.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div align="left">
        <table border="0" cellpadding="0" cellspacing="0" id="ftable" width="100%">

            <tr>
              <td colspan="13" valign="bottom" width="99%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>OUTSTANDING
                  EQUITY AWARDS AT FISCAL YEAR-END </strong></font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff thin solid;">&#160;</td>
            </tr>
            <tr>
              <td colspan="13" valign="bottom" width="99%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">OPTION
                  AWARDS </font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff thin solid;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" width="20%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Name</font></div>
              </td>
              <td width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
              <td colspan="2" valign="bottom" width="19%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Number
                  of Securities Underlying Unexercised Options </font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(#)
                  </font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Exercisable</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
              <td colspan="2" valign="bottom" width="19%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Number
                  of Securities Underlying Unexercised Options </font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(#)
                  </font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Unexercisable</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
              <td colspan="2" valign="bottom" width="14%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Option
                  Exercise Price</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">($)</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
              <td colspan="2" valign="bottom" width="19%" style="border-bottom: black thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Option
                  Expiration Date</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff thin solid;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="bottom" width="20%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Richard
                  M. Shepperd</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="18%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">--</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="18%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">275,000
                  </font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">(1)</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="13%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">7.10</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="18%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">May
                  17, 2017</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="20%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Michael
                  R. Cox</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="18%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">50,000</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="18%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">--</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="13%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">4.58</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="18%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">March
                  31, 2014</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>
            <tr bgcolor="#ccffcc">
              <td align="left" valign="top" width="20%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Ronald
                  E. Shoup, Ph.D.</font></div>
              </td>
              <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="18%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">4,000</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">3,000</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">20,000</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="18%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">--</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">--</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">20,000
                  </font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">(2)</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="13%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">8.00</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">4.25</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">4.51</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              <td align="right" valign="bottom" width="18%" style="border-bottom: #ccffcc;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">November
                  24, 2007</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">December
                  10, 2008</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">February
                  26, 2014</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="20%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Edward
                  M. Chait, Ph.D</font></div>
              </td>
              <td width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="18%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">37,500</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="18%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">12,500
                  </font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">(3)</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="13%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">5.69</font></div>
              </td>
              <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              <td align="right" valign="bottom" width="18%" style="border-bottom: white;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">September
                  29, 2015</font></div>
              </td>
              <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
            </tr>

        </table>
      </div>
      <div align="left">&#160;</div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1)</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If
                  approved by shareholders, the options vest as to 75,000 shares
                  upon
                  shareholder approval, an additional 100,000 shares on December
                  1, 2008 and
                  100,000 shares on December 1, 2009.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(2)</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Options
                  on 10,000 shares vest on February 27, 2008 and 10,000 shares vest
                  on
                  February 27, 2009.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(3)</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
                  options vest on September 29, 2008.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">25</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Fiscal
        2007 Option Exercises </u></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There
        were no options exercised by NEO&#8217;s in fiscal 2007.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>EQUITY
        COMPENSATION PLAN INFORMATION</strong></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BASi
        maintains stock option plans that allow for the granting of options to certain
        key employees and directors of BASi. The following table gives information
        about
        equity awards under the stock option plans of BASi:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br>
        <div align="left">
          <table cellpadding="0" cellspacing="0" id="ftable" width="100%">

              <tr>
                <td align="left" valign="bottom" width="45%" style="border-bottom: black thin solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Plan
                    Category</font></div>
                </td>
                <td width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
                <td align="left" colspan="2" valign="bottom" width="16%" style="border-bottom: black thin solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Weighted
                    Average Exercise Number of Securities to be Issued upon</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Exercise
                    </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">of
                    Outstanding Options</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
                <td align="left" colspan="2" valign="bottom" width="16%" style="border-bottom: black thin solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Exercise
                    Price of</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Outstanding
                    Options</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
                <td align="left" colspan="2" valign="bottom" width="16%" style="border-bottom: black thin solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Number
                    of Securities Remaining Available for Future Issuance under the
                    Equity
                    Compensation Plan&#160;(excluding Securities R</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">eflected
                    in First Column)</font></div>
                </td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff thin solid;">&#160;</td>
              </tr>
              <tr bgcolor="#ccffcc">
                <td align="left" valign="bottom" width="45%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Equity
                    compensation plans approved by security holders</font></div>
                </td>
                <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="15%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">240,870</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">$</font></div>
                </td>
                <td align="right" valign="bottom" width="15%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">5.08</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="15%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">347,373</font></div>
                </td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              </tr>
              <tr bgcolor="white">
                <td align="left" valign="bottom" width="45%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Non-qualified
                    options granted in conjunction with employment offers</font></div>
                </td>
                <td width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="15%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">50,000</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">$</font></div>
                </td>
                <td align="right" valign="bottom" width="15%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">5.14</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="15%" style="border-bottom: white;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">&#8212;</font></div>
                </td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              </tr>
              <tr bgcolor="#ccffcc">
                <td align="left" valign="bottom" width="45%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Options
                    issuable to officer upon approval by shareholders</font></div>
                </td>
                <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="15%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">275,000</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">$</font></div>
                </td>
                <td align="right" valign="bottom" width="15%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">7.10</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="15%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">&#8212;</font></div>
                </td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              </tr>
              <tr bgcolor="white">
                <td align="left" valign="bottom" width="45%" style="border-bottom: white;">&#160;</td>
                <td width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="15%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="15%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
                <td align="right" valign="bottom" width="15%" style="border-bottom: white;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: white;">&#160;</td>
              </tr>
              <tr bgcolor="#ccffcc">
                <td align="left" valign="bottom" width="45%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Total</font></div>
                </td>
                <td width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="15%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">615,870</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">$</font></div>
                </td>
                <td align="right" valign="bottom" width="15%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">6.00</font></div>
                </td>
                <td align="left" valign="bottom" width="2%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
                <td align="right" valign="bottom" width="15%" style="border-bottom: #ccffcc;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">347,373</font></div>
                </td>
                <td align="left" valign="bottom" width="1%" style="border-bottom: #ccffcc;">&#160;</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For
        additional information regarding BASi&#8217;s stock option plans, please see Note 9 in
        the Notes to Consolidated Financial Statements in BASi&#8217;s Annual Report on Form
        10-K for the fiscal year ended September 30, 2007. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>SECTION
        16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE</strong></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
        16(a) of the Securities Exchange Act of 1934 requires the Corporation&#8217;s
        directors and executive officers and persons who beneficially own more than
        ten
        percent of the Corporation&#8217;s Common Shares to file with the Securities and
        Exchange Commission reports showing ownership of and changes in ownership
        of the
        Corporation&#8217;s Common Shares and other equity securities. On the basis of
        information submitted by the Corporation&#8217;s directors and executive officers, the
        Corporation believes that its directors and executive officers timely filed
        all
        required Section 16(a) filings for fiscal 2007, except for one Form 4 filed
        late
        by director Larry S. Boulet.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>SHAREHOLDER
        PROPOSALS FOR 2009 ANNUAL MEETING</strong></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Shareholder
        proposals to be considered for presentation and inclusion in the proxy statement
        for the 2009 Annual Meeting of Shareholders must be submitted in writing
        and
        received by BASi on or before September 30, 2008. If notice of any other
        shareholder proposal intended to be presented at the 2009 Annual Meeting
        of
        Shareholders is not received by BASi on or before December 14, 2008, the
        proxy
        solicited by the Board of Directors of BASi for use in connection with that
        meeting may confer authority on the proxies to vote in their discretion on
        such
        proposal, without any discussion in the BASi proxy statement for that meeting
        of
        either the proposal or how such proxies intend to exercise their voting
        discretion. The mailing address of the principal offices of BASi is 2701
        Kent
        Avenue, West Lafayette, Indiana 47906.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">26</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>OTHER
        BUSINESS</strong></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As
        of the
        date of this proxy statement, the Board of Directors of BASi has no knowledge
        of
        any matters to be presented for consideration at the Annual Meeting other
        than
        those referred to above. If (a) any matters not within the knowledge of the
        Board of Directors as of the date of this proxy statement should properly
        come
        before the meeting; (b) a person not named herein is nominated at the meeting
        for election as a director because a nominee named herein is unable to serve
        or
        for good cause will not serve; (c) any proposals properly omitted from this
        proxy statement and the form of proxy should come before the meeting; or
        (d) any
        matters should arise incident to the conduct of the meeting, then the proxies
        will be voted in accordance with the recommendations of the Board of Directors
        of BASi.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">By
        Order
        of the Board of Directors,</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
        <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><img src="sigx1x1.jpg" alt=""></div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Richard
        M. Shepperd</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>President
        and Chief Executive Officer</em></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">January
        29, 2008</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">27</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div><br>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>APPENDIX
        A</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BIOANALYTICAL
        SYSTEMS, INC.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2008
        DIRECTOR AND EMPLOYEE STOCK OPTION PLAN</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Adopted
        by the Board of Directors January 21, 2008</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>BIOANALYTICAL
        SYSTEMS, INC.</strong></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>2008
        STOCK OPTION PLAN</strong></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>1.</u></strong></font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>Establishment/Plan
                  Purpose</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
                  Bioanalytical Systems, Inc., an Indiana corporation, hereby establishes
                  an
                  equity-based incentive compensation plan to be known as the Bioanalytical
                  Systems, Inc. 2008 Stock Option Plan ("Plan") and to be effective
                  as of
                  the Effective Date provided for herein. The purpose of the Plan
                  is to
                  promote the long-term interests of the Company and its shareholders
                  by
                  providing a means for attracting and retaining officers, directors
                  and key
                  employees of the Company and its Affiliates.
</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>2.</u></strong></font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>Definitions/Rules
                  of Construction</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
                  </font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        following definitions are applicable to the Plan:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Affiliate</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means
        any "parent corporation" or "subsidiary corporation" of the Company as such
        terms are defined in Code Sections&#160;424(e) and (f),
        respectively.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Award</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means
        the grant by the Committee of Incentive Stock Options or Non-Qualified Stock
        Options or any combination thereof, as provided in the Plan.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Award
        Agreement</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means
        the written agreement setting forth the terms and provisions applicable to
        each
        Award granted under the Plan.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Beneficial
        Owner</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        shall
        have the meaning set forth in Rule 13d-3 under the Exchange Act. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Board</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means
        the Board of Directors of the Company.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Cause</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means
        (a) a Participant&#8217;s dishonesty, fraud or misconduct with respect to the business
        or affairs of the Company or any Affiliate which materially and adversely
        affects the operations or reputation of the Company or any Affiliate (monetarily
        or otherwise); (b) a Participant&#8217;s conviction of a felony crime or a crime
        involving moral turpitude or entry of a plea of nolo contendre thereof; or
        (c) a
        Participant&#8217;s violation of the Company&#8217;s Code of Conduct. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Change
        in Control</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means
        the occurrence of any one of the following events:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">i.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">any
        Person, other than an Existing Substantial Shareholder, becomes the Beneficial
        Owner, directly or indirectly, of securities of the Company representing
        a
        majority of the combined voting power of the Company's then outstanding
        securities (assuming conversion of all outstanding non-voting securities
        into
        voting securities and the exercise of all outstanding options or other
        convertible securities);</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ii.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
        following individuals cease for any reason to constitute a majority of the
        number of directors then serving: individuals who, on the Effective Date,
        constitute the Board and any new director (other than a director whose initial
        assumption of office is in connection with an actual or threatened election
        contest, including but not limited to, a consent solicitation, relating to
        the
        election of directors of the Company) whose appointment or election by the
        Board
        or nomination for election by the Company's shareholders was approved or
        recommended by a vote of at least two-thirds (2/3) of the directors then
        still
        in office who either were directors on the Effective Date or whose appointment,
        election or nomination for election was previously so approved or
        recommended;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">APPENDIX
            A -
            1</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">iii.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
        consummation of a merger or consolidation of the Company or any direct or
        indirect subsidiary of the Company with any other corporation (other than
        with
        an Existing Substantial Shareholder or any of its affiliates), other than
        (x) a
        merger or consolidation which would result in the voting securities of the
        Company outstanding immediately prior to such merger or consolidation continuing
        to represent, either by remaining outstanding or by being converted into
        voting
        securities of the surviving entity or any parent thereof, a majority of the
        combined voting power of the securities of the Company or such surviving
        entity
        or any parent thereof outstanding immediately after such merger or
        consolidation, or (y) a merger or consolidation effected to implement a
        recapitalization of the Company (or similar transaction) in which no Person
        is
        or becomes the Beneficial Owner, directly or indirectly, of securities of
        the
        Company representing a majority of the combined voting power of the Company's
        then outstanding securities; or</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">iv.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
        shareholders of the Company approve a plan of complete liquidation or
        dissolution of the Company or there is consummated an agreement for the sale
        or
        disposition by the Company of all or substantially all of the Company's assets,
        other than a sale or disposition by the Company of all or substantially all
        of
        the Company's assets to an entity controlled by an Existing Substantial
        Shareholder or any of its affiliates, or to an entity a majority of the combined
        voting power of the voting securities of which is owned by substantially
        all of
        the shareholders of the Company immediately prior to such sale in substantially
        the same proportions as their ownership of the Company immediately prior
        to such
        sale. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Code</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means
        the Internal Revenue Code of 1986, as amended, and its implementing
        regulations.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Committee</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means
        the Compensation Committee of the Board of Directors.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Company</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means
        Bioanalytical Systems, Inc., an Indiana corporation.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Director</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means
        any individual who is a member of the Board.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Disability</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means
        that a Participant meets one of the following requirements: (i) the Participant
        is unable to engage in any substantial gainful activity by reason of any
        medically determinable physical or mental impairment that can be expected
        to
        result in death or can be expected to last for a continuous period of not
        less
        than 12 months, or (ii) the Participant is, by reason of medically determinable
        physical or mental impairment that can be expected to result in death or
        can be
        expected to last for a continuous period of not less than 12 months, receiving
        income replacement benefits for a period of not less than 3 months under
        an
        accident and health plan covering employees of the Company. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Effective
        Date</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means
        the date that the Plan becomes effective as provided in
        Section&#160;18.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Employee</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means
        any person, including an officer or Director, who is employed by the Company
        or
        any Affiliate.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Exchange
        Act</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means
        the Securities Exchange Act of 1934, as amended.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Exercise
        Price</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means
        the price per Share at which the Shares subject to an Option may be purchased
        upon exercise of the Option.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Existing
        Substantial Shareholder</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means
        any Person that alone or together with its affiliates is the Beneficial Owner
        of
        more than 15% of the Outstanding Common Stock as of the Effective Date.
</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Fair
        Market Value</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means,
        with respect to a Share as of a particular date, the per share closing price
        for
        the Shares on the trading day immediately before such date, as reported by
        the
        principal exchange or market over which the Shares are then listed or regularly
        traded. If the price of a Share is not so reported, Fair Market Value shall
        be
        determined, in good faith, by the Committee in accordance with such procedures
        as the Committee shall from time to time prescribe.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Incentive
        Stock Option</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means
        an option to purchase Shares granted by the Committee pursuant to the terms
        of
        the Plan, which option is intended to qualify under Code
        Section&#160;422.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">APPENDIX
            A -
            2</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Non-Qualified
        Stock Option</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means
        an option to purchase Shares granted by the Committee pursuant to the terms
        of
        the Plan, which option is not intended to qualify under Code
        Section&#160;422.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Option</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means
        an Incentive Stock Option or a Non-Qualified Stock Option.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Participant</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means
        any individual selected by the Committee to receive an Award.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Person</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        shall
        have the meaning given in Section 3(a)(9) of the Exchange Act and used in
        Sections 13(d) and 14(d) thereof, except that such term shall not include
        (i)
        the Company or any subsidiary of the Company, (ii) a trustee or other fiduciary
        holding securities under an employee benefit plan of the Company or any of
        its
        affiliates, (iii) an underwriter temporarily holding securities pursuant
        to an
        offering of such securities or (iv) a corporation or other business entity
        owned, directly or indirectly, by substantially all of the shareholders of
        the
        Company in substantially the same proportions as their ownership of stock
        of the
        Company. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Plan</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means
        this Bioanalytical Systems, Inc. 2008 Stock Option Plan.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Retirement</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means,
        in the case of an Employee, a Separation from Service for reasons other than
        Cause on or after the date on which the Employee attains age 60. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Rule
        16b-3</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means
        Rule 16b-3 under the Exchange Act and any future rule or regulation amending,
        supplementing, or superseding such rule.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Section
        16 Person</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means a
        person subject to potential liability under Section 16(b) of the Exchange
        Act
        with respect to transactions that involve equity securities of the
        Company.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Securities
        Act</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means
        the Securities Act of 1933, as amended.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Separation
        from Service</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        or
        "</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Separates
        from Service</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        shall
        mean death, Disability, Retirement, or other termination of employment with
        the
        Company.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Shares</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        means
        the common shares of the Company.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>10%
        Shareholder</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
        has the
        meaning set forth in Section 9.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        following rules shall govern in the interpretation of the Plan:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">i.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except
        to
        the extent preempted by United States federal law or as otherwise expressly
        provided herein, the Plan and all Award Agreements shall be interpreted in
        accordance with and governed by the internal laws of the State of Indiana
        without giving effect to any choice or conflict of law </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">provisions,
        principles, or rules.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ii.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Plan
        and all Awards are intended to comply with an exemption from the requirements
        of
        Code Section 409A.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">iii.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any
        reference herein to a provision of law, regulation, or rule shall be deemed
        to
        include a reference to the successor of such law, regulation, or
        rule.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>iv.</em></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To
        the
        extent consistent with the context, any masculine term shall include the
        feminine, and </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>vice
        versa, </em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">and
        the
        singular shall include the plural, and </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>vice
        versa.</em></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">v.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If
        any
        provision of the Plan shall be held illegal or invalid for any reason, the
        illegality or invalidity of that provision shall not affect the remaining
        parts
        of the Plan, and the Plan shall be interpreted and enforced as if the illegal
        or
        invalid provision had never been included herein.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">vi.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        grant
        of Awards and issuance of Shares hereunder </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">shall
        be
        subject to all applicable statutes, laws, rules, and regulations and to such
        approvals and</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">requirements
        as may be required from time to time by any governmental authority or
        securities</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
        exchange
        or market on which the Shares are then listed or traded.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">APPENDIX
            A -
            3</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">vii.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        descriptive headings and sections of the Plan are provided for </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">convenience
        of reference only and shall not serve as a basis for interpretation of
        the</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
        Plan.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>3.</u></strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>Administration</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>The
        Committee</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        The
        Committee shall administer the Plan and, subject to the provisions of the
        Plan
        and applicable law, may exercise its discretion in performing its administrative
        duties. The Committee shall consist of not fewer than three (3) Directors,
        and
        Committee action shall require the affirmative vote of a majority of its
        members. The </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">members
        of the Committee shall be appointed by, and shall serve at the
        pleasure</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">of,
        the
        Board. It is intended that the Committee be composed solely of Directors
        who</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
        both are
        non-employee directors under Rule 16b-3 and "independent" as defined by the
        requirements of any stock exchange or quotation system on which the Company's
        common stock is listed or quoted.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
        Failure
        of the Committee to be so composed shall not result</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
        in the
        cancellation, termination, expiration, or lapse of any Award.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Authority
        of the Committee</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        Except
        as limited by law or by the Articles of Incorporation or By-Laws of the Company,
        and subject to the provisions of the Plan, the Committee </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">shall
        have full power and discretion to: select the Employees who shall participate
        in
        the Plan; determine</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
        sizes
        and types of Awards; determine the terms and conditions of Awards in a manner
        consistent</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">with
        the
        Plan; construe and interpret the Plan, all Award Agreements, and any other
        agreements or</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
        instruments entered into under the Plan; establish, amend, or waive rules
        and
        regulations for the </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Plan's
        administration; and amend the terms and conditions of any outstanding Award
        and
        applicable</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
        Award
        Agreement to the extent that such terms and conditions are within the discretion
        of the Committee</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        Further, the Committee shall make all other determinations that may
        be</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
        necessary or advisable for the administration of the Plan. Each Award shall
        be
        evidenced by a </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">written
        Award Agreement between the Company and the Participant and shall contain
        such
        terms</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">and
        conditions as may be established by the Committee consistent with the provisions
        of the Plan. </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notwithstanding
        the preceding provisions, the Committee shall not have any authority to take
        any
        action that would cause an Option to become subject to Code Section 409A.
        Except
        as limited by applicable law or the Plan, the Committee may use its discretion
        to the maximum extent that it deems appropriate in administering the
        Plan.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Delegation
        by the Committee</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        The
        Committee </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">may
        delegate all or any part of its authority and powers under</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
        this
        Plan to one or more Directors or officers of the Company; provided, however,
        the
        Committee may not delegate its authority and powers (i) with respect to grants
        to Section 16 </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Persons,
        or (ii) in a way that would jeopardize the Plan' s satisfaction of </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Rule&#160;16b-3.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Decisions
        Binding</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        All
        determinations and decisions made by the Committee, the Board, and any delegate
        of the Committee pursuant to this Section shall be final, conclusive, and
        binding on all persons, including the Company and Participants.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>4.</u></strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>Participants</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        Only
        those persons who are Employees or Directors of the Company shall be eligible
        to
        participate in the Plan. The Committee shall determine from time to time
        the
        particular Employees or Directors of the Company who shall be eligible to
        participate in the Plan and the extent of their participation
        therein.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>5.</u></strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>Shares
        Subject to Plan, Limitations on Grants and Exercise
        Price</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        Subject
        to adjustment by the operation of Section&#160;11 hereof:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        maximum number of Shares that may be issued with respect to Awards made under
        the Plan is 500,000 Shares. In the event any outstanding Option under the
        Plan
        expires or is terminated for any reason prior to the end of the period during
        which Options may be granted, the shares allocable to the unexercised portion
        of
        such Option may again be subject to an Option under the Plan.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Shares with respect to which Awards may be made under the Plan may either
        be
        authorized and unissued shares or issued shares heretofore or hereafter
        reacquired and held as treasury shares. Any Award that expires, terminates
        or is
        surrendered for cancellation may be subject to new Awards under the Plan
        with
        respect to the number of Shares as to which a termination or forfeiture has
        occurred. Any option issued under the Plan surrendered in order to effect
        exercise of another option in accordance with Paragraph 7 (c) below shall
        be
        deemed to be an exercised option and will not be available for future option
        grants under this Plan.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">APPENDIX
            A -
            4</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Exercise Price for any Award made under the Plan may not be less than the
        Fair
        Market Value of the Shares as of the date of the award.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">No
        Participant may be granted Incentive Stock Options under this Plan that would
        result in Shares with an aggregate Fair Market Value (determined as of the
        date
        the Option is granted) of more than One Hundred Thousand Dollars ($100,000)
        first becoming exercisable in any one calendar year. To the extent that a
        purported Incentive Stock Option would violate the limitation specified in
        the
        preceding sentence, the portion of the Option in excess of such limitation
        shall
        be deemed a Non-Qualified Stock Option.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">e.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notwithstanding
        the preceding provisions, if the Company or an Affiliate consummates a
        transaction described in Code Section 424(a) (e.g., the acquisition of property
        or stock from an unrelated corporation), individuals who become Employees
        or
        Directors on account of such transaction may be granted Options in substitution
        for options granted by such former employer or recipient of services. If
        such
        substitute Options are granted, the Committee, in its sole discretion and
        consistent with Code Section 424(a) and the requirements of Code Section
        409A,
        may determine that such substitute Options shall have an Exercise Price less
        than one hundred (100%) of the Fair Market Value of the Shares to which the
        Options relate determined as of the dates of grant. In carrying out the
        provisions of this Section, the Committee shall apply the principles contained
        in Section 11.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>6.</u></strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>General
        Terms and Conditions of Options</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
        The
        Committee will have full and complete authority and discretion, except as
        expressly limited by the Plan, to grant Options and to prescribe the terms
        and
        conditions (which need not be identical among Participants) of the Options.
        Each
        Option will be evidenced by an Award Agreement that will specify: (a)&#160;the
        Exercise Price, (b)&#160;the number of Shares subject to the Option,
        (c)&#160;the expiration date of the Option, (d)&#160;the manner, time and rate
        (cumulative or otherwise) of exercise of the Option, (e)&#160;the restrictions,
        if any, to be placed upon the Option or upon Shares that may be issued upon
        exercise of the Option, (f)&#160;the conditions, if any, under which a
        Participant may transfer or assign Options, and (g)&#160;any other terms and
        conditions as the Committee, in its sole discretion, may determine. The
        Committee may, as a condition of granting any Option, require that a Participant
        agree to surrender for cancellation one or more Options previously granted
        to
        such Participant.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>7.</u></strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>Exercise
        of Options</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        Subject
        to the provisions of the Plan and the applicable Award Agreement, a Participant
        may exercise an Option, in whole or in part, at any time prior to the
        termination of the Option,</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
        by
        giving written notice to the Company of exercise on a</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
        form
        provided by the Committee (if available). Such notice shall specify the number
        of Shares subject to the Option to be purchased and shall be accompanied
        by
        payment in full of the total Exercise Price by cash or check or such other
        form
        of payment as the Company may accept. If </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">permitted
        by the Committee or the applicable the Award Agreement, payment in full or
        in
        part may</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
        also be
        made by:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Delivering
        Shares already owned by the Participant for more than six (6) months and
        having
        a total Fair Market Value on the date of such delivery equal to the total
        Exercise Price;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        certification of ownership of Shares owned by the Participant to the
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">satisfaction
        of the Committee for later delivery to the Company as specified</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
        by the
        Committee;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Delivering,
        if the Participant may do so without violating Section 16(b) of the Exchange
        Act, by surrendering sufficient vested options based on the difference between
        the exercise price and the Fair Market Value at the time of exercise of the
        Shares to equal the exercise price of the Shares to which the Option is being
        exercised;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any
        other
        method permitted by the Committee in the Award Agreement; or</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">e.&#160;Any
        combination of the foregoing.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">No
        Shares
        shall be issued until full payment therefore has been made. A Participant
        shall
        have all of the rights of a shareholder of the Company holding the class
        of
        Shares subject to such Option (including, if applicable, the right to vote
        the
        shares and the right to receive dividends) when the Participant has given
        written notice of exercise, has paid the total Exercise Price, and such Shares
        have been recorded on the Company's official shareholder records (or the
        records
        of its transfer agents or registrars) as having been issued and transferred
        to
        the Participant.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">APPENDIX
            A -
            5</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>8.</u></strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>Termination
        of Options</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        Unless
        otherwise specifically provided by the Committee in the Award Agreement or
        any
        amendment thereto, Options will terminate as provided in this Section.
</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Unless
        sooner terminated under the provisions of this Section and notwithstanding
        the
        provisions of Subsection (b) or (d) below of this Section 8, Options will
        expire
        not more than five (5) years from the date of grant if the Participant is
        a 10%
        Shareholder, and not more than ten (10) years from the date of grant if the
        Participant is not a 10% Shareholder.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If
        the
        Participant's Separation from Service (without Cause) occurs by reason of
        Retirement or Disability, the Participant may exercise all outstanding Options
        with respect to Shares for which it could have been exercised on the effective
        date of the Participant's Retirement within the period of three months
        immediately succeeding the Participant's Retirement, or if by reason of
        Disability, within twelve (12) months after termination of employment due
        to
        Disability.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If
        the
        Participant's Separation from Service (with or without Cause) is due to any
        reason other than Retirement or Disability, all rights under any Options
        granted
        to the Participant will terminate immediately upon the Participant's Separation
        from Service.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
        the
        event the Participant's Separation from Service is due to death, the
        Participant's beneficiary or estate, if no beneficiary, may exercise outstanding
        Options to the extent that the Participant was entitled to exercise the Options
        at the date of his death, but only within the period of twelve (12) months
        from
        the date of the Participant's death.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>9.</u></strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>Special
        Rules Applicable to Incentive Stock Options</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>a.</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Incentive
        Stock Options may be granted only to Participants who are Employees. Any
        provisions of the Plan to the contrary notwithstanding, (a)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;no
        Incentive Stock Option will be granted more than ten (10) years from the
        earlier
        of the date the Plan is adopted by the Board or approved by the Company's
        Shareholders, (b)&#160;no Incentive Stock Option will be exercisable more than
        ten (10) years from the date the Incentive Stock Option is granted, (c)&#160;the
        Exercise Price of any Incentive Stock Option will not be less than the Fair
        Market Value per Share on the date such Incentive Stock Option is granted,
        (d)&#160;any Incentive Stock Option will not be transferable by the Participant
        to whom such Incentive Stock Option is granted other than by will or the
        laws of
        descent and distribution and will be exercisable during the Participant's
        lifetime only by such Participant, (e)&#160;no Incentive Stock Option will be
        granted that would permit a Participant to acquire, through the exercise
        of
        Incentive Stock Options in any calendar year, under all plans of the Company
        and
        its Affiliates, Shares having an aggregate Fair Market Value (determined
        as of
        the time any Incentive Stock Option is granted) in excess of $100,000
        (determined by assuming that the Participant will exercise each Incentive
        Stock
        Option on the date that such Option first becomes exercisable), and (f)&#160;no
        Incentive Stock Option may be exercised more than three (3) months after
        the
        Participant's Separation from Service for reasons due to Retirement, or more
        than one (1) year after the Participant's Separation from Service due to
        the
        Disability or the death of the Participant. Notwithstanding the
        foregoing,</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">no
        Incentive Stock Option shall be granted under the Plan to any Employee of
        the
        Company who, at the time such Incentive Stock Option is granted, owns shares
        possessing more than ten percent (10%) of the total combined voting power
        of all
        classes of shares of the Company or of any parent or subsidiary corporation
        of
        the Company or any parent or subsidiary corporation of any of the foregoing
        (such employee being hereinafter referred to as a "10% Shareholder"), except
        as
        provided below. For purposes of this Section 9, shares owned, directly or
        indirectly, by or for a corporation, partnership, estate, or trust shall
        be
        considered as being owned proportionately by or for its shareholders, partners,
        or beneficiaries. The percentage limitations of this Section 9 shall not
        apply,
        however, if, at the time such Incentive Stock Option is granted, the Exercise
        Price is at least one hundred ten percent (110%) of the Fair Market Value
        of the
        Shares subject to the Incentive Stock Option and such Option by its terms
        is not
        exercisable after the expiration of five (5) years from the date such Option
        is
        granted.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notwithstanding
        any other provisions of the Plan, if for any reason an Option granted under
        the
        Plan that is intended to be an Incentive Stock Option fails to qualify as
        an
        Incentive Stock Option, such Option will be deemed to be a Non-Qualified
        Stock
        Option, and such Option will be deemed to be fully authorized and validly
        issued
        under the Plan.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">APPENDIX
            A -
            6</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>10.</u></strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>Restrictive
        Covenants</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        In its
        discretion, the Committee may condition the grant of any Award under the
        Plan
        upon the Participant agreeing to covenants in favor of the Company and/or
        any
        Affiliate (including, without limitation, covenants not to compete, not to
        solicit employees and customers, and not to disclose confidential information)
        that may have effect following the termination of employment with the Company
        or
        any Affiliate, and after the Award has been exercised, including, without
        limitation, the requirement to disgorge any profit, gain or other benefit
        received upon exercise of the Award prior to any breach of any covenant.
        </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>11.</u></strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>Adjustments
        Upon Changes in Capitalization</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        In the
        event of any change in the outstanding Shares subsequent to the effective
        date
        of the Plan by reason of any reorganization, recapitalization, stock split,
        reverse stock split, spin-off, stock dividend, combination or exchange of
        Shares
        or other securities of the Company, any change in the corporate structure
        or
        Shares of the Company or other similar corporate transaction or event, the
        maximum aggregate number and class of Shares as to which Awards may be granted
        under the Plan and the number and class of Shares and the Exercise Price
        of any
        outstanding Options will be appropriately adjusted by the Committee to prevent
        the dilution or diminution of Awards. The Committee's determination with
        respect
        to any adjustments will be conclusive. Any fractional shares so determined
        will
        be rounded to the nearest whole number of shares.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>12.</u></strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>Assignments
        and Transfers</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        Except
        as otherwise expressly authorized by the Committee in the Award Agreement
        or any
        amendment thereto during the lifetime of a Participant, no Award nor any
        right
        or interest of a Participant in any Award under the Plan may be assigned,
        encumbered or transferred otherwise than by will or the laws of descent and
        distribution.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>13.</u></strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>Rights
        Under the Plan</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        No
        officer, Employee, Director or other person will have a right to be selected
        as
        a Participant nor, having been so selected, to be selected again as a
        Participant, and no officer, Employee, Director or other person will have
        any
        claim or right to be granted an Award under the Plan or under any other
        incentive or similar plan of the Company or any Affiliate. Neither the Plan
        nor
        any action taken under the Plan will be construed as giving any Employee
        any
        right to be retained in the employ of the Company or any Affiliate.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>14.</u></strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>Delivery
        and Registration of Shares</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        The
        Company's obligation to deliver Shares with respect to an Award will, if
        the
        Committee requests, be conditioned upon the receipt of a representation as
        to
        the investment intention of the Participant to whom such Shares are to be
        delivered, in such form as the Committee will determine to be necessary or
        advisable to comply with the provisions of the Securities Act or any other
        applicable federal or state securities laws. It may be provided that any
        representation requirement will become inoperative upon a registration of
        the
        Shares or other action eliminating the necessity of the representation under
        the
        Securities Act or other state securities laws. The Company will not be required
        to deliver any Shares under the Plan prior to (a) the admission of such Shares
        to listing on any stock exchange or system on which Shares may then be listed,
        and (b) the completion of any registration or other qualification of the
        Shares
        under any state or federal law, rule or regulation, as the Company determines
        to
        be necessary or advisable.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>15.</u></strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>Withholding
        Tax</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        To the
        extent required by law in effect at the time any Options are exercised, the
        Company has the right and power to deduct or withhold, or require the
        Participant to remit to the Company, an amount sufficient to satisfy all
        applicable tax withholding requirements. The Committee, in its sole discretion
        and pursuant to such procedures as it may specify from time to time, may
        permit
        or require a Participant to satisfy all or part of the tax withholding
        obligations in connection with an Award by (a) having the Company withhold
        otherwise deliverable Shares, or (b) delivering to the Company Shares already
        owned for a period of at least six months and, in each case, having a value
        equal to the amount required to be withheld. The amount of the withholding
        requirement will be deemed to include any amount that the Committee determines,
        not to exceed the amount determined by using the maximum federal, state or
        local
        marginal income tax rates applicable to the Participant with respect to the
        Award on the date that the amount of tax to be withheld is to be determined
        for
        these purposes. For these purposes, the value of the Shares to be withheld
        or
        delivered will be equal to the Fair Market Value as of the date that the
        taxes
        are required to be withheld.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">APPENDIX
            A -
            7</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>16.</u></strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>Termination,
        Amendment and Modification of Plan</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        The
        Board may at any time terminate, and may at any time and from time to time
        and
        in any respect amend or modify the Plan; provided, however, that to the extent
        necessary and desirable to comply with Rule&#160;16b-3 under the Exchange Act or
        Code Section 422 (or any other applicable law or regulation, including
        requirements of any stock exchange or quotation system on which the Company's
        common stock is listed or quoted), shareholder approval of any Plan amendment
        will be obtained in the manner and to the degree as is required by the
        applicable law or regulation; and provided further, that no termination,
        amendment or modification of the Plan will in any manner affect any Award
        theretofore granted pursuant to the Plan without the consent of the Participant
        to whom the Award was granted or the transferee of the Award. The Plan shall
        be
        binding upon any successor to substantially all the assets of the Company.
        However, no Options shall be granted hereunder upon termination of the
        Plan.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>17.</u></strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>Repricing</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        Notwithstanding any provision in the Plan to the contrary and except for
        adjustments made pursuant to Section 11 of the Plan (relating to the adjustment
        of Shares and related Awards upon certain changes in capitalization), the
        Exercise Price of any outstanding Option granted under the Plan may not be
        decreased after the date of grant nor may any outstanding Option granted
        under
        the Plan be surrendered to the Company as consideration for the grant of
        a new
        Option with a lower Exercise Price. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>18.</u></strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>Effective
        Date and Term of Plan</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        The
        Plan will become effective upon approval by the holders of a majority of
        the
        issued and outstanding Shares of each class of the voting Shares of the Company
        voting in person or by proxy at the duly held shareholder's meeting, provided
        that the Plan shall become effective only if approved within twelve (12)
        months
        before or after the Plan is adopted. The Plan shall terminate on the ten
        (10)
        year anniversary of the Effective Date.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>19.</u></strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>Securities
        Law</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        No
        Option shall be granted, and no shares issued in connection with any Award
        unless the grant of the Option and the issuance and delivery of shares or
        cash
        pursuant to the Award, complies with all relevant provisions of state and
        federal law, including without limitation, the Securities Act, the Exchange
        Act,
        the rules and regulations promulgated thereunder, and the requirements of
        any
        market system or stock exchange upon which the shares may then be listed
        or
        traded. Participant shall not offer, sell or otherwise dispose of any Option
        in
        any manner that would: (a) require the Company to file any registration
        statement with the Securities and Exchange Commission (or any similar filing
        under state law), or to amend or supplement such filing or (b) violate or
        cause
        the Company to violate the Securities Act, or any other state or federal
        law.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>20.</u></strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>Mistake
        of Fact</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        Any
        mistake of fact or misstatement of facts shall be corrected when it becomes
        known by a proper adjustment to an Award or Award Agreement.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>21.</u></strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>Evidence</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        Evidence required of anyone under the Plan may be by certificate, affidavit,
        document, or other information which the person relying thereon considers
        pertinent and reliable, and signed, made, or presented by the proper party
        or
        parties.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>22.</u></strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>Notices</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any
        notice</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
        or
        document required to be given to or filed with the Committee will be properly
        given or filed if hand delivered (and a delivery receipt is received) or
        mailed
        by certified mail, return receipt requested, postage paid, to the
        Committee.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>23.</u></strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>No
        Company Obligation</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        Unless
        required by applicable law, the Company, an Affiliate, the Board, and the
        Committee shall not have any duty or obligation to affirmatively disclose
        material information to a record or beneficial holder of Shares or an Award,
        </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">and
        such
        holder shall have no right to be advised of any material information regarding
        the Company</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">or
        any
        Affiliate at any time prior to, upon, or in connection with the receipt,
        exercise, or distribution</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">of
        an
        Award. In addition, the Company, an Affiliate, the Board, the Committee,
        and
        any</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
        attorneys, accountants, advisors, or agents for any of the foregoing shall
        not
        provide any advice, counsel, or recommendation to any Participant with respect
        to, without limitation, any Award, any exercise of an Option, or any tax
        consequences relating to an Award.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>24.</u></strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>Liability
        and Indemnification</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        No
        member of the Board, the Committee, or any </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">officer
        or employee of the Company or any Affiliate shall be personally liable for
        any
        action, failure</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
        to act,
        decision, or determination made in good faith in connection with this Plan.
        By
        participating </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">in
        the
        Plan, each Participant agrees to release and hold harmless the Company and
        its
        Affiliates (and</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
        their
        respective directors, officers, and employees) and the Committee from and
        against any tax </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">liability,
        including, but not limited to, interest and penalties, incurred by the
        Participant in connection</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
        with his
        receipt of Awards under the Plan and the payment, and exercise thereof. Each
        </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">person
        who is or shall have been a member of the Committee, or of the Board, shall
        be
        indemnified</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
        and held
        harmless by the Company against and from (i) any loss, cost, liability, or
        expense (including, but not limited to, attorneys fees) that may be imposed
        upon
        or reasonably incurred by </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">him
        or
        her in connection with or resulting from any claim, action, suit, or proceeding
        to which he or</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">she
        may
        be a party or in which he or she may be involved by reason of any action
        taken
        or failure to</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
        act
        under the Plan or any Award Agreement, and (ii) any and all amounts paid
        by him
        or her in settlement thereof, with the Company's prior written approval,
        or paid
        by him or her in satisfaction </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">of
        any
        judgment in any such claim, action, suit, or proceeding against him or her;
        provided, however,</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
        that he
        or she shall give the Company an opportunity, at the Company's expense, to
        handle and defend such claim, action, suit, or proceeding before he or she
        undertakes to handle and defend the same on his or her own behalf. The foregoing
        right of indemnification shall not be exclusive of any other rights of
        indemnification to which such persons may be entitled under the Company's
        Articles of Incorporation or By-Laws, by contract, as a matter of law or
        otherwise, or under any power that the Company may have to indemnify them
        or
        hold them harmless.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">APPENDIX
            A -
            8</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>25.</u></strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>Mitigation
        of Excise Tax</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        Subject
        to any other agreement providing for the Company's indemnification of the
        tax
        liability described herein, if any payment or right accruing to a </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Participant
        under this Plan (without the application of this Section), either alone or
        together</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">with
        other payments or rights accruing to the Participant from the Company or
        an
        Affiliate</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
        would
        constitute a "parachute payment," as defined in Section 280G of the Code
        and
        regulations thereunder, such payment or right shall be reduced to the largest
        amount or greatest right that will result in no portion of the amount payable
        or
        right accruing under this Plan being subject to </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">an
        excise
        tax under Section 4999 of the Code or being disallowed as a deduction under
        Section 280G</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
        of the
        Code. The determination of whether any reduction in the rights or payments
        under
        this Plan is </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">to
        apply
        shall be made by the Committee in good faith after consultation with the
        Participant, and</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
        such
        determination shall be conclusive and binding on the Participant. The
        Participant shall cooperate in good faith with the Committee in making such
        determination and providing the necessary information for this purpose.
</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>26.</u></strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>Proceeds</u></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
        The
        proceeds received by the Company from the sale of Shares pursuant to the
        Plan
        will be used for general corporate purposes.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br>
        <div align="left">
          <table cellpadding="0" cellspacing="0" width="100%">

              <tr>
                <td align="left" valign="top" width="60%">&#160;</td>
                <td align="left" valign="top" width="40%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Adopted
                    by the Board of Directors of Bioanalytical Systems,
                    Inc.</font></div>
                </td>
              </tr>
              <tr>
                <td align="left" valign="top" width="60%">&#160;</td>
                <td align="left" valign="top" width="40%">&#160;</td>
              </tr>
              <tr>
                <td align="left" valign="top" width="60%">&#160;</td>
                <td align="left" valign="top" width="40%">&#160;</td>
              </tr>
              <tr>
                <td align="left" valign="top" width="60%" style="border-bottom: #ffffff solid;">&#160;</td>
                <td align="left" valign="top" width="40%" style="border-bottom: black thin solid;">&#160;&#160;
</td>
              </tr>
              <tr>
                <td align="left" valign="top" width="60%">&#160;</td>
                <td align="left" valign="top" width="40%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">William
                    E. Baitinger</font></div>
                </td>
              </tr>
              <tr>
                <td align="left" valign="top" width="60%">&#160;</td>
                <td align="left" valign="top" width="40%">&#160;</td>
              </tr>
              <tr>
                <td align="left" valign="top" width="60%">&#160;</td>
                <td align="left" valign="top" width="40%">&#160;</td>
              </tr>
              <tr>
                <td align="left" valign="top" width="60%" style="border-bottom: #ffffff solid;">&#160;</td>
                <td align="left" valign="top" width="40%" style="border-bottom: black thin solid;">&#160;&#160;
</td>
              </tr>
              <tr>
                <td align="left" valign="top" width="60%">&#160;</td>
                <td align="left" valign="top" width="40%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Larry
                    S. Boulet</font></div>
                </td>
              </tr>
              <tr>
                <td align="left" valign="top" width="60%">&#160;</td>
                <td align="left" valign="top" width="40%">&#160;</td>
              </tr>
              <tr>
                <td align="left" valign="top" width="60%">&#160;</td>
                <td align="left" valign="top" width="40%">&#160;</td>
              </tr>
              <tr>
                <td align="left" valign="top" width="60%" style="border-bottom: #ffffff solid;">&#160;</td>
                <td align="left" valign="top" width="40%" style="border-bottom: black thin solid;">&#160;&#160;
</td>
              </tr>
              <tr>
                <td align="left" valign="top" width="60%">&#160;</td>
                <td align="left" valign="top" width="40%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">David
                    W. Crabb</font></div>
                </td>
              </tr>
              <tr>
                <td align="left" valign="top" width="60%">&#160;</td>
                <td align="left" valign="top" width="40%">&#160;</td>
              </tr>
              <tr>
                <td align="left" valign="top" width="60%">&#160;</td>
                <td align="left" valign="top" width="40%">&#160;</td>
              </tr>
              <tr>
                <td align="left" valign="top" width="60%" style="border-bottom: #ffffff solid;">&#160;</td>
                <td align="left" valign="top" width="40%" style="border-bottom: black thin solid;">&#160;&#160;
</td>
              </tr>
              <tr>
                <td align="left" valign="top" width="60%">&#160;</td>
                <td align="left" valign="top" width="40%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Leslie
                    B. Daniels</font></div>
                </td>
              </tr>
              <tr>
                <td align="left" valign="top" width="60%">&#160;</td>
                <td align="left" valign="top" width="40%">&#160;</td>
              </tr>
              <tr>
                <td align="left" valign="top" width="60%">&#160;</td>
                <td align="left" valign="top" width="40%">&#160;</td>
              </tr>
              <tr>
                <td align="left" valign="top" width="60%" style="border-bottom: #ffffff solid;">&#160;</td>
                <td align="left" valign="top" width="40%" style="border-bottom: black thin solid;">&#160;&#160;
</td>
              </tr>
              <tr>
                <td align="left" valign="top" width="60%">&#160;</td>
                <td align="left" valign="top" width="40%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Richard
                    M. Shepperd</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">APPENDIX
            A -
            9</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">APPENDIX
        B - NOMINATING COMMITTEE CHARTER</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><br>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>BIOANALYTICAL
          SYSTEMS, INC.</strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>NOMINATING/CORPORATE
          GOVERNANCE COMMITTEE</strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>OF
          THE BOARD OF DIRECTORS</strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>CHARTER</strong></font></div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 54pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 54pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>I.</strong></font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Purpose</strong></font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
        Charter shall govern the operations of the Nominating/Corporate Governance
        Committee ("Committee") of the Board of Directors of Bioanalytical Systems,
        Inc.
        (the "Company"). The primary purpose of the Committee is to identify and
        recommend the nomination of qualified directors to the Board of Directors
        of the
        Company.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 54pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 54pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>II.</strong></font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Composition</strong></font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        membership of the Committee shall consist of at least three directors who
        shall
        be free of any relationship that, in the opinion of the board, would interfere
        with his or her individual exercise of independent judgment, and shall be
        "independent" as defined in NASDAQ Market Place Rule 4200. The Board of
        Directors may, at any time and in its complete discretion, replace a Committee
        member.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Board
        of Directors shall appoint one member of the Committee as chairperson. He
        or she
        shall be responsible for leadership of the Committee, including preparing
        the
        agenda, presiding over the meetings, making Committee assignments and reporting
        to the Board of Directors.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td align="left" style="width: 54pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>III.</strong></font></td>
              <td align="left">
                <div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Meetings</strong></font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Committee shall meet at least annually, or more frequently as circumstances
        dictate.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">

            <tr valign="top" style="line-height: 1.25;">
              <td align="left" style="width: 54pt;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>IV.</strong></font></td>
              <td align="left">
                <div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Responsibilities</strong></font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Committee shall:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Oversee
        the search for qualified individuals to serve on the Board of Directors.
        Qualified individuals will complement the Company's mission of advancing
        health
        care through innovative science. The Company's policy is that a majority
        of the
        members of the Board of Directors be independent as defined by the listing
        standards of NASDAQ and the rules of the Securities and Exchange Commission.
        To
        assist in the search for qualified directors, the Committee will consider
        shareholder suggestions for nominations that are submitted as required by
        the
        Bylaws and, as it deems necessary, employ outside search firms to assist
        in
        identifying qualified candidates.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Recommend
        to the Board of Directors those director nominees who, in the Committee's
        opinion, the full Board should recommend for shareholder approval at the
        annual
        meeting. The Committee will base its recommendation for nomination on criteria
        that it believes will provide a board perspective and depth of experience
        in the
        Board of Directors. In general, when considering independent directors, the
        Committee will consider the candidate's experience in areas central to the
        Company, such as science, business, finance, legal and regulatory compliance,
        as
        well as considering the candidate's personal qualities and
        accomplishments.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Oversee
        the administration of the Board of Directors, including, at least annually,
        review and recommend the appointment of directors to committees of the Board,
        monitor and review the functions of the committees, and review and advise
        the
        Board concerning the directors' compensation and benefits.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">APPENDIX
            B - 1</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Draft
        such policies as it deems necessary to carry out its functions, and annually
        review and evaluate this charter and any related policies.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">e.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Be
        authorized to delegate any duties of the Committee to subcommittees, and
        hire
        counsel and other experts as the Committee, in its sole discretion, deems
        appropriate.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">f.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Report,
        at least annually, to the Board of Directors.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">g.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Perform
        any other duties assigned to it by the Board of Directors.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">APPENDIX
            B - 2</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">APPENDIX
        C - COMPENSATION COMMITTEE CHARTER</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>BIOANALYTICAL
          SYSTEMS, INC.</strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>COMPENSATION
          COMMITTEE</strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>OF
          THE BOARD OF DIRECTORS</strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>CHARTER</strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 36pt;">&#160;</td>
              <td style="width: 36pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings 2, serif">&#8211;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Purpose</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
        Charter shall govern the operations of the Compensation Committee ("Committee")
        of the Board of Directors of Bioanalytical Systems, Inc. (the "Company").
        The
        primary purpose of the Committee is to exercise the power and authority of
        the
        Board of Directors relating to the compensation of officers of the Company.
        </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 36pt;">&#160;</td>
              <td style="width: 36pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings 2, serif">&#8211;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Composition</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        membership of the Committee shall consist of at least three directors who
        shall
        (1) be free of any relationship that, in the opinion of the Board of Directors
        ("Board"), would interfere with the member's exercise of independent judgment,
        (2) be "independent," as defined in NASDAQ Market Place Rule 4200, (3) be
        an
        "outside director," as that term is used and defined in Section 162(m) of
        the
        Internal Revenue Code, as amended ("Code"), and the relevant Treasury
        Regulations promulgated thereunder, or any successor rule or regulation,
        and (4)
        be a "Non-Employee Director" as that term is defined by Rule 16b-3 of the
        Securities Exchange Act of 1934. The Board may, at any time and in its complete
        discretion, appoint, dismiss, or replace a Committee member. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Board
        shall appoint one member of the Committee as chairperson, who shall be
        responsible for leadership of the Committee, including preparing agenda,
        presiding over meetings, making Committee assignments, and reporting to the
        Board of Directors. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 36pt;">&#160;</td>
              <td style="width: 36pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings 2, serif">&#8211;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Authority
                  and Responsibilities</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Committee shall have the authority and responsibility of the Board to:
</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.
        At
        least annually, the Committee shall:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a)</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">review
                  and approve corporate goals and objectives relevant to compensation
                  and
                  benefits for the officers of the Company. The Committee shall evaluate
                  the
                  performance of each officer, including the Chief Executive Officer,
                  in
                  light of those goals and
                  objectives;</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b)</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">review
                  and approve all elements of each officer's compensation, including
                  but not
                  limited to (i) annual base salary, (ii) annual incentive compensation
                  opportunity, whether in the form of cash or equity, (iii) long-term
                  incentive compensation opportunity, whether in the form of cash
                  or equity,
                  (iv) special benefits, and (v) employment agreements, severance
                  agreements, and change in control agreements, if appropriate;
                  </font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c)</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">review
                  the compensation systems in place for officers to make sure that
                  they are
                  appropriate in light of the Company's objectives and performance
                  and the
                  compensation provided by comparable companies;
</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d)</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">review
                  this Charter and any policies adopted by the Committee; and
                  </font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

            <tr valign="top" style="line-height: 1.25;">
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 18pt;">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">e)</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">evaluate
                  its own performance and the performance of any compensation consultant
                  retained by the Committee and provide a report of such evaluation
                  to the
                  Board.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Committee shall draft such policies as it deems necessary or appropriate
        to
        carry out its functions.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">APPENDIX
            C -
            1</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Committee may hire counsel and other experts, including compensation
        consultants, as the Committee, in its sole discretion, deems
        appropriate.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Committee shall review the proposed Compensation Discussion &amp; Analysis
        (CD&amp;A) section of the Company's proxy statement, discuss that section with
        management, and based on that review and discussion, make a recommendation
        to
        the Board regarding the inclusion of the CD&amp;A in the Company's filings with
        the Securities and Exchange Commission, as required. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Committee shall make regular reports to the Board.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Committee shall have the authority to approve all transactions between the
        Company and any director or officer, other than certain transactions pursuant
        to
        an "employee benefit plan," as described by Rule 16b-3 of the Securities
        Exchange Act of 1934 or any successor rule.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Committee shall establish "performance goals," as that term is used in Code
        Section 162(m) and the Treasury Regulations promulgated thereunder, or any
        successor rule or regulation, to determine the payment of any performance-based
        compensation, disclose the material terms under which such compensation will
        be
        paid to the Company's shareholders for approval, and certify in writing prior
        to
        the payment of such compensation that the performance goals and any other
        material terms have been satisfied.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
        Committee shall perform any other duties assigned to it by the Board of
        Directors. </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">APPENDIX
            C - 2</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">APPENDIX
          D&#8212;AUDIT COMMITTEE CHARTER</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>BIOANALYTICAL
          SYSTEMS, INC.</strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>AUDIT
          COMMITTEE OF THE BOARD OF DIRECTORS CHARTER</strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ADOPTED
          FEBRUARY 19, 2004</strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>PURPOSE</strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
          Charter shall govern the operations of the Audit Committee ("Committee")
          of the
          Board of Directors of Bioanalytical Systems, Inc. (the "Company"). The
          purpose
          of the Committee is to oversee the Company's accounting and financial reporting
          processes and the audits of the Company's financial statements. It is not,
          however, the Committee's responsibility to prepare and certify the Company's
          financial statements, to guaranty the independent auditor's report, or
          to
          guaranty other disclosures by the Company. Committee members are not employees
          of the Company and are not performing the functions of auditors or
          accountants.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>COMPOSITION</strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
          Committee assists the Board of Directors in fulfilling its responsibilities
          for
          oversight of the quality and integrity of the accounting, auditing and
          reporting
          practices of the Company and other such duties as directed by the Board.
          The
          membership of the Committee shall consist of at least three directors who
          are
          generally knowledgeable in financial management. In addition, at least
          one
          member of the Committee must have experience or background which results
          in such
          member's "financial sophistication" within the meaning of the NASDAQ Audit
          Committee Rule, taking into account the non-exclusive list of specific
          factors
          and criteria that the NASDAQ Audit Committee Rule specifies with respect
          to the
          determination of "financial sophistication." The Board of Directors may,
          at any
          time and in its complete discretion, replace a Committee member. Each member
          shall be free of any relationship that, in the opinion of the Board, would
          interfere with his or her individual exercise of independent judgment,
          and shall
          meet the director independence requirements for serving on audit committees
          as
          set forth in the corporate governance standards of NASDAQ.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
          Board
          of Directors shall appoint one member of the Committee as chairperson.
          He or she
          shall be responsible for leadership of the Committee, including preparing
          the
          agenda, presiding over the meetings, making Committee assignments and reporting
          to the Board of Directors. The chairperson will also maintain regular liaison
          with the CEO, CFO and the lead independent audit partner.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>MEETINGS</strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
          Committee shall meet at least semi-annually, or more frequently as circumstances
          dictate. At least twice each year, the Committee shall have a regularly
          scheduled meeting at which only members of the Committee are present (which
          may
          be held in conjunction with other meetings of the Committee), and the Committee
          shall meet at least annually, and more often as warranted, with the Chief
          Financial Officer and Chief Accounting Officer, and the independent auditors
          in
          separate executive sessions to discuss any matters that the Committee or
          each of
          these groups believes should be discussed privately. The Committee may
          require
          any officer or employee of the Company or its subsidiaries, or the Company's
          outside counsel or independent auditor, to attend a Committee meeting or
          to meet
          with any members of, or representatives of, the Committee, and to provide
          pertinent information as necessary. The Committee shall maintain minutes
          and
          other relevant documentation of all its meetings.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>RESPONSIBILITIES</strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
          Committee's primary responsibilities include:</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 15.95pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Directing
          the appointment, compensation, retention and oversight of the work of any
          registered public accounting firm engaged (including resolution of disagreements
          between management and the auditor regarding financial reporting) for the
          purpose of preparing or issuing an audit report or performing other audit,
          review or attest services for the Company or its subsidiaries, and each
          such
          registered public accounting firm must report directly to the
          Committee.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 15.95pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Approving
          in advance, as required by applicable laws and regulations, all auditing
          services and permitted non-audit services proposed to be performed for
          the
          Company or its subsidiaries by any such registered public accounting firm.
          The
          Committee may establish pre-approved policies and procedures pursuant to
          which
          the Company and its subsidiaries may engage a registered public accounting
          firm
          to perform services, provided that the </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">policies
          and procedures are reasonably detailed as to the nature and scope of the
          particular services that are to be performed and the maximum amount of
          fees that
          may be paid for each particular service, and the Committee is informed
          of each
          service that is actually approved pursuant to such policies and procedures
          not
          later than the next scheduled meeting of the Committee. The Committee may
          delegate authority to one or more members of the Committee to grant such
          pre-approvals, provided that the decisions of such member(s) to grant
          pre-approvals shall be presented to the full Committee at its next scheduled
          meeting.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">APPENDIX
              D -
              1</font></div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 15.95pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Engaging
          independent counsel and other advisers, as the Committee determines necessary
          to
          carry out its duties.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 15.95pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Overseeing
          the independent auditor relationship by discussing with the auditor the
          nature
          and rigor of the audit process, receiving and reviewing audit reports,
          and
          providing the auditor full access to the Committee (and the board) to report
          on
          any and all appropriate matters.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 15.95pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Ensuring
          receipt, from each registered public accounting firm engaged for the purpose
          of
          preparing or issuing an audit report or performing other audit, review
          or attest
          services for the Company, of a formal written statement delineating all
          relationships between such firm and the Company, consistent with Independence
          Standards Board Standard 1, and the Committee shall actively engage in
          a
          dialogue with such firm with respect to any disclosed relationships or
          services
          that may impact the objectivity and independence of such firm, and shall
          take,
          or recommend that the Board of Directors take, appropriate action to oversee
          the
          independence of such firm.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 15.95pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Reviewing
          the audited financial statements and discussing them with management and
          the
          independent auditor. These discussions shall include consideration of the
          quality of the Company's accounting principles as applied in its financial
          reporting, including review of estimates, reserves and accruals, review
          of
          judgmental areas, review of audit adjustments whether or not recorded and
          such
          other inquiries as may be appropriate. Based on the review, the Committee
          shall
          make its recommendation to the Board as to the inclusion of the Company's
          audited financial statements in the Company's annual report on Form
          10-K.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 15.95pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Reviewing
          with management and the independent auditor the quarterly financial information
          prior to the Company's filing of Form 10-Q. This review may be performed
          by the
          Committee or its chairperson.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 15.95pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Approving
          all transactions with related parties, if and to the extent required by
          Rule
          4350(h) (or any successor rule) of the Marketplace Rules of the NASDAQ
          Stock
          Market, Inc., as such requirement may from time to time be amended.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 15.95pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Discussing
          with management and the external auditors the quality and adequacy of the
          Company's internal controls.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 15.95pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Discussing
          with management the status of pending litigation, taxation matters and
          other
          areas or oversight to the legal and compliance area as may be
          appropriate.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 15.95pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Reporting
          Committee activities to the full Board and issuing annually a report to
          be
          included in the proxy statement (including appropriate oversight conclusions)
          for submission to the shareholders.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If
          and to
          the extent that, by reason of any change or amendment to applicable law
          or
          regulation or the NASDAQ Audit Committee Rule or other rules applicable
          to
          NASDAQ issuers, the Company is required to maintain an audit committee
          that has
          composition, structure, duties, authority or responsibility that is different
          than provided by this Charter, then (and to that extent) this Charter shall
          be
          deemed amended in such a manner as to cause the Committee to comply with
          such
          changed or amended laws, rules or regulations.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">APPENDIX
              D - 2</font></div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><img src="proxycardx1x1.jpg" alt="">
        <div>&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><img src="proxycardx2x1.jpg" alt=""></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN">
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
      </div>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>proxycardx1x1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxycardx1x1.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#`!`+#`X,"A`.#0X2$1`3&"@:&!86
M&#$C)1TH.C,]/#DS.#=`2%Q.0$1713<X4&U15U]B9VAG/DUQ>7!D>%QE9V/_
MVP!#`1$2$A@5&"\:&B]C0CA"8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C
M8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V/_P``1"`0A`RX#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#T"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M9(Q2)W"EBH)VCO3Z;)N$;&,`O@[0>F:`.0T/7I-:MS*VM16EZSL$M"B;!Z`Y
M&YOP(JUJ%YJ$7C+3].CU"5+:ZC9W0)&<$!C@$KG'R]ZK:YH3ZY`(UT1+.\9P
M7NRZ;0!U(*G<V?<#\*GOK'4&\7Z;?1V,TMM:1-&\F^,%B589`+9QSW]Z`'6]
MUJ%_XHU:P&HS6\-LJ&(1QQG!*CKN4DU3N?$U]_PCFL'<D.I:=,L3.B\,#(`&
MVMG&1GUJY;VNH6'BG5K\:=-<07*H(C')&,D*.NY@152Y\-7O_".:N`B2ZEJ,
MRRLB.-H`D#!03CH,T`:^A7<5TL#?V[]LG:(,]ONA.#@9X50PP?>I?$^IMI.@
MW5U&VV4+MC.`<,>`>?3K^%2:3-<K;6]K/IUS`8XE5I':,KD`#^%R?TJAXDTN
M[U?4-+MUC/V".4RW$@<*01T`YSZ\CUH`3PAJE[?6]U;:JV;ZTEVR<`'!Z<#C
MUKHJYJUT>YTSQ>UU:12/87,&V9WFWE7'0G<=QZ#UZUTM`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`07EU#8VLES<O
MLAC&YVP3@?057M=8L;NX:WBE=9@GF>7+$\;%?4!@,CZ5!XIAEG\.7T4,;R2-
M'A4122>>P%9EK:7=EXA22[2>\2>T\N&XV<P8Y*,%`')[D9[4`:UIKVGWL8EM
MFN)(B"1(+679@9S\VW'8_P`JE.KV`L8+PW`^SW#*L3!2=Q;@#&,U@^"DEM=-
MM;6Z?48I1O!MI+0K$N6)^_L].>6[_A4>FZ9=)K4.G26SKI^GSRW,4A3"/NP4
M4'U!9ORH`WYM<T^&21&F<^4<2ND+ND9]&8`A?Q/%33ZE:0+&S2[_`#5W1K$I
MD9QQR%4$D<CFN:M8IM/TK6=/GL9WN+F:9HO+A9UE#C"DL!@?B1BG:;IMUI&H
M:?>7<<CPQZ<+=Q$AD,;[@<;5!/X@=J`.ADU:QATY[^6?9;)]YV5@0<XP1C.<
M]L9I)=7L8=.BOWF/V:;;L=49BV[IP!G]*R=9@O-:>QM[:V:"U:8S323Q\$*/
ME#)D$Y/;(Z#-95QIVHVOA^33GAE=;:_1H9((RV8RV<A?F/!SP<]NM`'4IK5@
M]M<SB<A+49F#QLK1]^5(S^E3S7]M!IYOI9=ML$$A?:3\I[XZUR9L[E[?Q&T,
M-U/'<P#;-/`4EE<+C:%P.!_NBKU](UYX-GLX+>[-PEHJF-K:122`!@949_"@
M#=L[^"]SY*S@``YDMY(P1[%@,_A4%UKFGV=S);SRN)(E#R;878(IZ$D`@#ZF
MHM"<F'8UQ?2LJ+E;FV\H)[`[%S^9K-N=,O+WQ'JB(WV>VN;1(GE:$MN!R"%.
M0`<'W^E`&M-KNG0S)"9GDDDA$ZB&%Y<QGC=\H/%/.L:>+&*\%TC03';&RY)=
MO[H`Y)]L9KGI]%NXO$4,.FRSVT<.E>3'<;`R[@YPI)!'OQ@U%#:SKIVB,FF3
M1#3KDBYA$;$^\B@\L,\\9ZT`=,NLV+1SOYDB_9UWR(\+JZKZ[2-V/?%(-;TX
MBVVW&_[4ADB"(S%E`R3@#(_&L?\`>2>)KC64M+DVD5CY.#`ZO*^[.`A&3]<5
M1\+Z==Z/K`ENK`A-0C)0QHS"T^8GRSQP#D?B*`.F76].:TMKI;D-#=.(X2JL
M2['MC&>QK0KEM-T1H/%ER["7[%!F:V1E.Q9)/O8/MCIVS74T`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!5:_OK;3K8W-W(8X@0"0I;DG`X`)JS6%XR@FN-
M`>.WCED?S8SB)"S8##)P`:`+:ZW:2P73VRSSR6N/,MTA82C/3Y&`-:"-O16V
ME=P!PPP1]:XF>RNI%U][>"[N(KJV7]_<0E)9)!P%5=J\8]%_.GW]C<M+?_:[
M2:X>2TC73F6)G\EPN#R!\AW8.3CZT`=K17%:U#J4]FUK/8B2YAM$9;D6[S-)
M*`,[&7`C((//?TI]_I]Q=7.H/-:2R[]&"J6C)S*,D`?[6?QH`[*JC:A$NK)I
MQ5_.>$S!L#;M!QZYSSZ5R=\E]/H]O:S:<[RC3@PGEMWF?S0I^48^X_\`M']:
ML6NG7%]=6,=]#/MDT8PS2.IX<D<$G^+OZT`=7<3QVUO+<3-MBB0N[8S@`9)X
MJL-2B=;.2"*>>*[Y22.,E5&,@MGH*Y'2;6YUK3]1-S&))K2S;3H@QR#(`<MS
MW^YS5JQLBEKX=6"PEA>"8?:O]'9,-Y>"S<#/^]^M`'8TUV"(S'HHR:YC1K46
M27(NM-EDU4RRN91$1Y@))'[SI@\<9_"JNFQ7CZS!<_8C;+-;2B=([5XP&_A#
ML?OM_M8&>:`.IT^_AU#3HKZ(,D4J[QYF`0/>H[;5[*Z=%AF+>8<1L8V59#@G
MY6(PW`/0FJ.AV[Q>#H(+BVD+BV97@(VNW7Y>>A-9NFV=U!?6EE927LVF!76X
MCO8-HB&/E"DJ"3U'&1B@#KJANKF*SMI+FX?9%$I9VP3@#V%<=H5K<3:@]G/Y
MA31(Y8HG7EF9R=I';(0?K3(]+O3I^I:>MFES']F;;<FV:&227/0AOOGC.[]:
M`.WCD66-9$.4<!E/J#3ZXR[L&DAT>2WLMEE"K"XADLG8+(5'S-"-I;G///K1
M%I4PU+0$=)[JVC-SO>2W9%167A2&R5'8`T`=G17%:387<$.A,;:X66&ZEC=F
M1MRQ?-@'_9Z8SQ5C3(+K3]:+&+S[=O,EGNIK=HI8QC(!<G#]<<9QCM0!UC':
MI)S@#/`S5/3M5L]3\W[&\C^2VQ]T+IM;N/F`Y]JDLKQ;RPBNQ%+$DB;PDB_,
M!]!FN(EMKJ;PIK]NEE=^=-?F:-#;N"Z%TP1D<]#QU%`'H%%<E>:=>?:-?AL(
M'C6XM8_+P-J.^"&P>F2*T;":ST[3P]GI5VFT*KQQ6K*Q8X&<'&['=N>!UH`W
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***IZM)<QZ7<M91F6YV$
M1*/[QX'Y=:`$L-5L=2DG2SN!*UNVR4`$;3SZ_0\U=KD-'T2^T+4[,HJ36\UL
M89_*CV;&'(9LL<DDD9&/I570=-N;:U\.2&SFBG2699SY95E0EB`WMTZT`=S1
M7#Q:?=Q0:9+':3K.NKL781G<(BYSGCA2/PIOV.\CMKRU-G<F0ZT+@$1,5,99
M?F!Z$<?AWH`[JJEG?Q7D]U%&KAK63RG+`8)P#QSTYKE=32^NM2\U--,$UO?(
MJNEN[2/'NY?S1P%(/*\XYK=T2&6+4-8:2)T62ZW(64@,-B\CU%`%R#4[.XOK
MBRBG#7%L`94VD;<^Y&#^%&FZI9ZK"\UA.)HT<HS!2/F&#W'N*YJ;2]1EU74I
MK2)D=[I8R[#;NA=`'*DXSC`/'I5,:5J)TF^CAMY$4:PTKQO&?WL/'1>-X]@>
M<4`=[5>\O+>QC22YDV*[K&IP3EB<`<5R%SI5ZVER"R9I(#>1RO;BS>!`@!#*
ML;'+#."1QGG%%UI#/I<A2%KB(7D4H@6Q:%8U'WPD;$M@CJ!UH`Z];K=?O:^1
M.-L8?SBG[LY.,!O7VJQ7&ZE9R276IM9V4RV\FDB.%5@91G)^4#`P?;K3?[/O
MXM1/V""6%I=%"EPI53,.!D]-V/7F@#M**Y#1X8(->TL0VK6SFP?S0\>QV?*@
MEL\DY[]ZO:W;L^MVLM[;/=:8L#J8EB,H$N>"5&<\<`XXH`TM0U6*QN;:V\J6
M>YN2WE11`9.T9)RQ`''O4]Y>V]C");J01J2%'&2Q/0`#DGV%<?9:1=G4O#K:
MA9M*8UG\UI$W[%P3&';U&>,]ZW_$EG!>6]N)UNQY4HD2:U4L\3#H<`$D?0&@
M":YURSMX8Y2)6#S)#M\LJRLW3(;!%:=<5<0:K<V@6=;BYA748#`\D.V4QC[Q
M8``@`^H]:L&.ZL!K"P::\L+7:>7&8V*!2OS,%'WAGJ!UH`ZVBN"FT^].BZK;
M);3>6UW"T*16[Q+MRI8HAR0/Y5?U?1?L]_:"&W#Z<D<FY9(7NPLC'.XH&W$G
M)YYQ0!T<FH11ZI#I[*_FS1M(I`&T!<9SS[U;KD+72YC>:9%<K/>0I93(TL\!
M7.6^4,#G!QV//%5M,M;O^S]%.KVES-:113+-"\+.5;>=A9,9/'3CB@#K;K4(
MK6]L[617+W;,J%0,`J,G/-%W?Q6EQ:02*Y:ZD,:%0,`@$\\^U<S:66HH^A>;
M#-F*>X;Y@6\I"#LW'G';K]*9IME,KZ,9+*X%Y'=.;R9XCDG:V"7QR.F#T[4`
M=78V-OI]N(+2,I'N+8+%B23DDDDDU9KB-.TJ\COH3<,\%XEX9&E2R=VF3)X:
M;=MVD=CTP.,]9;'03+INIR2B[M;N2YF6.50^Y4+@Y5,@$''..2*`.RJO;7EO
M=23QP2;VMW\N08(VMC..>O6LKPNES'!<1S6L4$2.!"\<#0>8,<GRSR.?IFLI
M],GB_M^.RLS#?S.7MIEA(RA`R%D`P">>,]>:`.RK.O=;T^QNC;7$L@F6/S65
M(7?"=-QV@X%9>BVS)K8ELK66UL1:!)E>(Q!YL]=I`R<=6[^IJIK=M*WBR65O
MM\5N^G&(RVMN9-S%C\OW6QQ]/K0!T>FV]E%$\]@`4NW,[.'+;R>^2:N$@`D]
M!7#G3M1-GHIO;*,001.DD)MVN$C.?E)C#9)QWYQS72Z);26NB)`\TLY4-M:2
M,HV,G`VDDC\>:`)$UK3Y-.BOTN,VLKA$?8W+%MN,8SUK0K@;/2=03P?8*QO0
MZW*EK0Q+A1YI.<;=W3GK5G4=+NI=8U$SAXS,Z&UN5LWG=0`.$=6'EX/7(`.?
M2@#J+74H;K4;VQC602V>SS"P&T[AD8Y]J1;RVO+Z\TQHBYA1?-#J"C!P>/?I
MSD5S%[9:@;SQ`\<%P4E>T)**0944?.%]?<#Z5J:';"+7]2E@M'M[1X8!%F$Q
M@X!S@$#\J`+]SKEA9W*6DQG25B5C06LIWXZ[<+@X]JDM-5@N[^>TC2420HDC
M%TVC##(X/(/L0*S=;MYY?$V@2QPR/'$TWF.JDA,J,9/:L_5]/FGOO$+BTDDW
M6L1@81DY<`_=/J#Z4`=A17(S6]W'KHN9+:X=9]',`98RW[S.<-Z'ZU#::,UX
M^AP7UK<>0FGLDP^=`#Q\K$8Q]#0!VE5+K4(K6]L[617+W;,J%0,`J,G/-<Y%
M9WMMKS&V0W/GR.[RSVS*\"D<`2_=*YQA>?I4&FV4J7&@M]@N%N(9)?MDKQ$$
MOL(R6(Y!['./>@#M:*XJTCO;C6].O&TTV;F:2.X1+9PP7:0-\AX<'`QQCIS2
M:-:R?\)#_9<G_'IHTLDRG/!W@&,?@"U`';5GP:WIUQ:7-U%<AH;4L)FVL-I`
MR>",G\*FTZ]CU&S2ZB21(Y,[=X`)&>O7H>HKDM,TC4!%$5MV2&627[4K@JV%
M=FCP#UR3Z=*`.PLKN"_M([JU?S(9!E6P1G\#S4]<9:0W,?A_1[&?3-RNCK*T
M]L\HB.<@&,8//J<8JM8:;>7>G>'8;^WNR$EG$VX.K(O.,G@@=!0!WE4M-U.'
M4_M7D+(OV:=K=]X`RR]2,'IS6)::?!::Y>M>:?+(6,:V<JQ-(%C"@;0PSL(Y
MSG&?>LU--N5ANYA9S"X&N&2-Q&0WEDC+`]=I&>>E`':W%Q';1&24D*..%+$G
MT`')/L*JQZQI\EG+=BY"PPMLD+J5*-G&"I&0?;%/U2[-C8O<):S74B?<BB0L
MQ/X=/K7*+I]U/H=S)MGFOY;N.ZN(S;O$,`_=7>!G`'^>*`.ML[^VOA)]GD):
M,X=&1D93VRK`$?E4\LB0QM)(P5%&6)["N;M[@V>JZOK4UM.EK*(8XE,9625@
M,<*V#U(`S70SRB*U>5XG<*NXHB[F/L`.IH`AM]4L[EIE24JT`W2+(C1E1ZX8
M#CWZ4VSU>QO7*6\^6">8`R,FY/[PW`97W'%<S#;7.KKJ]U-%/#>WELT,,$EO
M(BQH.@+E0"2?>GQV-WJ,ELD5O-:^1I;VSM)&4"R%0H49QG'7(XH`Z*TUBPO9
MO*MY]S$%ERC*'`."5)`##W&:;;ZYIUU<)##<[FD)$;;&"2$=0K$;6/T-<Y86
M5W/<Z"JVDL;:9;RK<>=&47<5VA02,-DCJ,C%1Z-I][#<Z0HAN,V\DAFMY82L
M-N&))*-CYCSQRW7M0!W%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%-90ZE6&01@BG44`4
MK;2K.UO7O(HW-PZ;#(\K.0N<X&XG`SV%7:**`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*K06%K;R
MW,L40#W3;IB23O.,=^V.U6:*`&HJHBHBA548"@8`%.HHH`****`"BBB@`HHH
MH`8\:28\Q%;:0PW#.".A^M/HHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`*9(I>-E5VC+`@.N,K[C((_,4^B@#E;B[U&TT_4+D:A<3/;W:0(C)%RI:/
M/11SAB.N.:6]UK4%U1X@DMJ@:U`BE$9.'D*L<J6ZCCK6M)%I<MM>H^TQ+-YE
MQ\S##C:<_H.G''UIL<.EZK<O-Y4AG7RRPD62)OE8LAVMCC.><<T`4+/5+U/$
M!M-1>>'S)'6)#"IAD7DKM<<@X&3G/X4S5M0OUU6]M[6XN@\5O&]O##;B17<[
MN'.TX!P.X[U;LUT7^T%>".99?,;R]Z3"(/SNV;ALR>>G7FK-O=Z:VI220LWV
MB<",R%'"2;<X"L1M.,GI0!B7.JWXN[^-;RX2YBE2.W@6!3$S%%.UGV'J2?X@
M:T9+N]GBU&YBNA!]B9T6'8K*Q50?GR,\Y[$<5)OT:Y%W&P.RY_>2NZNB2;0/
MF5S@'`4<J>V:1UT:\:22591A1YBR++&)1P`64X$@Z<D&@"C/JU[_`&W:V*74
M<<5ZL<H8@;X."2F,8.['&>>OM5N"YU)M9.F-)\L+>>]QM7+Q'.U,=CG()QT7
MU-.D&C27$]M)%*7GG7>[12A3(OW0),8&,8`!ZU=+V,2OJO/SQJAD`8DJ"<#;
M]2>V>:`,[5+[4H]2O+>P'F-'9QRQQX&=QD8,1ZG:.`>*G\-ZB=0M)O,FG>6*
M0JR7$(CECXSA@.#]0!QVJ06^FZO+-(]M.7,:QNTT,L7R@DKC<!R#DY'(_*G:
M>VFP2?9[1_WLX,QWLS/(`=I)9N3CIUH`PX_$%]9SWBZD)H[B*&61+=X1Y4FW
MD&-QSC'7.:T9+F\L7LVDO&N1>;E*LB@1G8S@K@#CC'.?KZSPVFE6D*W<,$C1
M@%45%DE"`\$*G.T>N`*BTM=&D*/9)-B52L7FK*%VD9Q'OX`Q_=P.E`$4NI7:
M^#[2_$N+F1;<L^T<[F4-QC'()JQITMYJ(:\6[,*K.\?D>6K)M5RO/&[<<=<X
M'I4#VNB6L7V4B\DC5A&(5>XF"E-K#"@G&/EY_"K4D.F&(ZE)%,J!@Y5EE4;@
M>&\H_P`6<<[<]*`,Q;K4+C3[:Y&HSQ-)>FW94CBQM\UESRAYQ@?A3XI]2DUF
M]M1<:C)%;O&BM"ML`,HI);<`>I)X%7(Y=(2VCB,<T,*7"NGGPRQCS68D8+`9
MYS[4MW::6ES=7,DEQ'*2IF\FXF3<<87Y4/)P.PH`I27M_'%J%^+R1EM+PQBW
M\M-C)E1C[N[/S'G/I6EJ%Q.VI6FGP3-;^>CR-,H!8!=O`W`CG=W!Z56@BT6:
MY61/-,LUP?W4C2@>:%W9:-N`<+G)`[>U6M6?3V,<5Z)&D!WIY*R&1.VX%/F4
M=L\"@#(EU?4(K^*V63S1;W,B2G8,SHL:OZ<-@]L<CWJY9ZE<3Z%J=V)@SPR7
M`A<*.%4G;VYZ"I0VCVOV5XPS&,&2)HEDE(##!9B,]>>6IL,VCV\,^G6\4S1.
M3YJPP2R+EP&/S*"!D,#P>,T`8]SJ^J6=K(SS7*,]B\T9N4A)+KMY3RQC&#R&
M]O>KMU>:E9:8]P6U#S/-A51<"W.X,X!"[/4<?-ZBI3;Z$))+61+E]P-L6F\]
MT4'JHD;Y5S@#@CM4UW!I5FR6UQ]MF,F)%CWW%Q]Q@<X!;&"5H`J7&OW%M+JT
MD\3VZV]O$889C&#O8L.JDC!('4]J;IVLW$]I:QM>17$Z7PMYY8@I612&((QQ
MR,=.X-7KHZ.9XKV57EED*NOE)(Y.S."57/`W'J.OOBFWT>C32K<RB5Y9@KA[
M?S2V%R`Q\OIC<1GB@!NL75ZNM6UI:O=>6\#R,ML(=Q(90#F3C'/:K6IW,]O'
M8VT4C+)=2B$S,%+)\I).,8W?+Z8YZ56CN=(MKF&1!>RR^61%)Y=Q/N1L,<-@
MAAT[G%:%P+.^=["8!W55D*<@KSP0>QR.QR./:@##U+4=0LYVL([B:5UE@Q,J
M1^:RR%@5Y`3/R\'`K;M8[B33]DLUW%*V?GE$7F+S_L@I^AJG$NC^:ENHD9O.
M$BR/YC!I%Z?O3PQ'IDU<M]4MKJ58X1<'=G#&VD5#C_:*X_6@#"AO]1BTR"[:
M[GNI)+_R#'LB&5$C+@?*.2`.I_*H[O6-3>\EBC^TP?Z?%"(56$R*AA+$`G*\
MD9Y/^%:UP=)LW2R>*8F)Q=!(XI9-I+,=Q*@X^;=UIUQ9:1<SQ-(?WMW()XVC
MF=2[*F`P*D8^4T`30M<1:5-)*USYRJS#[2(MXP./]7\N*Y]-;U*QM8[FY-Q(
MDED\H%R(@'D"AAL\OD#&3\W.,5N&?3[*![<O=2K(S(5_?7#9`&1_$0/TJ.UM
MM(MK%KV/S&MXHF!,TDDGEH!\PVN25X&",9XQ0`>?<V%[9I/>-<Q76_?N11Y9
M"[L@J!\O!'.>HYK%@\37$]EJDBW<#.;9[FU"%2T(&1M8>OW3SZGTK2_XD4=K
M/),EU'!Y?EM)<).H1'(7:I<?*"2.%Q^57+ZVTJY>&TND#%$VHH+#"N"N,CL0
M"/R]J`,6;5KZ.SO9;6]N)EALS([7,"QM%+QMP-BY!&>H(X'-;%I-<6^K)937
M,MTDMN9@\BJ"A!`(^4`8.[T[4S5!HXF\F\CE:1XO(V1)*Q9""=OR=>%)]1[9
MJ;3O[/AF46XN!-.K%?M(E+E4(!_UG(`+#CWH`HS7]XUEJ6HQW)C6R>54M]B[
M7"?WB1GG!Q@CJ*33;R_OM6NMSW@MXIPJB,0>6J[%;#9&\]>WK5F^71X[QS<J
M_F'#2A!(8^G!D"_+TQRU2)?Z7975TJ&17:0/.ZQ2,@8JN"7P5'R[>]`$5Q)>
M3^(9;2*^EMXH[1)0J(ARQ9ASN4G'`Z$5BR^(;^:U\Y9F@#V]J^(XPQ4O(5<@
M$'.0.!S6U<C2KO4BSQWK7`Q`SPI<*A`)^4E?E(R3UXJQ=:;IB*99X`JXB3(+
M``(V4X'0`G_'B@#$N-4OTMKAK6[N)H1<011RO"B3;F;#IM90/3&0.35_[1?(
MUI:O+=Q/=3,IDN1"7150M\NP%><=\]ZL7]KI+R7#W>58B-Y2LCKR#\A^4_>S
MTQSTJ-#I#VYC:2Y(\Q!B>2;S49CM4C>=RY)QD8[T`)JZWUII9E34YA)&ZJ&6
M*/Y@S*/FRIY&3R,?2G(UW-J4NG+?S(+:))#-LC+REBW!^7&!CL`?>GW)TJUA
MDL9ED8921T59)'8DG:21EF.4/KTYJ0KI^JYF*S!X1M;B2&0#K@CAB/8\&@#G
M_P"WKB2?-U?W%I$EIO)M[<.I<2.A8Y1L*=H/)`J;4=5U>S@LI[M9K>%H%::6
MWA64))GG>#_#CT(/O6W';Z9#Y4T<<:K<0K!'MSM:,`L!CIC&3FL]8-`N$1$2
M9E2':NWS@)HQSM!_Y:CV^:@#=\P-;^8C`@KN!'?BN4CU74/[!^V17=Y++]B,
MLK3VH1(VV9!0[%#?-_O#%:L.I:3;K=21I<QAW'G$VLP!8[4`Y7K]T8%6K9+&
M\TQK"."=;58Q"8Y8I(ODQC`+`$\=Z`(==N+J%K&.T:<&:<HP@$>\@1LW'F?+
MU`J&[U"6PTV%9KEK>XF<A7OFB!&,GG9\O.,<<\TV5-'\J$M+?2@XFC99KAV0
M8*[L@DJ,$CG`K0AALK,13*[MO^2.225Y20W.`6).#@4`4I[RYNE@NK9[A+&2
M!9%DMT1VW')(96!.,8^Z,]>G%5H+R^O=0N/)GOI;='C"/:K;B/!C1B3O^;JQ
M/&>#4WF:#+8IJB2NEO*^T2QO+&7)<\$#!(W$\$8Y/:D5=%DNY%B:\A9I/*8Q
M-<0Q%UPF,C"9^4#CTH`OZAY\EW:V\-U+;*X<LT2H2<8Q]Y2.]4+K59+2T:&6
M\A2<3F))YBJ!@JALGH,_P\=SVJU/-INH7,<+R3B1&*I)&98E)[@2+@$^V3TI
MMG=Z5')&+>.93@HCM;R@-DY.&88))'KDX[T`0W=Q-=?V7<V6HW$,%](%VHD9
M`4QNV1N0G.5%)%)J$FHRIYFI/%',$W1BV$>`!G.1N[G./PJQ:7&F7EPD$$5Q
MYEO,90'MY4$;D$G)8`#(<\'U^E,D&DJC:DUS.D;3`,Z7,JH7W!>5!QUQVQ^%
M`&E>>>+27[*`9]IV9Z9K%:^NK>$H;JY,WG6X*7,*!U5I55L%1M(QD<9(]>15
MZXN+.""6TNVFN,#?(JPR2$*Q8K]T$X&TC/;`]J;8VVG7=N7A2YD0NC;KDS;B
M5(9<&3G&<'CB@"N]Y<+#%?27LL:R/Q"MMOC50V,,54L#CN2!GM44>JWBV]SY
MT@W&\=('"@?(LVPJ>V0._H?;-2W,FBQW<QF6X!A?,P5)C`K8#98`;.A!)/XU
M+(VDN6L3!/(%N/,.VWE91*6WYW@8')SUQSZ4`:=S<1VMM+<3-MCB0NQ]`!FN
M?76;B?2F^S7EO)=K<PH9(RKKB1UXX],E?7C-:)NK%?\`0KB:67$O+E'*!MV0
MI<#`P<#!/H*GGBL;J]$4N&N$59-NX@X5P5/'HP'^30!ER:C<W6I&WAN)+9"L
M((54+1L3*&'((_@'Y<=:T[!YDN;BUFG:X\H*RRNJAB&SP=H`XQZ#J*SUET34
M9O.5;A7NMK"81S0A]H)7#X`S@GH>:L:7?:6(P+0S*)1YH>:.4&48SD,XRW'N
M>*`,O1]0U*=;!II;PM/#YKF=8!$XV\[-@W9R1@'MUJUH4FHWUG!+<3ZDGG6Z
MOYK"VV9(!RH4%OID?6KLJ:9;:=9[HW^SQ%?LX17=AQ@8`RW3/X=:KVG]EV$,
M<T']H(BGRHXI/M+=NBQ-U`'H,"@".QFO%@\Z6_FF)O6M]KI&!M64K_"H.2!3
M=8OKV/44MK:28*TL:[8%CWX*2DX+\=57KZ59DGT@6/E%9)(9W:7RXXI'<-NW
M,2`"RD-],'TJ:.VTR"UCNPV8D;SUF>5G).TJ#N))/#$8/K0!EQ:CJ6+4H\KB
M2[>/9.L?FLJQLQ5MO`.5XQ[9K5TN]:[EOV,FZ*.=5CXQM4Q(W\V/6JYN='#O
M?LLB21R*[!HI%?<P\M3Y>,G(;&<?RJ:V73VM;UH;>X2.9F>=3!*C.2N"0I`)
MX'\/\Z`*=AK+Z@EXEG<V\\S(9;=493L7)`!'KP#SW;':KFE32F66&>>Y>0*&
MV7,2*Z]1PR`*1QVSCUY%127^DWBA9HY]D9$?[RVE15+$*%R5`SDKQ]#VS4ID
MT[2&D+/-OPF2[23N0S;5`SN/)["@"NES>6]YNO)KA-SL%C,2&%A@D!64;@>/
MXCZ\<B@W%Y;VEMJ#W9G6=XPUNJ+L`<@?(0-W&<\DYP:L6%M82R&>WBN4V-PD
MPF1%/JJ/@#Z@5-%I5G#.)DB8,IRJF1BB'U52=J_@*`,^.ZO%L+;56O-ZSF(F
MVPOE@.5&%.-V1GN>3V'8L]1NC!:I<2*9I95(8*!OC)/;U'0X]CWK032[..Y\
M]8VW`[@ID8HI]0F=H/N!4AL+4K;J801;-OBY/RGD?U-`%FBBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"HYF=(7:)/,
MD"DJF<;CV%25'.Q2"1E."%)!_"@#%@TR^M599O(O4EB*2(B&')R6R26.22S=
M`.2/PMZ6ETLLA=+J*WV@+'=2*[AO4%2QQC'4YX_/,NM6OHM)3]Z!>+;R.S*@
M^?\`<LRL!]1T]0>U6?$&H7-G9[[>78_V2:3.T'YE"X/(]S0!+9Z3+Y*_:;NX
M(5W98#LV*23@\+D]<\DTSR+V>UM;![/R1;O$S3AUV$(0?E`.[G&.0,9/6J_]
MJWDDUA%',@:/*WGR#+,-R@`'H"R,?P%5&U/4[?2WN));Q6>R>5'N$@*[PH(*
M[/Q/S4`7HK2[5/)AL)(H-C++;3SJ\+@J?E0Y+`9QV`QGBG"UO7BDBBAN8K?9
MM\JYE5V+!E(*L&)QC=G)]*BN[C4K;3)Y=^I+)YD*(9Q;$_-(JG;LXS@_Q<5<
MT6>ZEN+I)WN2D6U=MT(A(&Z\>7QMQB@"H^GW37C&*VNTD^UB43&Y'D[-X)^3
M>>2N1]WK^=/,=Y)HS6#:;=*R*/F$D8#X8'"D/D''3./PI\US>+I]QJJW9VP[
MV%L$4H54D8)QNW''KU[4S2I[^ZO9'E>_,*W,R`@0"':KL`/^>G8#Z^U`%_2D
M,?F+]DOH`<'-U<>;GZ?.V/TJI!IMQE&91')'%^[<D':X=C^6#S[&GZE+>PW,
MDAFG@MD3*21Q))&/7S`?G_+`P.M0W>K7D5MJ!BMIW$3D1W"^5L08!Z%LG&?0
MT`:6DQS0Z;"EP@CE`.Y0V<').,]ZSK72I6TS1[>Y61#;1@2^7,4*G9C[RD'K
MZ&I#K,0U[[']JAVY$/D[AOWE=V['7'0?4U3T^^OY+RT622]_?EF/G+"(64==
MI4;L],`^]`"R:7+!-Q;7L\(GD8>3=E9,%4`)8N"1D'J:OW,$D^A/#':W*OQB
M*28&4@,#]_>>?0[ORJAHMQJUUIT5RS7KRR6V]3.+<0,Y7C[GS@9_^O5_3)YO
MM)AN9[GS6CW^3<QH",$`E63@@9'KU'-`$"69G5(C87L<?FJTGVNY$N5PP./W
MC8Z^U,_L^^2[^T,GG?9IU>,!AF9/+9._`8;N_!Q[U=,UT+W[$&.6;S1-@<1Y
MY&,8SGCZ'/6JL5S>G3HM5:Z;$FUC:F-0@5B/ESC=N`/7.,]J`%N_MLT]E>+I
MD@\FX+-$'C\PKY;KD_-MZL.,GC\JGWW<-T]VFGRR"X15,8>,21E<]<M@CGL3
M2"\G_LZVE\SYWN5C8X'*^9C'Y5)<O<7.I&SAN7M4CA$K.B*68LQ``+`CC:<\
M=QTH`STT^XM@I^R7!G8,?.M)U!7<[-M8,0"J[N#SWX'>."SO(;ZYFO+*^N)9
M&C?S+2Z$<;$1(#\OF+_$#U'2I7U.ZB\V)YLRN#!"RQC'F!PF[ZG>N1T^4^]-
M.H7\J1K!,!+$8XI"RC:\F\JP/<?<[?WJ`)Y(KR2&[L18RA9Y6(G9TV!6.<\-
MNSCVJ>^L;FYUFVFAGEMXTMY$:6+83DLA"X8'T)Z=NM2:?>M=WMP,D1I'&0A`
MRC$L&!]\C'X5H4`9"VLNEW336MK)=QR1+&0C*)`0S-DEB`02Y_']*XL9X,.U
MG.TCL[[[.=4*%W9BK!B`0,CGGDG@5OT4`9\4%T9;"2XVO)'$PF9<`;B!_@:I
MQV.HK=K>N\1+RL7A6/$@1L+@N7P=H"G@?P\5N44`8"VVIQ6]E90I+']F\M6E
MS$8I54C).07W8!Z`<GK1IEK/;;4^Q7\4P##SI+D20*>>?+\WI[`#\*WZ*`,4
M:;?RZM)/->O$IMHXS);(BAR'D)&&WD8##OW_`"CGTJ]#DV;PPPVZ1QV\3H68
MA,'A@PVY/!R#P*WJ*`,7RKNWNDN!92S#S924C=-P#!<'YF`['O3I[.YFT/5$
M\K;<7B2E(MPX)3:!GIG@>W-;%%`'./932V9@BT_4(V,D+$W5T)%(65"<`R-C
M@$].U64TVX^V749`^SB!%MY"0<$,S`$?[)Q^&*VJ*`.?OK&YG2SN'M)WD^TM
M-/';SA'4&-E`#;EZ97.#ZTX)<PWEC<PZ;?-'%'-&R23H\@+&,@Y:0Y'RGO6]
M10!D*;VW-QLTYY?M+>8IWH-A*@%9.>V.J[JJ:?X?FC2ZM[FZG%L_EQE%V;9U
M$*(2<@L,E2.HKHJ*`,*"VD@U"1VL-08F<LLD=V!%@G@E/,'X_+^=;.!-"5EB
M(5P0R/@\=.<9%244`9$=A/%IT>V/?<1S^:RN_,F#@9/KMQCZ"H;VUO-1D%S]
ME:`PF,I%(Z[GVRJYSM)`X7`Y[GI6[10!@2V%QJ%^UU-;S6\;F)-GFA9`$\PE
MLHW'+CH<U=TJSDL9+J%A)(A?>D\DF]G!_A))S\O3Z8[YK2HH`R7TV6:.YMF)
MCA$4D4#AN1OZG';;P!2J+RZ>UCFLOLX@<.\A=64D`C"8.>_<#BM6B@#$U*QN
M)M,O(DA>1I+N.541PK,H="<'(P<*>XJYI:E%D7[)>VXR#FZN!*6^AWMC]*OT
M4`<]'97$$%L/L5P)U@6/SK:=0PZ\,"0"!G(^]U/3OHS074MG9K+M>='1I2G`
MR!R1GMFM"B@#D+31-0CLH;22W`ACMUEP9`<3[0A7'L`3GIDUJ66CRE)1>7$X
MC-W+,MN"FS_6ED;(&[T.,_X5MT4`84=K>-86VE-9[%@,0-SE?+(0J<J,[LG'
M<<'N>[;;2);4V-P%GD9&Q-`]P61<_P`8!;`*^W8GOBM^B@#)-M>(=7:!=LES
M,ODOD'`\M%+8SV()QWQ5232KV.+[.1#/$T]O)^Z3RU4(Z[AAF/\`"H/'H:Z&
MB@#&M;"ZAO[\NNZ%K:.*!RV2P!D.#[C<![_G5ZU8P0VEM(C"0Q<XP0-H&<_G
M5NB@#GKG1)9WU*8B7>]P)(XO/81SH(T!5E!QR0PY'Z4^.VDCU"61]/U%M\P=
M6BNPL8&!U3S!Z<_+S[UO44`8%S;ZHEH]E9QRI)N=H[A#$8CN)(WA\MWYP/QJ
M1;+4A>K?&2+!G+&`)\^PC;C?NQP,-@#J.M;=%`'-Z=HL]E::8Y2:22.(1SPR
M7#,L;%<;E!)7(/''8G%/M+:^ETW3K.6Q>W-G&H=Y'0[B(RN%VL>YZG'%=#10
M!@2I=7&FVL$FF7J&W:,L%FC1FP"#M99./S%2&%C:(!IFH?NY"1OO`9E..JL9
M#D>H+#Z&MNB@#":"[\J)Y[6\FD&[9)#.BS(I/"OR%;CW/]:N2V]W)I<"R%);
MJ)DD8-@!RI!QP,9]\8S6C10!SNJ6-YJY64VDMN$V)Y;2J'8&:-F.58@8"''.
M>:W+6VCM8S'&TK`G.99GD/YL2?PJ:B@#%OM/GN+"[@$9S+>1R#:^T[`Z$D$'
MCA3[\55U/190\AM8KF>-OLY(-TS.=LNY@K.V0<>XKI**`*.EJ4C=?LMY`,Y_
MTJ?S2?H=[8'Y5>HHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"FLH=2K#((P13J*`*K:?:.\#M`I:!2D9/
M\*D8(]QCUJ#^Q-/\N6-H7=98S$0\KMA#U5<GY1P.!CH*T:*`*BZ99K-+*L(#
MRR"5SD\L!@'\JA70[!87A,<KQM&8MLEQ(X"D8(&YCMX],5HT4`45TFT"E6-Q
M(I*MB6ZED&58,#\S'N!5D6\0NC<A,3,@0L#U4'(!_,_F:EHH`I/I5F]P9FB;
M<6WE?,;86]2F=I/OBK%O;Q6R,D*[59VD(R3\S$L3^9-2T4`4Y]+M)YFED1]S
M_?"2LJR<8^900&X&.0>*D:SMWAFA:/\`=S$F09/.>/PZ58HH`@^QP>08?+'E
ME]^,G[V[=G/KGFFFQMS##%Y?R0L'CPQ!4CWSFK-%`&;#H5A#&(D6<PA2GE/<
MRO'MQC&TL1C'M5BVL+>U<O&)&<C&Z65Y"!Z`L3@<#@>E6J*`(_)3SQ-M_>!=
MF<]LYJLNE627'G+$00Q<+YC;`V<[MF=N<]\9J[10!232[..Y\](V#;BX7S&V
M!CU8)G;GD\XJ2[L+>\96F5@Z`A7CD:-@#U&Y2#C@<59HH`J_V=:8MAY"@6S%
MXL$C:2""??J>M"Z?:HTC+$`9)A.YR>7``!_05:HH`KK96Z7$LZ1[)9F5I&5B
M-Q7@9Q5BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`IDA<1L8E5I`#M5FV@GW.
M#C\C3Z*`,%];OHH-0GET^W"6&X2;;IB6(0,,?NQQ\P'YUH+JUD899?,<+$P5
M@T3ALGIA2,G/;`.:J76DSS6.M0*\8:_8F(DG`S&J\\>JGIFFZAHTUU>W-PCK
M\PA,:B5XR2F_(++RH(?J,T`:D-W!-;&XC<^6N=V5(*XZ@@\@^U1RZG9PQB22
M;:IC$F=I^Z2`#T]2*AL-.-O83PN`CSLS-B5Y<$@#[SG)X`]/I5+^RK^5$$QM
ME*0QQ#8['.UU;/([@=.WJ:`+YUBQ$1?S7XD\K9Y3^9NQG&S&[ISTZ<]*AMM>
MM);..XEW1^8T@555I#M1RNXX'`XSD\#--FT^[34)+VV\AW\P,L<C%0R[`IR0
M#@Y&>A_6J*:!=I#&28WE/FB14NI85`:1G!&SEOO=#^=`&M-K%C#)(CRMF,`L
M5C9@,XVC(&,G(P.I[4G]L6AD7]ZJQF.21S(&1DV;<Y!''WN<D'IP>U8:1)'9
MW4");2*_E"-)-VW"*HP3U'W>#DD<'FJ1T2]"F2><!4BF")O><Q[C&5`)&YQE
M"?7G`H`U5US3V#_OG4H4#*\+JP+DA1@C/.#_`)(IYU:S%NDV^0J[%0JPN7R.
MHV`;N._%9=E!>:C?2WTT2P`O!A2'7(0N3]Y5/\7H*DN]$GDN?M,9#2+)(0@N
M)(<J^W^).01MZ<B@"QJ7B"SL;.29&\]UA\Y50,01VRP!"YQQFKUW>P62*T[,
M-[;55$9V8XS@*H)/`)_"L6ZT6^&G7-G:?9=MU;B-S([_`"-@\C.XL#GN01UY
MZ5IZM9O>01B.&&5D?=B21HR.",JZY*GGTH`@&OVGVQX6+"(1QR)*JLP.\L.<
M#Y0-HY/K5HZG:"[%L9&\PMLSY;;=W7;NQMS[9S64VAWKV>I127"22W=HD*.[
M$D,"_4XZ?.!GJ<5-/IVHSZBDKS1F&*X$J_O6&4_N[`,`CU).<=J`+8UJQ:$2
MJ\K(QPNV"0E_7:-N2!W(Z5#)K]G%>-#(Q$(@299E#.I#%AS@?*!MZDXYJM+H
MD_V;3RI5Y[2-HRHN)(0P;&3O09_A';%#:%/]EOHD:%?M%@+9?F8@/^\)))R<
M?..<D]:`-3^TK7[7]F\P^9G;G8VW=_=W8VY]LYJC/XBMX-+-VZ,9OLYG\E0S
M8'.,L!A02",FFC2;GBU+1?9/M(NC)N/F9#[]NW&,9'7/3M4$FBWZ:9/:VYMF
M:YM!;R&1V`0@-@C"G/WO;%`&J-4M#<BW,A$O`/R,55B,A2V,`\],YJ2TOK>]
MB:6W9C&/XVC90?H2!G\*R6T.8W[,=CP-,DQ+7,HVD8./+!VDY7@_H<<Z5G9-
M%HZ64K#<(C&S+TZ=J`*USX@LH=/N+N(R3"&,R!1&PWCU4D<K_M#(I]UJ5Q#;
M6+):QO/=R",(\C(JDHS<DIG^'H5!JA=Z+?WUFT<[6R21VDEM$49B'+;?F;CY
M?NC@9Z]:O:[I\FH1V@2&WG$-P)7BN#A'&QAC[K=V!Z=J`"'5F,@BN88X)1<&
M!OWA92=F_*MMYX]<8Y_&6+6+&6-G28[5&[+(R[AG&5R/F&2.1GK6:N@RD1X2
MVM4^T&1H("2B*8F3Y>!DDL#T'^+Y-,U2189/-MX9[:$PQ&-FQ("4R3D?)D)C
MC=C/?%`%W^V[#RPQED!,GE;#"X??MW;=N-V<#(XYI7UFQ2WCF\UW20,0(X7=
M@`<'*@$C!X.1P:H6NBWB7D=Q-)&<78N&!E>0@>4R8R1SR0>PQV%!TG45A:&.
M=!')).S*LK)C?(6!R!DX!QC(^M`&C#J<$MX8`RC<%\ILY$F5+<?@":@;7+?S
MY8HU8B./?YC(ZH?F*D9VGN.O?M6>VFW=AI*QIAKQ8[>.`Q*S@2(N#GCA3R,G
M'!]<5;FT>98_)MS&8C:I!EV.X%6SGH<YR?\`Z]`%UM5LDFDB><*8@Q8LI"C`
MR?FQ@D#J,Y%02ZY;!1Y`=W\Z*)D=&B91(P4-AADCK[''6HTL=1MXKJWM)8(X
MY'EE28Y+AG).,8P,$]>>.U4UT._>Z:XFDB#.]NQ4S/)@1R%CR0.H/```S^9`
M-:^OWM[B&WACC>:8,R^;)Y:<$9&[!YYX&/6G6]^DJ?OD>"4*SO'(""`"03GN
M..OH0>],U*VN+C;Y<5K<PX(>WN1A6/&#NP<8YXP<Y[5ESZ5(EK9V*KEV=U?8
MC&-(&.63<>@QM`'MTQT`-0:Q8M((UD<L1D?NGP3MW;0<8W8YV]?:H;;7[*:Q
MM[F5GA\Z(2E6C8^6I[L<<+_M'`/K33IMP-6-Q$(H8RV7>.5P7&.C1XVD_P"U
MG-9R^';M+>)#Y3O]F2V?%U-&N$R`V$QNR#]TX^M`&R^LV"3M"TQWJQ3`C8C<
M!G:#C!;'('4]J1M;T]84E,Y\MQG<(V.T`X);CY0""#NQC!J*/3)4,>&CVI=^
M?U/W=I&/K5)]$O%@"Q>0)?,E99EF>-X]TC,#D#YAAONG`SGF@#H:S4URT$*M
M<%HW8.VQ49SM5BI;@=/Y9JY;R2L94ECV^6X57S_K!M!W=..21^%9]MI<\08,
M\9S#+'P3U9RP[>AH`MRZG9Q7,<#S8DDVXPI*_-]W+`8&>V3S5F21(HGDD8*B
M`LQ/0`=:S+:ROK.=?(-L8Y%C$K.6RNT`':`.<@=R,=>>E6[VV:^TRYM9,1M/
M$\?RMG&00#G%`%2XUF2"TEG:QDQ';F?G./NLV-V,9^4#VS],RVE_=/>1V]W:
M1Q&6(RHT,QD&`0"&RJX^\,=<\TMS#+J&@3VX7RII[9H]LG&UBI'/MFL^UT:>
M&3S(;2PT^186C!MF)WDXY;Y%Z8R.O/I0!>@U>.5;UGB91;`N`#N,D?.&`]RK
M8'M[U$-7E6VDN)[:)81"\R2QS&1,*`<.0ORGGL&Z'K35T/[')$VF3RP8A:!C
M)*TFU<?*5#9'!`XX&":KW&BW5S'=_P"CV-K+-;20EH&;]\S#`+_*,`?\"//7
MU`+[:E+$D\LUKL@A`8R;CRNX@GD#H!G_`",R:AJ:6$MHKQLZ7$A3*`L5PC-P
MH!)Z8P/6EU..1])FMXEW22Q^4N!D`L,9/L,Y_"FW-B\MUILB,NRTD9FW=2#&
MRC'XD4`*^KV*0PRF5BLREEVQ.QP.I(`RH'<G&*5]5LDEDC:4YB4,[!&*J",C
MYL8YSQSS61_8%RB(5*.Y,JL!=2P@!I&<'*?>X;D'\ZLR:$SV%S:AU57,)BVL
MPQY87`)SD<KUR3[YH`L2ZW;K]F,8=EFG\E@RLCQG8S<J1G)V\#'.:GAU.SFC
M:2.;Y$C\QB5(PH)!SD=05.1U'>LV+2+M)+>=5A26.X\UE:YEFRHC9<;WYSEO
M08]Z9<Z?<,]K`1F6:9VN61"8Q$QW,NX\=0H]3DG'H`;-Q>V]M"DLK,%D("!4
M9F8XS@*!DG`)Z=JK'7-."1MY['S%+`+$Y(`."2`,C!ZYZ=Z?JD-Y-%&+*15*
MOEU+F/>N#QN"DCG!Z=JR++3-2L)1%$()28Y=SR,^/GD+#YB"21GH>OK0!KOJ
M]BES]G,Q\S*@X1BHW8VY8#`SGC)YI?[5LS.85FRX+*"58*S#.5#8P2,'('(P
M:RX-,O(WN+&)8_LA$,9FD)#X5%&5&,-G&.HP?6IUTN\VQVQ:#[-%,\RN"=[9
M+$*1C`QNZY.<=!0!/!KEC)'"6E`>18R=J.54N`5^8J,`Y&"<?GQ21Z]9D/Y@
MFC82O&%\ER3M."V`O3ID]!GK56ST6Y@TIK5WB+E;<9!./W:H#V_V3BDNM)NY
M-P2*VDQ-(Z/Y\D4BAR#D.HR,'J.<\'(Z4`:T]VD,4,HVM'*Z)NW<#<<`^_)`
M_&J2ZT':_5(,FVXC^?B8Y*XSCCYP1WJTUK.^D"UDG\RX$04S$8RX'WL?7FJ*
M:--G32\L9\@$W(`XD;(<$?1QG\30`]M<`W[8E?:2,JYQD2^7CE1]?\>M2_VU
M:)&7E<\/(I$2/)@(Q4DX7@<<D\>YZU170[D+*"\/SR.PY/0S^8.WI^M-?1]2
M\B2WCGB$4KS,<2LFTN[,#P,MP1QD=.IH`TY-8L8Y_):8[N,D1L5&1D98#`SG
MC)YJ:"]AN;9YX"S*F00R%&!'4$$`C\16:-(N#:M&6BW-+;2=3C$>S=V_V3C\
M.E7K>TDB6]#%?W\K.N#T!4#G\J`&:?=:A=)!-+:6T4$J!\K<LS`$9'&P#T[U
M/J%RUG923I&)&7&%+;022!UP<=?2LS2-+DL&@SI.EQ,B;&N(9#O/'7_5CJ?>
MKVHVTU]I,D!CA\Z11E&8E,Y!(SCI[X_"@!D6HR1R31ZA#'`8D5]T4ID4@D@#
M[H.<CIBFR:Y:B-7C+-^\,;HT;K("$+XV;<YP.AQQ^`-./2+J+SY;.WLM.E=%
M0);,=KX;)).P8.,@'!QG-,AT.\\]999(^;GSV!E>0@>4R8R1SR0>PQV%`%RW
MU^UDC224^2KQ1N%97W9<L`,%1W7@]_3IFS_:MGY"3>8Y5V*A1$Y?(ZY7&1CO
MD<5FVVCWBSP2S&`&..WC(1R<^6SY/0=0P_7ZDNH)M.O!?HIED,DH"+'(XVOL
M.3L5B""@[8/K0!H-K6GK'')]HS'(GF!@C$!/[S$#Y1[G`J:"^@N+F6")G9XN
M'/EMM!]-V,9YZ9K`CT*[DM89&11++;)%,C7$L00C)Y$9^<?,?E)'UYK=T^U:
MT696*D/*77;G@8`_I0`S^U['[08?..[+#/EMM)7.X!L8)&#P#G@T1:Q8S1/(
MDYV(@<LR,H*GH1D?,#[9K,N-'U*YO(Y)IXW6*61E)E;E65E`V!0!C</4\=1S
MFQ<Z/-.D(\Q`T,,:CDX+HZL.W3Y:`+EAJ,=_+<K$K!8&"Y8%2<J#RI`(Z]Z0
M:B/['?4&54"QM(0S'`QGJ0">W8'Z4FG6]U'/=SW8A5IW5@L3%@H"@<D@9Z>E
M438:F^BW&F-%:*KP21K*+AB<D'&5V>_K^=`%]=6LS<BW\UO-W^6<1MM#8!P6
MQ@$@C&3S3K?5+2YN?(BD8R%2RYC90X'4J2,-U'0FJ#:/<&.=0\69+^*Z')^Z
MGEY'3K\A_2DL-,U%-2@NKV=)#%&Z,1*S;\X^8+@!>G09Z]3B@#<HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`IDS%8
M793@A21^5/IKJ'1E/1A@T`<WIVI322V0%]>SRR())XI[41H$V\L#L7OC&"<U
M+!XLM98GE(A*>0TZ"*X5W`&.''&P\CU'7)%:C:9`T5HFYP;3`C<$9QC!!XY!
M'6HH]'B6)H7N;J2`QF)(FDPL:^V`"3P,$DD=J`*UGXACN91$1;LP=%D:WN!*
MB!]VWYL#)RN"/<=:;<>)(X5B.VW0R*T@\^Y$8*!B`5)').,X_6KCZ0DUE<6U
MS=W4XG4*7=QN7'0J```0><XSTSG%/ETQ&$7D3S6ICC$682HW)_=.0?S&#[T`
M4[?Q`ES?)"D<:PN%97DF".RE0VY4(Y7G&0<YSQ3=0\06\#P2VLZW4++("(,2
M`N`I&2N<``DD^E76TM'N$D>YN'C1E<0NP90R]#DC=V]<59DMDDN8IV)W1*R@
M=B&QG/Y4`95SJYTQ;>*YN+:6>X5I=\TPAB"C'"M@YZC'<\\TQ_$A,$US!:!X
M(+5;ERTNUL,&P``""<KZXJVNBQ1(JVUS<6YCW"-HRIV*V"4&X$;<@8!Z=J67
M1+:6&ZC:2<BZ@2W<E]S;5W8.3DY^8\G-`%>XUXV@N$NX889HVC"AI\(0^=I9
MR!M^ZV>#T[YI+37S>W$$%I#!*[^9YC+<91=A3.U@IW<.#VJY/I4,]Q-<>9*D
MLHC`=",H4W8(R.OS'KD4Z'34CN8;EYYYIHD==TC`[MQ4G(`P/NC@8'7B@!FJ
MZA)I\?F+%"R*I9FFN!$,#L.#D_D/>J[:U)N9TM`UO&T0=S+AL.%P0N.<;AGD
M?TJQ?:3%?3B5YIHSY9C81E1N4^Y!(ZGD$&A=)@6WDA\R4B0QDDD9^0*!V_V1
MF@"G_:EY-J.G!(5BL[B>1`V\,T@5'/(Q\O*@C!/OCI3M4\10:;=O#)Y`6*,2
M2&2<(Y!SPBX^8\>W;K5A-&B2\AN!<W!6"1I(H2RE$+`@]LX^8]3QVXXJ2YTU
M9[AIENKF`NH6187"B0#IGC(/)Y4@^]`$,VK-#?Q0/%"(Y9!&A\\>821G.S'3
M\<^U5[C5KU["2YAM-D1*F&42!BPWA<%2.,@\=??!JR=$A-V9_/G'[X3A`5"A
MORR1[$GVQ0-%B"LGVFY,)(*1;QLC^8-P,<\COG`X&*`)K&\EG-PES`L$MNP5
MPDF]2"H8$'`]?2J$FMW#6!N([5$2>!I;5VESNPN[YAM^7CGC/X5JQ6R13SR@
ML6G(+`].`!Q^54TT2!8S$9IVA$;111DC;"I&#MXSTXYSB@"&:?4;;2+)D9)K
MF26-9#+(`"&;IE4QWQ]T<>_6"TUNXBRU]$&MVN;B))@_S#87(!7'3:A&<YR.
MG>M:YLDN+1(/,DCV%61TQN4J00>01V[BH/[&MC'&C&1ECGDGP2.6??D'CI\Y
M_2@"A#XGCECDVI;RRA%D2."Z$F5+!<,0/E(W#CD>]68]7N/.\N:SC39<+;S%
M9BVUF`*[?E&X?,,YQC/>IETE?):*6[NID.T*'8?(%8$`8`ST')R?>I#ID)DE
M?=)F6X2X;D?>4*`.G3Y10`S5=0DT^/S%BA9%4LS37`B&!V'!R?R'O5>/71)J
M26HA1%<+M,DP1WRH;*J1A@,X.#G(/%6+[28KZ<2O--&?+,;",J-RGW()'4\@
M@TPZ+&S1![JZ>&,QMY+,I0LF-IZ9'0'`('MR:`'WM_<078M[:T$Y\HRLS2[`
M`#C'0Y/I_2JIUXLKRQ6RO;CR@C^9AG:0+L`&.GS#)S^=6;S36NK]9Q<2PJ(3
M&?*8`L"<D'((QQUZ^E..DVIAFB`8)(4(`.-A0`*5],;0:`(CJTD"2F\MEC,#
M#SO+D+A58'##Y03R,'@8YI7U9XD<2VI28+&8XRV=Y<[0,@<$'KUQUIZ:3#C_
M`$B66Y9G#N9=OSD?=!``&!U``'/-,.F,VH6<C',%FK;"7)=R>`",8P!TZG^H
M!'K=Y<6L]H8Y!%;#?).X8;MJ+DC!4\8^A]Q39=;FMT(N+)5E=!)"BS9WKN53
MD[1@C>..1[UHW-G#=.C3`L$##;V8,,$'\*J#1(2#YUQ<3,`%1I"N8U#!MHP!
MQE1DG)XZT`+J5S?065N\,4`N'FC1U,IV@%L$!MOX=!UJC8:W.D:-?QJ8I);A
M4F#?,?+9S@J%P!M4\Y[>];%[:K>0>4TCQ$,KJ\>-RD'(/(([=Q59=&M5C@0F
M1E@EEE`8CYC)OW`\=/G/Z4`0Z3KL6I7!@!M_,,?FJ(;@2X7('S8`VGD<<_6K
M!U+K^ZZ70M_O?KT]^E26=B;0DFZN)QC:HE880>@``S]3D^]1-I,371F\^<+Y
MHF\H,-F\=^F?PSB@"HFO2"&.:>RVQRPM)%LE#,Q!`VD$#&<C!S]<5`^MW5G=
MW@OT@BV)`(HS,!&&<R9)D*C`PH[=N*T3H]LUO#`S2E(8FB7YL$AL9.1WX[5&
MNB1AYI7O+J2>4)^^8IN0INVD84#^(]N?SH`BMM=-ZT*6D,$SL[I(5N,HNT*3
MA@IW<,.P_"HH=?:ZMI7\I8F0I\B3`R)N<##J5RIY]".O-:<6GK'+%*\\\TD8
M?YI&!+;L9Z``=!P,"JW]A0L^^:ZNIV50D9D9247<&P#C)Y4<MD\=>M`$;:W,
MLD+&R7[-.\BQ2>=\QV(S9*XXSLXY/!YQTIKZ^;>U:>]ME@!B26,><#D,0H#'
M`"\D>HQSFFQZ+.^H!II"EI$TC11B;?@NK*<#8,?>)Y+8Z#`J]+I-O*BJYD(6
M)8E.1D8((;IU!`-`%.WU_P"U*([>*WGN6E\L"*Y#Q?=+9W@=,#^[G/YU:T.Y
MGN[%Y+K_`%@N)DQQ\H61@!QZ`8I3I>Z(![VZ>97WI.2NY3C'`V[<8)XQWI;+
M3VL3''#/(T`,KR"0@EF9MV>G;+?_`%^P!7EU&[@O;J,P1RJ&CC@428)9AW^7
M@=23STZ5:M;U[A+E#"%N;9MCQA\KNVAAAL#@@CG%)<Z7'<2RR&:9#)L(V$#8
MR]&''7V.0?2I;.S2T63#O))*V^21\;G.`,G``Z`#@4`43K@=(_LUNTKR1QLH
M+;1N<G"DD<8P2>XQTIG]K7+7\<)ABC\IG6Z7S"<80,-IV\C!![5871+6.">.
M-ID,T_VC>'^9'[;?8>G(I4TB%'63SIFEWEY)&VYE)7:0W&,8`Z`=*`*^D>((
M=3N%A'D!WC,J+%<"4A01P^!\K<CCGOSQ4EYK#6=]%#+#"(I)DA4FX'F$MP"$
MQR,GU!ZG%6++3Q9L,7=S,JKL1)7!"+Z<`9Z#ELGWZU!-H=O-=&8S3KF9)]B[
M<;U((.=N2.!P3B@"#1+^YN[HI/+O7['%+C:!\S-(">/]T?E4%WK\S6NIK#''
M!+;PS,F909%*YPS1D=#C((R/6M2QTN"QE\R)I"?)2'YB/NJ6([=?F-0W.APW
M8E6XN;F1'5U5693Y6\$':<9Z$]210`R+5;G]_#+9QK<11QR`>>-A5R0"6(&,
M%3D`'VS4=OKLMT%2WMH))O/>%]MSF,%5#$A@O/!].O%6KK1K>ZE>5I)5=TC3
M*[3MV$E3@@C.6/7(HM-'@M)O-669W,AE.\CEB@4]!TPHX_\`U4`4+?Q3!<*[
MQ1QS`Q-+%'!.'E8*,X9,94G\?PK2TK4#J$#N1`"K;<PS"53^.`0?8@4V#24@
M0QI=W0A"%(XA(%6('^[@`\=LDXJ6RL5M&ED,TD\TN-\LFT,0.@^4`=SVH`S9
M]=F%E]HCMHUCN(W-I(92=Q"EOF&WC(4D<G\*6^N;RS\.P2O<R"X:2)7E15=L
M,X!P`@!.#@?+^=6/[#MRI1IIVA"LL41*[8=P(.WC/0D<DXS5F\T]+RR6V,LD
M81D973&X%2"#R".H':@#-M-6\E-0::YEFBM8UD!N8O)EYSG(VKQP`#CUI++4
M[F[TNX%M/%>75O*$>6':0RD@Y7L2%)'U%74TB+S3-//-<RDH2\NWD(25&%4#
M`)STSG%276F074S2N9$=E524;:?E;<ISZ@Y_,T`9<>J2Q[D-S-,!/`F)HQ%,
MN]]IW`H`5]"!SR,\9J]JVKC31(##YCB(/$N_!D;<%V]..67GWI3HT4AWW%S<
M3R[XW\QRH/[MMRC`4`#/7C)JQ=V$-Y-;2RE@UN^]0IX/&,'U'0_4"@#.DU:Z
MFOX8["!)$(88>3:KX5&SG:2,;L<=335U_+&012?/!`R1,PQOD=E`X&1R!DY(
M]!ZW;'1[6P2V2WWA;<.$!.<[B"<_EQ40T&T"%=\W,<<8.1E=C%E8<=<G]!0!
M7GU'4X]1AC6TC#&VED>!I@%)5D`8.%)Z$X&!UYQ4^H:E-_8UM>Z>J$SO!M$A
MV_*[*/0^N/;.>V*GCTN-)UG>XGFE$3Q%I&!R&*DG@8'W1C&![4K:7"=)ATX2
M2K'"L81P1O!0@J>F,Y4=L4`9UCK-RK`7L2F&2ZGA297^8%"Y`*X'&U",YSD=
M.]3:1X@AU.X6$>0'>,RHL5P)2%!'#X'RMR..>_/%6%T>W5(5+2,(KB2X&2.6
M?=D'CI\Y_2I++3Q9L,7=S,JKL1)7!"+Z<`9Z#ELGWZT`0/K&SS_W&?*O8[3[
M_7=L^;IVW]/;K4(UUHX?M%U:B*W*2NK"3<QV9SD8[@9'/Y5/-HD$MTTWGW"*
MTZ7#1*R[#(I7#=,_P@8SC\>:D.DVS01PON>.,.-K$?,'!!!X]Z`,^XUNYLIY
M6O((XD$49C0S#9N9R,ER!C'&>N.V:EM]>:\\M+.&">8RM$Q6XS&"%#9#A3D8
M/IUJ8Z)&Q=I+N[>1E55D+J&3:25(P,9&>^<]\U/#IZQR12/<3S21LS;Y&!R2
M,=```,=@`*`,X:\TR70$21F%<X2=3(O(&'0KE2<YZ$=>15AM8DWAX[0/:M,T
M`E\W#;EW9.W'3*D=:>^BQ2LQFN;F7Y"B;V4^6"03@XR>@^\359M(N9-24[EA
MLEF:;8LN[<Q!!^78,9+9^\1[<YH`2/Q%MMEN+JV6%)+4746)<[ERHPV0`O++
MW/6EM_$27'[F%;::[,BQJD-SOC.59@2X7CA&SQV[U971+41V\9:4B"U^RIEA
MG;\IST^]E!S3SI8:("6\NI)E<.D[%=R$`C@!=HX)'3G/.:`(K:]N&TF]N+@%
M987FPH(RH4G`!QCMU(ID&M&34ELS"BC@9DF"R-E0=RJ0`R\XR#G.>*MPZ;%%
M83VGF2NLY<N[L"V7SGM[TPZ4C3H[W%PT:,KK"Q4H&7H1QD=.@./:@#0HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`J
M*ZE:&UFE1=[(C,%]2!TJ6FNZQHSNP55&23T`H`Y8ZGJB6ZY>53+Y+"2;R#C=
M*BD*J$DJ0QZ\C'6GR274FHV]M+>2M]FU$QB3:@+J;<OAL+CN1P!P?7FM&&?1
M4AG>.WCB0%99`;4H7.?E8`J"W.,$9YZ4Y[W2)(#,\:ONG`*&V8R&4#(^3;NW
M``'IT&>E`'-Q-)+;P2O,V#;:<WE*JJF3,>@`XZ=O7Z8OG6=2C26Y$<DBDS@1
MN80@V*Y`0!MY;*C((]>!BM26;1HXK>5H8F79B(I;EBB*0>@&54$#K@`@5>CM
M+19VNH[>$32#YI50;F'N>IH`SM.#C6Y?,O/M1-I&V2%!&6;^Z`,>G]:JQ&X7
M4;BW34)8Q<WC`L50E=L8;:N5QD^^>%]>:VX;2TM-SP6\,.1\QC0+GOSC\:C^
MRZ?>0M,UM;RQW*J[%X@?,`&5)R.<9[]*`*MO=7=SHL\L1!N8WE2-L#$FQB`?
M^!8_6JL>IS:E)";:[\BUNI2L4B*I8A4R<;@1DMNZ@\+6BNJ:>EE'-%)N@9S%
M&(HV;<02"%51D_=/0=!GI2N--FTHM)';M8!2Y#QC8`.22".,<T`8,E_=^8]\
M)VWV]M<*JX79)LD"ASD=^#P0.!VS6MHUS=R3SP77FD1HCJT[1>8=V[.1&2`.
M!@\=^N*<+S2GA$YC&+?Y5#VS!TW#&%4KNY''`YJQIBV(M<Z=#'#$6.52+R\-
MT.5P"#]10!BS:C<MJ$,4=Y<-%=F9,^5&B)M1B"F1N)!7J<C]!4\D<G_"(VBB
MZE#;8#Y@"[L%EXZ8XSZ=N<UK+86:3&9+2!92V\N(P&+8(SG'7!(_&G"SMEM3
M:BWA%N008@@V'/)XZ4`8L3W-K/-,EPS1F^,9AV+A@0.2<9SGT./:ET/4;^ZG
MMC<APES`92)#$`"-O^K"MN*\D'<,].G2ML6\(&!#&!NWX"C[WK]:;#9VT$LD
ML-O#')+]]T0`O]2.M`&+KDES)>![6UN)_L($@,13:'R"0=Q!^YD<9X?Z4Z:^
MNG>XN;>[(@BE@V1A%*NKA<Y.,_Q<8/\`A6T6ABE6/Y5>8D@`?>(')_*JSMIU
ML)(62%`@C9T$?&"=J'`'JO'IB@#(AU&^"V\[W3.+B6YA\O8H5=GF%6'&<_(!
MUQSTJQ)JKJL6ZZ"![1')5`YWLP`P/4YP.U:ZVUNNS;!&/+8LF$'RL<Y(]"<G
M/U-1KIUBL;QK9VX20$.HB7#`]<C'-`'/VUW/<:S9Q3R2R>1?.BF94#X-NQYV
M<=_0'UI^IR+9^*_[1=ML=O:Q+*<?P.\@/_CVTY]C6_%8VD.SRK6"/R^4VQ@;
M>"./3@D?C2F&WG:4O`K%AY;EX_O`<XY'(Y/MR:`.7MYKNS:58DE\Z]NE:4QE
M"ZEHM^%WX7/0<^E3G4]3E"1@3!D21BT)MR6VN0-^YMHP!\P4]?2NBEM;>9)$
MEMXI%DQO5D!#8]?6H19V-S;Q(UG$T4)(C22#`0@XX!''2@#(CDG:[%Q)(=TT
MEMNB(1U0E<G:0/US4?\`:5_;V4%R]V)//MI'(>-0L9!7#<8.`"<Y/;M70M:V
M[3><T$1EP!O*#=QR.?:H85M+NU#6NU47?$CK&`4P2K``CU'ICB@"KIDMP-6O
M;2:]:Z2&*%E9E0$%B^<[0/053>]NY($F^W%?/GEM_)55^0+O`*Y&=PV@G.1U
MX%:FEZ5;Z6CK!R7QN;8B],X&$``ZGMWJ<6EL+AK@6\0F<;6DV#<1Z$]:`,73
MXD@\$VR^?Y/FVZ,TI3HSXZ[<<9/)ZXY)ZFJMQ;BUBN;=+:"TD=8F46K9B8"5
M0&*X&&Y]\@=>*ZA8HTA$*1JL2KM"`84#IC'I59;+3[&VEV6MO!`/G<)$`..<
MD`=L4`9CW5S"\UG)?SLZW`1)$@1I7!CW$=-HQR<D=..O-5].U*_NX5E:XD_<
MQ3.4")F4I(5`8@$<@<[?P-;CVUE>K(LMK%,K$,PDAR&..#R.>*FBMH(6W10Q
MQGGE5`ZG)_6@#F)+N_GL7CG,NV5(Y5>8P_*WF(/E5&)*\]_3KS5P7%Z+XZ:V
MH.,S;1<%$\PCRPVT<;<YSSMZ#\:UX["SA5Q%:0()&W.%C`W'.<GCDYJ"_?35
M8V][%$YG!D96AW@A<?,W!``XY/M0!BG4KDN9P1YJ@P>;CC;]H">9CITY]*)+
MB[M;^XMX+F6=Y;I4:2,1>;@1`X^;"9X].G:MZU:TNX=\,!";=@$ENT?R^F&`
MX_2G?V;8?9VM_L5MY#8)C\I=IQTXQB@#(MKR_NBA>Y%N8X9'89C96*N5&\C(
M'`Y`/!SR*M:+<W+S3P7DDS2*JN%D6/H<\JR<%3CC(!'/6M)((8]NR*-=J[!A
M0,+Z?3VIMM:6UH&%K;Q0!SN81H%W'U.*`,`&2XFTZ<SO'))J4P?9CD*LJA3D
M'L@'XD]<&H8+N]TS28)4N?-62TD=8W10L97;@@\'')SD_E6["MC/<W,"KYS1
MRB1U>,E(Y,`\$C&>AX.1G/>H[:_TR:2*&)"OWDB+6SHA]0K%0.W0'G%`#-&N
M;N2>>"Z\TB-$=6G:+S#NW9R(R0!P,'COUQ6=X@TO$-C%!*YD>\#H7P<.L4A7
MICN!6W9BPMIY+&SCAA=`)'CBCVCGOP,=OY4S^T-/N+N.!CND5SY3/"VTN`<[
M7(VDXST.>OO0!S\VH--=G6K="Q6TE6%6Z?*JL<C_`'B0?]VIVU/4HE:']^2Y
MBVLYM_-7<6R0%;;@X`!;OGK70PQ6Y1'C@50`2N8]I&>3P1D9[U21M'CDDL([
M>)5E8K(JVQ$;MW!.-I;VSF@#-\V[G:)KB66-H&G4*WDL9`$!^<+D`\D8&/I3
MTN[T0O,EUL2!K<"(1KM8,$W`\9_B.,8Q^E6EOM%PELT`A6%&F1)K-XU15'+#
M<H`QG]:M6T^GW,,IC1%1=ID66$QD8'RDA@#T'!]J`,M[FYN)+4/=D1WEU+;R
M6^Q,*H63ID9S\H)S_+K=E@CTZXT\6_R^9<.C`_Q!E9ST]P#^!]:+:PL9[E=9
M64S;AYD;&-``,$9R%#'@GJ3UJPT]G+=V<GFEI)$+0(`3P0,MC''&!D^N.]`%
M/4KNX6XOA'>+;+9VZS*"JD.3N^]G^'Y0.,'KS3/#L1:]U:ZD=FE>X"_.JY4>
M6C8R`#CYL8]O7).O-:6]PZ//;Q2M&<HSH&*GU&>E!,%LW1(VGD[+C>^._OA?
MTH`YC3[<V_\`9UR-/LX@\^UKB%_WSYW#YAM&1G&>3TJS;7,PUI;]K>=;>Z<P
M^:QC\LIQY9&#NZ@]1_RT/M6G-;:1I:27SVMI;A1\\JPJ#SUR0,U=,43Q",QH
MT8QA2H(&.G'MQ0!SMK#'%<VMYY<$JRS86\B)2=BQ/RR*1DCID9XQT&.+#EY_
M"49$AA9D4EHU48^8=L8_2M9;&S2Z:Z2U@6X;K*(P'/X]:>;>$VYMS#&82NTQ
M[1M(],=,4`8OVZ[1OM!N'8+>"T^S%5P5WA=V0,[L?-UQCM4VH;_[7/EW8MF%
MFS`X!)PP/?C'KQWZBM%;*T6X%PMM")E78)!&-P7TSUQ3IK6WN/\`7P12]/OH
M&Z'(Z^]`'.KJ^I7$QD6&:)8Q#F/,0C.]58[RY#=6(&WN._2M+4XI9M5L$AN'
MMVV2_.BJ3CY>FX$?I5BZ_LY9'NKF*$RV:;S(T6YHQR<@XSV/2I([FTN'MG1D
M=Y8S)"V.2G&2/0<K^E`'//K&IR0JR;PT5FDQ=/*5&8[LE][`A?E'W?4\U9MK
MBX>^:V28VRRRS2M(H5N5"?+R"/XB?H*V9+"SE$0DM('$)S&&C!V'VXXI)(;*
M>1K:6&&1N)BC1@\YP&Z=>/TH`S+2YDM?"-M-$RLXC0;P/E&6`+?0`Y_"H)[N
M^CU2+34OI&5ID!N"B;\-'*2OW=N1L4].XSGON6[VLBRVT"IL@;RGC"853M!Q
MCIT8?G35M+&S@!2V@ABA)D&V,*$.#EACH<$\T`5]*<ZAICI>A+C$LL+[T&)`
MKLH)'3D`9[5DOIUI!I&J26MK;PS"5T618@"!N&!QV]JZ"R>"2V62VC,<;DL`
M8C&223DE2`>3D^_6I#!$49#$A1SEEVC#'U-`&1]JNK:^%L]TTJ_:8UWNJ@E6
M1CMX`'4#WJ"&_N[O4_)2]V1*+A\A5P?+D50"2#Q@G..?>MF[CL_+87443),R
MHP=`P<DX4'UZT6T5F27MHH@8RT>50#'/S#\P/RH`PH;^_6/R;BZDCEE:,"1T
MB8*&;!9&7@@\`!AD$\YIMI+)"^H0+?3F5KYOGAC0R.%BCSU&T8XSQ^5;Z:=9
M1Q2QQV=ND<W^L58E`?ZC'-00V>E3B2WBL[5EMY1N3R``K[00<8QG:5Y%`&7'
MJ]V=.MY?-W27L0C@.Q3B7=MSQP>"&],*:Z"08@8$Y.T\GOQ5:6QMUEBN&)2*
MVW.D2J`BL<Y?`&<X)[]^F:DLQ!LD,`8K(WF$E"`=W/''/^<\T`</N/\`PAQT
MG</^/3[7C<<^5Y>_/_?WCTQ6[=ZE/!>6YAN9G0W45NT8B01`-@$$GYBW.>#^
M'6MW[':^7Y?V:'9Y?E;=@QL_NX]/:FM86;3&9K2`RG&7,8W<'(YQV(%`&1'/
M>R16@;47C:\F=2_EQ_(%#$*OR]3@9SGH<8J%9+J.:[NXK]9`DL`;RXU\N;(0
M$]R.#Q@_G6_+9VLUO]GEMH9(<Y\MD!7UZ=*=]F@VE?(CVMC(V#!QC'Y8'Y4`
M5-66Q:*,7L"W!)(B@8;O,;'0*>">.IZ=>*P+JS58-0340ADM-.1X&^\86)D)
M*$\Y!"C/7@5T]U8VEZ%%W:P7`3[HEC#X^F:8=,T\B$&QMB(/]4#$O[OG/R\<
M<^E`%B,L8D+?>(&?K3ZABMXX99Y4'S3,&?@=0`/Y"IJ`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"F2.(XW<AF"@
MG"C)/T'<T^D9@JEF(``R2>U`',322:E&;UH+M)HY(7%NUM(I2-959ADJ-S'&
M2!GH`/4RH[KJ#:D;6Y%LUT<8@??CR0N\IC=C(QT]#TK476;!DD?SF41@$[XG
M4D$X!4$?,">!C.:@M]=AN+IH@HC03F$-)N5CB+S"=I7@CD8..GX4`98MITMU
M,OVN!91/M\B$NQWR,P1AM.T8V\\8YY%=%9RAHEB9=DL:*)$`.%)'0'O4":S8
MNA83,`&5?FB=<[F"J1D<@D@9'%$NJ6%M+(K.?-\WRV5(F9B^P-C`!)^7!H`P
M&M9)]7A9=-$:N\R7!^SN2ZE'P'D;A@2%]1T&1TK=TBW@.@VUN;8)%Y01X7BV
M<_Q`J1W.?KU[TZ+6+&60HDK$@.<F-@IVG#`'&"1CIUJ,:_II0O\`:&VA58DQ
M/]T]'Z?=_P!KI[T`9]FDEC;VDLEM/Y<=Y<[E2)F959WVMM`SCIT'<4Y;9O[#
ME5K9VNG$\L8\L[@C2%MF2."05^4GM[5K?VE:_;/LOF'S<[?N-MW8SMW8VYQV
MSFJD_B&QCLYYXF>4QPM,JB-EWA>N"1S@XSZ9YH`IRM)-J,FI)!<_9D,`*F!P
M[;?,W$(1DXWKV[5?L=_V2]G$,I$LCR1QL"C$;0`,'D9Q^M27NJ1VEG!<M%,R
MS.B!1$Y8;CW4#(^F/:H]/UNWO3L8-%+OD7:RMM.QBIP^`"<#.,Y&:`,[1`8-
M0DF6R:VMVMP2([61-SAN<YY9N>N.?>G-IB27GG/:L7:_;<Q4\QE",'_8)QQT
M-::ZS8-!)-YS".,`DM$ZY!.`0"/F&>XR*7^UK,2)&SR*SX^]"XVYZ!B1\I/8
M-B@"OHK?8]-\F:.6/RWG95,;86,2-M`X]",#N.E2:PZOIRM]F-U$[+E=C,-I
M[E5!+#VQWISZM8MYT>]I-@8$")B'Q]X*<88C!R!FGZ1>G4=,@NS#Y(E7<J9/
M`[=0/\/0D<T`8NF6FV:T>XL2OE7,HCQ;$",$`J0.=J_C@>W2GZM8B75+U_LC
M.T]O;JLB1$YQ*=XW`<<;?P'M6J^K6T+,LSD-O956-'<MM`)X"]>>V:L?;+<V
M0O!*OV<IY@D[;<9S0!S=_IS0R2106H6P6Y5S%]E::/F,#/EJ1D;O3//..]6K
MB*:/P9=I*9&?RI-H9/+8`D[0!DX&,8R<XQGTK1&LV)A\P22'YBGEB%S("!DC
M9C=T(/3H139M7TQAY4DHD5U4D"-G7:V0"Q`(`X/)XH`RC8)/,R063II[R0!H
M7B*@L&;>2I'3!7)Z'WJ:/3$EU%(IK/=:K)/A6C^3!"`<=,<''TK575+-KK[,
M)290YC/R-M#`9VEL8SCG&:(=4LYI'1)N4!;+(RJ0.I4D88#OC.*`,*SMF62V
M.HV=S.%MX5M\(Q:-U9MV3_"<;>21D#'M4$-M$KHE]8SRG9<%%$3-M8SL5..V
M1R&Z#U&:W6URTS#Y7FR>;,(L")P5R"0<8S@XX/0T#5[!4CGF=%=XPQ9$9@B$
MGECM^5<@\M@<4`8=[#=N\*2V):\A,!-QY+NS8V[RCCA!G.1G)P>#G-:,%O=#
MPM=0QI(EPSW&U<$-S*Y&.1U!XY'7K6BNJ6;W7V9929-YC^XVT-C.W=C&<<XS
M3[O4+6R25KF7RUAC\QR5)PN<9X'/(Z"@#G[.TF^S3K;QM'N,8MU2R:V2*0$G
M?M9B?3=T!''.327]G*PM@\'[M8F7#V;W!$V[YF&TK@GJ'Z>XK:O-7M[;S`")
M#'&TC*H;=PH;`P#V([]ZCAUZU>X,4HDB.4"EHWQ\X!&X[?EY.!G&:`*:6X34
M(CJ%K<W5R%A\B=8S\N!\Q+`X3G)(SR#CYNE5O(FN+."S-G,6AM)XI-\1"[R!
MM`)X.<=1Q717=[!9A3,7RV=JQQL[''7A035+^VXGO$A@02Q.D+K*'X(D+#IC
MMM_6@#,\J>VBDO;&REW0-&8X5BV%U,04J`0,8.#_`,!J'4=-N8G6)MTJBV1(
MG%HTS"7+;F4JRA&)(.X\>XQ732WEO`THEDV>3'YKD@X"<\Y_`_Y-1_VI:&X\
M@2-OZ9\MMN<9V[L8W>V<T`5M6B+I9>?%)<6R.3<(J;]PV$`E!G<,XX&>WI6(
MVE>;,\C:<Q3['="$219*@NNQ?8X+8'4`D5NPZ[:/;0S2>;&92VV/R7+8!Y.-
MN<=.<8YZU,-5LFN1;K-N<X&51BF2,@;L;<D$'&<\B@#%>R:(%?LC?8EGB,T*
MQ$AXQ%C`4#D!L9`]#4&HVDLD@,4$T=N;<);(]H\SQMELE2''EMRN"W;'(P16
M_=ZK!9W\5K.&4/"\QEVG:@7&<G&!UZ]N/45%+KEL$!A#N_G11,DB-$RB1@H;
M##)'7V..M`%"WMGB\0)(L#R.7;S))+=E91@\^:#M9>F$.2./2GZQ;A[NZ,]I
M/<%X%6T:-"VR3YLX(^X>5^8X[<\5I2:M91K&S2,1+G9LC9BP'5L`$[?]KITY
MYH;5[%9A$9\L2JY",5!;&W+`8&<C'-`%30+(VLVIN]NL<DMR"7";=X\M.<]Q
MN+?B36=8I/FR02Z@SPS;G@EM=L2KR#AM@S@'CYCS717=[!9A3,S9?.U4C9V.
M.N%4$U6EUO3H2`]QG*+)E49@$8D!B0,`<'D].]`&?%:7\-W!J;^6?,E)DB2W
M(E"28&"VXYVX3/'\-);+(MS!'%'=QLL@,EM+&7@CY)++(5[9XP?P';7OKY+)
MK8.COY\HB&Q"V,@G)P#Z57L-<M+R(,S&%_+,C*ZL%`'4AB`&QD9QTH`71'$=
MA;VLBNDZ0JS*R$8!)'4CVZ5!+=_;-62WEANHH;>4$$VSD3..AW;<!0>^>2/3
MK>M+RUO))&@/[Q0-VZ,HVWG!P0#CK@].M4X->A=IS+$\<:2F*/$<C22%?O'8
M$S@>V??%`$=S;3SP:M.8F:1OW<*8Y**`<#/JV[\Q4EI&FH:C>7$EN_V62.%%
M6>%DW,C.Q.U@.F5Y]J>VM1F^6"*,21LL++*'X(D9ATQVV_K4JZQ8L7`F.%&=
MQC8*PS@E3C#`=\9Q0!#HD,D7ABTADC=)5M@I1E(8';TQ6?IEE>Z;;*I,L\MY
M;*HE:/#02!.%..B>GH<YZUL/JEHOG@2@O`XC<8/#$9`Z>G<4P:S9!D1Y<.VP
M'",54N`5RV,#.1C.*`.?M["8VLJ+$P4I&LL<=D\.Y_,7))+$LP`;Y@._6KLN
MG117A`LLVT=]'(JK"65<QX+*,=-V,X[\UK?VK9_:UM?-;S7<QK^[;:S`$D!L
M8)&#GGBDN]7L;.X,%Q*RR*@=@(V8*I)&XD#`'!Y/3O0!%JD%S>7$,$#1QQH#
M([2QLZL2"H7`(SU8]>,#CFLMX-1BLK:-4E>X`:PED5<?*3\LW/8`9^K&MA]8
MLHY98S(Y:$[7VQ.P#<84$#!/(X'-#ZS8I'&YDD/F$A46%RY(ZC:!D$9Z8H`Q
M&L9TUIMB,CB>,QR+9L["(;>!+O"JN`05QGKP213)-)E&DQK;VCK<36$\<GRD
M%F(&T-GWSC/O6_+K%A$J,UP"K()-RJ6"J>C,0/E'!Y.!Q3O[4L_M?V8RD29V
MY*,%)QG&[&W..<9S0!S]\D]]+=30VUP(3!;*PDMG^<*[EAL^4MUY'<>N>=/0
MLVT+1REE6:8^0GV9H5`"C(5225'!/..<\=*E?7+0QN8-\CKM(5D:/<K,%W*2
M/F'/49_6K$.H6=S=F&-]TJ%@"8V`.#AMK$8.#P<&@"GJUO*]];B&)BER5CG=
M1G:J-O&?8C>/^!5GR6>H-::A%&A7R&$4/[L_/'YF]L<C(V$+@$9*GGTZ*ZN8
M;2`S3OM0$#H222<``#DDGL*S[?7[659W=9$6.<PH!&[.^$5B=@7<,;N1CC%`
M&.;$-8'='(+<3ADB337$0.T@Y@+%BN3V`YY]ZT-)MRFH0S360BE:T"*XC8XP
MS<;CR.-IP3GMVK0;5[%9(T\_<9%5@41F4!CA26`PN3TSBB75[&%YEDGV^2K,
MYV-@;1EL'&"0.PYH`IV5R+34]2CFAN@9KH-&RVTC*P\M!G<%(Z@]^U8PM9+F
M21QI9A$EI,DJ?9WW%\`J&9O]8>.#@CT/.*W9-=@68*HRI,8RX=&&]F4'#*./
MEXP>?RS8;5K-;=)M\A5R5"K"Y?(ZC8!NX[\4`<_?6S^;'%;Z7Y;P-"4D6!V.
MT;2VQAA4[@CJ<'CFI[FVNIIKZQM@1]DCDE@;.3OE!VX/8C,@QZ%:T]1UVTLK
M.2=6\]E@,RH@)!&#C)`(4$C&34SS6]CY`2**(74IW8!&6*LQ/`Y/R]\?7L0#
MG5T]7B=I;,RVR2PLT2Z>\:Y#'<0C,Q9L'D@<CN:6YL&20A;1%MA<3M,C6+3*
M[,04;8N-W&>1G'\NCLM3M+YMMM(S'8)!F-E#*>A!(&1]*HS>(H8;QK=H)L)=
M"W9MC'K&7R`%^8\8P.>A[C(!<TMC':06TSR-.L08[T*G&?J?RR36/-8/<:FR
MS6KO`VJ;VW(2I3[-C)]5SQZ=JUCJVGJD4XD+&8$+LB9FPIYR`,@`]<XP>M/U
M"^-K8+<P(DY=XT0%]JMO8*#D`\?-GI0!SR692&1+RRGE@43QVL:PLQC/F/C'
M]W*[=IX``ZU*\,D<)$^GO/&SQ;@\;NHQ"!DHH)?GC&,`\]JU1JYMI)(]3CCM
MV0(089&E!W'`'W0<Y[8J9-6LGG$(D<.<#YHG`4D9"DD8#<CY3SSTH`Y[3M,D
MG,,-_9,T26]TH1XB$4^:I0`'(''09.,<=*C=+N>"S,NGR?;(UMF,SP.TAX0N
M0W`3G((ZG!XYKI_[3L]JL)<@^B,<?-MYXX^8XY]#Z&IUGC>26-6RT6`X`Z9&
M?Y4`,>3S[><6['S%W("01A@/>N8>R,D$26=C/#'Y06\5XF4R2>9'R3_&1A\L
M,_6MBRU5IDCF%F!:S`LKPL793@M\ZA?E)^IYX[T0>(K&2Q@N93)%YL2RLIB<
M^6I[L0.!P?F.`<4`2ZI#'#I7DQ62R0AE7R40[0N>?E49(]@.:Q-)TYIKORKN
MQQ:K-,4C-N4C"LD>,*>@)W<>N>!T&TFMVQFNXY!*GV:419\MCYA*AOE`')Y/
M`SP,]"*?)K6GQJC&<D.K,-L;,<*<-D`<8/7/3O0!C"WG2WT^T9'_`-/A6"<2
M9)54Y.0?5-RY_P!WK74=.E9W]HZ6)9KG<@EB15:3RCN*D_*%XRP)SC&<FI&U
M>R6-',C_`+QBJH(G+E@,D;<;LXYQC-`%ZBJ-OJD%S?"VA#L&A$RR;&VD$D8S
MC':KU`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%,F#M"ZQ,$D*D*Q&<'L:?4=Q(8K>61<$HA89]A0!@IHVHO.+B>2+S%1
M-H,SR`NKANI``!QV''O4,^E7=SJ&RZ55^U322.8-S+&AM_*^\0!G/Y]:GDU?
M4(U@1O*:62$3DQV<L@P>B84G!Z_,?RJU:ZE=WD\CQ1)%!!L$L4JD299`YQZ8
MW`8(Y.>E`%:ZT>^O0DDQMHYK=%2$(S%7Q(CY8X!7/E@8&<9/6GP:5>?VHM[.
M8%_TLSLB.3@&#R\`D#)S]./RJE+K]W-I-Q.;=MC6CS+^XFB\H@`A2_&[.>JD
M=/QK2;6)(YG@94,L#2M,H!_U:C*D>YW)^M`$2Z+<BWM(]\689[B5N3R)!)MQ
MQU^<9_&GW>D7$]C<0J\0:6P%LI).`PW<].G-5X=<O64*8-SR[/+=K66*.,LP
M7!+?>^]GC&<'I5S2)+IKC54NIA(\=P%!7(4#RD/`)..N<9ZDT`0+HD@U'></
M!YXGW&ZE&#G./+!V]>_Z&DGT2XFTN&T\R-62TF@9LDC+@`$<=.*AT[4-1BT>
MQ=O+N&ELA*N<ERR@$@DGG<#UXP?6M>SO&O7N6BV^0A"1/C[QVY)Z\CD#MT-`
M#;V"YN+&$(L(N(WCD*%SL)4@D;L9_''X50&AS-;6D,DD8$4]Q)(5)^[()`,<
M=?G'ZU6L[G5/*MW6YA=_L32N9$8JV&&.-W7'&<_A4ZZ]<2W1$-N[1J\:%!;2
M,6W!26\P#:N-W0]<=LT`)%H5P(VWB-9%5$5C=32Y`=6)^?A?N]`#]:DNM$DD
MU*>9,/%<NCONN94VX`'W%.U^%'4C\:TYKEX]1MK<!=DJ.S$]1MVXQ^=8?]O7
MS6L]RJVPCMK:.YD&QB7#%\J/FXX7@\T`6UTJ[;[/!*T`@M9'DB=6.Y\JP`88
MP,;^N3G':K>DQSVEK;6$L:D6]K$IE4G#,!@@9'MG\>@JE<WUY)(LR,B6J7@A
M*`,)#M)!.<X()'3'3G-51XCO/[/EN_LV5^RM<+NMI4$9`!"EFX?.>HQT[]:`
M-2#3IH]2%P638))6P"<X8+CM_LF@:;+_`&"EB703*@`;DKN!R/PR*KW%_J-G
M>117'D>4=N9?L[A'R>1N!.P@8^\#D^E06FIWL\#I:^2KQ>=*YF#N&`E=0H.[
M(^Z>><<8&*`+;6VIM=17Y2T-Q&KQB$2,$V-M/W]N2<K_`'1UQ[U4;0+G['J<
M*RQ%KNU6)2<@!\R$YXX&7&.M":U?-OF*V_D17$$+($;<WF+'R#G`P7]#D>G6
MB/7[D.\KVTCP`R?*EK*#&J!B"9"-K9VXP.Y'6@"^=.E(8;DYO!/U/W>..G6L
MZV\-NEL]G*P\E;=X$E^TRNQ##;G8?E3CTS^%7K&6];5%%W)$RO;;PL0(`.X=
M02<D>O?T%5[K7I+6_2"58U1)G$[E2-L?R[".>I+J/P-`%DVVHRI;F86H:WE1
ME5';#``@DG'7G(&.W7G(JQ:1?6UL\4+6S&>W6"0N6^0C=\PX^;[W0XZ=:A6^
MOYK^R&]("]R@E3#,"#`7Q][CIV[X/;FQHEY?8LH[IXI8[B%F4@-O4KC[Q).[
M.?08]Z`+$>ERQQ+&'0A;M9@23]T8]NO%+JVEMJ%Q:N&41HV)U)(WID-@8[[E
M7KVS52^EU!;^817";?M$"HA5AM!ZY.[D>V!FDGUJZB:.U(3[27E5I4M9)5PF
MWG8IW<[AWP/RH`6WT.Z2SCCFN(Y)O*F223GYBP"J>G8*,U,-,NGMKE9#"LDS
MPMA6)`V;<\X']TXXIU_<3W/AMIAYMI-(JC(RK(2P'&<$?C5"75[F"]ACE.ZY
MM[>998LE4D;=$$?Z'.<\XR1ZT`:NJVU]<-"+255BPPE0RM&3G&"&4$\<\<=>
MHQ6?9Z%=6\ENSRQ,(HX$)!.3Y;.2>G<,/UHOKS45E%CY\"W"R0.94B8*RNY7
M&W?GJO//(]*6RU"_N8XX;,6ZR9G=C.78$+*5"CG(SZ\@=AV`!=U;3)+Z>U>*
M14"-MGS_`!Q$@E1]2J_AFH6TJY+FWS%]D-T+KS-Q\S._?MVXQC/?/3M3%UFY
M;4C&L+-")_(*+:RL1S@OYF-F`>WIW[5:O+NZ^W-:V9A1HH1,[3(6#`D@*,$8
M^Z>><<<4`49=&O"(&`C9H@\95;N6'*ELAMR#.?52,>]$>B75O<V_V86\"1>6
M&EADD0E5`!4QG(?(&`2<@$=<<R:-/+J&HRWS2MY+V\310Y8;`PW<C=M)]\9J
MO#+JCWL:)=Q;FFN0-\;%0JL`,KNY]N1C-`&CJ=E>3W<5Q92QQNL$L.YCRI;:
M0PX.<%>A]?PK,?P_>7,LLERT1$S6^]#.\G$<A9AD@=0>P'/YTYO$-VZ(8;?,
M@MDF=%MY91(S9^0%!\OW>ISUZ5/XFDNC:Z>;.22&9[D$*K%=V(W;8WL2H!%`
M#)M%N\6VQUE,"-"!]IEA)3/RDLG)(``(/7KD5+%HLL-C-;1F(!C!L`W``($!
MZY/\)QR?K5*XUA_MYU*&222SCM9"D*M\LC!5?/O]X#/L:F;7+R.-U>%F9F18
MY?L4R*"V<C81N;`'8\Y[4`:5]:W!O8+VT$3RQ1O'Y<KE5(8J<Y`.""H[5GG0
MK@6U_$LL1:YLO(4G(`<F0D].%^<>M)]OOK@POGR@AE5P]O)%YP"`A@"05'/O
MR#3EU2]$;2*(/)A,"LK!BS!PN><\$;N^<_K0!I7EM+*EH8MA>"57(9B`1@@\
MX/K6?+H<L^G6]I)(@"6TL+D9/+`8(]N/:GKJ=XUS:.!!]EN;IX`FT[U"A^<Y
MQR4]./>MJ@#+TG3YK6>::=45F54&+F6<D#)SESP.>@'XFHAIEW;W0O+?R))E
M>8".1RJE9&#=0#@C:.U;-%`&!%H4\=TLAEC9=L6[J#E7D9L#T^?BGP:-.UM!
M8W?DFUMH6A1D8EI05V_,,`+QZ$\^E;E%`'.6F@7B2QS7$\;R-"YFP3@S$MM(
MXZ`.P]>!5I=)G%I/%OCW2-`1R<?($![?[)K9HH`YR**Y.IVEI'$6M[2ZDG,I
MC=3AE?CE0IY?'!.?:IKVUOIM8OEMHXA%/9QQ&27(`.9,D8'S$9Z9'4<UNT4`
M8BZ//%YSQO&TBW@N859B`P$2IACCCH>@/:HOL6H6^HQW,44,D\SRRR*781IE
M8U`W[<]%SG'/-=!10!A#2;VWBF2W>W?[3"(I&DRNP_-E@`#N'S="1TZTX:5=
M1Z@);<Q0J,9E25\N`N`&CQM)S_%G-;=%`'-?V'J,MTL]Q-&S"'RSNG=\GS(V
MR/E`&0AX`].3VMPV%U:WLMS&D4<:[W*0ROB8G)&8R"%.>XR36U10!2O89KFT
MB:((D\;K*JR$[<CJI(_$9Q[XK';0KU[F2]D\KSVF=Q%%=21+M9(Q]]0#D&/T
MP?Y=+10!@2:+<KY`MQ#$ZQJIGCFD5T())XY\P<GACZT^;2KXV%_80M;^1<B=
ME=V;=NDR<$`8`!/7GCMWK<HH`QKC2[I]2^U1/"`$@`#9_@9R?S##%5Y]#N99
MEO25-R7=GB2ZDB4!@@P'4;N/+';!R>*Z&B@#GKC1;Q;"XMK3[,?M5KY$GF.X
M"'#<@D,6^]W/O[5H:A82W7V'RV0?9Y2[;B>1Y;KQ^+"M&B@#(T[2Y[6736D:
M,BUL/LS[2>6^3D<=/D/Z4QM*N3JWV@-%Y/VP7.=QW?ZDQD8QCK@]>Y].=JB@
M#G&T*Z5ED0H[>9.2HN98?E>0N#N3DXSR"/Q];USI(ET2WTY5A*1M#N4@["J.
MI(P<G!`/!)]S6K10!EW6D0BVBAL+>WM@MS%,P1`@(5P3T'7`J*?3+J5Y;?=#
M]DDN%N/,W'S`0RMMVXP>5ZYZ'I6S10!C_8#`E[-<X=+M";A8E+$'H`@`R>/U
M&>YJ?18+B+3%:[.V[FS),0!PQ[=^@P/PK1HH`Q(=*N6OK>XGBLXY82=]S#D2
M3@J1@K@`#)!QENE4IM#U6725TXSPB(6HM_EF=0"`1NP%RV>,@G`]^_444`<_
M<:)<RSRR@QG]^MQ&!.\1)\H1LI91E>F01GKC%/M=&GAE60F)?]&GC8"1W^=V
M5A\S9)Z')./H*W:*`,"\T.XGD,B/&"MO`BCS'3+1LQ/*X(!#<$<^U36&DRV]
MQ%.PC1O->20":24\H%'S/RQX]N.WKLT4`9>G:?<6=RKL8F0PE&PQR#O9A@8Y
MX;VZ=ZU***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`*:Z+(C(XRK`@CVIU%`%.?3+2X2)9$<")=B[)&0[?0D$9'L:&TR
MS:X2;R<.F,`,0O'W<J#@X[9'%7**`,XZ'IQ25#`2DJ&,J9&(53U"C/R@_P"S
MCI5H6=N+N6Z$0\Z5!&[?WE&<#'3N:GHH`H)H]C&CH(6*N-OSR,VT`Y`4D_*`
M>>,5-9V%O9+*+=&'FMO<M(SEC@#)+$GH!5FB@"C#I=O9QC["BQ2)%Y43/N<(
M/3!/3@9P1G'-2:=91Z=8Q6L7W4!R<8R2<DX^I-6J*`*D.FVL"E8XR`4*8+L<
M*3D@9/`_E3#I%B94D,)RFW"[VVDK]TLN<,1@8)!Z5>HH`KW5E!>;//5B8SE6
M5V0CUY!!P?3O4`T:P6WF@6W`BFB6%U#-R@S@=>/O'IZU?HH`IOI=F]T+EHF,
M@</_`*QMNX?Q;<XS[XJ(Z'IQ25#`2DJ&,J9&(53U"C/R@_[..E:-%`%2?3;6
MXN!/(C%QC.)&56QTW*#AL>X-4K[0DGCCBMGCMXQOW95V8[SEN0XXR2<$$>U;
M%%`%)=*LUB:/RLJ[I(WS'EDV[3^&Q?RHCTJRCN3.L/SEF;!=BJD]2%)V@G)R
M0.<GUJ[10!3M-,M+.4R01L'*[,M(S87.<#).![4EQI5C=/.\]NLAG18Y,D_,
MJG('YU=HH`JR:=:RR^:T9\SS%E#!V!#`;0>#Z<8Z'O3HK*WA\CRX\>0I6/YC
M\H.,_P`A5BB@"L]A;27/VAD8R94_?;&5Z'&<9YIDVF6DP(:-P2YDW)(R,&/!
MPP((S5RB@"`V=N;06OE@0@`!`2.G(ID^G6=S<&>>W220Q&$ENZ'D@CH>E6J*
M`*(TBR$#P^7(0Y4EVF<OE3E?G)W<=N>*;)HMA)&D;0$*A<C;(RGYSN8$@Y()
MZ@\5H44`4_[,M/M0N/*(<$-@.VS(Z'9G;GWQFG7>GVUXRM.C%E&,I(R$CN#M
M(R/8\5:HH`BBMXH7=XT"EPH..F!P.*BCL+:*X,Z1D2%F;.]B`6QG`S@9P*M4
M4`4)-&L)(TC:$[$79A9&&Y?[K8/S#V.15F6VAF:%I$R8'\R/DC:V",_D34U%
M`%./2[**-8TMU"*'`7G&'.6X[YIBZ/8K'(GE.?,QEFE=F&.@#$Y4#M@C%7Z*
M`*0TJS$:)Y;X1BP/FMN)(P<G.6R/7-/&G6HC>,1?(Y0L-QYVXV]^V!5JB@#(
M71`=56\DE7:CM)''&KKAB""3ER.YZ`9-:D:"*-8U+$*``68L?Q)Y/U-/HH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*0D`9)P!2TA`(P1D&@"EI
MNK6NJ-<?9&9U@<(7Q\K'`.1ZCFKU8UI;W=C<:M/':"3SIT:%!(J[EVJI^F,'
MKZ5LT`-D<1QLYSA02<5EV6O07?V9FM[BVCNE+0O-LP^!D_=8XXYYQ6E.I>"1
M5&25(`_"L+2M"EATJT^V2327-O`5CA<IMB8K@XV@9],DF@#6_M33_(,_VZU\
ME2`9/.7:"1D#.?2G3ZA96P4W%W;Q!EW`R2!<CCGD].1^=8MMIUY9VVC2_9FF
M:SMC%+;JRY#$+R"2%.,$=>]4HK6XT[4K"!K<W4PL[@^4C+\NZ0'`+$#`!QUZ
M?E0!U,UY:VYC$]S#%YIQ'O<#>?09ZT/>6L=REL]S"L[_`'8F<!F^@ZFN:AT6
M_L[%H&MQ>--8):\.`L3#=G.2/E^8=,GCI2W&C:@E_"UN)"<P"1V='ADV``LR
ML-RMP<;<]CD4`=$;^T\V6%;F)YH@6>)7!<#W'6FV^HV\VEQZB6\JW>(2YDP-
MJD9YKGTTO4FU.WEEMVQ%+<EG21%0APVW"@^_)(SGUY-;>BVKVVA65K=1@21P
MHKH<'!`_*@"32]1AU2S%U;!Q&S,HWK@\$CI^%7*R]!M)[33'AG4Q2&:5A@@X
M#.2#W'0BIX+*XBF5WU.[F4=8W6(*?KM0']:`([K5)+:Z2#^S;N4R$B-D:+#X
M&3C+@],]0*LK>6YN!;&:-;DKN\@NN\#Z9J.[@DDOK&1%RD3N7.>@*$#]36:U
MC=F0VPA;!O1=?:MRXV[]VW&=V<?+TQCOVH`V+B[MK79]IN(H=YVKYCA=Q]!G
MK49O[=&N1+(L*VY`=Y"%7D`]<^]9VLV5U+>K/!]H9&A,)6`Q`C)SSY@/!]N>
M.AJK+I%ZA1XS/^XEC<>6\9D<"'82"XVDY]0/PH`W9+ZTBCBDDNH$24@1LT@`
M<GI@]Z9:ZC:W<ES'#,C-:OLE`8':<?7IU'/<'TK&ATZYMA%(VG-=AXYD>&62
M,E2[AOFX"X/<*#CWK5TZ*:&>]66$HKRB1&!!5@5`P._!'<#M0!'8ZY:7S#RF
M"HQ8([2QX?!"\`,3R6&./KC(S;GO;2V1GN+J&)48*Q>0*%)&0#GOBL0:1=2-
M$&39MM)D#Y!VR&163_T'/X4U].U'99WK"=;G]Z\\5L8MP9]N,;\J<!=OK[]J
M`.C:1%C,C.H0#)8GC'KFJ46KVDTNV&19%\P1^8KIM.4WY!SSP.V3^&35>33I
MCX?AM$!\R,QN49@=VUPQ0D`#D#'3%4WL+RXOOM(LC`K7?FE2ZYV^0R9."1G<
M0.,T`:_]J:=Y8D^WVNPOL#><N"V,XSGK[5+)>6T4R0RW$*2R#*(S@,P]AWK`
M_LR^AM-**1SAX;(6\JVYAW*V%S_K`01QS@YZ=:L6=A<64D<+6(ND98!YDDJL
M(M@QR2`21C((7DGM0!H0ZQI\MI'<B\@2*1BBL\B@%O3KU]JEDU"RBD:.6[@1
MU7<RM(`0.N2,].163!;W=O)%*VG-/MCD@*[TR,MG=R<;2.O?@<5%;:/<6^E7
M%O/";F3$&"DH5G**O()[@@XS@''H:`.@@GBN(EE@E26-NCHP8'\152YUFPM[
M2XN?M4,BV_#B.120W]WK@'/KBH=,MKS^S[J*YW(\K-Y9D""3!4#+[/E)SGD=
ML=ZSY-.O;B&%5L_LWV:U,&S>N)"2F-N#]T;3UP>>E`&M<ZHL%M:2_9II6NG"
M1Q1E"V2I;KNV]%/0TL.J126US+)'+`UJ2)HY`-RG:&[$@Y!!X/>J_B"UENDL
M3%!-.L-R))%@E$;[=CC(;<O<CO56'3+J6&2`"YM()KA93YDRR2H%`/))8'+`
M<$GC/TH`TCJD/V*"Y6.1C.0L<(QO+\_+R<9&#GG'!HAU.*5UC,<D4OF^4T<A
M4,C;=WK@\?W<_H<9W]G75M'/;&'[?;&83#S-BNVX$L%(V@,&^;.`,-CKS206
M-X9K)_*G2"*[,@CN)A(\:>4Z\G)S\Q&!D]?R`-8ZA:K?-9M,@G6/S2I8#"YZ
M_I4EM<V]W%YMK/%/'G&^-PPS]169JUC<W-S-Y,>4D@0;MP`RDFXJ>_S`XZ>M
M3Z=%.U_=7DL#6RS)&BPNRDY7=ECM)'.0.O:@"U'>VDKRI'<PN\/^L59`2GU]
M*9_:>G_9Q<?;K;R"2HD\Y=I(&<9SC.`:PVTF]E6>&.&2&+RBJB5HW`^8';&V
M-VTXYWC'3BGP:;>/?6UU(ER<7*NXN'BW*JQR+G$8`ZL!U)Z=,4`;RW5N\<<B
M3Q,DGW&#@AN,\'OP#^5%M=6]W%YMK/%/'G&Z-PPS]16%=:/=SRZA"H46QC<V
MPW`!GDY<'KW!YQCYSP:N:-:W$=Q<7%RMTK2(B`7#Q$_+GM&`!UZY)/MB@"6'
M7+"7[0QGCBA@D\LS22H$9O0?-G\P/;-6S>6HG2`W,(F<92/>-S#&>!WZ&LA;
M.[MKU;S[,UPJ27`\E&7=AV!5AD@=`1USS4FAZ=<65Y<//&JJ\$2J5((!#2$J
M/8;E%`&G)>6L,Z02W,*32?<C:0!F^@ZFEN;JWM(O-NIXH(\XW2.%&?J:Q-6M
M=2N;J6.*W_<F6*0,GE@.%*D[B?FW<'&`.@YZBK^H0SKJ-M>Q0-<K%')&8D90
MV6VX8;B!_"1U[T`69;^SA=4ENX(W?&U6D`)SG&.>^#CZ4_[7;?:OLOVB+[1C
M=Y6\;\>N.M<ZVBW8M-1C\A&>;3A#$`PQOW2'8,]AN49X%3)I=X-0PYNO+-R+
MC>KPB/\`'*E\]L=".XH`Z#S$$@C+KO(+!<\D#OC\14/VZS\V*+[7!YDPS&OF
M#+CV'>LG5XI[6"`0WKSWTDACA,P0-AAM;`51D+P__`>M02Z-<17DL4(N3:RM
M%L$31*B*BJ,-N4L,;<C;Z]NM`&[]NL_M#6_VJ#ST&YH_,&X#U(ZTUM1LQ937
M:W$4D$()=XW#`8ZC/K6#<6&IW%W%FV"10SROA/+5&#*X##G<3\PSG')/![;)
MM9#H)M%4+(;;RPO8';C%`$L>HV4A@5;J#?.NZ)/,&7'L,\_A36U73D+A[^U4
MH2&!F4;3SP>>/NG\CZ5B-IE])=2,R78CN3$Q17A"Q[5488D,W!!(VYZ]NM6(
M-,N5^Q;X1^[U*:X?D<(WF[6_\>7WH`V(;RUG<)#<PR.4#A4<$E3T;CM[U'J6
MH0Z9:_:+@.8]ZJ=@SC)QGZ"J-G8S6[6C^1_JFN&<*5S\S$KW[\5<U&"2Y@@"
M1YQ/&[*2.%#`F@"8W<0F:,M@+&)2Y(V[<^OX4S^TK#[.MQ]MMO(8D"3S5VD@
M$D9SCL?RK$ET>]62X@B56M8Q$;<;@,JLF\Q'\L`],$>AJ8V-U<ZG;WK6AA3[
M4LC1NREE"Q.NXX)&264<$]!^`!J/J5F(I'2XAE*1>=M25<E,9SR0,'U)`]Z>
MM[:M.(!<P^<<XC\P;N.O&:PKS2+I]),,5N/,,5TN`RCE\[>_?BK<>GS(I(A4
M.;X3$Y&2N`,_EQ0!>EU6QB2X8W<+&V4O*BR`LH'J,\4Z/4;*0P*MU!OG7=$G
MF#+CV&>?PK!33]4N)%,]L(@MK-#L'EJBLP&-NW)V\=SZ<"E;3+Z2ZD9DNQ'<
MF)BBO"%CVJHPQ(9N""1MSU[=:`-J;5+2*]AM/-5YY9/+V(P)0[2V6&<@84TN
MHZG::9;O+=3(I5&<1[@'?`R0H)Y-9:6-TEW8Q?8SLM[R6=[C>N&5Q)VSG.6&
M>/SIVN65U*NHBWLS<F\M!"A#*-A&[KN(X^8$8SS0!I#4[0%A+/%#A_+'F2H-
MQPIXY_VAP<'VY&98KNVFEDBBN(I)(O\`6(K@E/J.U9%CIMS%K$D\D6(S-(ZM
MN!X,<2@_FK#\*IVNBW_V0VDDER'CMI(4F=XMFYAC*[1O/K\Q'XT`;DFKV$8B
M/VN%EEE\E2LBD;O3K4HO[,M,HNX"8!F4>8/W8]6]/QK-,%S(ENZZ;Y#0RIN`
M=-S`*RYX.,#(QDYQG@=#1FTN^ET=;$6A62VLY8?-+KB=F0J-O.<$\G=CGUH`
MWEU.P9XT6^MBTI(C`E7+D<$#GFK*.CYV,K;3M.#G!]*P]1L+DW:O:6\@=XXT
M+AHVB.TD@.C<X&>"O-;B,6SE&7!P,XY]^*`'4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110!GB:6;6)X4;:MO`K*
M">&9RW)'ML_4U3CDNHM%OY'N7EGMI9'5S\N=O(&.PXQCTK4^S`7WVI3AC'Y;
MC'W@#D<^V3^9ID]A%+:S6Z_)'.Q:4==P)^8?B.*`+"L)(@W(##-<X;NX$MJ?
MM$S?V<%6Y&<"0L_E[F]<!6;\<^E=+TZ55;3;-TNT:$%;S_7C)^?Y=OX<>E`&
M-+>7!AW^:W[X"965F&%:90H`SC[I%-L=2GC@)::/=F;$EQ(Q`_T@J!C//'`'
M7H,BMR2PM9=N^+.U0@^8C`!!`_,"HCH]B8S'Y)`Y/$C`@E]Y(.<@[N<B@#+@
MUJ]N)DM8S;^:UVUOYS0NJD"+S`VPMGVZ\]>]6['4KN6\M(KA8=ES#(X$8.59
M"H/)/(.[T&/>K4&D6-O*DD<)#I)Y@8R,QW;=A)R>3MXYJ5+&VCDAD2/#PJRQ
MG<>`Q!;^0H`RKM6EU6Y4VNI7"HJ;?LUWY2KQZ>8O/X5N(,(HP1@#ACD_B:J7
M&EVUQ.TSFX21@`QBN9(P<=.%8"K,,*PKA"Y&`/GD9N@QW)_^O0!RMM<31A;E
MQJ"_Z>T;7+3[X=OG%=NS?QV7[O'6KTVLSI?+`9+>6.;S5"Q1O^[*JS#,F<'[
MIX`!_*M"/1;&.7>L<I_>&78T\C(')W9V$[<YYZ=:/[%L/-67R6+*S,N97(7<
M"#@9P`03P*`,VVO+O>SR2J\9F@5$^<%=R`GG=SU[_CFFV^NWPM;::XCMW-U9
MFXC6,,NU@4&"23D'>.<<8[]:V!IEHK[A$01LXWMCY1A3C.,X[TQM)M/LT<,<
M*`10-;QB3+J$.,@C/(^4?EUH`SI]7O[.>XMI_(DD40B.2*"0C+E\DH"2<!.@
M/_UI;?4[ZYEMX%1(F9I`\DUM(F\+M.51B",[L<YY'>I+'08H(IQ<OY[S[=S*
M74C;G;@EF8$9/.[Z8J[!I]M;M&T<9#1[L,SLQ.[&223DDX')H`M5FN&N[N\C
M:XE@BA5$S&^T\_,QS[C`SU'.",UI51NM,ANWF\XL8IT59(PS+N*G(.001WSZ
M\4`4(VEALI;FWFF:V2=&@\V1G+IP&Y)R0<G&3Z'IBMF<D02$'!"G!_"JATN(
M1+"DDQB\Q9'$DSR%MO(&68X&0/KCWJ\RAE*L,@C!H`PK6(VEGIEU'<7323&-
M9%DG>0/N7GAB<8Z\8Z4T:S>-<M%"UK<EX))(Q'&X4,N,+O/#9SVQCCCFM*UT
MFSM'1HEE8QC">;.\@3C'RAB<<<<46ND65I*DL$3*\8*H3(S;%/\`"`3P/8<4
M`9=UKV6AN85\RT67`*[LOB!Y#C!PW\(P01G/?&+EC+>MJBB[DB97MMX6($`'
M<.H).2/7OZ"K,6E64,4,4=N%2&1I47)P&;=D^_WCQ[TMIIEI9RF2"-@Y79EI
M&;"YS@9)P/:@#(U&6[S)86L[K<)+).N9#ED"[P,]=N]E7Z#%:FF7!O#<72MF
M%V"Q8;(VA1D_]]%A^%6/LD`O#=^6/M!C\HOWVYSC\Z2WLK>UMHK>WC\J&(Y1
M$8@#_'K0!4OMUSJEO9-+)'"T+RL(W*,Y!4`;@00!GG'M48EGM[N"PM+N.4%G
MWM-F1HP`I"GY@2<-U//(Z][]W9P7B*LRM\IRK([(RGV92"/SIL.GVL!C,<6#
M&&VDL2?FQDDD\DX')H`P-1UJY-M>1I/"P>RFD1[='7RV4<8D/#=>V"./6K5_
M=7ZM';,\8?S;9T>,LN5,@#*WKTZ]\]/6Z-!TT(R?9V*F-HL&5SM1A@J,GY1[
M#`J4Z38D,&@#;F1CEB?NG*CKP`>@Z4`&GW4D[W4,^PRVTOELR`A6RJL"`2<<
M,._:GZE.]MI\\T6/,5#MW=,]!FI+>VBM8RD*D`G<26+%CZDGDFEN($N;>2"4
M9212K#V-`&3J\3V<,5S'/=GRB@:0SX2-`1N9ES\V1GJ"?IUJ]:2,+Z\MV9F5
M"LBECG`;/'Y@_G0=,@E9)+C=)*%`<J[(LA'=E!P?QS4UO;^3)/(S[WF?<3C&
M`!@`?0?KDT`9\%\]KX>FO9`\S0^:V"<EL,V!^F*KKJVHM!/LMFD9`C"06<J`
M`D[AL;!8@#/!YSVK0CT>SC9BHGVMNS&UQ(T9W9S\A;;W/:A=&L5C=!$YWXRQ
MF<N,=,,3E0.<`$8S0!C2ZI<//'(95;%I,66,R1J6$L8!*G#*<'IVR1DU<M-9
MN;F_5!`Y@:9XL"VD&P*6&\R8V$$KT[9Z]JO#2+$`?N22$9,M(Q)#$,<DG))*
MCD\\4Y=,LUNQ<B(^8&+`;VVACU8+G:#R><9Y-`&1J+32:[=1K#J%P([6)D6V
MN?+",3)R1O4'.!V/2MC2I_M.E6DYE\TR0JQDV[=QQR<=J;<:5:W-R;B03+*R
MA&,=Q)'N`S@$*P!ZGKZU/#;10;1$I1501J@8[54=,+T'U_PH`R3;><=3N#=7
M44L4K"-EN'"H`BG[F=I[]13+G6KB$0.KV_)B#P>6[O\`/C.6'"8SW!SQTS6A
M)I%G+-)*ZRDR-N=//DV,<8Y3.T]!VI9M(L9YVFEA8LY#,!(P4L,8;:#C(P.<
M9XH`S/[8O<+)(+<P2W$]LJHK!@4\PAMV?]C&,>^>U-CUVY:81PPLZPB)706T
MLA<LJL<.,A<!A][.?;K6N=,LRBH8?E25YE&X\.V[<>O?<WYTC:39-(CF)LH%
M``D8*VWIN7.&Q[YH`Q8]4O[:V=P08A<3@RS1O(.)6`4E>4``'S$$#TKI@0R@
M@@@\@BJ#Z+8."#"P!9BVV5UW;F+$-@\@DG@\<U?``&`,`4`9][=B+48(Y'\N
M".&2YE;=CA=HP?;YB?P%96F:B=3U+4434$/F6T;PI%,&\KE\XP<9^[GZ@=,5
MO36PDN8+@';)%N&<9RIZC\P#^%-FLD<W$D9,4\\8B:4<G:,XP.G&X_G0!GW=
M])<:#87D;-$UQ+:L=IQPSID?3!(JUJEW);+&(IX(F?)_>1M*QQV5%()_/TZY
MJ:>PMKBS6TDC/DIMVJC%"NT@K@@@C&!4)T:R;;N%PQ0G#-=2EL'&1DMG!P..
MG'2@#)_MZ_DM)KF);9%AT];ME9&8LQ#\`Y&!E1VS_2Y+J-[:!XKAK=YY44VI
M2-@"Q8*01N)(!922".#VJXNCV"PRPK;@1RPBW90S<QC.%Z\?>/3UI9K`3W]M
M/(RF.URT:;>0Y!&2V>F#TQ^-`$.L"9_(BB+/G<SPQ3^3)(`/X3D'@D9Y'4<^
MLFCN6LV4O.QCD92L_P#K$[A2<G=@$<Y.:GN[."\15F5OE.59'9&4^S*01^=$
M%G#;HB1!E"$G[[$DGJ6)/S?CF@#%U,RR>()8A#J%PBV<;*EK=>4%8O(,GYUS
MG`]>E+:ZG?R6`,+PR-:VB2S-,I!E8ALC@_+]WKSUZ5J76E6MU<_:)!,LI01E
MHKB2/*@D@':PSR3^=)+I%A,%5K<!501[58J&4=%8`_,.3P<CF@""/5)9(ED"
M(`UVL(!!^Z<>_7FLN'6[N.UABBC>:2.V65B8)9C*26^7<N=OW>ISUZ5N'2[,
MW/V@Q'S-X?AVV[AT;;G&??%-DT:PDC2-H3L1=F%D8;E_NM@_,/8Y%`$6D37,
MU]JGGRAHTG58T*D%!Y:''7W].N3WP-2H(K2&">6:)"KS8WX8X)`P#CH#C`S[
M#TJ>@#(OS=W#ZA%:LPDCMPD01]IWOG+>G&!C\:KB5[.TN5(ECN+0I.X^U23J
MRG(QN?'4!N,<'!K4EL8Y;AY'P5EC$<B8^]@Y4Y[8R?S]J8=,A$`AC:0(7#2%
MW:1G`YP68DXSC\,CO0!6UPN9;&-4NI5>5@T=M-Y3-\C'KN7COUJA9WLD;6[*
M)U@DO6C6*XF9Y(]L3E@?F/=>A)_ECHGACDDBD=<O$24.>A(Q_(U`=-M#=?:3
M"/-WB3<&(^8*5SC.,[21^7H*`,:XOM2N-(M+P/#&MS-;/%Y>X%0SK\K<_,,$
M9QC/(Q5@:I=>5+$\]K'<0W#0M(878/A0PVQALGA@/O5=31K!/NP'AE=09&.T
MJVY0.>`#S@<4LFDV4LC2&-U=I#*625U)8@*>01P0HXZ<4`9,>O7LL<LRI`(X
M+19V0HP+L2ZX!)^4?(.H)'-7;![P:]=PWDR2;;:)E$8*H,M)G@D\\8SWP*M6
M^E6-LKK#;JJO&(F4DD%,L=N#V^9OSIUIIMK92O+`CB210K,\K.2!G`^8GIDT
M`<_9WUU&=2@:XD>2ZN)5M2SEBA\TQD#T"C8?Q-;FA,[:+:&21Y'\L9=SEF]R
M:D73+-)(Y!`-T<KS(22<.^=Q_')J6"UBMT1(0RK&NQ5WD@#Z9_6@#$U,W,<M
MW<%[EHXSF.6VER+<!1G?%N&_G)/4X--AU"\AO+N7S4DM?[0C@V,I+`.D8&TY
MP`"V<8/4UK7&DV5S*\DL3$R?ZP+(RK)QCYE!PW''(-..G6C;\Q??G6X;YCS(
MNW!Z_P"RO'3B@#'CU^Z=9)1`S1M'(R#[+*HCVJ2"SGY6!QVQR>]23:IJ5LD:
M2"T>:<Q&,J&"J'<*0<GG&>O&?2K\NCVK)/Y:LCRHZ@EV94+#!*J3@=>V,U$V
M@VAMA"@8?/&S,SLQ(4Y"@D_*/0#@4`5)]:NHI&M"$^TI,8VE2VDE7`17R$4E
MOXP.O'/-*VM78A>X:%8HX+5KB6.2)@[8+#`!(V@[<C(Z&M(Z59F`0[)`%;>'
M$KA]W3.\'=G\:DBL+6'_`%<*@&/RB.2"N2<?F3^=`%.R>]_MB1+N2-A]F1E$
M0(4$LV>"3STY[^U:M5+33;6SE:6!&#LH0LTC,=H)(')/`R:MT`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M4"W<3J&3S&4C((C8@C\JGK'T_6M*BT^VCEU.S1TB565IU!4@<@C-`&K%(DR;
MXSE<D?B#@C\Q3ZI:1(DUB9(G5XWFE964Y!'F-R#5V@"*YN(K2W>>9BL:=2%+
M'\AR:BM;Z&[9EB2X4J,GS;>2,?FRC-0Z\"VD3@,5)V@,,9'S#GFH-0CO++3)
MWCO;FX8L@+.J9C3<-Y7:HYVDGOTH`UZ*Y.>X8K-'I][-+8F6U59EG9R&:7#J
M'R21C'?O6UJSQV6D[2]PL8*H76;#`9'5VY`]6SGWS0!>EFCAV>8V/,8(O'4G
MM1!-'<0K+$VY&Z'&*YC3KAYG9#(SPIJ$?DYF:;"E,\.W)&<^H]"1S5R21X?!
M-Q)$[)(EM(593@@\\@T`;]%<S>275E=7L%M/<,AMX)6+.SLFZ1ED9<YQ\HS@
M<#'`J*:Y;$T>GWLTMCYUJJ3B=G(9I<.H<DDC&,C)Z_A0!U=,CD65=RA@,D?,
MI4\''0_S[US+F6!IS'=7/^BZC#!&&G9AL?R]P;)^;[YZYQVQ2V)EOKV"">ZN
M?+87A8),R$[9P%Y!SP.!^72@#J**XM=0O)K73WNIT2)[)'622\>WWR\YY53N
M.`ORGUZ'L^\O;Y)/]*NHHIA;1F$FYDA#.1R5C"'S#N_A//3@9Y`.QJ*6XBBD
M1'8[W!*@*23CD]*YRXO)+?7`7NVE=I8U%O',T;J"!G$1&UUSDENH&>>*TM99
MDN(&4E6$,Y!!P0=HH`U5.Y01G!&>1BFI(DF[8P;:=IP>A]*Y>:[>/48&:\>1
MCY6(5N&CD&0N<(1ME!R<GJ.><BF3R&U66.&<K']O?[3YEV\>T;25RXW%`>#G
MC/'/-`'75%;SQW,*S0MNC;.#@COCO7-P7+D6:W]Z4L'$I6:.X?!8,NQ3)A2W
M&[']['>M#1I5A\+1R[I75(G;<J_.0">0,=?:@#5GGCMH'FF;;&@RQQG`J2N(
MDO?-%U%%<2-;2V#R$_:3<$N&49'4`X)X'Y"M"XO)-UT=.NYIK0>3YLH<OY9,
MA$FT]CMY('3T%`'3T5SL$[C[7)87$ES96QCEB?SFEWGYO,0,2=PQCUP3[<5[
MZYNP+62>01VUR))7,MT]LJG*^6N]02/E[<`G/TH`ZJBJ6CO-)I<#W+J\A!^9
M22",G')`)XQS@5=H`****`"BBB@`IDLB1)OD.!D#IGDG`_6GU2U:6."S$LTB
MQQK-$6=S@`>8O4F@"9KJ)5+-YBJ.I,;`#]*GK(O=9TN:SFCBU*S>1U*JJSJ2
M3Z`9K7H`****`"F22)%&TDKJB("S,QP%`ZDFGTR6-98GC<95U*D>QH`0S1"9
M83(@E92RIN&X@=2!Z<TU;JW9BJW$1*D`@..,D@?F01^%<QYTB*VK.DK26$B6
MI`7[^`5;`]"S_P#CHI+J(0RO;7=S*(;9;)F;SF0*2[AF)!&,]2?8>@H`ZI)H
MI(S(DB-&,@L&!`P<'GV(/Y4Y65U#*0RD9!!R"*Y*UW6]O;/'++_I-Q>1R(9&
M*;096&%S@'*CG&>34I,UE;V\<=S<^5);PM,Q<L5&]0S#^[P3G&,=>.M`'3M+
M&CHCNJM(<("<%CC.!Z\`G\*7>GF>7N7?C=MSSCUQ7*332-=V_P#9\SW,:7$G
MV5W<N&;[,YP'.2PW=\GOZ5=T=[9]5!MKN2Y_T7]X7D+[6W#(R>A_V>WH*`-U
MI8UE6)I%$C@E4)Y8#J0/;(_.GUS>HF\DNY-2@@B>&S<;7,IW[4SYFU0O.<L.
MO\(I[7ZM,;;[2WFM?+A`Y#>60,?13^5`&ZDT4C;4D1CMW8#`\>OTJ2N-M+=&
MLF:&YN$:WT[<#'.V5D#/UYYP1]T\>U7)+MS-(TEW,E\)HQ;P*Q`="$SA.C`Y
M;+8..>1B@#HWECC9%>159R0@)P6(&>/7@$_A2HRNBNC!E89#`Y!%<K$998[-
MFN+EC=75U'(//?!51,%`&>,8'3T'H*?9R/'96%K:7$CQ7T4:H_F,_EE?];\V
M>..`.,$?A0!U-%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!34=7!*,&`)!(.>1P139RX@D,?WPIV_7'%<
MO=SR16VGJLZQV[6H9'DNW@WR'W53N/?:>N3P:`.LHK!MY[DWL(FF?RB$,K*2
M%\\K]P9Y"]#C`YP.Y%45NYO[(,D5W*VH$(;N)I&VQ?.`_8^7QD<=N<'&:`.L
MIN]0X3<-Y!(7/)`[_J*Y-+LL+83Z@4L6NF4O#=NZA1$3@S$*2-W?)P>,\<6M
M-._5K.6YED\QHIT@+RL/,42?+QG#'9ST]^U`'245RNKZAY>J;8)IUGCNH5*M
M<E0$)4-B(<%>>K=\\\`59TF=O[:EB-V;@G?NVSL=O/&^)A^[(Z#!Y]*`.AHK
MG-1,HN[J9;FX5H[JWB15E8*%<HK?+T/#'K5>YN4MVDLY+BZVK+(L.Z\:,'A"
M`7Y=CEC@#/&>#Q0!U$LL<,32RNL<:#+,QP`/4FGUP\DT]]HE_+=3S.T>E0OM
M\PA=[+(&)4<$\#K5^]NKE(`MQ*(W%VRW3-<O"@&W*`2!254C;TQSP3G.0#J&
M(52S$``9)/:F^;&$5S(NQL;6SP<],?6N6:Y=[1?[2O3'$8)#`\4K@2-N8`9(
M4N0NW&1AN3@]:O:BD+:!I[7$C1Q(\#,ZRM'M&0"201@<_P!:`-ZHWFBC)#RH
MI7!.6`QDX'YGBN?LKEVO;81W,LMX\[K>0M(2(TPV/DZ*,A<$`9SWS4>LQ1_V
MM?9D=))+>VV#S",_OB"0,XX^7MQGW.0#J**Y2_DFLY)+87,@M$N5#-/=O'M!
MC!`,N"P&[W]L\XK0CN+[_A%9YHW$MT(Y3$R;FS@G;@L`6XQSCGKWH`VZ*YMY
M[()"$U2X-@TI\Z8W#85MO"^;U`)Z_-UXXSBHX3<W8<37-RJ)!,T121D+*)"$
M<XY)V@?7/.:`.F#J6*A@67J,\BG5RQVRW)S<3)-<FV,@2=E)4CG`!X&>,BEE
MO4CUB&*":?>ERL+B2Z8X7&,&/D8/9FP3GJ:`.HIKNB8WLJ[CM&3C)]*YJ*:7
M3M)MM3$ES</(A21'F9PS-]S`)P/FVCC'WN:OZA$;?3;"*:>5BDT0>7JS$=2?
MKW/;VH`V*8)8S*T0=3(H#%,\@'.#CTX/Y5RES=SJL2K<`Z9YL@2>6]>$,`$V
MYE`)/)?'K@<^K?/G%Z'N)RL;VUN+F=&9=L>Z;G=@$<[<G`ZD\4`=A36=5*AF
M`+'"@GJ>N!^1KEI[JYCM7DM[B9K=YGM+:42%LAU7:^3G=AP0&]_QI\$L\VDW
M<LLDK/;%+:,R-]Z6-N7'N6./?%`'44444`%%%%`!1110`4444`%%%%`!2=.M
M+4-V@DM)D.[#(P^4D'IV(Y%`$B,KHKHP96&0P.013JXV&YCCTP>5?3":.S4V
M,8G8B23!R`,_.=WRE3G:`.!6]K%U+86L-_\`.5A;]]&@)W!ACH/1MOZT`:E-
M5U8L%8$J<,`>AZX/YBN7NI9K:.9+F]F&H1VRM:QB1E$LF"3A<_/\W&#G`QTJ
M&YD^S37*B<Q[[P&Y$EY)$%!CRN6&2@)SR,9P!GC%`'7,RHI9B%4#)).`!389
MHKB)98)$EC895T8$'Z$5@W9EN/!%\US(';R)B&C=N5&=O)"EN`.<8;W!J&65
MH)9HVNIDNHFC6QA\YOWJ[5_A)^?DL"3G&.U`'44R66.&)I976.-!EF8X`'J3
M69X>#/927,DLTDDDTJG?(S`!9'``!.!P.U<UJ%^+BUN_(FF:*6RF\P27)D.X
M`8#)]U&'/`P>N1Q0!W*.C[MC*VT[3@YP?2G5E6Q*VNJ,I((FD(([?**S)'N;
M6WC$-S<OYMM#),SR%RHWJ'89Z?*3T],T`=15:6*VAF:^F(1D0@R2.=J+U/4X
M'N?:N?$@GU&UMK6]N)=/DN"HD2X9BW[IV91)G)`('?@YJMJ-Q=6U@)([RYWR
MV%R68RGJA4*1Z$9/(Y/>@#LJ*P,RK=-<"XG+"_\`*"&0[`A`&-O3W]:R[:]U
M)K:9EG7[9]G=IXUN7E=&_P"N>S$9'.,=?]J@#LZ9++'#$TLKK'&@RS,<`#U)
MKE8KF5[.XV:A"MJICVL+R65<_-N#3[05!^7H>,=LBK-U,9O`UZQ,C8@E`9Y/
M,W`9P0^!N'H>I%`'1(Z/NV,K;3M.#G!]*`ZEBH8%EZC/(KE]3N9$=VDOQ$B7
M$H$<EP\"O@+C$@Z$<X4\'/3BF3SL!-/&\L4DRP/,L]RT;)&5Y)QG9R`"0..>
ME`'6TV.1)4#QNKHPR&4Y!KF+>YD86XO;P)IY:39+%<N02-FQ3*0I;J^.H.`,
MFK=K<);>#[>9GFV")`70A6P2!DD_='J>PS0!MM+&CHCNJM(<("<%CC.!Z\`G
M\*?7&VTZ37L7G7$BVT=VQC;[2TFU3`W/F'G')YS@'H:LK=,P4:E>306X1S:R
M"9HS*1(P7)'WCL"$`YSGH:`.IHKG(+B_:YM+.X\Q9KM([ER&QLVJ/,7V&X+Q
M_MFH_#]U=S7L8GGC\XQL;F(73R,K>\97$>#Z'GWZT`=/1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`5'%$D*;(QA<DXSGJ<FI**`"BBB@"-X8Y)(I
M'7+Q$E#GH2,?R-2444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0!#/:PW#Q/*I8Q-N4;B!GU(S@X[9Z5-110`4444`%1RPI+L\Q=VQ@Z\]QTJ2
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`*YW2M6NKC5W,[YL;OS/L:[0-OEG!Y[[N2/I6]/%Y
M\$D6]DWJ5W)C*Y'49[UEIX:TR%;3[/`L$EJRLLT2J';`QACCD'O0!4M/$TUS
M!;2?V=M-W;R30KY^2Q3JI^7C/&#S]*T=.U=-2N-D$9,0MXYC)GH7SA<>N!FF
M6VAP626)MVD=[".1(1(X`;=C.X@>W;]:/#^D_P!DVDJOM\V>5I7"$E5ST4$]
M@`!T%`$,'B%)]:DTX1QJR.T?S3`29`SG80,J?8D^U5-!\07,UGIXOXMSW4$D
M@FW`%BAYRN``,$8.?RK4;1H7OH[J2>XD\IS)'&[!E5CGD'&[')XS@>E0IX;L
MEM[2`M,\=K#)"H9A\RN,-GCV[8H`IGQ7MANG-F&:$1.H24E9%D8*"&*CD9[9
M'O4M_P")H].N&@NHX4>*,23#[0`<$G`0$`N<#)''XU*/#5L4<275U*72)"S,
MN<1MN7HH^G_U^:MW&E1S7INEGN('=0DHB<*)`#D9XR,9/0CK0!EQZY<PWMYY
ML8FM4O4MU?<%9`RKC`Q\W)YR1U[U;CUS?-$WV;_0Y;@VR3;_`)MX)'*X^Z2"
M,Y_"I9-$MI//W/+^^N4N6P1PRXP!QT^44J:+;)<I*))3&DIF2#(\M9#G+=,Y
MY/&<<]*`,ZPURZELK2(1BXO);>2=W+!`JJV,@`<G)''`]ZK6WBY(+"U-XT;R
MBVCFG=Y%C9MW]Q<?,>,D<5K)H%M%';K%-<1M!&T0=67<R,<E3QZ^F#26_A^W
MM1$+>YNH@D2POL<`RJOW=QQD$9/*XZT`36&HR7M[=Q+;HL-M)Y9D\S)8[588
M7'OZ_P#UJ<GB"=;F2-+!7CCO!:%O.P2Q`(.-O3GGG\ZU+2RCM);F2-G)N9?-
M?<1P<`<>W`JM_8MMO=]\N7NUNSR/O@``=.G'_P!>@"JWB!A8^:+9!.)I(3$T
MW!9,YVD*6;IQA?RJ-?$ZM:M,+4@M;QS0*SX\W>=NWIP0V!WZU9/A^VWJZ3W$
M<@EEEWJ5S^\.77D=/U]Z@'AY5O-+"X^S:<A",SY>3T!``&`0#GVZ4`7]1U(:
M<;8S1?NY2RNX;B,A"P[<YP161)XH,^DS7$5N\3QVS32A9!NB8.5V\J1U#<D=
MNE;6JZ;!JUD;6YW^66#?(<'@Y_\`K?C563P]9/'J*9D7^T,>:5(R,=EXX[GO
MU-`&9>:SJ:-?!1$@@OH88]AR65BN0<CN#U[9]LF2[UV\+6T<4(BG34EM9HU<
M.K@H6X8@''3G`/%:,VA6\TTSF691--'.R`KC>F,'IGG`SS2MH=LUQYYDFW?:
MQ=XR,;PNW'3IC_\`70!6AU][@1PPVBF]>:6'RC+A`8_O-NVYQTQ\O>H6\0C[
M9',2R6J6MQ)-%M!(>-E!Y_.KHT&W0%HIYXIA<27"RJ5W(S_>`R",>Q!I1H%B
M"F58J(9(64D8<.06)[Y)%`$%CJ-]<:\L%Q&(86LO.$:L'&=^,YP#G'4=/K2W
M>OBUU-+5H%:-ID@+K)E@S8P2H!`'(ZD'VZ9LV6CQ6EZ+O[1<32B'R!YK*0$S
MD=`/SJ.70;>6\-QY]PF;A+DQJPV^8N!GIGD#&,_K0!!;^(&N(+!TM`'O)9HE
M5I>%*;N2<=]OX9[UG6.NZK/_`&?(8X9#/9R3M$'VJV&7!SM)'!(QSVY[UKP>
M'[6"XMY4EGVVTLDL498;5+@[ATSCDGK1::!;6ABV33L(87@C#%<*C$''`[8X
MS^M`$2Z^;B.-K*T\TFV6ZD5Y-FU#G`'!RW!XX'O3?[?:Y2[:TM\P06RS^<9-
MK89"PP"I&>.__P!:IQX?MD@ABAGN(O+@%NS(5W21C^%LCZ\C!YJ9='M8TNTC
MWHEU"L+*I&$55*C;QQP?>@#*&O7D,MW)+!'):V]K!,<2?/AL[F/RX/`)QQT]
M^-BRO_MLUXL4?[NWD$:R%N)&V@GMP!G'YU7DTA81-):YDDDMEMVBE<!'5<@$
MD*2#@GI^52Z'IHTG2H+/?YCH"7?^\Q.2?S-`&;IVN7LUM"DEM#)>7$\RQHLI
M5`J,023MR,<#H<\=,\:,>J&?1YKZWMVDDB#@PEL$LA(*YQZCK4:Z#!&BB*XN
M(WCE>6*12NZ(OG<!E<$')ZY_E5ZSM(;*V6"%<("2<\EB3DD^Y)H`RF\1QLS?
M9X#,F(51E?[TDO1>G&!@D^_2HKG7+S[1;VT-O$DXO5MYU:0D<IO&T[>A'<@'
MCISD6X/#MC;Z>]G&)`C3>>&R-R.""I!QVP`/84YM#MV129I_/$XN#<97>S@;
M<GC;TXQB@"M9>)K:[U%;5?+'F2/''B4&3*YSN3^$'!P<G\*CU#5;JT\03+(^
MRPM;/[2ZH06?DCG*GN.@(]<]JTK/2H[.=GAGN/*W,ZP%QY:ECD]!D\Y/)..V
M*+C2;:YNY[B8,YGM_LSH2-I3)/USSZT`4;GQ!+90W)NK';-%")T1)=P="<=<
M##`]1@_6M*:[>VTZ2ZNHXXVC!)42C:!GCYB!_GUJH^@6\L4Z3SW$S3(L7F.R
M[D0'(48&,9]B3W-7=0LHM1LI+68L$?'*G!4@Y!'N"!0!CQ>)7E=(19#SVNOL
MQ`E(4'86#`E02/P'MFIH/$*N+=I[?R4E>:)V\S(1X\Y'3D$!N>.G2I8M`MX[
ME;AKBXDE$XN"SE>7";.RCC'856U+P\+C31IT!'DRW)FEDD?YERV6"@#G()')
M'![T`7/[7":"FJ3P/'O17$(.6RQPH[<G(_.L[5];OH;66".&*WOD>(-B7>H2
M1MH*DKR<\<CCKSWW+JS@N[)[29,PNNT@'&/3'IBJ3Z%;RQ.L\\\TKO&S3,5W
MG8V5'"@8S[=Z`&ZM=7UA:V(MQ'++)/'$[2OC.>O(7'/KC\*I6&O7*S.MW'YD
M3ZE+:)+N`*XR5&T#D8!&<Y^M;.H6*7\*1O))$8Y%E1X\95E/!Y!'YBJRZ%:J
M$_>3'9>->C)'+G.1TZ<G_&@"MI7B:WU.^CMXQ%B9&>(I,&;"GG>N/D)SD=>_
M2I-3UX:?>I"85D3?&CD2?,N\X!V@'C_>(]LU:L=*CL''DSW!B12L<#/^[C!.
M>``,_CG';%07>@6]W<RS&>XC\YXY'1"NUF0C:>03VQUQ0!4LM;N4\QKR,/`=
M0DM5E#`%?GP@V@<CMG.?K4\&O--Y$@M<07;,MJ_F<R$`D;ACY0<'!R?PJ2+0
M+:.8OYUPZ&Y:Z\IV!3S"<YZ9X/09Q]:DMM%MK:9'5Y7CB9GAA<@I$6SDKQGN
M>I.,\8H`H-XJ@6U6X,!"?9A-)E\&-F;8$/'KGGC&*OZ-J\>JK.%\KS('".89
M1*AR,@JV!GKZ=0::F@6*17L85RMY)YK\_=.<C;Z8//U-2KI5N\!BO<W^7WYN
MPKX.,<#&T<>@%`&99ZO<&6V69I)#)>W,7R[1\J;R`1MYZ#H0?4FH&\4RW.C7
MUS9Q0+-!#Y@4S[BG."&7`(8>F"/>M:/0[:.2%Q)-F*>6=?F`^:0$-T'3YCBH
MCX=M9%G%Q-<3M+"8-\C+N5#V!`!/0<G)XZT`5I_%$5K=BVG2`/&8TG'G_,&?
M'W%(!<#(R>*+O6KJ66V-I'LMCJ"VS2[@2X!(8;2.!D<'.?I5]=&C6X$RW=TK
M-M,VUE7SBHP"V`/3^'&>],?0;9IUD$TZ(ER+I858;!)W/3/.>F?IB@!NL:JV
MFW*X1W5;6><H&`#;`IP?E)[]C^!JN?$WE1RM=69C9;:.Y15D#%@YVA3P,'=Q
MWK0U'28-1?=,\BGR)(/D('RN`">1UXXJ&70+.8N9#*P:U6U(W`?*IR#P/O9[
MT`9T^L7\%Y?)<*8Q%]E"QQ.I`+N0V&*\CZCMQCK5O^WBTBVXML7'G2Q.GF<H
MJ#._ISD%?^^JD;P_;R-.\US<RR3^47=F7/[MMR]%P/>IQH]J-3N-0`83SQ>4
MW(P!ZCCJ<#\A0!C2>(;J31I&LXB9H]/%U)-(ZY0LIVX`7#'@D\`?RJT_B%H+
M6_9[?S&L;:*8G?CS"X)QTXZ>]2MX9M#;"!+BYB0VPM9-C+F1`#C.5ZC)Y&*=
M=^'+2Z29#-<1K/"L,H1E&\+]TG(/(]J`&W/B`6VHQVS0*8WF2`NLN65G`QE0
M"`.1U(/MTSGQ>)Y+6PM6NE2229Y_WDKB),)(0%!"D;L=,X'')K4DT"V>Z,XG
MN$S.EQY:L-OF*`,],\@8(S^M']@0"T6VCNKJ.,%]P#*0X=BQ!!!'4\$#(]:`
M%UR^FMM)CN;4[7>6$#[IR&=01W'0]:B_MUH[O[-<6JQNEPD$K++N5`ZY1@<#
M.3QCC!JW<Z3;7&F16&7B@BV;/+."-A!'/X"J6HZ$\VG75O`_G37C@RSW#X9<
M8P0%7&1@8''UH`M6^J^=H\NI?9V\M1(R(AW-(JDX(^N,_C63)XFN+G23<V,=
MJ7$T2$BXWC#D#^Z"#SCD#UYQBM]+.*/3ULD+)$L8C!C8J0`,<$<@U0/AVV=)
M_-N+B6:8H3.VP.-ARN,*!UYY!SWH`KW^N7$=OJI2VV+8##2),-Q)56&T%"._
M?_\`4VUUV0^(KK2S^^D\X;%)"B.,(I)SCGD]/Y"K\VB6\UM?P/+,1?D&5LC(
M.T+QQQTH;0[4W3W(>59GG6XW`C*LJ[<#CH1P?J:`,^U\03O'%'%:F>21)Y,R
MS!<".0KC(3\N/3.>M3'Q%YEN);2T,NVS%Y(KR;"JD'`'!R>#Z58MM!M;9XV2
M28E(Y8QDCI(VYNWKTJC>>'IUCCAT^15B%I]D=GDVNR\XR0ISC/0;3[T`:4NJ
MK%I$%\T1)G$>R,'JSX`&?J>M53KSQ7,=K/:!+@W26[JLNY0&4L&!P,].F!5T
MZ9#)I4-A,2R1(BAAP05QAA[Y%0-H-N\;%YYVN#,L_P!I)7S-ZC"G[NW@<8QB
M@"G-KEW)>6\5M;Q*AU![20O(<L%7.1\O&?Z>^1:U*_O(-9LK6!(O)FBE=RS$
M-\N.G!]?Q]L<K'X?MHE79-<!UNFNP^Y2=Y&#VQ@@GMWJU=Z?'=75O<F22.2`
M,%*$<JV,@Y!]![T`8NF^))(]-M9-3CSYEFUQYRD9;;C=E0`!U&,?I6CH^MQ:
MI--"OE>9&JO^YF$JX;..0!@C'(_G2+X>LA#;0L99([>W>V"L1\R-C.>.O';%
M6[*R^QALW-Q.2`H\UP0H'0```?CC)[DT`6Z***`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`(KABEM*ZG#*A(/OBN
M5@UN^M[6WN+F[,BS:8URW[E3L==O(`QG[W0G\JZX@,"&`(/!![U"+.U4*!;0
M@(AC4",?*AZJ/;CI0!RQU?4XWN+<W))CN;5%D8(S8D/S`X4#ICMWZU/'J.HP
M3IONVN%&HO:;&C0%UV%@20!\W&.,#VK?33;",`1V5L@!4@+$H^Z<KV[$\>E2
M?9+;(/V>+(D\T'8/OXQN^N.]`&%X?U74+ZX@:X5A%<0-*0[1#:00/D"G<5YP
M=PSG\J-1U.]BDU.:*4QBP9!';[01/D`\Y&>2<#!'3O6[#:6T$CR0V\4;R'+L
MB`%OJ1UI)+2VEGCGDMXGFC^Y(R`LOT/44`8VAV^=?UFYD=I)5E6-2ZKE5**V
M`0,X]LXX]>:KVNK7XU)X[F1F28S"!HQ')$VW)&TK\RD`<[L\^E=(D,4;N\<:
M*TAR[*H!8XQD^O%,CL[6*X>XCMH4G?[\BH`S?4]30!R[:_?QV5E,D@ED?2Y+
MEU*#YG&W!./J>!BI=8,QTZ-'U)+EVN+9U4HH:/+CGY<94]N.W4UT,5A9P/OA
MM((VY^9(P#SU[=Z(].LHHS''9VZ(7$A58E`+#HV,=?>@"GHES<2R:A;W$QG^
MRW'EI(R@,5VJ>=H`[^E8FGWU]*L$$-R+=6ANY#Y4*#YEE(4XQCZ^O/?FNLCA
MBB9VCC1&D;<Y50"QZ9/J>*8EG:QD%+:%2`R@B,#`8Y8?B>3ZT`<Q+J=WJ.FN
M)9Q;+_97VAR%&)68$$'(X`QVYYIEK=W5O;W$ML4'V6SLI6`C7+IAMX)QD\`X
M].V*ZA]/LI(XXWM+=DB&(U,:D(,8P!CCBGI:V\>[9!$NY0C;4`RHX`/L,GB@
M#G(]2N9KRUO#MDBE-R]NIC7(15&W!QD9P3U[UGW%]=J+74?M?F7+:3-<`[%_
M=D[3@`#H/?/0UV:6UNGE;((E\D;8\(!L'H/3\*9'I]E"Y>*T@1SG++&`3GKV
M[]Z`,*YUN:"YN<S$Q)8PR*%16/F.Q&>W7CJ<"JL=W=SZA;07DGF-;:H(U8E2
M<>2QP2H`SSV'Y]:Z6/3+"*-HX[&V1'78RK$H#+G.",=,D\>].BT^RAV^59V\
M>U@R[8E&"!@$<=<<?2@":*:.>/S(9$D3)&Y&!&0<'GZT^F10QP1^7#&D:9)V
MHH`R3D\?6GT`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%-8E5)"EB!D`=30`ZB
MLVQU.6>_>RNK46\ZQ+,%642?*21@\##<=.1Z$UI4`%%,E?RXG?&=JDXK&L=?
MDF2REN[2."&]0M$R3&0C"EL,-HQP#TS0!N45G+K=@]LDZ22-')_J\02$OQG*
MKMR1CN!Q2S:UI\(BW3EO-C,J".-G+*,9/R@],T`:%%4)M8L($C=[@%'02!D4
MN`A_B)`.%]S@4Z35K**Y6W>;#DJN0C%06^Z"P&`3V!/-`%VBJ']KV;3/`DA:
M5=V!L8*Q7[P#8P2.^"<46M_)=Z-#?PVI>2:)9%A#COVW'%`%^BJ&F:@UZUS%
M+"L4UM)Y<@1]ZYP",'`SP?05?H`**S+R]U""]B@BL[:1)F*QLURRGA<G(\LX
MZ'N:G74K;[2+9GQ-G:<*Q0-C[N_&,^W7VH`N455O-1MK(@3NX)!;"1L^`.YV
M@X'N>*C;5[%;G[.9CORH)$;%1N`*Y;&!G/&3S0!>HK/36K"29HEG.Y6=23&P
M7<N=R@D8)&#P.<#/2D_MNP\I)/,EVODK^XDSC^]C;]WG[W3WH`T:*K?;[7:S
M>:"%D6,X!^\V-H]\[AS[TVWU*UNIVAAD)<9(RC`-C@[21AL>V:`+=%4Y]4M+
M:<0RR,K%@I(C8JI/0,P&%SD=2.M275Y!:!3,S`N<*%1G)]>`"<>]`%BBLX:W
MIQ*XG)!B$VX1MM"'/S$XP!\IZTHUNP*N3*Z%&52KQ.K9;[O!&3G'!H`T**SQ
MJ]N\]K'$LKBX+*#Y3C85ZAACC\<5+=:G:6<FR>7:P7<V$9@B_P!YB!\HX/)P
M.*`+=%9^GZG]OO;V%(62.U<1[V#`LV`3P5QCGU/KC!!*PZSI\V=MQA1&9=SH
MR*5'4@D`''?TH`OT50_MFP\MG:9D"LJD/&RM\QPO!&<$]#TJQ:7<-Y$9("Q4
M,5(9"C`CJ""`1^-`$]%9S:WIR[]TY`1'D),;8*K]X@X^8#VS4TVI6D#R))*0
MT:*Y4(2<,2%P`.22#P.:`+=%95QKMNEOYT0W(!)O,@:/847<0P*[A^7X&HX=
M>6;5'M!"$C240F20NI9MA?Y1LP1@=R..>XR`;-%4(M8L)HWD2?Y$7=N9&4,N
M<97(^89[C(YIUAJ,=]+<K&K!8&"Y8%2<J#RI`(Z]Z`+M%9<FO60M))X3)*$`
M(`B?YP3C*\?,/<9%3C5+,W/V?S6\S(!S&VT,>0I;&`W(X)SSTH`NT5F3:W:*
M)%A8RR1D#:0RAAO"DJ2,-@GG&:O13QS(SQME%)4MVXZT`2T5GKK6GM#)-YY$
M<:[RS1LH*_WAD?,ON,BFOK5J/(\L3/YLPA(\EP5)!.2,9QQ0!I45G#6K-88W
MFE"ET$AV*S!%.?F8X^4<'EL=*D_M6R^U?9A*QDW^6<1MM#8!`+8P"01CGF@"
M[152VU*TNIV@AD)D"[@"C*&&<$J2,,,]QGK5==;MO/NXI1)&;>81#]VQ,A*A
MOE`')Z\#)P,]"*`-.BJ4^I1)I%QJ$&)DAB>3;G;DJ#E3QP<C'3BJ3Z^%TRSN
MUMBTEQ((VB#_`.K.<-DX_A/'O0!M456M;^WO'E6W9V\IBC$QL%R"00"1@X(/
M2HKN[NH[V.VM+:&5FC:0F68Q@`$#LK9ZT`7J*SK755F""98XFS('&\L`4(S@
MXP1SU./I44^OVD?V<Q[Y%EF\IOD<,N49@0N,MG;QCKGB@#6HK/?6;%+>.;S7
M=)`Q`CA=V`!P<J`2,'@Y'!IQU>QW.OG$A$#LPC8J`0"/FQCD$8YYH`O452L-
M1COY;E8E8+`P7+`J3E0>5(!'7O5"/Q#OT>YOC:,)89/+$&[ER2-N#CH<CG''
M/I0!N45%;R^?;13;=OF(&QG.,C-4%U65YY!%:B2"*7R7*R?O0=V,[,?=[YST
MYQ0!J45F6.MVUW*T+[HIA++$`5;:VQB.&QC.!G&<XIZZWI[0O-YY$:`,6:-@
M""<;ER/F&2.1D4`:%%9YUNP6%9&ED`:3R@IA</NP6QMQNS@9''-*VL6*Q12>
M<S";.T)&S-QPV5`R,'@Y`QWH`OT52?5K))"AF)*H)&948J%(R"6`P,]N>:+'
M48[Z:=(E8+#MY=2I.1GE2`10!=HK,.NV,8Q--M8+O;8CL%4L0&)V\#*G).`/
MRJ[<W4-I%YDS$+D`;5+$D]``.2?I0!-15!]9T]%5C<95EWDJC$*O(RV!\HX/
M)QT-._M6R^U?9A*QDW^6<1MM#8!`+8P"01CGF@"[15&#5K&X<I'-G`9MQ1E4
MA3AL,1@X[^E":O8R0R2B5@L8!;?&RD@\`@$9(/8C.:`+U%9,FOVPFCCC#L'A
MEEWF-P%*8R&^7*]3G(X_$5975;-IQ!YO[S@$A&*!B,A2V,`\C@G//2@"[15.
MVU2SNYA%!*68@D?(P!P<'!(P2#U`I9]1M+8D33;")$B.5/WFQM'3OGK0!;HK
M*O==M[0M@&4(Z(1&K%@6?8>`O8Y[\GCTI]KK-M/<M;-NCE\UXE!1MK%<_P`6
M,9P,XSF@#2HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`IDOF>4_E!3)M.W<<#/;/M3Z*`.>TC3-4L([J61+-[^X8,]
MRTS-O.1QMV#`"YQR>:Z&BB@!DR&2%T&,LI`S6/I6@1V.F0QR?O+N.`Q[VE=U
M4D8.T,?E'T`K6NG:.UF=#AE1B#[XK%_MFZ6S@^TP&*200,K)("6#NJG.5P#S
MT&>#P1V`'0:1=VD&E20F"2YLK<P,CN51LA<D-M)'*^E4X]+OM/U&SCM(TF9;
M6?>\F5CW/(&(R`<<DX&.0*U=/U<WM_-;&&-/+W9`F!D7!Q\R$`C/48R/I4-Q
MXCMX-1>U/DXCE6)PTX60LV.53^(#<,G/KC.*`*D/AZ[L;5H;26"3SK-;61I2
M1MQN^8``Y^\>#CZT3^')_MT$MK(D)C$2_:$E=)"B8&&495\@$9XX/>K>HZO<
M1V.H_9X`EQ:0N[EV^53C*D<?-D<_H:C;Q)'#=_9IA;JZ.D4J_:1OW,!]Q2`6
M4;ASQWX-`$":!?'4H;B9X)?)DG/FL[&1E<$*.F!C.,=/RQ5Z.QU"U\,16-G)
M"M]'`L2R,3L!Q@D<9^G%1IX@P%FN+=8K5VF19/-W-F/=G*XX&$8YS4<^N7%G
M*9;V%(83"K(GF@@EG"C<Q`VXSSU`]Z`+7A_37TW3C;2PQHQ)9WCF:1I6/5F)
M53FK$&F6]O,LJ2799>@DNY77\0S$&J5OKQNU$=I#!/<^:8\)<AHN%#%MX&<8
M('W<Y[=Z=8ZI(GAZ74+[+/$\VY>`<+(P`[#H`,T`7KFV>6\LYE*A8'9F!ZG*
MD<?G5!M*N2YM\Q?9#="Z\S<?,SOW[=N,8SWST[5'!XB$ZE(H[>>X#QJ5M[D2
M)\Y('SX[8.1C\Z>NN3*T?GV00.\D)(FW?O$#$XX^Z0IYZ^U`$NL65_>-LMI5
M6!XBC`RLA5CW^49;Z9'ZU3@L+\O<VNR%8'\E9)&+9&U%SM&/FZ8ZC'Z5)+K%
MR;9?,@%K-*B2Q`.')0NJL#P,'YAZ]>M3?VQ-A'%FOE3LT=L3+\TC`,0&&/E!
MVG!R?<4`4[33[^>!XI$BBA6[N)5+9WMEI`!C'`^;.<G([=ZN&PO('CEM?(>0
MVRV\@D=E"[<X88!SU/'&>.:676LF/[+;^>)!%@E]HS(3@=.P&34:ZZZ-&;JT
M$4;/)$S++NPZ!F.!@97"GG@^U`!;Z&]M=V/ES9M;>!4=3U=T!5&_(G/T%,T?
M19=/FA#[6CMT*1N;F5RW;[A.U./3/MBF0^)XY8Y-J6\LH19$C@NA)E2P7#$#
MY2-PXY'O4DNJWQOK6V6WBC?[7Y,P\W(9?*+@@[?Z#D8Z'-`!J>F:C>W3XG3[
M/YD<D8,K+MVD$J5`PV2#R3WZ<"IM7+VUW;7T2-)(B/%L$<C@JVTD_(K$$;1U
M'-3:KJ$FGQ^8L4+(JEF::X$0P.PX.3^0]ZKOK3L'DMK42P1-&DC&3:RLX4\#
M'.`P)Y_.@"#3M,OX[9Y=Z07$MC'$O<QR`N3D<C^(>M-M]&OA?M=SO'EC"2OG
M/(1L9B>2!UW=@!_,R/XA,=LL\L,$*2SO!"TMSM!*E@2QVX4?)QUSFHW\56_E
M1LGV4,0Q;S;M47"L5^1L'?D@XZ>^*`+J6%Q%>+,OE,OVAW8%B"%90...O'3]
M:2^L;QY[I[4P%;N%8G\TD&/&[YA@?-][IQTZU$VO,Q\V&U$EKNB7S/-PQ\P+
MMPN/5AGD?C3)_$0M@L4\=M#=&1T*RW6R(;<$G>5]&7C'KZ4`7M*L7L3>!V5E
MFG$B8/.W8B\^^5-4I-$FET^VMFEC4QV\D3,,GEL8('<<>U-?Q&QBDFM[02PP
MVRW4C&8`A26!`P""1L..<'U'>]I=S=7,U\)UC$<<^V(J^3MV@\C`QU!ZGJ?3
MD`J7.F7U[.L\YMXW22`A$9F&U)-Y.2!R>PQ^-3V^DA;J[FG>3]Y<^=&(IW08
MV(,,`0#RIX.13M1OYX9)+>TA665(3*^9-NU>0,#!R20>.!QUJM+K4MI#:M-%
M"R2")69IPKN6QRJ8YZGN.AQ0!5DTB\:&#3'\L0)9S6R3J"QP54`MP`/IDYQ4
MYT_56GGN=UO#*\,486.5N0C,2-Q7C(;KC_&F-X@EM04NQ:++)/*L1EN?+38A
MQRQ7KR.,'-%]KT\NE74^F0@^7:&9I6D'R$AL;1@AB-N>PQZT`0MX>O6M+R(R
MQ;[AIF!:1VQOB"#)(SP1^7Y5:?1)WO&D,D81KL3'!.=OV?R_3KGGZ4[Q#>WM
MI9V,ED^)'G&]=H/F*$=BO/3.W&:1M4N)-:`MF\VT6!CY:A<R2`*WWCTX9>^.
M>:`*T/AZX\M1*8A)`JB)_M$TNXJZ,.&.$!V#(&?KQSK:?;W4<]W-="%6G=6"
MQ,6"@*!R2!GIZ54@UTM<302P1;H6BWF"?S557)`)^48((Y'H<YK2L[K[6DDB
MIA%D9%.?O!3@GIZ@_E0!BPZ-?1I,B?9X8S%M6&.9S&[Y!#;2/W8P,87/7VYL
M2Z9>3&2W<P"VEN$N&<,=ZD,K%0,8/*_>R.#TJ;43=P3++'>MEY%2*U6-<..-
MV202>,G((P.WK2CU"\'E7QN&:&6ZFA-N57:JKY@!!QNSE!G)/4T`2G2[Y]/;
M3G-M]E7`5@S;W`<'GCY>`1QG)]*O6EBT.GRV3,/*^9(BO58ST'X9Q]`*H6LE
MXTMO;S:A*6N[4S^8J1@Q,I3(7Y<8^?OD^]6M#:XEM&N)KN2XCF<M`9%0$1]C
M\H`.>OT(H`S[W3+^6T#S"#S;>W:"(1;G\S<4^8@@8^X/EY^M6CI]Y)="]D$"
MS^;&3&LC%=BAAUV]?G)Z=@/>MFB@#`BTB^MK9XH6MF,]NL$A<M\A&[YAQ\WW
MNAQTZT\:+.L4L:O&0U_#<J23]Q/+R#QU^0_I6Y10!D:=IUS:W[2MY<4!4@QQ
M2NRN21@[&X3'L3G-,?3+Q-2FNX#`W^D"=%=B-V8A&5.`<=`0>?3%;5%`&4^G
M3R:'?6C/']HNUEY&=BLX.!ZX&1SC\*K/H<YFG82QE&V&)3GY#N4R=N^P$?4U
MO44`4--M9K*V:-O+<O<2R'#$85G9AVZX(X_6FWVDV^H7T<MY;P3PK"R;9%W$
M$D<CTX!YK1HH`P?["F>T6RDDB$$<,\",@PVQP`O&,9'?\^]3_8]0GEL7N?LR
M+:S!]L;,<CRW7.2!R2PXQQSR:UZ*`,`Z3J*PM#'.@CDDG9E65DQOD+`Y`R<`
MXQD?6BTT.XBTHVTDD7FJ+=D*DE=T2IUXZ$I^1K?HH`H:=;W4<]W/=B%6G=6"
MQ,6"@*!R2!GIZ5GIH5P)("9DV+"PD0,<-(-P0].F';/T7TK?HH`KV<<D-O'#
M($Q'&JAE8G)`P>,5F7.EW5Q=*9([20K+O2\.5FC7.=H`7GCC.X<=0>^W10!A
MC1IS%;QL\>$O9IV()^Z_F8QQU^<?K5%]$NX+3<8T>6)$BC(GFF+?O$.=K'"#
MY>0,_7CGJJ*`.>O+343>6=UY,+7#708QHS&-%$4@Y;;GG/7'<=:)=%NR\<X:
M-Y6,GF(MS+`!N;<,,G)QTP1SUXKH:*`,6/17CLYK=6C4&.$1[=V`T?(SDDXR
M!W/%6[""Z2YN;B[6%&FV86)BP&`>I(&?RJ_10!SW]A77V74(O,AW7-E]G3DX
M#;I#D\=/G'ZUI:A9RSQVCPE#-:RB55<D*QVE2"<''#'G%7Z*`,::QU)C<.K6
MA>[A$4N=P$>-W(X.[ANAQT]\!@T6=8I8U>,AK^&Y4DG[B>7D'CK\A_2MRB@#
M%FT62XL(K2215`29'92>C@@8X]Z@70KEHF+^6DR-&T9-U+,&*.&YW_=!QT`/
MU-=#10!C7=A?W;I+)]F5S;SP,JNV%#[<$''S8*\\#K[8IATF[*&T+0?96G2<
MR!CO!5E8KC&#RO7(X/2MRB@#,MM/EA^P[F0_9VD+8)YW9QCCWJOJVBRW][YT
M4JHAA(.2<B4!@C`=.-[9^@]*VZ*`,"31+KR$VR0M*J0DY)4/(DOF-V.`3GGG
MKTJVFG3`1Y:/*WK7!P3]T[N.G7D5J44`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`R6,2Q/&V0'4J<
M>]4I]'MYUB#/*/*6-5P1T1U89X]5%:%%`%*'3ECNQ</<SS%=WEI(5(CSUP<9
M/XDTCZ:K733)<W$2NX>2*-P%=AC!/&1T'0C..<U>HH`SY-'MI(IHV,G[]'25
MMW,@;KGZ=O2A=*"RAUO+H`E6D5651*P`&6P,CH,A2`>XK0HH`SET:U6.!"9&
M6"664!B/F,F_<#QT^<_I3!HD1R9;JZE8($1G9<Q@,&7&`.00.3GWS6I10!G'
M2MT:[KZ\,ZOYBSEEW`XQ@#;MQCMMQWZ\T^#2X(=,:PW2O$V\EF;YOF8L>1CN
M:O44`4(],`"F:[NKAE=7#2L/X>@P`!WYXR?6FSZ1%)&-KOO2629,D8W.K`YX
MZ?,:T:*`,J#0XTMECGGGE941%+,#L"D':..F5')R?>I(M)BAF61999%B=I(8
M9&&R-B#DCC/<]2<9XK1HH`RK#2!#;8G($K7)N6\MB0&SPH)Z@#`[=.U3/I-M
M(8]Y=@DSS;21@EPP(/'3#&K]%`&<NDKY+12W=U,AVA0[#Y`K`@#`&>@Y.3[T
M^72X9;H7'F2I*)EF!4C@A-F.1T*DC\>U7J*`,^^TF*^G$KS31GRS&PC*C<I]
MR"1U/((-4;G1;EIDBMG$5J3$96,OS2%-O)0)UPH'#`>H.,5O44`9XTF%+5((
MY9HVCE>:.52-RLQ8GJ,8^8C!'2D.DC:A2]NTE4%7E#@M("<D'(('/3`&.V*T
M:*`*,FE02"0%Y?GEBE/S9.8RI')_W1G\:;)I,32M-%//!.79Q+'MW#<`".01
M@[1U':M"B@#.DT:"6.Y1Y9S]IMA;.Q?)VC=SDCK\Y_2GI8O;S.]O<2!995>1
M&VD<+@XXSS@=^W&.<WJ*`*5[IR7C[_/F@8H8W,1`WJ>QR#^8P:JMX>MF<L)[
MA5;860%<$IC!SMS_``CC./:M>B@#-?1XS(TD5S<0R[W=739E-V-RC*G@D`\Y
MYIMWHD5U"\1NKJ,20^3*5<$RKS]XL#SR>1CKZ5J44`5KBRBN#:ERW^C2>8F,
M<G:5Y]L,:IKX?LEM%M1YGE!)$QN'1\9'3L``/85JT4`8[Z*88+K[/*T\]Q$(
M6,[!5"@GG"*,8W'@`9_6KEK:/:?9HHI3]GAA*,IY+-QALXSV;OWJY10!GR:6
MS:BUZM_=(Y`&P",J`.PRA(![X--31H5NA*9IFC61Y4MR5\M'8'<1@9_B;J2.
M36E10!FVVCQVX(-S<38A,$9D*YC0XX!`'H.3D\"KL<`BABBB9D2(``#'(`QC
MI_*I:*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@"KJ5
M]'IMA+=S*[I'C*H`2<D#C)'K207C/'))<VLMFD8R6G>/!'U5CC'OBJWB2TFO
M]#N;:V3?+)MVKN`SA@3R?85%J6DL;!([3S92EQ',T<T[OO"L"5RY..GTS0!?
M.HV*P+.UY;B%\[9#*NUL#/!SCH#5E6#*&4@J1D$=#7-#2KN34XKQK?8CWXN&
MB9ES&HB*Y.#@DG'3-=+0`M%%%`!1110`4444`%%%%`&?K&KVVC6JW%UYA5GV
M@1KD],DX]``2:LS7=M;JC3W$40D.$+N%W'VSUK*U/3K[4-85D,,5K#`R*TL?
MF!V?AOE#`C``Y/J:QG:;2GL3JH7*6<UH-\B@'!&U\DXY`'&=WL:`.K.HV*^3
MNO+<>>,Q9E7]Y_N\\_A2?VC;*\JRRQQ>7)Y>7E3YCMW<<^G8X/MBN0_LG5+C
M0HX4M7(DL843:ZQE64DD/G!/7@=,^E:C:3>-JPG,&8O[2%QDLOW/)VYZ_P![
M\:`-Q]1L8[9+F2\MT@?[LK2J%;Z'.#35U2S?4CIZSH;D1B38".A_KW^E<\^C
M7HLTQ!<)+'<W#HUO,@8*['`VM\I4CKR"*O:387UIJ-O+<PH0;".!WAVJJ.K,
M<;>..1T&/I0!OT444`%%%%`!1110`4444`1W$\=M;R3RMMCC4NQ]`!DUFP^(
M+.;2XM0"3+%),(=K*`R,6V_,,\<T[Q!:W5]8+9VH&)Y%65VP0B=3D9!.<8P/
M6L>[TG51+<Q"**YAEN(+D&,"-=RL-XVLQ/0`T`=%_:-C]D^U_;+?[-G'G>:N
MS/3[V<5&VK6(OK>S%S&TUPA>,!@<KZ_CV]<'TK#GTF[N!<W1M;B)Y;Q9XDAG
M198L(%W=2A)YR,]#USQ4MCIVI03:=++"A,<,\3;=@V;F!4L`0#TYVYY_.@#8
MDU6S6"XECN(9OLX_>+',F5]B20!^)%2F_LQ-Y)NH!+NV>69!NW8SC'KCFN0D
MT359;696M'$ATTVV/-0*9-P.%4'"K@<=/?%:%WI%Y(=29+<%I[V"6,[EY1=F
M3U[8-`'3T444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%-8;E(!*DC&1U%.IKHLB,CJ
M&5A@@]"*`,72Q-9Z[=6,MQ/*A@26/S9#(6Y(9B3]TYQ\H&/2MRL]=$T]89(A
M`2DFT-ND8G"G*@$G(`/8<5H4`17!*VTI!((0D$?2N4T.XN6M=.N+9[Z1O(9[
MQKDRF-OD.,;^"=V/N]LUUS*'4JPR",$5%!:06UFEI"FV!$V*F2<+Z9ZT`8MI
MJVHW46G1@VJ7%]"9PQB8I&H"Y&-V6)+>HQ[TV'7+Z^EMHK1;>%I()G<RJ7`:
M-PIQAAD'G_/%:SZ59M:P6WE,L=NH6+9(RL@QC`8'/3WJI>Z+9&>&YFD$%K;6
M[Q%%<Q@`D'.\$$=/QS0!2A\0W5]:F:TBAC,-HMU*LN3NSN^4$$8^Z?F.?I2S
M^(KB._MPT(@LYA$4>6%R'#@9^=>%()Q@C\1FM6;1M/G1$>W`1$$85&9`4'12
M`1E?8Y%++I%C+<>>\'S[E8@.P5BO0LH.&(P,9!Z4`9/]NW,FH+"%C>VG:>-'
MC1AL,8/\1/S=.R@#U/6KVCB2^\,60DN)EDEMT+3*WSYP,G)SS4JZ)IR7`G6W
M(D#.P/F-A2PPV!G`SGD?C4_]G6G]GK8&$&U10JQDDX`Z<]>,#F@"AH$DJ'4;
M:XDD=K:X("L[2;%*A@`Q^9NN>?7%7(-3M[B98DCNPS=#):2HOXEE`%26]M;:
M?&1&`@=P69W+,['`&68Y)Z#DU9H`QM1LHWU2S_?7:B=V$BI=RH#A"1@!@!R!
MTI/[3N(SYP$?V-;H6FPJQDSOV;MQ/KVQTYS6M)!')+%(ZY>(DH<]"1@_H:@_
MLVT-W]I\L^9G=C>VW=_>VYVY]\9H`K:Q?S68_<36Z%4+E'B>1GQV"J1@>_/T
MJO\`VI?.TTZ+;BV@$99"I+L&52<'.!C/H<^W6M&[TVTO9`]Q&S':4($C*&7T
M8`X8>QS5>+0[1+IIF#,,IL3>VT!5`&1G#=,\CB@"G'JU_L-Q(+8P&XF@5%5@
MXV%]K$YP?NX(Q[Y[4^&^U*8K$KV@E\A;ER8FV[6SA!\W7@Y;Z<58M-#M;<N\
M@,TCRRR9+,`-[,>%S@'#8R.2*L3Z9:7"1+)&V(EV+LD93M_ND@C(]CQ0!GV^
MN/<"%41%DN?*DA5@<^4R[F)]QM?VZ4:-K-QJ,L3-"WD3H77_`$:1/*[C+M\K
M9'IC\:TQ:VAO(YPB>?!&8U(/W%..,?A3;?3;2VG,T,;!^0`9&*KGKM4G"Y]@
M*`*&J:M-9W06*2W95DC1HO+=W(8@9+#A.O<'/'3-6[VZG6]@L[4QK+*CR%Y5
M+*%4J",`CD[A2/I>G7DAN2GF>:5<E96V,1C#8!P2,#GKQ1J5FVH*JP3PH\3'
M+,K,5..GRNI'!&1W':@#/M]7OIV8LUG"D5FEQ)O#`%B7&-V>%^4<X/>FQZU>
MM<R6JFWE</#ME\EXUPY8'@DYQMZ@X/3BM&WTBRM+/R67<OV=8)&<XW(N>O8?
M>/3UIJ:=IEMMN,@%V3$LD[,7(/R?,QYY/'UQ0!!%=7TU]:H\T*^7++',%C;$
MF`""/FXX/?-2WU]>)/=):B`+:0K*_F@DR9W?*,'Y?N]>>O2K7V.T-PI`Q,KF
M8!9"#D\$D`]#Z=*+K3+2\DWSQ;F*[6P[*'7^ZP!^8<G@Y'-`%#09+BXO-3GG
MG,BB<)&GS`(NQ6QC<1_%Z9SGGH!`-;O8;2.ZN([>1);:2540%2&7&`22>#GT
MX]ZVX+:&W:5H4VF9_,?D\M@#/MP!47]FV?E1Q&!6CC1HU5B2-K=0<]<X[T`9
MUWJ=_92>1*+:25WA".JLJ@/)L((R>GKGGT%3V6JMNE@O%9YXIS"7@MW*-PK`
MG&[;PPZGL:E72]/1_+V;I"R2_/*S/\C97DG.`>W2K<-O%`\S1)M:9_,D.2<M
M@#/Y`4`8,NMW\>GK?!+8Q36<MS&NTY3:H*JW//7DC']:MW.J31W=Q`KV\02"
M&17E!P&=F!X!Y^Z,#CZU*=$M/M:S!/DV2(\3$LI#XR`"<*..@'>HYK#1K(8N
M)%A:8*@:6Z8.VTDKABV<C)Z&@#*N=9N9;&XD+`O;&X0E%>%9-L08';G<.H[^
MX-*EW=1:U++/,94%V(516D4*GV<R=-^TGIU'7)],:CV&B1.UE(T2R7.XF)YS
MODW+M)P3DY`Z_CUI^S1Q>NOG6_VF-_/=/.^92$V;BN>!MX].]`&?#K]X85:2
MW+&54*-]FEB2-F=5"EF^]]_.1C[IXK1TM[HW>H)=R+(R2(%V9"XV`\`DXY[9
MJ&P@T&=GALIK>X8QD;$N?,*)D<*-QVKG'3`Z>U:%I8V]EYGD(P,I#.S.SEB!
MC)+$GH!0!A-JFHS6EQ#,T5I=A`XC,+JR#<`0#G#CG&Y2/IS5V34KR$R7#B`V
MT5PEN4"'>Q+*I8'.`,M]W!X'6K$>B:?&CHL+;70QX,KG8I.<)D_(.!]W'0>@
MJ0:59BY\_P`IB^0QS(Q4L.C%<X+<#YB,\=:`,RXOK^32GO28EMW*M&(0PE7]
MX!@\X;(SZ8Z<UI6E\9M->]=0,!F\L=4VY!4_[0P<^](-&L!([^02SG/+L0OS
M!OE&<+D@$XQG'-6HX(HO,V+@2L7<9R"3UH`Q9]7O[6%#,ML\L]NT\00,JI@K
M\K$GG[X^;CITI9[O4/MT%FTT*RI/&7=(F"NC*_&-W7Y#W]#[5;DT*R-K+!%'
ML$B[/F9G"KD':H)X7CH,"IETNT6,($<XD$FXRN6W#I\Q.?;&<8XH`R[;5+V6
MS9[=8!]GMEF<2EF,A.[Y0<Y'W>ISUZ4]=9NFF>4+"+5+R.V*;#O(<)@YS@8+
M^AS[5??1K!T1&@^54$>`[`,O/RM@_,.3P<CFI#IMH0X,/#S+<-\QYD7;@]?]
ME>.G%`%/3M1NIM0>WNUCB.TL(C$Z,,$=&.5<8/48QZ<U6CO;]=4O+9)H6\R[
M\J(R(2(@(5<\;N>W''.3GM6K;:;:VLQEAC8-@@`R,P0'J%!.%_#%-ETJSFDD
MD>)M\C!V99&4A@-H88/RG'&1@XH`IW=Y/)X;U.5B([B"*=-\1(^90<,.X['V
MK,EO+HZ=:V8NI1/:RKY\BN=S*&4*&/\`M!U)_&NC%A:BQ>R$0%O(K*Z9/S!L
M[LGKDY//6FMIMFSR.8!NE"!SDY(0Y7\J`(=)NKJ\6>6=H1&LTD2(B$$!'9<D
MDG/`'854U6>:#7+*59I%@C0F6,'Y6#,JY(]MP.?8UJPVD,";(E9%\QI<!SRS
M$D]_4GCI27-C;76_SX@^^)HFR3RAZC]*`.<T^^N)-5NIFF>2*XDMWB0R-M1&
M:0#:`>ZJI/;)[U;N+S4IM*>[5H$AD*F()N5T/F``,<\@CKC&.G-:HTVT$OFB
M$!\1C(8_P9V\9[;C48T:P$COY!+.<\NQ"_,&^49PN2`3C&<<T`4VU&\B$T$T
M]G'-',$\WRG(8%`W$8;)/;[WO[55C\0W4]O`8HP)"CLY%I+(&*NR8"KRF=I/
MS=/0ULSZ9:3R-(Z.'9@Q=)&0YQCJ".W%1_V+8"%(EA9$0L5"2NOWCE@2#R"3
MT/%`#=*N9+FXNW<2("8V$<F<QYC4D8/3DUB1R3;[,1IJ$5S-<?+<379,+`-E
MAMWGJH(`VC\,5T\-M#;L[0QA"^-V.G`P..W`%,>PMI+5;9XLQ*P8#<<@@Y!!
MZYS0!+<.T5O+(@W,J%@/4@5F6L`2"UOGU";S'"M(6E)27</NA2=HY(QM`/UK
M51`F<%N3DY8G^?\`*J<6DV4,ZS)$=R$LBF1BB'U52=JGD]`*`*=IJ5]<16LQ
M^SA+Z(O`NQLQ';N`8Y^;CTQCWJYI5\VHVQN0JK$QP@!R>.I)Z=>GM@]Z$TBR
M0N5B8;U*X\QL*#U"C.%!]L5:C@CB=WC4*7QNQT.!@<?3^E`'.#6;]+262$6^
MRVLDNG$@=F?)?*@EN.%ZG/X]MC4;R2!+5+<();J41(T@RJ_*6R0",\*>,THT
MFQ$4L7D?)+"+=QO;F,9XZ_[1YZ\U/<6D-S"(95)0$$;6*E2.A!'(/N*`,V:^
MU%3<(JVH>TA667.XB0G=PO(V\+U.>O3C-1+K-TTSRA81:I>1VQ38=Y#A,'.<
M#!?T.?:K[Z+I[HJFW^4+L(#L-ZY)PV#\PR2<-GJ:D.FVA#@P\/,MPWS'F1=N
M#U_V5XZ<4`9(UN\@LTN[F."2.2VDF5(E8,"F.,DG.<^V/>E&M7B12!X=S%HD
MCE:VEA3<[[<$/R<<'(//M6L-.M!'''Y(*1(T:J22`K=1[].]1II%BD<L?E,P
ME`#%Y&9L#D`$G(`/(`Z4`8^L76IVKYDF@^2PN9&2,.H<KMP>&!4\CN<<\\Y%
MQ]4NHP]R5A^R1SI;F/:3(2S*N[=G`Y;I@\#K5J31;"2(1O"Q4*ZD^:^Y@XPV
MXYRV>.N>@]*D_LNS^T_:/*._(8C>VTL.C%<X+<#G&>*`*>FZC>3RVAN1!Y=U
M$[@1J04*D=R3D$'VQ[U'J&L7%G>&!4A8B:,G.05@(^9OJ"&'I6I%96\/D>7'
MCR%*Q_,?E!QG^0IEUIMG>2-)<0AW:%H"=Q&4;J.#^O6@#G[C5+VX9V@ECAWF
MV:-UWL"CSLHXW`<J%)QC.2/3%G3+^^CEB$\D<L%Q?7$`!#;UPTA!R3C'RXQC
MCCGM6K)I5E*K!H>&C2,[79<*A)7&#Q@G.1S3DTZTC$06+'E3-.GS$X=MV3U_
MVF_.@#)U.]OK/4]0FMY(S#;6,<S12AB&PTF0N"-I('7GH.*9)JM]'-=F"(>2
MERRO*8Y)MH$<9`VALC.X\C@8Z9-;4^GVMP;@RQ;C<1"&7YB-R<\=>/O'IZU#
M+HUC*S.8G5V8N7CF=&R0%/*D'!"KQTXH`;>ZC)%IMM<VWDNT\D*`Y+)AV`R#
MQGK6=)KMVDQLCL^TI+(C3):R2+A0AXC4EN?,4=<<'VK;>RMGMXH#$!%"R-&B
M\!2A!7IZ$"HI=*LY3(6C=6DD\UG25D;=M"D@@@C@`8%`&3=^(;FWMPS6PCE9
M4D5)$8$K\QDXX.0$)Z#J*V=/N6NX&F^7RS(PC('50<`_C@GZ8IITRR+0-Y"Y
M@C:./D_*K8!'OTJ>VMXK2VBMX$V11*$1<YP!TH`EHHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`BNFE6UF:`9E
M",4'JV.*Y!;JZ:V(CO!M9H!*8KR29PYF0')*@)D%@5S^%=I10!SJ+)!-\ES<
MD17WDJ'F9AL*`D')^;D]3DBL8W(F\,L8KV>YDDTUVNEDE+A6VKC.3\IY/ID<
M\]:[HC(Q4=M!%:VT5O`NV*)0B+DG``P!S0!@/<R?;B/M$G]H?;`@MO-./(WX
MW;,XQLYW8Z]^U5[NXNWC:`7%Q']BDAMW=9"#(S3)R3W.P`_\#-=94-M:PVB,
MD*D!F+,68L6)[DDDF@##19;>;,5Q<-Y5[Y**\S,-A0'!R?FY/4Y(K*%_?#3+
MJ3[6!<+9.\ZI<O(ZR8&"5*@1$'/`//OC-=O10!RNHHD=U<VT]Q.+6&6UF+O<
MN"A9F#'=G@?*#CH.O%7_`!#<QQ201223(71R@6Y,",W&!N'S%N>`,]^#Q6W1
M0!Q-Q?R/H;37=_<0WGV!'M@DI3S'*G<0!C<<]>N.#QUK1O6G2&\N%GE_X^_*
M<O<O&D<7!ZC.WG^(#//45MW%A!<RK)-YK;?X/.<(?JH.T_B*M4`<>]Y=B.'S
M;F`6.9-LGV^1%XV[1YVS+=6QV/J<5*DEW-Y[S7DXE@M;9U*.R+N8N"2I`SD`
M<$?A75T4`<E>W$]O<7-O]I<6D=XJLTUT\0`,*M@R@%E&X^W89[5-`;F[B'GW
MDORVLKJ8)74'#_*<X4M@8YQ@]>0:Z>B@##TN:!+Z>:>X"3310,5>8X.X8&%)
MQR>.*FU>4)>VJW,[V]DRN6D60QYD!78"1_P+COC\*TY8DE4+(NX!@V/<'(_4
M4^@#A;B_^SZ%$89YQ<0VBR19N#$#U.0B_?Z<Y&/IS5N[D6VN;M8[@HKWN;CS
M+V2(!3'E<L,E`3GD8S@#/&*Z^B@#DVN7>T7^TKTQQ&"0P/%*X$C;F`&2%+D+
MMQD8;DX/6M"_@CN=!L()1F.1X%8>V16Y10!RLMS>137-NYD\^VBA228#EXC)
MS(,=]N<^A!J1K[[&DM[:7$UUI]M(HR)&FWA@0P#9);#;#G)QR*Z:B@#D+^:_
MM9A%+=JMPMLAB,ES(@:0YW$(JMYO.!MYP,<<YJZ4EDN@[7=R"]\T)596"[-A
M)4#MR,YZCL:Z*B@#D;:9&YO;R>,1QSQK)YA!.V<JH+=2>``,_-WS0UYJ)OD%
MU+'!<XA\I&NG0G*KOQ$%(D^8L.>F.W6NNHH`Q]$=1'--/<N99;N:)!+,2#MD
M?"JI..@[=A[4FMZC9VK_`&5Y;:*[N8BH><A55.A))QD<\+W/XD:SQI(4+C)1
MMR\]#@C^M/H`Y:22VA-Y9O/')+++;FU4L&:10J!6'J`P8Y^II;.6(W%E:%U:
M^BU&>21`<LBGS?F([`AE_,5U%%`&7IKJPN]2N&">9(R*SD`)&A*CGT)!;_@5
M:E%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!167XDNY['0KFYMI#'*@7:P4,1E@.A![&H5U#[':F;S[Z\:25(8X[F`
M0G>QP,?(O'/)YZ4`;5%8;Z_*LRVHLE-W]I^SNAFP@)3>&#;<D8]L^U;2Y*@L
M`&QR`<X-`#J***`"BBB@`HHHH`****`"BL3Q'>WT0@M=*=5NY`\N64$;$&2.
M?4D#\:<==$IM5LX!.T]L;H[GV!4&/8Y.3C''UH`V:*YN;Q6(K""\-HOEO`D\
MB^=EE#''`"G./4[1Z9YQ,=<DBOI+=8&F9KT6R[I`H7]V&R,+T^N3[]J`-ZBN
M=G\4K!903/;I&\DLD+>;,5C5D."-X4]<<<#\*L66J75WK@@$<0M&LTG&)`S9
M8D=1D'IC@X[Y.<``VJ***`"BBB@`HHHH`****`"BJ6L7IT_2[BY49D5<1K_>
M<\*/S(K$&J:E;Z5Y5Q*'U"WO8H)6"`>8K,,<8P,J<4`=117/W/B7[)!+]HM4
MCGAN%MY,RDQ+N7<&+A<@8_V>OYTZ'6;JYU/3DBB@%M<022N1,&.5('!`P1SZ
M]^<8P0#>HKE[CQ23:W8\@QNEJ;F-H90V5#`8W%"N>1TW#WJY-X@>&XN5-GF&
MVN(X'D\WD[P,$#'8L.,T`;E%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110!5U&QBU*QDM)F=8Y,9*$`\$'O]*6^LHK
M^W\F;<`&5U93@JRG((]P:LT4`9B:);K+%,TDSS1S^>TC%<R-M*_-@8Q@]!BM
M.BB@`HHHH`****`"BBB@`HHHH`S[C1;&[OVN[N%+EC&(U29%=$`)/`(X)SS6
M9<>'IK8P?V5(H6-94(DDV':YSM!"L-H/;&?<5T=%`'/Q^%;?[`EO)<SJ3;I!
M*8B%$FSD'D'&#_\`7S5W^Q+;[9]I\R;?]I^TXR,;MFS'3IC]:TZ*`,K^PX5@
M,45U=1`R22$JRG.\Y(*D%3[9&1ZU)9Z-;6-Q#+;-)'Y4`M]F059021G(SG)/
M0BM&B@`HHHH`****`"BBB@`HHHH`J:AIT&I)%'<Y:*.02&/@JY'0,".1[50E
M\,:<TSO"KVH?RRT=N%1<HVX'&.M;5%`&6NBQK%(%O+L32R>;).&7<YQC!&W:
M1CC&W'X\TD&@6EN;<QO*#")`3D?O`YRV[CN>>,5JT4`87_"+6A@:%KF[9&MC
M:@%E^6/((`^7MCK^>:M3:';3?:=SS#[3/'.^".&3;@#CI\HK3HH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBHY_-\B3R
M`AEVG8'.%W8XSCM0!'#?6T]Y/:12AY[<*95`/R[NG/3M5BN4T>"]TG5-1FN;
M%G#Q0EW@+2&5\MDC*C/4D^@`ZUU=`#68(I9C@`9)JE9:S8WSQK;R2$RKNC+P
MN@<?[)8`'\*M7`+6TH`))0@`?2N=TG2;M]'T^2]?FUMSY5NL)1E8H5^8DG)P
M3V%`'3T5R-MIRV^GZ.;JQ9[06_\`I4(@+L9=JA2R`$G&".G%0&#9=6$6KVTE
MS_H<_P"Z\LRL!YB[`0`22!@>Q^F:`.UHKC/L5XMDJ:I;7%S+]A1+?:I<QS?-
MDY'W6^[\Q/;K3KNROUUBWG\I[BX!@#"2`D9``9DF4_*.N0V,XZ'-`'7LP12S
M'``R33+:XBN[:.X@;?%*H=&P1D'IUKD8K:Z.MQ3_`&2:&0R7*SE8#M92IV9<
MY+9XQS@=..!6O96U]_PB%K;6P$-W]F1/WI*%.`#V.#C/;K0!J6E[;WJR-;2B
M18Y#&Q&<!AU%6*P/"EI<65K?026J6JBZ<Q*"2,8'3(&5XX/?GI6E!'J2S*;B
M[M)(OXECM61C]"9#C\J`&W&KVEM<>1*+GS"<`+:RL&.,\$*0>/2KJL&4,,X(
MSR,'\JIWD;MJ.GLJ,521RQ`X7Y".:R6MI/MQQ;R?VC]L#BY\HX\C?G&_&,;.
M-N>O;O0!TE%8'B.,S.(A8?:&,+&-VA:4!O0`<*W^T2.O6J*1++=3;K2=[_\`
M<>5+Y3?NSL7.6_@]\XSTYH`ZVBN/M+=)#(UM:2_:Q=W7F3B,@&/=(,;NA&<?
M+Z\X[U9.GV]LL`GT]I+<VJ[$C@+E9_XF(`X8C;\Q]#S0!T]%<Y!:7ZW-I:W"
M%TF2.>YEZ@2QJ`03TY(0_@:C\/VES#>QFX&V=8V%RRV;1^8W^U(6P_/(P/RZ
M4`=/17+ZU'+-J+>7IY,L<L3)/Y+NQ4%22KCA.X(SDX/!S6EJ\0>\M7NH&N+)
M5</&L9DQ(=NUB`.P#<]L_C0!K45R&G6@E@:Z^PO.%TR+R,Y!)S)D*XY#8(Y'
M//O26UD\M](%L3%9R/;MLCMWB0D,VXD'G/3)(&1CJ.2`=:TJ)(D;-AY,[1ZX
MZT^N?@L8X;^V+66(X;F582(<B,$`C''RKG//2C6+</=W1GM)[@O`JVC1H6V2
M?-G!'W#ROS'';GB@#9BNX9KB:")F9X2!)\AP"1G&<8S@CC/>IZQM`LC:S:F[
MVZQR2W()<)MWCRTYSW&XM^)-9HTV>+3[<V=M)'=26<J2%<HQ/RD`GL>N,].V
M*`.KHKE;FT65\6%C/#:--;"1/*9`Q$OS':>>%ZMCGU.*T-,M;NWENX;7R;6U
M2[.R-[<D%"B'Y,,`!DMV//TH`VJ*XN6S9[9;5+64:B]A<1SL4*B67:HSD\-D
M]#Z<>U7)F:XN;J?[!<2P/;V\966&10<.^[*XRP&1D8Y^AH`Z*>ZBMRHD+;F#
M%55"Q.!DX`'I4:ZA;O=M:H9&E4@-MB<JI(S@MC`./4]QZUR;6=V=+OHELY%7
M=<>3'';LBA6@&-J]LL3^.>G2K0TV6/5'EM[0QLU^'\P18X^S'YB<=-Y//J3W
MH`ZRHXYXY)98T;+Q$!QCH2,C]#7(6EC=BW(BCD3$:BYC6S:$R'S$+;F9SYC%
M0XRN<Y//2MS1(HXYK]K>UDMX'D4QJT9C!&P#Y5(&![4`:DTJ01&21MJ+U-/K
MC(+'%M<VXL))H?)W.TMHR2;@PX;JLK'D[E';W%79+8FY?R;.5;XW,;13F(@+
M!E<@-C"C:&&S@Y[<YH`Z*>>.WB,DK;4!`SC/).!^II]<K]DS9S1QV5RFHG'G
M7'E-M8^:ISZ/ZC&<`$9'2MFPCG33)X"&%RA=3(W_`"T;L^??CZ'CM0!I5')-
M'$4#M@R-L7W.,X_0UR<]OML6-K93P1K:LMVK(8VDERF.3]YN&^8$]>M6?L4+
M7,<L5@RV*7,3)&UL05;#AF"D9`R4YQVS[T`=+&XD0.H8`C(W*5/Y'FG5R2VC
M"SVW=C<2R&T1;7;&28Y/FSC^XW*_,<=N>*E%C.LLMRULS7:ZE#ME\O+",B(.
M0?[OWLD<=?2@#J*CCGCE>5(W#-$VQQ_=.`<?D1^=8.BV[0:M(4MWVLC;Y)(&
MB<'(P&;.V4]<$=/7FH9K)$U6\>:Q=[=[L23!("PDC,(`R`/G`?.5YY.<4`=)
M<3QVUO+<3-MBB0N[8S@`9)XJLVK6*65O>-.!!<%5B?:?F+=!C&:SFMY3X4U*
M%()5WQ3B"$@E@I#;1CK]!VX%4Y+&ZPUN;>3R+9UEA(!.XNZDX_W?G&.P(H`Z
MJJEWJ-O9RI%+YS.ZE@L4#R'`QD_*#CJ*IZ';):0SRR6QCGFNY@6\H[F'F,5R
M<=,<CMS[U'JV]-5MY?.O8$\AU+VMOYO.Y>#\C8Z>U`&K'<QR6WV@>8L>"3YD
M;(P`ZY4@'MZ4^.198UD0Y1P&4^H-<]>QI<!9+B&[O8C;,D)>V82++DY)&T;2
M1C!P!QUYJI=6EY$T7E6UPRP(E^-H)S(JJAC`]2`>/>@#KZ*XW5;*<6!@&G^9
M=FUWK,(7D_>DLS;,<(<G.2<G(ZXQ5Y]/4QS7,MF7W7>9_P!R6>2''3'4C=@X
MYS@\4`;Z7$3K*RMD1,5?@\$=:J/K>G)I(U1KD?8CC$H5CWQTQGK[5!I<(33[
MU8K>2%&ED,:.A4X(&,`]O05A7FG7CZ1+9BUE,*6AN$`4Y,C1[=F.YSO;'J10
M!VE4O[6LO/\`)\XYW^7OV-LWYQMWXV[L\8SFK22*[.`&!0[3E2.V>,]1SU%8
M]C,]I8PZ>]E<37$9"'=&=C#=_K-^-O\`M8Z^U`&M;W$5U&SPON579"<$?,I(
M(Y]P:>[B-=S!B,@?*I8_D*Y:*PDMVANHK*0W)O[GS"JE6:,^:0">RD[<=LD&
MHH;>5FE,%@T$4D<1*QVSQ[F$JYSNY+8[D#\:`.K2>.1'9&W!&*M@'J.HIZL&
M4,,X(SR,'\JR;&V6"RU**.V,3M-*2!%MWYR01Q\W!'3Z50&G,T,TS6K_`&A'
MMC$VP[EP$W8_4'\<T`=/163KD4<CVQNK9[FS4MYL:1&3G'RDJ`2>_P!"0:S7
MM6+R[K*X^U,8_L,CH7,*!%&"_(4@ALY//O0!U%%<K%I\D307"6KK<-?7(D<(
M=QB/FD9_V2=I';)'K446G74-C;+:6SPRS:6!<$1D%I`8^&Z$M@N,9!ZT`=?4
M+W$22-&22ZJ'*JI8X)QG`^E<S%9R"$'R2VG^>C2V\=BT*E0K9Q&2S'YBF1@9
MQWJ6YLXR\CV^GS(7M%2(M$2PQ(<@GG'!'!/3Z8`!T]%<RELXF0"TG%^)Y&FG
MV'#1G?@;^C#!7"\XXX&*DT&R>TGTXK;-#YFFC[2VS&9!Y>-Q_O#+=?>@#HJA
M>XBCD".2K,P5<J<$D$X![]#7.:M!?1:E+);V\DL=LPO8\*2&8[5*#'4X$A_X
M$*<--,4\'VBU,PBF@9F\K=\VUMS#C^\1GTH`Z.">.Y@2:%MT;C*G&,BA)HWF
MDB5LO'C<,=,]*PM'TX6DNG2I;-%(\$@N&VD$GY<;OUQG\*=J-AYMUJ%S]F9Y
ME$1@?:201G)7W]<4`;D<BR*2H8`$K\RE>AQW[>_>GUQ]Q8N;?,MO*SBXN2B/
M:O*K9E8C!7#(QX(?IBNMBW&)"Z[6VC(SG!^M`#Z***`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@!KNL:,[G
M"J"2?:J4>L6$L3R+.=B*KY9&7*MT*Y'S`^V:MW$9EMY8UP"Z%1GW%8][HDMU
M#"A=`8H(U&'9<NK*W48(''4<B@#0CU2SD&5E(P&+!D92NT`D$$9!P0<'M1;7
M%C>R13P%))&A#H^SYO+8^I&0#CI[5DRZ#<36+IF.*>2;<?\`2)9?D*[&!=N2
M=I..`!QZ9K0TC3I+!KDRR*_F2'RL#[D>257\,F@"0:O8EY5\X_NMVYMC;3M^
M\`V,,1@Y`STI@US3R,^;)C(',+C`/1NGW?\`:Z>]9G_"/7!,B'RRB^:8I&N9
MFY=6`_=D[5(W<D9[\#/%NXTF>7[9M>/]_:10+DGAE+DYXZ?,*`+@U6S:Z:V6
M4F56*'Y&VAL9V[L8SCMFJ]KKUI-:VLLQ,3SPK,R!6<1ANFY@,*/<XSBH$L;R
MXGGC=8TMOMGGAR2'^4@@8Q@@D=<].,5!#HE]#I9L%>V9+BT2WF<LV8R%VDJ,
M?,,>N*`-EM0M5C\QI,+YACY4YW#.1C&>Q/TYJL-?TTH7^T-M"JQ)B?[IZ/T^
M[_M=/>JHL9)M6N0BLMM'%A?,0@-,R[203U`4#D#')]Z?=Z1<3V-Q"KQ!I;`6
MRDDX##=STZ<T`7_[2M?MGV7S#YN=OW&V[L9V[L;<X[9S52?Q#8QV<\\3/*8X
M6F51&R[PO7!(YP<9],\U`NB2#4=YP\'GB?<;J48.<X\L';U[_H:2?1+B;2X;
M3S(U9+2:!FR2,N``1QTXH`UGO88K1;F0NJ,!@&-MQ)Z#;C.?;&:@74[!8OM"
ML?WKE2%A;>6'!RN-W`ZY'%+>1WTMA&MN8X[@%2ZB0@$=P'VDCZ[>U8XM+G2'
M2[;]_-OE`55FE!5]IY(5CD%>_!]NP!IPZOI:KB&550H9R4B8(%;)W,<8&<$Y
M/4U*NK636[S^8ZJA`*M$ZOST^0C<<]N.:RK'1;I]/N%N"D3W5G%%CG*.N\G.
M.WS#H?6E_L&=XI)'5$N-T94"]G<MMW<&0G<!\QQ@<>^:`--]9L8XHY&DD(DW
M;56%R^5ZC:!D$9Z$4J:O8N)")_EC02%BC`%3W4D8;TXSSQ56QTF6WGBF(13F
M5I%\Z24Y8*!\S\GA?;Z56?P_-+IMI;/*@:"T2(E689=61A@C!Q\G7@\T`:7]
MLV(C5C)("SE`AA??N`SC9C=G`STYJO+=:;JEY:VDUHMTDL331O+;EE7!QCE<
M`]<YQC@=Q4-KH]PEY:W+B-#'.9'7[1),2OEL@^9^2<MZ#CUI;:PO--"SHD,Y
MC6Y+('8$[I#(N,*<]@?KQGN`:UQ<0V<'F2G:@P`%4DGT``Y)]A5.+6[9XGD8
M2`"1HU5(W=VVXR=H&1UYXXJ6_MY;F&"2(*)X)!*J.Q"DX(()`]">QK/?3]5(
M.V6%1+*[RQQS-'PP&"&"YXP>.,YSD4`68]=LY+F6,,WE);I.)MK;&5B>^/;\
M<X[&I3K%D(!*9).7\L1^2_F;L9QLQNZ<].G-9*^';G[*;=Y8R#;0QEP[`[XI
M"X]\'/7.1[]:L0:7>6[+=1)!]I5\F.2ZED#+MQS(P)SW^[[>]`%A=9#^'Y]5
M6'*Q"4B/=]X(S#KCC.WTXS4MOJL5Q':R*NU9BP<,<&(J#N!]P0155=*N3X8N
MM.=H?M$PGP5)V`NS,.V?XAVHO=$>XO6=)@EO-$Z3(.N\IM#K[X//T%`%R+5[
M*4$K*P`*CYXV7.XX!&1R"3U''O3I]4M("X>1BROL*I&SMNP#@!02>".G2J/]
ME7-VQ:],,92V>WC\ER<[BIWG(&#\HP.?K4#Z'=&"SE=UEO(A)YVVXDA5V<@D
MAD&>"!@8Z4`7Y-6TQ9D+S*SA0P<1E@JOT)8#"@X[FDEUNV5H!&&<27!@?*LK
M1G86^Z1DYP,>N1BJL&B30K=*&B`F@AC4!F."K.6SG)Q\WJ:=+I5W_:C7<30D
M?;%N`K$\J(/+QTZY_3\J`+C:Q8K%%)YS,)L[0D;,W'#94#(P>#D#'>I8M0MI
M[DV\3L\@4,2J,5`(R/FQCD'UK)FT6[9XYPT;RL9/,1;F6`#<VX89.3CI@CGK
MQ5JQLI=)M;@QQI+A8Q''&6&=J!<<Y(Z>I^M`%Z[DN8T7[+;K/(S8^>38JCU)
MP3^0/7\:SDUJ>>+_`$>R5Y8PYF1IMH78Q4[3M.[)4XZ?A5S4UOG@5-/\H.6^
M<R2%"%[[2%;G\*I_8KZ-4:VM[.-C"8&C,S%4&200=F6ZG(('UH`<VLL69X+9
M9;6,QB63S<,I<`C"XP<!@3R/QJ7[=>KJD5I)9P;)`S;TN&8J@[D;`.20,9_E
M50:1=0>9;6WD?9IS$9)'=MZ[`JD!<8.0@[CJ:T8+5TU"[NG"$RA$CP3D(HZ'
MT^8M^E`%RBF1ES&IE55D(&Y5;<`?8X&?R%/H`:Z+(I5U#*>H(R*=110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`45'//%;PM+/*D4:_>=V"
M@?4FHK6_L[W=]CNX+C9C=Y4@?;GIG'TH`LT444`%%%%`!1110`4444`%%%%`
M!14<\\-N@>>6.)"0H9V"C)Z#FI*`"BBF)-'(SK'(CM&=KA6!*G&<'T/-`#Z*
M*;N7?LW#=C.,\XH`=1110`4444`%%%%`!1110`44A(4$D@`<DFH5O+5X$G6Y
MA:&0A4D#C:Q)P`#WYXH`GHHII90P4L`S=!GDT`.HIDTL<$32S2)'&HRSNP``
M]R:=0`M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110!B^+\_\`",WF.OR?^AK2:L^H6VF@RW*',\:RR6\1C*1%AN/+
M-^?85MT4`<AYT\UW!!%=W#6#W_EPR+.V9(_))(W@Y(W9YS^/%=:J[5"@D@#'
M)R:=10`4444`%%%%`!1110`4444`<QXD0ZKJ4>F"UFNHH86EE6)E!#,"J'YF
M`X^8_E5:/5);L6)O+B2VC%K*K[)"F;E"%VY'4]2%YS[UV%5+W3;6^='N$?>@
M*J\<K1M@]1E2#CVH`XJXU6Z&CP2"\FCN8K**5'>9OWC%CN.T8W=LEL@#L.^E
M+<7,NL&'[5.L;:H(\)(1\GD9V_3/-=7#%'!"D4**D:*%55&``.U/H`XF>[N_
M[+B_T_:L5S<1GSYY(MZJQ"_O1W'8$\^^*NZ.XE\0P7-QY\<T^FQE5FE.6;<V
M>.`<#!Z=\X&:ZFB@`HHHH`****`"BBB@`HHHH`R/$\[QZ2UO`&:>\86\:H0&
M.[KC/'"YKFYG6RMYM+:"6SCCO+>XA1RI98VD&<;21PP/YUW=%`'&3W4YL[G[
M+J.+)+U1#+-/)ME38"R^<.0-V<$GJ,9[4ZQF\[4='O)S<!OL\Z*7G)\Q@PQ@
M\!LC)''(`)SC-=C10!Y\VJ77V2[>&^E`?33,09G9XY0X!^8\!ADY"A0..*TK
MRXN4N-2G6ZN`T%_;I&HD.T*P0,-O0@[C77T4`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!11378(C,W11DT`.HK%\/:M+JD
M0DGEB#/&)!`+=XV53T.6/S#W`Q6U0`44R9S'"[C&54D9K`T_6[TQ:;->?9Y$
MOHV?9#$RM'A=W=CD<8[=10!T5%9,6O136]O)%:73/<KOAB^3>ZX!+?>P`,]R
M*&\06S&$6T%Q<M-$TJK$%R`I`8'<1@@G]*`-:BLE_$-GY*RP)-<)Y(G<Q*/W
M<9_B8$@]CP,GCI3O[=M3?BTB269ODW/&`0H894D9W$8[@$#O0!J45E/KL"WQ
MLS%+',P?RC(``Y49.!G=CW(`/:F#5IAX4&JM&AG-L)=B@[2Q'`]<9H`V**S]
M'O'O(':6XBED1MK*EN\)0X!P58D_RK0H`**RKZ74X[^"*"XM%CN&*J'MF8KA
M2>2)!GIZ"I!JL:SB)XY"@D$)N``(_,Z;>N>O'3&>,T`:-%5+V^-F,BUN)P%+
M,8E&%`[DDC\AD^U4[S6UCC8VL+R[6C5I-HV(7*X!YSG#`\#C(S0!KT5F_P!L
MP;_]3/Y)9D6;:-CLN<@<Y_A/)`![&H)=>S9/-#9W`DV+)&D@4&1"0-P^;MD<
M'!H`V:*HWU[+;&SV6SN9YA&PRN4!!/K[>]4[+7T>U62]ADM\PM-YA4;'"XW;
M>2>,]\9[9H`VJ*J6E^MU*\30302HH?9*!DJ<X(P2.Q]QW%8L>OSM<LIN]/9A
M>-;BS`Q,5$FS.=_7'S?=[4`=+163%K:LK!89KB17D#+$@&Q5<KDY;GH>G)QT
M'2I9=8BC$<BP7$ML^S_2$4;!NQM/)R1R.0#B@#1HK+BUN"6=8_L]PJM+)"LK
M*-K.F[*C!ST4D<8_'BFSZPRQ.!:S02KL95G`PRLX7(VL?7H<'VH`UJ*R[O64
MALFFAAEDD_>@1X`(*`Y)R1QD?J*1-8`1C+#)YI9$2!54,69-V`=V#W.<@#'X
MT`:M%9MSK"VT'GO97AC6/S)6\L#REYSG)&<8/"Y/YBI-/O7NI+Y65<6]QY:;
M1U&Q&Y]\L:`+U%8=EK%Q-.@<P.S*6DM$&R>#`SR&;YN>.`.35F;7+6,1%`\Q
MFC61`A7D-]T<D`9P>O'!H`TZ*QYM<\FY@$MK-%;O;RS2M(H5HMA`.1GW[9SD
M8R,FI'UN&)&\ZVN8Y`T8$3*NYM[;5(P<=??([B@#4HK+76X=\:RV]Q#O=HB7
M5<*X!)4X)YP"<C(]ZGT[45U!2R03Q+@,K2`8=3T(()';IU'<4`7:*IWEVUO<
MVJ``I*SA^.<!"W'Y55AU^VDB\UH9XD:`7$9<+F5#C[H!)SD@<XZB@#6HJO9W
M)NHV9K>:W96VE)E`/Y@D$<]03535[F_LX9KJW-MY,$>_8ZLSRG^Z,$!<\`'Y
MLD]/4`TZ*QY-2NDF>8B%;1+E+<H5)D)8J-V[.!RV,8[=:CM]5O6ABNFCBFAN
M;=YH8XU*N"`"JDDD'(/M@T`;E%9>CZDU^\R^=;W"(%(FM_N9.<K]X\C`_,<"
MH&U:X%^8=ULC";RUM)1LED7.-ZL6P>.<`?CF@#;HK(AUIF+H]E.T_FR)'%'L
MRZH<%N6P,9'4CD\5-_;$#-&L,4\Y=!(PC3)C4DC+`G/4$8&3P?2@#1HK,TC5
M#J"%64&5'D#E!\J!9&50>>I`S_AQ3I+B[N+R:"Q>",6Y42-*A?+$9V@`C'!'
M//7I0!HT5CQ:\K(JFTGDG`?S4A`8)L;:W)(R,CZGTIRZN7NF01$0;XA'-@$.
M'&?[V1]<4`:U%9+>(+9+=KF2&X6#RS+'(57$R@9.WG/3GG&:MV=\MU+-"898
M98<%DDVY*G.&X)X.#[\=*`+=%<\VMS"YF47NGETG:-;/8?.8!L==_7'/W:M0
M:S(;6262SFF*2S*?(485$<KD[F'.!T'/M0!KT5F-K4"R%1!<-&K1JTJJ-J[P
M-I/.>XZ#BK=W<M;A=EM/<,V<+$!V]2Q`'YT`6**RX]=MYI8D@@N)?,C25BJ#
M]VK$@9!.>QZ`XQS5R[N6MPNRVGN&;.%B`[>I8@#\Z`+%%4FU.$:4NH*DK1.J
MD*%^;YB`!@]^:B.L1K(4>UN%"%1,WR$0D]`V&]QTSC/-`&E164FN12NRK;W"
M+YDD*RNHV-(F<C@Y_A/.,>^>*9;:V3I]G<7%I.1-'$TDL:#RT9P/4Y(RW8''
M>@#8HK..L6ZF=FCF$$&_?<;08\K]X<'/'N,=J8^MPQ(WG6US'(&C`B95W-O;
M:I&#CK[Y'<4`:E%9B:U"9(DEM[B'?(T1:0+A7`)*G!/8$Y&1[TS^WK<0^;);
MW,890\2LHW2IN`W*`?5EX.#STH`UJ*R9-9;S(HX[.?S#<B"5'V@H"N[/WL'C
M!X)[]^*35-6DL=2MX/+Q;F*2>:8J&PJXR`-P.>1V/48!YP`:]%9<FMQ0JWG6
MMU'*&0")E7<V]MJD8;'7WR.]37>I"TBMFDMIVDN7\M(DVE@VTM@\X_A/.<?S
MH`O45EIK<+R0QI;W!DD#LRX4&((P5MV3V)[9SVS1'KD#*K/!<1"0!X_,4#>A
M8#>`#P!N&<X.#TH`U**S9]8@AG<.66*(2;V*9SM"DX(.?XL=#D_J'68D;9/;
MW$,A>-`CJN2';:K<$C&>O.1Z4`:5%94NNV\=TULD$\LRR-'L0+D[55B1EAD?
M.O'7VK31@Z*P!`89P1@_E0`ZBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"FL"RD!BI(P".HIU%`&0NDW?G-<R:B&NQ
M$(8YE@`VIN#'*YP2<=>!Z"M>BB@!DJ>9$Z9QN4C-9VF:':Z;IRVT4<(F\KRW
MG6(*S\=3W_6M&9G6%VC3>X4E5SC<>PKG7U'4;F+RA/#!.MQ""&MY$8`M@@J6
M&1G'S`X(R,"@"['HKP6^GBVN52YLH?)65XMRLI`!RNX>@/6JG]B75M?V@L)0
MD<=M*CSR+OR[N&.5R#SR>.E6%U:YC$%Q.L)MKF1HXXT4[TPK,"23@Y"'C`QG
MO44U]J*6%O=W"QLLDD3HEJ&W8;JA!//;GC/H*`'KX<^SP>3979A5[=;:4M'O
M+*,\CD8;YCSR/:DN_#,5S<P/YD8CA,>S,`\U`F,*L@((''<'J<8JZ;^1-$^W
M8CED9`ZA20N3T&>O<9/Z=JJ3ZEJ%O<&R;[-)=9B(D",J;79A]W<3D;3WY]J`
M&0^&VBNXY1=J8XI)I%4P_,?,!SEL\D9X/IQ[UHVEA)::-#80W)62&)8UF"#M
MWP<BLFYU"^,S*98@;:.X64*C*LA5%8$8;(X8=SCFK(U.[V23HL'V>WD2)T;<
M7?(7+!L\8W="#G'49H`NV&GM;O<S7,JSSW3`R%8]BX`P`%R>WJ32P:1IMM,L
MUOI]I%*OW7CA56'T(%4++5;N:XM3,(/)N9IH%5$(92A?!))Q@A#QC\:=J&IW
MEM<WQB$'D65NL[A@2[@[L@<\<+UP:`-*>V\ZZMIM^/(9FQC[V5(_K5(Z0QF*
M^>OV,W'VDP^7\WF;MWWL]-W.,?C5<ZA-$L^RYB1FN'V^:CRM@!>%12">OKQQ
MUS59?$%[):372I;I';VL5S(I1B7#;MRCD8^[P2/PH`T=6TA]2D&;A5B,9C9'
MBW]?XEYP#]0>@J,Z)*L1BAO%CCD,;3#RLEF0*,@[N`0@!'/UIRZC=+K(MIUC
MBA9BJ*T3@L,'!63E2>/N\'\JUZ`,>31Y?*,2W.^W1GECBV`-N;=P6SR`6XX!
MZ<FFQ:/</:@7-TK3K;B&)O*^X."=W/S'*C.,=*VJ*`*MW:R7"VY$JI)#(LF[
M9D'`((QGT)[\>]4WT-)+."UEF+)'!)"V%QN#`<^V,>]:U%`&;I.DKISRN!:@
MN`N+>U6$8&>3C))Y]<>@%0)HUR%E@>\A:TDN6G*"W._E]^-V['7OMK9HH`QH
MM$EMGDDM;Q4DE,@D9H=V59V<`?,,$;SSR/:H9?#(8HB7(\B+RO*62+>T>P``
M*<X`..>,\GGFM^B@#(.B$PQ1BZ93'=2W`95P?GW\#GC&_K[5!#X=9&9WNHR[
MHB,4@VYVN&!Y8DGC')^F.^]10!C1Z6UQ?:C/,KQ1SQF&-6()&1AW&"<!L+Q[
M9(YIW]C2'$IND^TK(DJ.(CM#*FSE=W(()XSWK7HH`P=1\/S:BCI<7P<21>6^
M^'.#R<H-P"]>X)X'.>:T;&P^R?:\R[_M$OF<#;M^15QU_P!G/XU=HH`RTTVX
M\VV:YO!<):-NB_=`2,=I7YFS@]>P%06NDS-97(?;$]Q*6$4\:RJL?:-@#@CD
MG@]^M;=%`&'_`,(ZI@BA,XV+%-#(HCPI60@X49^7!48Z\40^'5C7A[6,^=%)
M_H]HL0(C<-S@Y)/KG'H/7<HH`S9=*,CQ,)RICNFN>$]49<?^/9S[=*AM=+N+
M!I9X6MVFD*@B.W\M6&[YF8!N6QGGCZ=JV**`*MW9_:98)/,V^46.,9SE2O\`
M6L_^P`8+6(W)_P!'L_LH8)U(*$/U[%!Q[UM44`5;6*[C'^DW23,6);$.P`8X
M"C)QZ\D]^G:O?6-[<7L<T-W`D48&V*6W+@-_>X=<GZ]*TJ*`,J3299+EMUTA
MM7G2X:+ROFWK@\-NZ94'&#]:A707>W^RW%V&M4A>"*..+855N.3DY(`QP!6W
M10!1L[*:&ZEN;F>.65T6,>7%Y:A5)(XR23\Q[_A4,NF7$K&)KT-:&3S"DD6Z
M0?-NP'+<#/3@D#C-:E%`&3_9$\=R;FWNXTF#R%"\)8!7(+`C<,\@$'C\:(]'
MDMI$>SNS$YC$<K-&&+@,6R.<`Y9NQ'/2M:B@#+TW1UT^;S8Y06;S/-P@'F;G
M+KGW7<1^-336=P+EY[*Y2%I<>8LD6\''&1@C!QQW'`XJ]10!B#2+F"X06ESY
M:>2RR22(&\QF;<QP",-G)STYZ5,NC!'C6.8+;IY6V,ID_(,=<]"/:M6B@#"F
M\//-IYL7O!Y$<+0VX$7*`KMRQS\V!QQBM.*S\K4KF\\S/GQQILQ]W:6YS[[O
MTJU10!7M+;[*DB[]V^5Y.F,;B3C]:R9O#CRH\9NU,4C2EE>'=C>Y;*C=C(SC
M)!S@<"MZB@#*31RMK+";C)D,1+!.FP*.F>^W\,U)JNFOJ#0E9U5$#!XY(]Z.
M#CJ,CD8XSD<G@UHT4`81\/$VMK;&XB:*!`@+6X\Q<'JC`C:?S_"KFJZ:^H-"
M5G540,'CDCWHX..HR.1CC.1R>#6C10!G1Z4(]%ATX3<1!`'V]0K`]/PJO<Z!
M#/J;W@%KF5E>0RVJR/E0!\K$_+P!V/X5LT4`85CI-WM874X2);J:9(@@S\S/
M@EL],-G&`<]^U1#PPWEP1/>K(D*PA2\.64QA1\IW84';TQGD\UT5%`&2VC,T
M=S;&YQ93F1FB$8W9?)/S$GC))`Q^..*AA\.K&O#VL9\Z*3_1[18@1&X;G!R2
M?7./0>NY10!F3Z0)S'NF^5+IK@C;URC+MZ_[77VJG;>&4@0J'ME("JK16:QL
M0&5LL1R3\N.,#GITK?HH`SIM,9[EITG"N9TF`*9`VKM(ZCJ,\]O>C4=*74)U
M=Y611!+"0HY^<J<@^VWT[UHT4`9$NCS7,BS75XKRK)$P*1;5"H^_&,GD]SG\
M*EU>UNKF73VM&5&AN#(SL-P4>6XY&1GD@<'O6E10!EV^C^5=+/+<&5C%*DGR
MXW&1E8D<\`;<`?K5>R\.0VR2QO\`9BKPM#F*T6)BI[LPY)X[8'MTQN44`8PT
M!6LH;>6Y=BD4B22!<,[/@E^^#D9[TL^CSW6Z2XO5:X!C,3+#A4V/N&5R2<GK
MR/;%;%%`&%)H$\D4ZR75M,;B8RR+-:!XR2BKP-V01MX.>_.>M:]I!]EM(;<2
M/)Y2!-[G+-@8R?>IJ*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`:Z+(C(ZAD8$,#T(JD-&LA$\?ER
M$.5)8S.6&TY7#$Y7!Z`$5?HH`IQ:79PW!GCAPY)8`NQ52>I52<*3DYP!G-,@
MT>QM\>5"1AE*YD8[=O0#)X`ST''M5^B@"N+*W%J]MY0:"0L61OF!W$D]>V2>
M*JRZ):/"L2AP/,5V9Y&=VV]!N)R,=N>*TJ*`*)TFR,21F)BJ;N?,;)W##9.<
MMGWS2MI5DTXE,/S`JV-[;6(Q@E<X)&!@D9X%7:*`*L>G6L7D[(L>1(\L?S'Y
M6;=N/7ON;\ZAETBWGOY;J?+[U1=@8J,+GK@X8<]"*T**`*4VDV<S[WB8/N9M
MR2,I.[&1D$<'`XZ<4U=&T];>:!;<"*:(0NH9N4&<#KQ]X]*OT4`5!IMH+K[2
M(V\S);'F-M#'JP7.`??&:L1H(HUC4L0H`!9BQ_$GD_4T^B@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`I:Q?G3-,FO!%YICQ\F[
M;G)`ZX/K2"\FMX9)M3CM[:-<!3%,TFXGC&"B\],`9SFFZ]82:GH\]G$4#R[<
M%^G#`\_E45[HL#6:1:?#;VK1SI.JK&%5F4YP<#OTS0!*VMZ>L2.9F^>3R@GE
M.7WXSM*XR#CL15Y6#*&&<$9&1BL)=$N6U"*^D:%9&NQ<2HK$JH$90!3@9/0\
M@5OT`%%%%`!1110`4444`%%%%`&7KVL#1[9)!;O<R.QQ&AP=H!+-^`%6)]4L
M[<1>9*?WRET"HS$J!DMP#@>YXJG>Z3<7VL"Y>[:"&*`QQ"+:6)8_/D,I&,!>
ME9!LK[1VLR8VN?+MI;4-&CN`FX%"=JD[L`#&`/<4`;IUW31'%)]H)25%D#"-
MR`I.`6./E!_VL4'6K6.>2*>15*S^0H0.Q9MH;!&WKCTS]<\5SY\-ZC<Z-%;.
M8<-9Q1^7.[?N74Y.``1STSU&.]:?]B7)U,7.^'9]O^TXR<[?*V8Z=<T`7SK5
M@+:.<3,R2%@H2)V;Y?O?*!D8[\<4D&LVUSJ@L80[Y@6<2A24(/3!QCMU_#KF
MLF;PY<26:QLEM*ZW$TRGS7C9=[$@AU'''48.?6KVG:7>6>H0SS3K<_Z&EO+(
M[$.64DYZ'.<]R.G>@#9HHHH`****`"BBB@`HHHH`@O;J.RLI[J4_NX4+M]`*
MRH_$6[2([Z6T:*3[0MO+"S\QDL%SG'/!!Z5;UNPFU*UCM8I1%&TJM,V?FV`Y
MPO!!.0.O%95SX?O_`+1.T%VDT<TL$Y-Q@-O1N>$4#!4#\J`-;^VK`P>;YKX\
MSRMGE/YF_KMV8W9QSTZ<U&NN6DE_:6L(DD^TQM(L@C;:`#CDXZYZ^G?J*S[C
M0+BZBN9+B*TDFN+E9C%YKJ$VJ%&V0`$-QG.WVQWJ6TT:_@EL97N5E>&*6)RS
MDE`Y!&TD?-MP!SC/Z4`6I=?L1:SS0RAC#'YO[Q7167.-P.TY7W4&I7UFP2X>
M!YR)$D6)_D;"LPR`3C`SFL!_#&H20S"1[4S/8FU,AD<L[;@=[$COC\/?-7[G
M0[F87^UX1]INX9TR3PJ;,@\=?E-`'04444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M-=UC1G<@*HR2>PIU-=$D1DD571AAE89!'H:`.9M9KA+N5YH+BU&HQN?-<I_K
M`"4V@$\[/4#[HXJS)')_PB-HHNI0VV`^8`N[!9>.F.,^G;G-;CQH^W>BMM.1
MD9P?6HQ9VRVIM1;PBW((,00;#GD\=*`,6)[FUGFF2X9HS?&,P[%PP(').,YS
MZ''M6=-JNH2Z-/+.IVS6,DVV80,H8`?<4$DKR0=P/;ITKJIEM;6W>65(XXHL
MRL=HPN!][Z\5''9V#-<A+.$&3Y9B8,>9QGDD?,.??O0!'I[3RW5Y)+<NR)*T
M:1;5"J!CG.,D_C6)<S3S7&G74MV)"\UQB#:NV/;%(,#C)QC!R3SZ=*ZE$1-V
MQ57<=QP,9/K4']GV7VAKC[);^<W+2>6NX\8ZXST)'XT`8MI>WJ7,#2RDVS&.
M-5A6-HQE!\K#AE;)[<8QQ3#J%ZVCPW?]H!)[HPGR=B9BW2JK`<=`#@Y!Y[CI
M6\+&T6X6X%K`)E7:L@C&X#T!ZXH%C9AG86L`:1@SD1C+,#D$^I!H`PWO]1BO
MI8U:9X[>>.'<Y@5'#!<E\D-N.XXVC'3@U1ANKBQ_>"<2-_IS!YD4[,3J,Y`!
MQU)&?T`QU;V=M)<)<26\+3Q_<E9`67Z'J*%L[5)6E6VA61\[G"`$YQG)]\#\
MA0!C375[!>&P2]:7YH#]H9$+`.S`K@`#HH(X[]ZT]+DE>*:.>4RM#,T?F,`"
MP'3.`!GGL*EALK2WB$4%K#%&K;@J1A0#ZX'>E-K#]H28(%="Q&`!DMC)/Y4`
M<WKR2MJ=WMN)%&VRVIA2H)G//3/&/7N?;$LVH:A',]BL\\K+=^4)46(2LOE!
M\#=A,Y/IT'3/-=!+:6TTJRRV\4DB@`.R`D`$$<_4`_44V6RM9TD2:VAD25@T
MBO&"'(P`3GJ>!^5`&9)J%V/"US>LRQW,228;*OC:2`3M)&>.0,X.:BFNKV.Y
M:R2]=\M`1<;$RN\L"H&,=%!''?G-;$]G#/8O9[?+A9-F$`&![4L5G:PILBMH
M47=OVJ@`W>OU]Z`,<7MXA$YN7?;>"T^SE4^9=P7><#.['S>F.U0W-]<O!(LD
MBN(;B"-2T:D3`S*-_(Q[<=P3Z5O&SMC<_:3;PFXQM\W8-^/3/7%*;2V945K>
M(K&`$!084`@C'IR`?P%`'/V^J:B\WF$D1RR2I^^:%8DVAL;<-O)&T9S[GC%7
M]%N;EYIX+R29I%57"R+'T.>59."IQQD`CGK6@MG:I</<);0K/(,/((P&8>YZ
MFBVM+:T#"UMXH`YW,(T"[CZG%`&!+JMS'J,(CN9I8K@S+\T2+&NU&(V_Q'!7
M&3D=>G%++=ZDBV\:SW4K-;_:&D18!R>QWX&T>W//6MP:?9"5I19VXD9MQ81+
MDG!&<XZX)'XTLUE:7"1I/:PRK$<H'C#!/IGI0!5N+N0Z7;R-(UO-.$&(5$C;
MB,D+U'KSR..]4M+U.>:X@CEF+)OG1C($#-LVXSMXR,GI6U<6T%U"8;F&.:(]
M4D4,I_`U&UA9M'Y;6D!CW!]IC&-PZ'&.O`H`Y7S;B\2>X:[=FDM+1@,+MR96
MYQCV_4^V-,7%Z+XZ:VH.,S;1<%$\PCRPVT<;<YSSMZ#\:V#96A96-K"2J[5/
MEC@9S@>V0#2S6=K<(Z3VT,JR$%U=`P8CIG/6@##AO;R\+*UR42*.8G:B$3;'
M*@G(/!`[58MQ<SRVOV>^G5%CC>:-4C\M1M'RCY,Y/UX![<5K""$`8BC&%V#"
MC[OI]/:H#I.FF<3G3[4S`@B0PKN!'3G';`H`P+?6-3-D;QDD'FV[RA9O*V(P
M'&T*V\@=]PS]*T--1X_$5ZLETUR?LL)WL%!^])Q\H`__`%UJ1V=K#-)-%;0I
M++_K'5`&?ZGO26UE:VA8VUM#`6X/EQA<]3V^I_.@##M'NOM9LUOIHUFFN9#+
MM0L"K@!1E<=R>0>E6;F:6]\,F5IC&[8S)&!\V'QD9!&#C/XUI2Z?93JZS6=O
M(LC;W#QJ0S>IXY-2O#%)"89(T>)EVE&4%2/3'I0!B"ZNM]^9-0F18KE;:)4A
M1B<JAR./O?,?8>AJ#3[^^OKDVGVR:()--&9&2,R$*J$9P"H(+GM]1FMXV5HT
M+PM:PF*0Y=#&-K'`'([\`#\!2Q6=K`P:&VAC([H@'8#M[`#\!0!SXU/4#';W
M4DY\A88WE$"HV"2=Q=3\VTX&-I]>M2-JEPNJVHCN)IXIYY8BAB1(\*&.%_C)
M!4#/(//3(K:;3[)GB=K2`M#_`*MC&,I]../PH6PLTG:=;2!9F;<9!&`Q/KGU
MY/YT`<]/+=76B6T\FI,)+E[67RU5`T6Z50<<=!GN#R.N.*T]:FO8I+=;25@-
MKLZ1&/S6QC!`?@J,G.,'IS5[^S[+9*GV2WVS',J^6N)/][CG\:=<V5K>1K'=
M6T,Z*<JLL88`^P-`&,-8DDL[B>.X!7?;^42@7APG8^N3UJ#4KF>XT;5I9KL(
MNRYA6U95YVA@"#US@;NXP?QK?DLK66599+:%Y%&U7:,$@>@-#V-H\DDCVL#/
M*NQV,8)=?0GN/:@"CIDMRFHSV<]PUPJP13*S*H*EBP(X`X^48SS[FJR7MU((
M9C>X^T7,EN8`JX0#>,CC.X;03G(Z\"MP11K(9%C42%0I8#D@9P,^G)_.F+:6
MZW+7*V\0G88,H0;B/3/6@#C;%[NWL7NX;V020:/!/RJ'>1YA"GCIVXP?>M5M
M3OSJ,C('\I+B.'86A6(!MN<DMOW?,2,<'@8/6MI+"SC1T2T@5)%VNHC`##).
M#ZC)/YFG&SM3<K<FVA-PHVK*8QO`]`>M`%+3'GFT7[1<W#S/-&6Y50%XZ#`'
MZYK(M[VXL-+TZ.&Y$D;V4;;MJXCVM&OIT(8]?2NH2.-(Q&B*L8&`H&`!]*C2
MSM45U2VA57&UP$`##&,'UXH`Q[V]O9+JX@M)_P#5W"H5C,8DQY>XA-XVDYP>
M>V:IMJ=RUR&AE"NZ6D;2-`JM\TSHV>OITSCTZUT)TVP-N;<V5L8#@F/REV\=
M.,8I_P!CM<@_9H<@*!\@XVG*_D>1Z4`8+ZA?B1K))+F5DNGB,T:PB5@$5P/F
MPF?GQTZ+3)-4U%8H[F67RX8H=\RPF*1EP[`NZYY4A1]PYSNZXKH);&TGC>.:
MU@D21M[J\8(9L`9([G@<^U)+I]E,T32VD$AA_P!46C!V?3CCIVH`R[2^NAJX
M2YG9X9Y9(X?+"-$=N2%R/G5@%.<Y&0>E)K6HRVLTCP7,P\ED!C6--F6(X9FY
M.0>-I!^M:R65HETUTEM"MPXPTHC`<_4]>U$MA9SS&::T@DE*["[Q@MM],^E`
M&5:WUVNK^7=3LT,TTD<7EA&B.W)"Y'S*P"G.<C(/2EU"YODNKIH+ORT@:`+'
MY:D-N;#9/7OV(_I6HEE:)=-=);0K<.,-*(P'/U/7M4C01.6+1(2V"V5'..F?
MI0!A"]N=]S:/>S^9%<LB/%$AD=1&C=QM&"W7'3'UID>KW9TZWE\W=)>Q".`[
M%.)=VW/'!X(;TPIK;EL+.?/G6D$F7\P[XP?FQC=SWP`,TUM.@-S!+RJ0$M'"
MH4(&.<MTSGD]\<],T`5]2DG%S8VT5X;?SF96<*I9L+GC((SQZ>M92:K?N+N?
MSF(M+/S5B5%Q,P:5<GC."$4\$5OW=C;WK1FYC654S\CJ&4Y]0:E2"&-BR1(K
M%0F0H!VC.!]!D\>]`'/WM[>6;1PIJ/F><86\YT3]V&D"D#`Q@@G&?3K1-J%^
MLQL8WN)2EPT?GQ+$)'`16Q\^$SEB#Q_#TK7?2;%H3$EM%%&9%E98T50[`YYX
MYJ1K"S>U%JUI`UN.D1C!0?AC%`&$]U>WMI.)IVB5+%W:-/+8.<NN21GJ`#@'
MK5I+RX6ZAT\2$22-'(C!1\L.W+=>O*E?4;Q]:U_LT&"/)CP4\LC:.5_N_3VJ
M)+*-+UKLLS/L\M`<8C7C(7`[D`\YH`IZC//]N\E+Y;&..`S&1E4AN<?-N_A'
M?!!Y'(JJ-0NRGVO[21NNGMQ;;5P`&(!SC=NP-W7&.W>MJ>TM[DH;BWBF,;;D
M,B!MI]1GH:3[':_:3<_9H?/9=IEV#<1Z9ZXH`YT7NI#1C=F_8N=.%[_JDX<+
MG;T^Z>_?T(J7^U-0:_=U#F)+B.'9NA6(!MN<DMOW?,2,=>!@]:WOLMOY7E?9
MXO+\ORMFP8V?W<>GM2&RM3<K<FVA\]1M67RQN`]`>M`&;?H6\00%;K[.PLY<
M-@$_?0]^.U9W]LZG/&MPD,J;((I#&IA6-BP!.\N0P'.!C]>E=)-;6]Q_KX(Y
M>,?.@/&<]_<"DEL[6::.:6VA>6+_`%;L@+)]#VH`P+:.6/59XX[EXGN[B3?<
M"./>`@7:@)7_`&CUSPO&*(]4OY89K@2L?LUM)((D1<3LKNH/0G!"@\>M;\UG
M:W$313VT,L;MN9'C!!/J0>]/6&)#E8T4A0F0H'RCH/I0!E:+=7DL[)<F5D:)
M9`9C#NR?01D_+Z9_,U36WG;48U2^E4M=S?-M0E!LZ#Y<>G4&MZWM+:TW_9K>
M&'>=S>6@7<?4XZTJVMNLS3+!$)6.2X0;B<8SGZ<4`<X^JZE)L2/SLQV_FM)$
M(@'8,R_-YA&%^49V\\]1Q72PNSP1NX`9E!(!R`<>M12V%G,L:RVD$BQG<@:,
M$*?4<<59H`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"H;L%K.=5!),;``=^*FHH`Y*ZT@)IUSY%F_F#3D9`
MJDGSANPP_P!L<<]:D-G=G66?[MP9PRRBS9F\OT\W<%"XX*XS[&NIHH`XF/3;
MN33KJ%H6:<V,B2J+-H_,DP,%G9B)&R."H]>G2K4-@)M3C7["XLFO-VQH"J;/
MLH`RI'`R,8/?BNLHH`Y`6_E60_M*SEDMXHYDMT\DGRB)'P?]GY-F&XX'6NET
MYO\`08$PP9(D!RI`^Z._>G7%C:74B/<VL$SQ_<:2,,5^A/2K%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`%2UDN+BUBGWQ+YB!MOEDXR,^M26<S3P%W`#"1T..AVL5S^E4;<:O;6
M\4"V=DXC4(&-VXS@8SCR^*N:?%+#:[9P@D9W=@C%@-SEL`D#/7TH`LUD+JUT
M$BGGM(5MI91$K).6?);`RNP#Z\\5KUFZ?H]K:('^R6PNOFW3)&-QR3_%C-`#
M+77K2:UM99B8I)X5F*!6<1ANFY@,`>YQG%66U.T6Z^SM(P?=MSY;;-V,XWXV
MY]LYK#7PW<K:Q0,8I`UK'!+FYF105&"=JD!P<]#M^O/%N?3-1GO4=Y8C#%.)
M$S*W*?W=@`&1ZDG..V:`+\.L6,T4DJ3$)&H<LT;+E3T89'S`]B,YJ>TO(;Q&
M>!F^4X971D93[JP!'Y5A_P!@W,EK-`S1V\9";(H9Y&0LKA@0#@QCY<84]^O%
M:>DV4EHLS3(JR2L#@7$DQP!QEGY/Y"@".XUZSBCF,;^8\1&5*LH(W!202,-@
MGG&:D_MFQ\GS?,D_UGE[/)?S-V,XV8W9QSTZ<U4&G:A]B^PDVHMXRNQLL7?#
MAN>,#@$=\GTI+_1[B>[DN8F4GS@ZIY\D61LVD;TY![]Z`+T^L6%O%'))/\D@
M+*51FP!U)P.`.Y.`.].M]1BFF:(\.)&10#G<%`);V'/\O6L^#2[VQ\F2S%J9
M`DB2+(\A`+/NW!CEF(/7.,^W2IK72YK74GO$9"TTK>=\QPR$#&!Z@CIZ$T`+
M>ZY%9W5S`T+DP1QR%L$*0[%>N,<=??GT-2#6;1VBV2`!I&C<2J\;(0A?[I7T
M&><<<^QAO],N+B]GEC,7ES10H=S$%3'(6Z8Y!#'\O?AEUI$\VIBY5H=GG%]K
MY.083'@COR>F>E`&A9ZA;7ID6!V+1XW*\;(0#T.&`.#@X/3BH+#6(+M!O_<R
M%Y%"G.#L9E/S8QG"YQU`IFD6-S9R3&4K'$P`2%)WE4'G)&X#;G^Z.!BJKZ)<
M7-JEI<R1+"CS2!XR=QWAP!C'8/G.>HH`T(]7LI$=UE8*F"2T3+P3@,,CE?\`
M:''O5C[3&T4TB,&$1(8G(&1UYQ_+-9@T^^ED$LWV=)(X&MDV,6!5BNYCE>N%
MX7D>]6[:R>WTV2R4J452D3$\[2.-W'7^?6@".SU0WFH/;1PXCCB5VE.\9+<@
M#*@$8[YS[5.^I6B0I,\P6-PQ#,"``N<Y],8[U'IUE):/(TC(0T<2#:3U5<&L
MY=,>\GU!DS%%RML9(BNUB0SG!P2"P'IGF@#4AU.TF4%9'4EE3:\;(V3T^4@$
M9]:F6YA9)7#Y6$E7.#P1R:RI=-OI[AKYQ;I=#R@L2R,4(1F/+;0>=Q[<>]68
M;6XAL+T3;&EF9W"QY(&1P*`$.MVKVS36Q,NW9@%63<K,`&!(Y'/4<5+_`&O8
M_:##YQW989\MMI*YW`-C!(P>`<\&LY-+O;FVA:X\B.2*%(D"LV&&Y&8D8X/R
M<#GZTVXT?4KF\CDFGC=8I9&4F5N5964#8%`&-P]3QU'.0#6L]1M;XD6TA;"A
M^49<J>A&0,CW%0)K5L7N5D$L?D3>2`8G)D.,_*,?,>O`SP,]#3[6RDAN()&9
M"([40G!/WLC].*K/I]XMX]Q#Y#;+@S1AW(WAH]A4\';C@@C/TH`T$O;:2S:[
M69?(4$LYX"XZYSTQ@YJE/K]G''N03NPD2-D\B0,`QX;;MR1P<''.,5)%9W<>
MFW$:S)'=S%W#J,JC,>,9ZXXYQ^':LU-&U$7$UTS0M*_DE4>X=QF-R<;BO`(/
M8?AW(!?M]=M9;8S.LT>)GB">2[,Q4D$@!<GIG@<=#TJ1]:T]'"F<ME5;*(S`
M*V<$D#`'!Y/%9LFAW6Y)%*.\,TY0+<R0[DE??RR#((/&.0?Y*^@W'V+48$:%
M3=6:0)\S$!AOSDG)Q\XYR3UH`T;C5[>*Z2V3<\K2K$?E8*"?]K&"1Z9S4.KZ
MXFF/(A@DE=+9YQA6"G;VW8('?]/44TZ==K.(X_(-L+K[3O9VW\G)7&,=3P<]
M.,4:[IEU?K(ML8<2VLD#&1B-I;!!&`<\CVZ_A0!:75K(PRR^8X6)@K!HG#9/
M3"D9.>V`<U8MKF*ZA$L+$KG'*E2#Z$'D'V-96H:--=7MS<(Z_,(3&HE>,DIO
MR"R\J"'ZC-6K"RFLK"=46-;B5FD`,SR#=@`9=LD]!S@?2@!;;5$FN;J)D*)!
M\RR9R)%!(8CZ,"/R]:$UK3WA>83D1HJN6,;`%6.`1D<CW%5&T!8##)9RN951
MHI#/,[AD9><`DA?FVG@=J=/I4\L<2J\>4@CC.2>JNK'MZ`T`7(M4LY615E(9
MY?)"M&RMOVEL$$9'`SS39-9L8X]YE=AN=<1PNY&PX8X`)P",9Z55N],NFO3=
MVYA9TN5F1'8J&`C*$$@''4GH>E5QI&IK;>2)X]KO,T@25D`WN6!R!DX!QC(^
MM`&O:7J7<LZQ@%(RNUP<APRA@?UK/CU_?IE[=-:E)+:0QK$7'[TYPN#C^(\?
M7-3:%ITVFVWESM&S>7$GR$D96-5/4#N*JIH<XF@8RQA%WF51GYSN8Q]NV\D_
M04`6[76[6>"T>0F.2XBCD*A698]X!`9@,#KQG&:F.JV?GM")6+KN'$;88@$E
M0<8+#!X&3Q6+:^&Y[=8HV*2*R0B4_:I4"E$53A%P'!V]\?CTJS;:'+!?*WRM
M`LSS!VN)2<L6.!'G8#\W7GZ<YH`FL_$-K<6Z3R_N4>**3#!]P+D@#&WID<$$
MY^F";0U>S,"R[Y,,Q0+Y+[\CKE,;ACW%9%OH%ZB6ZR/;CR4M(_E=CD0R%B>G
M<$<>OYT^XM9M,U&7457S7EF?;&L<CC8R1@YV*<$&/Z'/6@#96^MFL1>B9?LS
M*&$G."#TJE=:Y%'#&UK$\TLDPA$;QR)M;&?F&TE>/;].:;%I\\_AVUMY<17*
M".3!'`=6#8..V1BE73[N6Z2[N/)23ST=HT<LH558#!(&3\WH*`+-]?O;SPV\
M,<;S3!F7S9/+3C&1NP>>>!CUJL^O)#/#'=6TT.^*21OD9V4HP4C:H)(Y)W=,
M#WJQJ5M<7&WRXK6YAP0]O<C"L>,'=@XQSQ@YSVJG9:-/;3Q.7BV);S1!%)PF
M]U957/\`"`,?T]`"[)JUE%(B-,?G*@,J,4!;&W+`8&<C&3WI/[9L2)"))"(W
M,9Q"YRX)!5>/F.0>!FL@:'JGV2VM7N(C%`D`7$SJ`4"Y&T#Y@2"<D]^G%6)-
M$F:SC7<K2Q7<MPH69XPP=GXWKRIPW;/XT`6)=?M(KB%?G>&6%Y/,C1G(*LH(
M*@$]SGTQS5E]5LDF2(S9+;?F5&*C/3+`87/;)&:HV6CSP7$<K&)<6\R,HD=S
MN=U8?,V2?NG)./H*@L]#O;73_L(:!HITB$TFYMR%8U0[1CY@=G&2,9[T`75U
MVW$#23!D?S)46-0SDB-RI8X'`X')X&>M.MM;M9;>T>4F.2XA24J%9A'N'`9@
M,#TYQFJL.EW]IO>W-M(\C3AED9@`KR%U(.#R,\C'/KQ59/#DZV\,#E)%:WBB
MF_TJ9%!50IPJX#@X[XH`U3K=@-V))6VR&+"P2-N<$@A<+\Q&TYQGIFKL,T=Q
M"DT3!XW&58=Q60VD3BP\GR[>9Q=2S`-(\>`S,1M=1E6PWH>X]ZT;"*XM[:.&
MX<2E5YD+DDG/3IS@=^IH`M4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%(2%!)(
M`'))H`6BJMKJ5C>.4M+VWG8#)6*56('X&K5`!1110`4444`%%%-9E7&Y@,G`
MR>IH`=13&FC65(FD02."50L,L!UP.^,BGT`%%%,:6-)$C:15=\[5)Y;'7`[T
M`/HHHH`***CBFBF#&*1)`K%258'!'4?44`24444`%%1QS12,ZQR([1G:X5@2
MIZX/I0TT22I$\B+))G8I8`MCK@=Z`)**:[*BEG8*H&22<`4Z@`HJ.2:*(H))
M$0R-M0,P&X^@]3Q3Z`%HJ"WO+6Z+BVN89BAPWEN&VGT..E3T`%%%%`!1110`
M4444`%%%,:6-)$C:15=\[5)Y;'7`[T`/HJ,S1+,L)D02L"RH6&X@=2!^-24`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`5%<_\>LW^
MX?Y5+10!R6C6EW<:-I5U((H8K2V9HVCD+/)E".?E&T=^I[4EM*R:?H[WUY<1
MV=S;^9<3M<NO[S:NT;\Y4'G@8R17744`<5>WVH#3[-O-N_M#1R"<1D@K;[L"
M7'9\8QWY-7+R>X758K"UN9F@U'RI(91(Q*(O,F#G@$!?Q8UU-5Q90"]-YL)G
M*[`S.2%'H`3@=!G'6@#*UDR2:Y86XGGCB>WG9UBD9-Q`7'0]LUBQW-^=.C>*
MZNI)KK2))F_>,3YB[<%1_">3TQGZUV]%`'&76I2W<ET;/4]D8L(6$FYFC#;S
MN)*\KQP6'(]1BHQ.+JTT^2Y>58X-3"F87;/'M*'E9."1G`R23G(SSBNWHH`Y
MW7W@3Q!I1NIV@A,-P&=7*8X3JPZ?7(K)FOM3:VLQ<W!@1H)#'+).T)9PY"$E
M5.YMN#M/7)ZUW%%`&+K$ETN@1.;F."?]V97RZ(?[P+``H#Z\8]JS+&^O)!IX
M1IMV+H`--YJR[0"I#<;EYX)Y]SUKK:0@,"",@\$&@#@I+^86<;0ZA<M,=+FD
MG'GL=DPVYXS\I!SQV]JO75SJ%K]NCLYYI6^QV\OSN6*EF(=AUQ\HSQ]<5T5G
MI-E8R>9;Q,K!=B[I&<(O7"@D[1[#'05>H`XQ;N<11>;?XTQKT*\L5U(^Q-A^
M4S$*2-^.0>,XSVK3\-R"/1[Z2/?(%NKAEQ]YOF./QKH**`.`DU.Z_L_49(+Z
M7:VGI,-LSL8Y"^&^8]".X&`/2K][<75K=ZE;1W-Q]F26U:1VE8M&CD^80Q.5
M&!VZ<XQ7844`<_X<*?:M9-NYE3[2-C,V[=^[7'/?ZUDVER6OM(GDGFFO@EPU
MQ%N+%'V?=`/"GT%=M10!Y]-<R7EA?*;J22![&.X*^>[;'W_-DD]AU`P!Z5I/
M>79U?RX+I`BRPBUW7,C>;$0,D(`WF9YRY/'J._7T4`<4)_.U&Q-Q<R->C56$
MD+2'$:`/LPO11C&"!SGO73S3VVH:--*DKFVEB<>9&K;@,$$@8SG\*O44`<'I
M]QJ5I;7L-K-:ZB8;$^1>6Z`R(!C"-[\D[3SQ5AKV_&FRR074<EH980SI=R2;
M%.=Y,I3('3.,[>>E=I10!BZ/+<-HMP\LZR@-)Y,B2-)\G;YV4%L'//<8Y-8A
MN+N+3-(=KE_*N;;S)IIKR2/,FU=OS`,1W^7&"?7OVM%`'(WT^J0QV:>?(\NI
MVR6^]"RB.7(RX!P5)4L>@^[1%<W_`/PD#0FY"21W018I+A\M!M_YYA2#Z[R>
MO&:ZZB@#BTDN!X5TRY;47628AI6N+B1%D&#@&0?<[>F2.<TVZU&^EM['S)9+
M6)[9RCS7+1EI0V`=RH=YQR%(YST-=M10!BZQ)=+H$3FYC@G_`'9E?+HA_O`L
M`"@/KQCVK,L;Z\D&GA&FW8N@`TWFK+M`*D-QN7G@GGW/6NMHH`X$W4VVUN+.
MXEGOQIDS298NR2_)N&#G!!S\O;`XK;T34?*2:6XNXGM&:)(BDTEQB1N"-Y4=
M21QSCVKHZ*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
=**`"BBB@`HHHH`****`"BBB@`HHHH`****`/_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>proxycardx2x1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxycardx2x1.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#`!`+#`X,"A`.#0X2$1`3&"@:&!86
M&#$C)1TH.C,]/#DS.#=`2%Q.0$1713<X4&U15U]B9VAG/DUQ>7!D>%QE9V/_
MVP!#`1$2$A@5&"\:&B]C0CA"8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C
M8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V/_P``1"`0A`R\#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#T"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`*9(',3B,@/@[2?7M3Z;(I>-E#%2P(
MW#J/>@#SRROK;3HF@\4Z7=)=O(V;\KN//3#CD=_NYZ5IZI:6LGQ"TC,$+K+"
M[OE`=Y"M@GU/`Y]JUKW0[K4[46>HZ@LUJ&#,$@V2/@\`MN(^N%'X4EUH-Q-K
M]KJD=[#']E4I'$;<D;2"#D[QD\GTH`R["PM+_P`;ZZEY;0SJ$CP)$#8^4=,]
M*RKR\G?PQXETZ:5YDL;E%BD=MQVF487)Y.,?K74KH=W!K5]J5G?PQM>!04DM
MB^W`QP0XIL_A:!]`NM,BN'5[IQ)+<.H9F;<&)(&/3%`"^';>V2"UD31/LLGD
M+_I.R$;N!W5BW/N*H^/0&BTD-'YJF^0&/`^;VYXY]ZW-.M;ZU2*&:[MI88D"
M`);LC'`P.2Y'Z5#K^C-K"VFRY$#VTXF4M'O!([$9%`&-X>`M?%^I0>6;".:-
M9(K$@=@`7&W*CH>A[^U=?61:Z,RZPVJWMPL]UY?E)Y<?EHB_0DG/7G-:]`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`444A(`))P!U)H`6BJ=OJFGW4ACMK^UF<#<5CF5CCUP#2VVJ:?=R^5;7]
MK-(1G9',K'\@:`+=%4XM6TV><00ZA:23$X$:3*6)^F:ECO;66X>WBN87F3[\
M:R`LOU'44`3T53BU;39YQ!#J%I),3@1I,I8GZ9J9;JW>!)EGB:*0@(X<%6).
M!@]\GB@":BJ*ZSI;RB)=2LVD+;0@G4DGTQGK5DW$(A\XS1B+^_N&WTZT`2T4
MQI$618V=0[YVJ3RV.N!0LL;2/&LBF1,%E!Y7/3([4`/HJM+J%E#;I<2W<$<,
MG*2-(`K?0YP:L*P=0RD%2,@@\&@!:*KI?6DETUJEU`UPO+1+("X^HZU"NLZ6
M\HB74K-I"VT()U))],9ZT`7J*C,\(B$IE01D@!RPP23@#/UXJNVK::EP;=]0
MM%F#;?+,RAL^F,YS0!<HJF=5TX7/V8W]J)]VWRO.7=GTQG.:FNKNVLXQ)=W$
M4"$[0TKA03Z9/TH`FHJ"&\M9XDEAN89(W;:C(X(8^@(ZG@TY[B",R!YHU,:A
MGRP&T'."?0<'\J`):*KQWUI-`)XKJ!X68()%D!4L3@#/KGBGK<0-$TJS1F-2
M59@PP"#@@GV-`$M%4I]7TRWE:*?4;2*1?O(\ZJ1]034KWMK'<I;27,*3O]V)
MI`&;Z#J:`+%%5WO;6.Y2VDN84G?[L32`,WT'4U,[HFW>RKN.T9.,GTH`=15=
M+ZTDNFM4NH&N$Y:(2`N/J.M+<W=M9H'NKB*!"<!I7"@G\:`)Z*AGN[:W@$\]
MQ%%"<8D=PJ\].33DGAD"%)482#*$,#N'MZT`2457GOK2W5VGNH(E1@CEY`H5
MB,@'/0X(-1C5M--N;@:A:&%6VF3SEV@^F<XS0!<HJ"*\M9X5FAN89(F;:KHX
M*DYQC([T]YHHR1)*BD`$[F`P"<9_.@"2BH;FZM[2+S;J>*"/.-\CA1GZFH1J
MVFFW-P-0M#"K;3)YR[0?3.<9H`N45%;W,%W$);::.:,G`>-PP_,56_MG2S+Y
M7]I6?F;MNSSUSGIC&>M`%ZBJYO;077V4W4(N",^5Y@W_`)=:==7=M9QB2[N(
MH$)VAI7"@GTR?I0!-154ZE8"U%T;VV%N3M$OFKL)],YQ3[6\M;U"]I<PW"J<
M%HG#`'TXH`GHJI%J>GSW'D0WUM),"1Y:2J6XZ\9S21ZKITMP+>._M7F)*^6L
MRELCMC.:`+E%4VU;34N#;OJ%HLP;;Y9F4-GTQG.:E-[:BZ^RFYA^T$9\KS!O
MQ].M`$]%4VU;34N#;OJ%HLP;;Y9F4-GTQG.:F^U6_E22^?%Y<1(D?>,(1UR>
MV.]`$U%4)-:TJ*1HY-3LD="596G4$$=01FGMJVFI<&W?4+19@VWRS,H;/IC.
M<T`7**J#4[`W7V47UL;C.WRO-7?GTQG.:M$A02Q``Y)/:@!:*K3:A9001SS7
MEO'#+RDCRJ%?C/!)YI8+^SN87FM[N":*/[[QR!E7OR1TH`L451CUG2Y7V1:E
M9NV"=JSJ3@#)[^E6VEC4H&D0&0X0%A\QQGCUX!/X4`/HJE!J^FW,RPV^H6DL
MK?=1)E9C]`#5C[1#]I^S^='Y^S?Y6X;MN<9QUQGO0!+15:74+*%'>6\MXUC;
M8Y:50%;T//!]J8-6TTVYN!J%H85;:9/.7:#Z9SC-`%RBJ/\`;.E^5YO]I6?E
M[MN_SUQGKC.>M2V^H65T`;>\MY@25S'*K<XSC@^G-`%FBHDN(7B25)HVCDQL
M<,"&STP>],>_LTNEM7NX%N&Z1&0!S^'6@"Q114`N[8Q"47$/EEM@?>,%LXQG
MUSQCUH`GHJ"2]M8IT@EN84F?[L;2`,WT'4T/>6L:2O)<PHL)Q*S.`$/HWIU'
M7UH`GHJM/?V=OGS[N"+:H8[Y`N`3@'D]":9#JNG3D"'4+60E@@"3*<L<X'!Z
MG!_*@"Y15>>^M+8L+BZ@A*`,WF2!=H)P"<^IJ)=7TQXGE34;1HX\;W$ZD+GI
MDYXS0!=HJ"UO;6]5FM+F&X53@F*0,`?PI;FZM[.+S;J>*"/.-TKA1GTR:`)J
M*K1W]G-$LL5W`\;OL5UD!!;T!SU]JE$T33-")$,J@,R!AN`/0D4`24444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`5'<
M?\>\O^X?Y5)2$@`DG`%`&!9V%S/IUA/=7,+1V\(DB2*`H<F,KRQ8YX8]`*AM
M1=HNB_;IH6M"J&-HH2K+)L^56)8\$$\C&3QQFM.RUJ&]&^*WN?(*,Z3%`4<#
MKR"<'V;%$>MPSPVSVUO<3R7$(F6)`H94/=B6"C\_6@#.T#4!Y%I`=6TUOEV_
M9E7$W^[GS.O_``&F6$L/VFPMX9XIUB<E;:1<7-L<')8@]LX.1SGJ:TY]>M+:
M2RCN$GA-X[1IYB;=K#^]GU/0C(-*NN6S3^2$EW?:S:9P,;PN[/7IC_\`50!G
MZ!J`\FT@.KZ:PV[?LP7$OTSYG7_@-95E&]CH6CHBLUM=S6K#`SY<GF*3^#`9
M^H/K700^([&>T:XC$I"W(MF3`W*Y;:,\].<U.^K())1#:75Q'"Q226)`0I'4
M8SN;_@(-`#(O^1JN?^O*'_T.2H-&N]/NM-CL&N;:61E97M_,4L1DY!7K6G=W
M+6T'FI;37'JL94$#&<_,1_C5&WUZ*:&SE:TN8H[R14A9]GS94L#PQP,#OSS0
M`FB6Q5YY9I6FDB<VT;-_#&IX'U/<]\#TJM/$\.L7NHVZEI(/+$B`_P"LCV\C
M'J.H^F.]79M<MH9KB)DF+6\T4+8`P6DQMQSTY&:6+68)[U[>&&>54E,+S1J&
M1''4'!R/J1CWH`R-!GM[*TLY[^1(8VL(5AEE8!!P=R@GH>1]>/2M73D<Z==?
M9P8TDDD-N"-N`>G'89R1[&IM0U);&6VB^SS3RW+%(TBVYR!D_>('056/B"`K
M`([6YDFFE>'R5"!E=1D@Y8#H/6@"HUQ92Z;:V-IM^VQM&5@!_>Q,&&XL.HXS
MDGK[YJ]%_P`C5<_]>4/_`*')0FNVQA=GCFCF2;R#;LH,ADQD`8)!XYSG&*<=
M8C6"Y=[6Y6:V3S'ML*9-O.",,0>AZ'M0!D3I?#1(&:XMS;?:H?W8@8/CSUQ\
MV_'_`([4UGJ`@N[B%M7TV`?:Y,P2K^\Y<]_,'7M\OYU</B*S:.XDMXYKF*WB
M6622%05`;G'7D@<D>GY5;@U*"XOC:P!Y"L2RM(H&Q0WW1G/4CGZ4`8-VMY_9
MU[NEA_LYKJ5;@+$?-2/<=S!MV..O3@9[BKWB281+I<RW,$`%X")IN47]U)R>
M1_.K,VN6L(NQ(LHEMG6,Q8&YRWW=O/(/;Z&G3:ND<LD<=M<7'DX\]H@I$7&<
M'+`DX.<+F@#(MY5'F7CS030K?K+)=0@B,CR]N>IP!P"<FGW,EM=W-[>"8M:'
M[,JW$($BJZ.[9/4%067)[>V,C8@U2VN+U+:$LYDMQ<K(,;2A.![Y_"GZ;?Q:
ME9K=0*ZHS,H#@`_*Q4]/<4`<[+/Y\4C>9;W/^E6>;NW!"2GS1QC)&1CD@]QZ
M5`B/9:7=7,:N\%W<S1S*HSL?SF"O^6%/X>]=!9:[9WWVWR/,_P!#)#Y7&X#/
M*\\C((_"F6FO17+6F^TNK=+P9@DEV;7XW8^5B0<>H%`%)-0%KJ-^C:OIMJOV
MG)BN%^<_*O.?,'\JBU&:&&6^6.>-FE?<]C.F'G;"X,3`@]`,'G'MCC5T[5SJ
M*1RP:?=B"0D"9S&%X)'3?GJ/2K%Y?I:O'$(Y)YY<E(8L;F`ZGD@`#(ZF@#"U
M&:*&6^1)HR\DFY[&=,23-A<>6P(/88/.#Z8XV=4ZV/\`U])_(TCZM'$L'FVU
MRCSR^2(V0`AMI;UP1@=02*:FMVTEG8W*)*PO9!'$@`W`G.<\\8P<_2@#*M9H
MOM-K!'/%/LFW?9)4`N+=B3EB5/0!N<CD=SFKVL2107\$S7B64HC94EGC#0L"
M5RI)(P>!W'XXIT7B.QDFL(B)4:_#&$N!C@XP>>I[5(FMV\D0:.*9W>9X4B51
MN=D)SCG`''4D4`9]E/!;M9W5XB6MN(I$C=B1&K;^H+?=W#D9[<5+N$\UHVD[
M+=3+*0\L)9'XY8`,.">_XUK6ET;E&+6\]NZ-M9)E`/X$$@CZ$U336&?46L?[
M-O!*JJ[$F+"J20&^_P!.#[^U`&--)-;7%T]Q=VL4JZE'NG>,K$/]'7JI?\/O
M=?RJ[-J,+16D\^J6%PD=V-TL!"(@V-@'+MS^-7$URV?3[6]$<WEW4RPH,#(8
MMM&>>F12VNL&[D<6^G7;QI,T+2YB"@J<$X+YQ^%`&9<RK/>SWUH1+8AK8M)$
M=RLRR-N88ZX4KD^WM3]2O+>Z%Y<6\R2V\<$8:9&!3/F9(W=.!U]*V;F^BMKJ
MTMW5R]T[(A4#`(4MS^`JNVMVJM.I64O#.+<(%!,CD`@+SZ'OCH:`*FK:G:30
MVLUIJ5D!'=+NF+AT3*M][##^8IDVHPM%:3SZI87"1W8W2P$(B#8V`<NW/XU<
MEUR"WM;J:XAGADM4$DD#!2^T]",$@YP>]6-0U"/3[1;AXY)`SJBI'C<2Q`'4
M@=3ZT`5=.D2YUB\NK1UDM'AC7S$.5>0%]Q!'7@J"?\*G'_(?;_KU'_H1J*77
M(+>VNI;B">&2UC$DD+!2^T]",,0>A[TLVKFVLI[NZT^[@BA3>2QC);V&USS]
M<4`94DMN/#LNGNR'5"K#RL?O#/GAP.N-V#NZ>]6_$<K01Z5(UQ!;LMX,RS#*
M*?*DZ\C^8J[;:JLUZMI-:W%K,\9D02["'4'!P58],CKZTZXU)(KEK:&":YF1
M0\BP[?D4YP3N(]#P.?:@#GS<;%>Y^VV0#:@K_;`I\ACY1'3=VQCANM=!I=V+
MJ%S]OL[TJV"UJ,!?8_,W/XU`VNP-);1VMO<737,;2((@JX"D`YWLN#D]*NO/
M(MJ)A:3,Y`_<@IO'XEMOZT`96GV5U=6EMY]S%]FCE\U42$A\J^0"VXCZ\#-4
MG6[^P67VJ:'^SC<*7,<)$D>'RN6+$8W``D#O^(T8O$4,ED+MK*[C@:40JS>7
MRQ?9T#'H?\FI[[6[:Q>[65)2;6!9WV@<J21@<]>*`,ZSU`07=Q"VKZ;`/M<F
M8)5_><N>_F#KV^7\ZCGEA2=X$GC8M=[VL;A<3%M^=R%3G'&X'!&...VK-K4$
M=[):QPSSO#M\[R5#>5NZ9&=Q_`''>IM2U!-.BB=X99FFE6%$BVY+'..I`[>M
M`&19Z@(+NXA;5]-@'VN3,$J_O.7/?S!U[?+^=95Y&]GH>LW42LT5Q+=1SH!G
M#>8P5_Z'VQZ5T+^(($C.ZUN?/%PMLUOA-X=AD<[MN".^:D76[95N/M$<MM+!
ML#Q2!2WS<+C:2#D^AH`2?_D:+/\`Z\YO_0XJH6>H""[N(6U?38!]KDS!*O[S
MESW\P=>WR_G6DNK+^\22SN8KA(S*L#A"\BCJ5PQ!Z],YJ!/$=G.CO:1SW02W
M%P_DJ#M4]%Y(^8X/'M0!0N+NU?2=3L$GB:^DEG6*!7'F;RQVD#J.<'/;K6KJ
M_GO8I:0JDD]P0A#L54KU?)`..`1G'4BI+?5;:ZNH8+?=+YL/G[UQM13TSSU/
M;Z&HY]86*]GM4L[J=K=%>5X]F%#9QU8$]#T!H`IV;31:9J5C<HD<L"NRJC[A
MY;@E<'`.!RO0?=K7LO\`CRM_^N:_RJF==L1YK;V,45LMT9`,J4;.,=\\>E.A
MUB)[::XN(+BTCA02%IE&"I&<@J2#],Y]J`*+?\S-]?\`VW2FRI?+>Z*;JXMY
M(_-;:L<#(0?(DZDN<_E5^36%AMYYKBRO(4BB:;+(IW*/0@D`^S8--AUJ-Y8H
MYK2YMFFC:2+S=A$@`R<;6.#@]\4`9OAC4`UCIMN=7TU_W"+]F1<2_=Z9\P\C
MO\O8]*35G^R>))-1"LWV2UA9PHR2C/*&'Z@_\!K3LM8>^MX[B'2[SR9$WH[-
M$,C&1QOSST_'G%1+X@79>2/I]Y&ED&\YF\KY2%W8X<Y.".GK0!D*K6`9I)X+
M:4WL<DLLPRBNT1+$\CN<=?2KMYJ`DM+:;^U]-D,=VO[]%_=Q_(WWAYA_]"%:
M<FJQB4106\]S+L61TBVYC5NA.2/0\#)J+_A(+`W5C`'?-\K&)BN!D=0<\@YX
MQCK0`B78NM(O3]OL[TK&PW6HP%^7H?F;G\:9-UTC_=;_`-%&IFUNU73+B_*R
M^5!(T97`W,RMMP!GG)Z4DFN6ZV-C=10SSK>L%B2,*&R03SN(`Z'O0!AZ4CV&
MF:-"%=K:[,$B$#B*3`+#Z-R?KGU%6)[I;;1FM8WM?[0&]GM9HR[SODGY0&!Y
M/\7/Z5I-K]M'%,\\%Q";>1$G1U4F(-T8X)&WW!-7+>^BN;NXMX@S?9R`\G&W
M<1G:.>H&,_6@":.5)&=5=6="`Z@Y*G&<'TX(-<5$EW_PC]LQFA^S?VF,1^2=
M_P#Q\'^+=CK_`+-=3-K-K!K$&EOO\^9=P('RCK@$]B<''TI)-9MXX=1E*2[=
M/)$N`,MA0WR\^A[XH`QQ+;6]AK%KJ&TW<\LI\LCYYP1\FT=6XP..F*HW%E<2
MZM!I-U&S+J$$,MPW;=&I#?F0E=%-K1BNH8!IMY(TX+1%3%AP`">KC'7OBGMK
M-ND&H3-'*!89$HP,GY0W'//!H`XU))I]&N;VY81RPSVMH7DY4&)AN8].,L>_
M:NAOI#J>BW7DZA97US;%9X_L@QM93N`/SMUP1VK3?5H_-,4%M<7+JBO((E7]
MV&Y&<D9/L,GVJ)]<@,EJEK;W%VUU$98_*VCY1C.=[+CKTH`YR[F%[HUSK6Y8
MQ=7L(B:0<)&C@`GIQG<>W6KVL7GVO1]L>I6%Y*MU!AK9>$RXQN&]L_F*U4UV
MWE6W\N&=I)WDB6+"AE=`2RG)QGY2.N/?O3$U[>+HC2[[_1,B7_5$@A=V``^2
M<$=*`*=G=K9:OJ=QK$BQW$,*9:.,B-X03A@,DDY)!YJ;Q;)Y5MI\GG1P[;Z(
M^9*,JO7D\CC\15U=1L]0ECM(PTZS0B8LI^54/3=SGGT]C3;S5S:7L5J=.NY&
MF8K$R&+#D+N.,N".`>N*`,FSMTU:368IIH;F.98V6[M1M0,`<;1D_,I`.<GJ
M*O\`A1&DT>.^F<R7-[^]E<]ST`'H`!BK,NKHDLB1VMQ/Y.//,04B+C.#EN3@
MYPN:NP31W$"30N'CD4,K#H0>AH`DHHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`I&SM.`"<=#T-+10!R.FZ#<6FIF>T
MM9["!TD$]NTRO$[$8&S!SUQR0.*L:=IEYIUO`[VLLQDL8[>:*&55D1EST.0/
MXCR&R,<5:TW6Y;O6)[>5(UM6W_97`.Y_+.U\_B>/:I].O+_4((;V,6RVLQRL
M3!M^S/#;LXSCG&W\:`,G^PKR\%C%?K(T:M<ERTV]HE<?(-Q.21QTSTIFDZ/J
MT/DF^0/*FJ-.\@9?F3RMN_KW/;K[5J6MSJCZW-92W%F8X(XY&9;9@6#%N!^\
M./N]>>M)K.KW%A<SQQ)$PCL);D;@3\RD`#KTYH`Q/^$:U".*TF@C"2F[S=1;
ME^:,3%U;KC('XX-:-QI]_#IUU86T$[,\LDEO<PW/E!"Y)^?#`\$GC!!P*?IG
MB.34+G38?*2-IUE%RC`[HW0+P.>AW9Y[8JQXBU>XTQ85LH$GF;=(Z-GB)!EB
M,=^@'UH`TS&YL3&?FD\O:>>IQ6"='NI='T"UDB=6M9$,X27:4`1@<,"#U(Z&
MM*:_FGO(;2P:(-)!]H,TBEU5<@#Y01DGGOVILU[>QRVEEMMQ>7&\EQN9%5?X
ML<$GE>,]^O%`&5+HEVD]^(8G:.2\MI8VDFWLRIMW$EB3Q@]?PI)M#N&U];^S
MMI[*?SPTLJ3JT,L>><C[V2.V,<]:UKF^O;;[+:N+=KRZE,<;J#L`"EBQ7.>W
M3/XU3U'6[S3K6_CE%N]U:QQRK($(C=7;;RN[((P>]`%K6;"YO+_3'MW>)897
M:26,KN0%"!@,"#SQT/6JMWH'[_3DA,[QI<237$WG;)"60C=D$'K@<?RIKZ[<
MQPWS13V5^L%H\ZSVZD(KCHC?.V<]>#5RWOKR&\LH+UK>5;Q&*/%&8]K`;L$%
MFSD9YXZ4`9UMI%_;I$3"));*\,JR%QNNT*E<DYX<`]^N*N2)J)N+K4HK)EF-
MNL$%N[INSN)+,02N.>Q/`HTS6Y;S69[:1(UM6W_97`.Y]AVOG\3Q[5GV/BNX
MN;&!I(8DNFO(X77!VF-VP&7GV(^HH`O^']+N=&\RQD`GM9%\WSL*,2'AE*^A
MZCVXJ;PUIK:982Q/`(G:>1L`@Y7=\O3_`&<46E[?Z@/M5I]F6U$K1B.16WL%
M8J6W`X'0X&T_7GBK'K4TNIW=L^HZ;:>3<>4D4R$R2#`.?]8.N<=.U`%F]TPS
M^)=/OA`K1PQR!WR.&XV<=^K?3-,2"\TZXOQ!:-=+>2F9'5U4(2H4AMQ!QQG@
M&K>I7TEE=6`VJ8)Y3'(Q!RORD@C\16/IWB2[O(HE>&&.>:[2-!@X,++O#=>N
MT'VS0!-:Z9=:/<64L4#7JQ60M7$3*K!@<Y^8@8Z]\U/9V=]IGA9K>",27P1V
M5%88#LQ.,G'3/Z56;5]4?2K"^B>S3[3*D+(T#-@L^W(.\>W'ZU:;6A9ZPUCJ
M5U9Q*MLLHD8^5N<LP(&6/&`.*`*,&BZCI[VXC:*XC-HUK)Y<?ED<95F)8[CN
MSTQ]XT:7HUWI\ND2F)YE2$1SQ2S;_L[[?OIDX'<$#MTK4T>]N=4T"WN\PQ7$
MR;L["R`Y],@_K6:VLZG#HM[J,LEFPMY6B""!ER5D"[B=YXQGC]:`%\.V,]A#
M;Q7%AJ"2H6W/]K!A&2>=@DQT/]WK6C?VTZ:I!J,$37`2%X'B1@K88J<J20.,
M>HJA?>)56YN4T^:TN8X;"2YW(V_#J0`#@].?K5S1M0>^8$ZIIUR3&&:*V3#K
MTZGS&X[=*`*%OIFHF>VDECE\M+_SECFN/-:*/RBO))/\1Z`GK4FG:1=P:_(T
MR*+"W>26U.0<M)@GCJ,?,/\`@56)K[4GOM1CM6M1'9A"$DB8M)E=Q&X-QZ=#
M5*]\33):W%Q:I$(ULX;F/S`3@NY!SR.`*`*\?ARYN(M/AN8O+$-K*AD#*3%(
M7#(1SUXSQ4ND:5J=E#:7=S")+N&2?S8E=1O60YRIZ9R!P2.#VJ=]=N8X;YHI
M[*_6"T>=9[=2$5QT1OG;.>O!J2VUS%E->2ZEI]VL-N9G@M4PXX]?,;Z=*`+.
MB07<4UY)<)/%#(ZF&*>X,K(`,')R<9/.`34D5K,OB.XNRG[A[6.-6R.6#,2,
M=>XI;8ZJZ!Y7LP)(\@*C9B;'&>?G'_?-9O\`:FJQV^KS22V;C3MX"K;LN\B,
M,#G><#)Z4`5(/#US'I.F#RYOM4-XDDL9N6**HD))"[MO3T&:L:78SV=S,9]/
MU!F:[DD5XKL"+:7)!*>8.W4;:O0W][?W$T5D;>,6ZIYC2HS;W9=Q48(P,$<\
M]>E4)/%31W&ELT"K;72O]H/),+*P3KZ!C@\4`:&LZ=)?W^F%5<PPRNTK1RF-
ME!0@8((/7'2LZ+1+NWNI;B*-F\F_\^)))MS2H8PI^8DG/7&?2M72]2>ZT^XN
MK@(HAFE3Y!_"C$=SUP*JIJUXME:ZG,L'V.Y,8$2J1)&'("DMG!ZC(P/KZ@%?
M5=.OM3M]1G6V:*2:T%O#`[KN/S$DD@E1UXYJ?5/MM_IR1QZ9<H\4T,FUWB^<
M*X)QASV'?%-TO69KZ]EBDU#3HV2YDB%KL/FLJL1G._K@?W:M:[=W]C''-:2V
MP1Y8XBDL+,<LV,Y#CUZ8[=:`,_5=-O=3BU*Y6V:*2:S%O%`[)N)#$DD@D=^.
M:6[L9[C1+^TM[#4(YI8=J_:KL2!CZ#,C8_2K1UK[%J[V.IW=G&JVRRB0_NMS
M%F&`&8\8`K/A\27,T.EM+<V%D+N!Y7DG0E00P``^<>OK0!?L=-GL-<,@1[BU
MEAP)992[P,,94%B25/7ZBI?)N;#5KRZAMGNH[L(<(RAD91CG<1\N,=.>O%27
M-]+;^'KB^2:WN9(X'E62-2(WP"1QN/'XU0L-?>2[CCDNK*\C:W::1K52#"5P
M<-\[9SD^G2@"&U\/SK>V)N`^Q(IVE:&=H]KNX;:"I#$=?RKI8T$<:QJ6(4``
MLQ8_B3R?J:Q4U:\6RM=3F6#['<F,")5(DC#D!26S@]1D8'U]5NM;FAU^.T2*
M,V2LL4\I/*2."4`_(?\`?0H`J-I%X_AB*R,)$PO/,91(`0GG%LY!_NG/!S3-
M2T*Y)U9;2.61+BS2.,RW!<LX9B1EV)'!'M2W/B&ZCFU%4N+'S+68I%:,A,LX
M`!X^?J<D?=/2KSW^IRWFH+;&U5+-481R1,6?*;B-P;`],X-`&?KVASWNHM=6
MEK/;WJA1%>0SJ%(']]3@C'L#GBM77K&YO8;%+<L'CNXY'D3:"BC.6&[C\,&G
MSZPB:"FIQ1[O-1#&A.,L^`H)^I%,>^O+*ZB@O#;R"X1S&\2E-K*-VT@DYXSS
MQTZ4`5-0T$M'`(6GN))+Z.>YE:0(Y4`C.5VXP,#Y<5"-$O5%S!CS/+NHKJWN
M))-S2A6SY;DG/'0'ITJUX=U:75(H9)=0T^1WBWO;0(1)'TZ_.>F?2GS7VI/?
M:C':M:B.S"$))$Q:3*[B-P;CTZ&@!)%OI[\:D+"2-K:W=(H)'3=*[;3U#$`?
M+W-1>']+O-'N9$D`FBNQY\TB[1Y<W<8ZE3V],>]07OB:9+6XN+5(A&MG#<Q^
M8"<%W(.>1P!4CZ[<QPWS13V5^L%H\ZSVZD(KCHC?.V<]>#0!<\/Z:VG?;]T(
MC\VZ=H_FSF/^'OP.O%1/'>V^MZA/'8RSQW,,21NCH`"N[.[+`X^8=`:9;:YB
MRFO)=2T^[6&W,SP6J8<<>OF-].E7K8ZJZ!Y7LP)(\@*C9B;'&>?G'_?-`&5:
M:+<V8EB>WCNXQIT5OAGVK*P+;AW(Z]<54L/#=U':ZC;0?:+6TFC7R8+J57VR
M!MW&TD!>@]36C%JU]"NISWLML\&G,598H&5I,(&X)<@=<=#5E;Z^MI+-KX6[
M1W;B,+$I!B8@D9)/S#C'04`-U$ZAJ&E7MJNG-$9+9T!>5,LY&`%`)X]R1]*J
M0:/=66H0RQH]Q!):F)A+,7:W?'52S=&Z$#T':HM-\175VEHYGL9Y)I=CVD*$
M2QKN(W$[SP`,\@5-;>(GN-?ET_?;0&*<Q>1,&5W7'WU;.#G^[C\:`%\-V<UC
M;VD,]AJ$<J1['=[H/$#CLOF']%ITVFW;6/B&-8LO>,Q@&X?/F)5'?CD'K6AJ
M%[-'>6MC:B/S[@.V^0$JBJ!DX&,\D#&169J>O7MA9WBB&&:]M9(E`4';*KG@
M@9R#U&,GIWH`L6]M=Z;>SW$=J]REU'$"J.H:-U7:<[B!MQCI[\5FGPS/,]K'
M.``(9V>5&'[J5W#KM[\'OCM6MIFL_P!I:BT<(7[/]ECF4X.X%BP(/TQ5.Y\1
M/'X@?3?,MK<HR!5N58><#C)5P<#KP,'..U`%2QTG6#865K<+%$ZW4ES/(X$B
M$AB5&T,"<DY]L4X:+J+&"TG3?!!J/G++"_E?NV1B<?-N&&..N:T)M9N([77)
M0D6[3R1%D'#80-\W/J>V*F2^O+RYD@L_(C,$<;R/*A8,S#.T`$8X[\]>E`$.
MDZ9-;)J-E>1">&5R4N';<TR,,;7R<DCID]L58\-V,FGZ%:V\T0CG5<RC(/S$
MY))'6H6UP6NKM9ZE-9VJBU27+28RY8@@%L9''I26^L7$O@\ZNR1"X%L\NT`[
M,C/;.<<>M`&?<Z1J\ZWMZIA2X:Y6:*!DR^(^$`??@9`]/XC4UWI]^8=7MXK1
MG_M/E'WJ%B)0*0V3GC'8&H/^$HO6@TO;;Q">>;R[H%3B,"0)\O/4ELC.:T+K
M6YH=?CM$BC-DK+%/*3RDC@E`/R'_`'T*`+$UE-_:FE2(NZ*V219&R.,J`./P
MK*O-!GN(M>8QS>;<L3;JERR*_P`@'*A@.H_B%7Y[G5$UR*Q2XLQ'+&\JL;9B
M5"L!C_6<GYNO'3I1%<ZHVNR6+7%GY<<23$BV;)#,PV_ZS@_+U]^E`#;6WO-,
MNKF2.T:Y2Z$;?(Z@HX0*0<D?+P.1D]>*I1>'KGSM/25Y$6.WF$DL$Q0I([!L
M#!!(Z^W%6-'UJ;4)5$NHZ;&YE=/LH0^:0K$?\].I`S]VJUIXBNYA$XGL9I&N
M3"UE$A\Y5WE=V=YZ#!Y7%`$UCIU]&^D":U1#9SR^<Z,,."C`/USEB1GOFM+2
MK6:WO-3DE3:L]SOC.0=R[%&?S!K.MO$3W&ORZ?OMH#%.8O(F#*[KC[ZMG!S_
M`'<?C71T`9'A_36T[[?NA$?FW3M'\V<Q_P`/?@=>*EU&UFGU72IXTW1V\LC2
M'(&T&-@/KR16E10!B)!>:=<7X@M&NEO)3,CJZJ$)4*0VX@XXSP#5_2;,Z?I5
MK9LX=H8E0L.A(%7**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"HYTDD@D2*01R,I"N1G:<<''&:DHH`PH?#,-JF
MGFVN9UELV!+/([JXQAAM+87=GM5JSTVXLECMX+T+9QG*Q^4"X&<[=V<;>WW<
M^]:=%`%.*Q\O5KB^\S/G1)'LV]-I8YS_`,"_2JVJ:-_:$\LOVCR_,LY+7&S.
M-Y!W=>V.E:M%`&+%X>BAUNVU..7:\4/E2*%XD.,!NO!P/T%2W&AQ7>JR7MU-
M*P,0BCCCD>+8,DMDJPSDX_*M6B@#%M=#ELHK<VUXHGMXVA5WB+*T9.0I7<,D
M=CD58ETV:3[--]L)O+<OMF:(;2&ZJ5&..G?/`YK2HH`S9M,FGCADEN]UY!(9
M(I1$`JDC!&W/*X)X)S[U7NM!>\MKP7-V&NKI41I5BPJJK9`"[C[]^];5%`&-
M>Z%]HFOWAN3"E];F*:/9N!;&`XY'..#ZTX:3=.T4EQ>1--;QLENT<!4(S+C<
M06))Q[CJ:UZ*`,*#PS%:KIYMKJ=)K-PQ9Y'=7&,,-I;"YSVJ`^$HC'I7^DXF
MT^7?Y@C_`-8N_?M(SQSWYKI**`,N'3+BU;RK2]$-H9#(4\G<X))8@,3@`D_W
M2?>FP:9?6EU=RVM[;B.YF\XK);,Q4X`QD./3TK6HH`S=>TLZQICVBSFW<LK+
M*%R5(/ID?SJ%=`A37;?4TE($,`A$.WC(!`;.>N"1TK8HH`R%T/;I5E8_:/\`
MCUG27?L^]M?=C&>/2K2Z?MUB74/-_P!9`L/E[>F&)SG/O5VB@"EH]A_9>E6]
MEYOF^2NW?MVYY],FJ<FA>9HUUI_VG'VB=I?,V?=R^_&,\^E;-%`&3J>B_P!H
M7,TWVCR_-LI+3&S.-Q!W=>V.GZU8L+>^MPD=Q=6TL2(%`CMV1N.G)<_RJ]10
M!DRZ7=F]O)H+V*..\"B16@+,H"[?E;<!GZ@U!=>&HYHIHH9_)C>VBMU79G:$
M8MGJ,YSBMVB@#&O="^T37[PW)A2^MS%-'LW`MC`<<CG'!]:FCTZZDLVLK^YM
MY[5X3$5CMVC8C&.I<_RK3HH`HVEK>0NHFO5EAC7:J+"%+>[')S^`%02:-OMM
M6A^T8_M$L<[/]7E`OKSTSVK5HH`RQI<UO.\MC=K"9E190\6\$J,;AR,'&.N1
MP.*B7P[;A[96D+PPVTD#(ZY,F\@EB?7(/;O6S10!F:)HZ:3I7V`RFX3<Y+,N
M"0QZ&HDT200P6<MV'L+=E:.(1X<[2"H9\\@8]!T%;%%`%+2[#^SX9H_-\SS9
MY)L[<8W-G'7M2ZI8_P!H6\<7F>7LFCESMSG:P;'XXJY10!273]NL2ZAYO^L@
M6'R]O3#$YSGWK-M?#UQ8KIYM;Z(26<#PYEMRP<,0<X#C'3UK?HH`HW5G->Z1
M<6=S/'YL\31F6.(JHR",[2Q_G5:+1YGGM9+ZYBF6U1DC6*$QYW+M.XEFSQ]*
MUZ*`,=-$D$,%G+=A["W96CB$>'.T@J&?/(&/0=!4$OA>*>VNA)=S&ZN)3+YR
MNX56SE3Y8;:=N`.?2M^B@##D\/>;;W:M=$7$UP+F*=8\&%PH&0,\]/R.*D;2
MKT75W+'?1*MVJ"4&W)887:2IWX&?<''O6Q10!1GTNWETD:<-R0JBJA7JFW&T
MCW!`-1?V9/-<I/>W:RM$CI$(XM@&X8+'DY./H.>E:=%`%32[/^SM,MK/S/,\
MB,)OQC=COBJDNEW9O;R:"]BCCO`HD5H"S*`NWY6W`9^H-:U%`&%=>&HYHIHH
M9_)C>VBMU79G:$8MGJ,YSBI+W0OM$U^\-R84OK<Q31[-P+8P''(YQP?6MFB@
M#,CTZZDLVLK^YMY[5X3$5CMVC8C&.I<_RJ6TM;R%U$UZLL,:[5180I;W8Y.?
MP`J]10!FII$134HYW\R*_<LR@8V@H%QG/MG--BTN=I+;[9>">*U8-$JQ;"6`
M(!<Y()Y[`5J44`8<'A[[/:Z>L5V5N+)V*S"/[ZL260C/0Y]>V:==:"U[>Q37
M=Q%*D,PEC)MP)5P<A=X/W?PS[UM44`4KZP-S/!<PRB&YM]VQRFX$,,$$9&1T
M[CI5.;0FN(I3-=;KB:>*:201X7Y""%"YX'![GKWK9HH`R=.T.+3M8O;Z&3Y;
ML#,6WA#DDD'W)SBH]5T%M5D9;FXC>V+!@K6X\R/'4(X(P#[@FMJB@#&N]#><
MWR0W0B@O_P#7J8MS?="G:V1C('<&IWTV6*Z>XL+A8&E14D$D?F`A<X(Y&#@]
M>?I6E10!GV^FM#J;7KW+2LULD!W(`25).[CCG/3%0PZ+Y7ADZ-]HSF!H?.V>
MN><9]_6M:B@#G_\`A&$%S-,MTV9)8)`I3(7RR"0.?XB/_P!=++X7BGMKH27<
MQNKB4R^<KN%5LY4^6&VG;@#GTK?HH`HFP9M4M[YILM#`T14+]XL5.>O'W>GO
M3DL=FKRW_F9\R!(MFWIM+'.?^!?I5RB@#)TS3+[346!+VW>W$C.5-LV_#,6(
MW;\=^N*A3P]Y5K:K#=[+FVG>5)Q'_"S%F0C/((..O;-;E%`&+=:"U[>Q37=Q
M%*D,PEC)MP)5P<A=X/W?PS[UJ6T<T2,)Y_/8NS*VP+A2>%X]!QGO4U%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%,D<11M(P8A020JEC^`')^@I]%`&6/$&G[9F+7"K""96:TE4)
M@;CDE>#CM[CUK2=PF,AN3@84G^7\ZYZ^MIWTOQ(BP2,TSL8E"'+_`+E!QZ\@
MCCTI6L6M]5ECM;5H[7S+:0"./"ELOO;ZX"Y/TH`Z*L^;6;*"61)&F'E';(XM
MY"B'`/+A=HZCO67X<@:UO6CCMY!$8COEEMVBD#9'#G.V1CR=P].O(JRNER7<
MNHI/<W4=O-,0T*A`LBE%!Y*[L'D<&@#:I:YR?3E'GSM9EE-Y^_`B+-)#CH!U
M9=V#@=<'BHUM+AHW%K;RQQ&5VB7:8RMOM7<@!'!9@<#C'7C&*`.GHK!:(MK$
M5G''BUE*WC`@_+M&-N#]WY@A_!JT+T#4-)E^SGYF7=&64\,#D<'GJ!0!;EE2
M&%Y9#M1%+,<9P!UI58.H93D$9!KD8[2^G6X,EK,J744EZ<J01(0R+&1ZA2O'
MM4]UIDL$<L>GP&%'@@:4+&2'(<[\@$;CMZ\Y(H`ZFBN4M=/:6:S22W9[,W;D
MQ_9&AB5?)8?<8DA2V.N`3VYYL21RQ^"KR*2-T9%G1$(VD*'8(!Z#;C'MB@#H
MZ*Y@V"3S,D%DZ:>\D`:%XBH+!FWDJ1TP5R>A]Z<+-H[L)':LM\MV&6=82%%N
M&'RA\8QLXVYZ]N]`'2T5QMI;&72U_LVUGBN3;N)Y1&5\S(^4!CC<?3!XZ9%3
M6NGM*GE^03:--#F%;%K>/@MN.QF)Z$9.`#QUYH`ZB*:.;?Y;9\MBC<=".U25
MS5RDNG0RW-K!ME6X>"),;05<*JX]@P4_0&KFJV+Q:)!:VPW10E!(IC,NY!UR
MH(+<X)&>?>@#9HKF8K.Y-BB6ZN)/,=HR(&MU2+`W(`22N3T!P03G'RU%/:3O
MJA=8RBL8C:'["[O$@5<@/N`CYW9!]>_2@#JZCEFCA56D;:&8(..I)P!^=<Q<
M6+2Z?J</V*=]3D2X!F"$*ZEB4&[@-Q@`<X]J+R)-0O;JZET^>2VS:$"6U8DA
M7?=A2,G`/(QT/H:`.KJ/SH_M'D;OWFW?MQVSC-<K!97WVR7RMT5V6F+R"S8%
MLAMNZ4OAER5P`,C`X'-7=-%M:WOGQ6<]M$ML%E9H&4%]PSVY/J>_K0!T--=P
MF,AN3@84G^7\ZR_$*W*VB7%G&\D\3$!%&=P<%>?8$AC_`+M9EC87,+)$\+[+
M.XC@A.T\QABV[Z8*@GU4T`=!:W]M>.RV\N\JBR$;2/E;.#R/]D_E4EM<174/
MFP/O3<RYP1RI*GK[@UB^&[>>&YF,T,D8-I;J"ZD9(,F1]1D?G5:"TN`D*V=O
M+!=K+<-)(Z$`HWF;1N[Y8J0/QH`ZBBN=\.6LL-RS;?+3RMLB+9M`&?(Y)9CO
M;KR!@YZT7%I?-?W-K;(R1(LEU!+C"B5U*A??YB['ZB@#?FE2"(R2-M1>II]<
MG+8QRPR"VTZ1+<6_^D1/;D&24,I!P1\Y`#<C.<CDT]+.X_MC>B^7)YX9'%B^
MX0]E\PL%"XXVXR/0T`=*T\:3QPLV))`2HQU`QG^8IRN&9E`;*G!RI`_`]_PK
MG-(MO+O[`M:3)=1P2+=S&,A7D^7DMC#9P<'TX]J?=V+W&O();9I+9KK+[D)0
MK]G(Y[8S@?6@#>GFCMH))YF"1QJ6=CV`Y)I(YXY9)(T;+1$!Q@\9&1^AK#^R
M32^#;RT:!C)LN$BB9<'`9O+`'T"X_"HGTZ)_M%S!9,KI);FV/DE&10$SM&`1
MW!'M@T`=-17+Z9:7*:PK.K)*)I&F<6;`R*=V-TI?#+RN``2,#@<U-J%@;C4]
M0F:W=RL-OY$@4Y#!GW;3ZXQG%`'145R\]KY$U[#_`&=YEH;M61&A=XQF)<G8
MH^;YL^V<GK46G::\]FB7UFS&*VG15>,@*?-.W`YQP!CK@=#0!UM%<R;"26.>
MYDMI&NE>V:-RIW`@)N(_7/XYJO;V=T+R0E'6;?,9F6S8&12&VAI2^&'*X`!(
MP.!S0!UU0?:X?M+VX9C*@4LH0G`;.#T_V36?]A\CPTT%I`8Y&A!9(QL9FP-W
M/'S'IFLRUM8_[4EDL;":WM2]J5!MVC'!DW$`@8QD9^N>]`'545R$FF/%8:<?
MLL:PE'-RCV;3[I#C:612"<#<,\X_E9@M62ZA.HVUS=`01"W81'=&X9BV2"=A
MP5Y+=!C/:@#HH)X[A"\3AE#,A(]5)!'Y@TEU<16EM)<7#[(HE+.V"<`>PKDG
MT^2.-4^R*ENES<F:-[%IE8L^8VV+@L-O`(R!T^B:E9,=+N([JSNKNZ>T"VK^
M0S%3@Y'!;8>F<GD8&3B@#KIKB*"2%)'VM,^R,8)RV"<?D#4M96MV@O)],C>#
MSH1=$R*5W*%\M_O>V2!SZUA/8W`C1)8#]GC:=(4>S>?9^];;M"L-OR[<,>,=
MQ0!V5,>149`0Q+G:,*3VSSCH..IKFI]-N6M;Z01E[W$"^<\7S,H5/,P`>X#9
M`//3/>H5LYO*@\F%_)%RS!([-H$0>3("0A)(!)'IS]:`.NJ.*:.;?Y;9\MBC
M<=".U96DV0L[J'RH#$KV:^:=I&YP1]X]VQGKS5<VQ-ZVRUE6Y-[O69D)7ROE
MWX;H`1D8[GG!ZT`=#58WULLJQ&3YVE\D#!^_MW8_+FLS1XW;4)4=?W6G*;:(
MYZY(;]%\L?7-4I=,ADU3RSI^5;4?,E/D?*Z&%L$G&"-Q/XGGKR`=317&O8W`
MC1)8#]GC:=(4>S>?9^];;M"L-OR[<,>,=Q6[>)-'IEDT@EG>!XFE*IESC[QV
MC//?`S^-`&K45S/%:VTMQ.VV*)2[M@G``R3Q6%#9B]U!&N;-V@:6=MLT9P00
MF,@^O/7^E9UW9.VCRK=V5S<3-IXCMOW32%'`;(Z':>5Y/4<4`=D""`1T-+7+
M1V=T-9#L-LWGAA(+-F;RN/E\W<%"XXVXS['K4,VEQ1:98,;1UE",7!LS,I<X
M^^J_,&XP&[<^U`'6JX9F4!LJ<'*D#\#W_"G5S`@F<B2^LI/LYDC:X@VF7/[D
M#&.2X#8SUZ>U5]-T^*[AE9K1FA"7/E*ZG`/G,5_X%Z=Z`.OJ*:XB@DA21]K3
M/LC&"<M@G'Y`UR[VEZ]^KSAO-;R3!)]C:1T`5=P$@8!.=V0>N>_2I4M-NJ6)
M-G,;Q+V1Y[CRFP4*R;?GQ@CE0!GCIQ0!U%16]Q%=1L\+[E5V0G!'S*2".?<&
ML+6K9CJR7$<#S3!$$:O`SIPQ/RR*?W9YY)X/'6H+>P>WEM[J.S<7#:A<^8P4
MAFC/FD`G^Z3MQVS@T`=317$BSFDN"(M.,,,MN%E6.W==SB6,_,QY8X+<X]>3
MVN76GS1ZNZQQ+&F^/[(8[)G,:`#(5PP6/G=D'J#WZ4`=+;W$5U&SPON579"<
M$?,I((Y]P:6>>.WB,DK;4!`SC/).!^IKF(M.FB:&XM[9X[M[^Y#R["&V'S=N
M3_=SM([9Q3?LC&.$6-E/`JQJ+M6B*EY/,C()S]\C#DL,_6@#J)KB*"2%)'VM
M,^R,8)RV"<?D#4M<JUFPOK39:3?;UNY7EN/*;!4K)M)?&".5P,\=.*JVVGW!
MM3'Y,@'EJL\:V31;W\Q,EF+G>W#?,N1C//2@#M*HOJ]D@YE8DS&`*L;,Q<=0
M`!DX]>E68%AA7[/!$(TC`PJIM4#VXQ^5<N-->34[626R9PNJ3N6:+.$*D@YQ
MTSC!]<4`=;1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!378(C.QPJC)/M3JCG0R02(N,LI`S[B@"G;:WIUU_JKD8\K
MS@71D!3^\"0,@=_3O4UGJ-K>LZ02$N@!*LC(<'H<,!D'U'%89\-3RVEK;RRQ
MJL>G/:.R$D[CMY''(XK2L;&Z&I->WGDJRP"W1(6+`@')8D@<^W;U-`#=1UZW
MLF,:`S2K+'$Z@$!2Q`^]C&<'..M/CURTW*DL@$CR2HB1([EMAPW\/4<9_F>M
M4+K0[UVNHH'MS#<7L=WN=B&&"N5QC_9X.?;'>I+'1+BWU*WN9'B*12W3D`G/
M[U@5[>@Y_K0!I1:I92W#0)."ZEA]TA21]X!L8)'?!XJI<^(["&RFN8VDF\M0
MP58V!<$X##(Y7/\`$,BJ5IX::*9EF*M$KRO')Y\A8;\](\[%(W$9YS[5(=*U
M)]`;2G:T5(X%BB8,Q+E<8+<?+P.@S]:`+L6H6,<MY,5BAV^69'V,LC%E&T,"
MH.>@`Y/TZ4Y=8TZ.*+;+L5I/)5!$P8/C.TKC(..Q%4;C1KNYFN;AF@25YH)X
MT#%EW1@94G`X//./?':D&B7+W\5](T*R&\%Q*BL2J@1E`%.!D]#R!0!KV][!
M=6AN;=P\?/)!&".H((R#^%5(==L6BMVDF`::-)/D5V10W3+;1M!/3=C-+IFG
MRV>GW-O(R%Y9I74J3C#L2.WO6.WAJ\\BS6-X(KB&WCB^TQ2NCH5Z\`8<>@.,
M>]`'17E_;6)B%PY4S-LC`0L6;&<``'TJO#JVFW^V%91()58@/&P5@/O#D8R.
MXZCO1J-C+=7FG31L@6UF,C[CR1M(XXZ\U0M]#NXEM`)HD:&2Y<LI)(\S=M(X
MZC(S0!H)K6GNLK"?:(E#MO1E^4G`89'()Z$9S4$&OVLDUZ)`8HK7RQO8,&8N
M,@;,9![8ZFLI/#%XX9IGMUE^SQ)N5V;?)&^[<Q(S\W?T]ZGN=!OKR6[N)F@C
MEDE@FC2.5P,H""I<`$9SU'/M0!NV,]M<6JO9E?)&5`"[=I'!!'8CTK/U'7XK
M&XNX!!+));6IN#\I"MUXW8QVZ_AUS2Z;:7.GR10K%&$G>26X(>20@X&W#L>3
MZYQGL.M0ZOH]U>7-Y)`T.VZL3;?.Q!5LL0>`<CYOP]Z`)9M6T^2UDO"L336<
M8E_?(R[`PZ@[2<'IE0:MC5;,W@M/-/FEM@^1MI;&=N[&,XYQG-96H:#=7*7R
MQO"/M%C';)DGAE)))XZ<T\Z)<#7%O86CMU,OF2/%*X,JXQM:,Y4_[V>W2@"Y
M?:C<0:G;V-K:Q3231O)NDF,8`4@8X5O6FVFO6EQ'!N\Q)IMV(A&SD%6VMR!T
M![^G-)J&D&^UFUNG=E@BA=&$<SQN22,<KCC@]Z='I0@U:UGMUCCMH+9X0@SD
M%F4_T/>@">/5K*69XHYBS+NZ(V&*]0IQAB.X&:B77M->,2+<[DV))N$;$!7.
M%)XXR?6J-KHMW`MI"S0&+3W=X&#'=(2&`#C'&-W)!.?:H8-$EL-.U&&\E%Q;
MWD9>41QLSK*>#M4#)7ICTQ0!OI>0/)<1I)N:WQYH`/RY&?QX]*IMK>E/%EKE
M&3[.+O!4G]WGAL8]>W6F>&[2XMM*5[X?Z9<,9I^.=QZ#\``/PK)'A6YWJ?M$
M6!<]<'/V;(/E].N0/:@#7EUE4N1$L:O_`*4EN<,05W)NR05_0$_4=*(M8\S0
M+C5/(QY*S-Y6_KL+#KCOM].]5Y-&N'U"2X#Q;'OH[D#)SM6/:1TZYI\.D7$?
MABZTPO'YTJ3JK`G:-[,1GC/\0SQ0!:@UFRE@:1I1'LC$KAP1A3W&0-P[9%3V
ME];WL;R0.S!#M961E93Z%2`1^585UX=N]0BQ=2PQO';)!'Y1;#$.KY/`(Y0#
M`S]:T]&T][(7$DJ(DL[AF"S22G@8&7<Y)_`>E`$T>JV,JP,EP,3HSQY!&57[
MQ.1QCWQ5:Y\064-A<W2&63R$WE!$RLP[$9'*_P"UT]ZIQ^&B9=36651;W$;Q
M6P7DQ*Y+/^;'\A1=:%>7\,_VAX(I?L;6D7EL64Y()9L@8Z#@9QSR:`-,ZQ9+
M)%&\K(\@7`:-AMW?=#''RD]@<9J&\UVWM[F&WB!FDDN5MVX(52>OS8P2/0'-
M4)?#T\U])/(L3)<M$\RFXE"H4`'"KM#]!@G&/?I3SHEZKQ0Q/;FVCU#[9N9C
MO())*XQC()ZYY]J`+^H:C<6^HVME:VT4TEPCOF28QA0N/16]:)-0N1<I9Q6L
M3WAB\V1?/(CC&<#YMN3GG'R]C3-1TA-0U:RN+B*":W@CD5XY5W9+;<$`C'8T
M2:=+:WZWFFQV_P#J!`T#DQK@'*D$`XQD\8H`A?79&:VBM[,-<33O`R2R[!&R
M`D\@-D8'''<5<TO4&OOM*2PB*:VE,4@5]ZDX!X;`SP1V%9K^'&GEMGNOL\X^
MU27%RK+\K;D*@`8.<?+U],U>T/3YM+MY;1VC>V20_9ROW@A[-QU'K0!5@U^9
MU6>6SC2U:Z-J'6<LX;=M!*[0,$^]75UJP>)Y%E<HC;,^4_+9(VKQ\QR#P,FJ
MNDZ#':`O=9EF%Q),@$KE%RQ((4G:#@]<5'%HEQ%86RJ\1N+:[DN4!8['W,W!
M.,CANN.OK0!??6;!(8I#,V)F*(!&Q8L`25V@9!XZ$9H.L6`MH[@3%TDSM"1L
MS''7Y0-W'?CCO6-/IM[;7ME<1QK+<2WLEQ*JY\M,Q%0-V,@<`9(ZGIVJ>UT2
M]L9(KR%K>6[!F+QNY6/]XP;AL$\8].?:@#1DUK3H_+S<A@Z!PR*S*%)P"Q`(
M4'U.*>^J6<=X+5I2)2P3[C%0Q&0I;&`<=LYK!F\+W*PVRVSPB>*+8+I9'BD0
MEBQ.!D.N3PIQC'6K%WH5[<:BLSR031I=Q7"/*[;E50,H!C`Y&<CKT]Z`+EMX
M@M'LXY[G="TC2`(JM(0J.5+':.!P.3P,U?N;N*VM#<G=(G&T1J6+9(`P!ZY%
M<])X;N6L;>+%NTL33$2+-)$\>]RP(91SP>5(_&NCM8I(;2**64RR(@5I#U8@
M<F@"OIFI+J&D1:AY31K(A?8/F(`SZ#D\5GV_BBWG^QOY$R1744DF2C%EVD<!
M0,MP>HXX[U=T&PETW1+6RG9&DB3:Q0DCJ>F:SM-T.[M6T\2M`5L[>6#*L26W
M;<'IQT.1_.@#435[&6>*&*8R22QK*@1&8%&)`;(&`,CO31K>G$2G[1A8HVE)
M*,`R+U*G'S`?[.:H:-H4]E)&;AXB%L$M3L)SN#,21D=.140\/7,UK!9W$D*P
MVMK);Q/&26?>NW+`@8P.P)R:`-AM5LD;#W"K^X^TDL"`(_[V?Z=:I7GB2S@@
M=XMTCH8M\;HT957;:"=P_'%9EYH5_-;7#7!C(_LW[*J6Y+L65L@C('7'3-,6
MQOM:N;J=H!;AEMA^\5T!*.68#<H)X[XQSB@#I[2]M[T2&!R3&VQU92K*?0@@
M&J.FZQ_:-]<0Q+;".&1T.+C,ORG&2FW@$^]3:?8RVM]J,\C(5NIED0*3D`(%
MY_$56ATRZ.HVTTRVL45JTC)]F!4R;\_>4CCKD\G)YXH`MRZO8PNZ23A6298&
M!4\.P!4=.X(YZ5'+K5JCKL;S%S*&VJQ;,?W@H"\_F/;-4-8\/3:AJ<ES%,B(
MUN0`V<K,`0C].P8_D*DAT2:--.4R1DV\4PF89^9Y!R1^.:`(K/Q%8Q+;(EFU
MM;36K77R1-\OS#(V*O/4G=T[^];%QJ%K;6:W<TP$#;=K@$@[B`.GKD5BVFA7
MD8@\UK<>5IK67RN3ELC#?='&!^'O5J72)W\.V.G!XO-M_(W$D[3L*DXX]CB@
M"VVLV"21QO,R/(`0&B<;<G`W9'RY/`W8S3AJUD;LVWG'S`2O*-M+`9*AL8)'
MH#FLS4=`DNM3N)ALD@NA&)%>>5-NW_90@/D>I&#3#H5RFL/>Q-'"K.\DAAE<
M><""`K1G*YZ9;/;I0!IVFM:?>%?(N,AHS*I9&0,HZD$@`X[XZ41ZUI\D,LHN
M`J18+;T93@_=(!&2#V(Z]JP]/T.[O](L(KW;;QPV4D0`SYF77;\RD#&!]<^U
M2Q^&YS`WF&))T$0C;SY9=WEMNY+'Y03V`XYY-`&C+X@LTDM4C$TAN)O)P(G!
MC8#)W#&0>G!Y[],FI[G5(K;5+6P:.4R7*LP94)50,=2![_AW[9K7%GJ-V]G/
M,+59;:Y\T1([;=FTKC=CD\Y^Z/3WJ74-/FN=3LKJ,H4B26.168@[7"\C@\C;
MTXZ]:`%^U:7JSFT<17/&]4EB)5P.ZEAAL>HS4D^HV.GNEO(XB`V@!8SL3)P`
M2!A<]LXJCIVD74$VGBX:'R=.B:.(QDEI,@#+`@;>!T!.346M:)>:C<SLLD+Q
M2"(Q^:[`Q%&R0``1\WKUH`LIKNZ_%K]FQF\:UW;_`$CW[L8_#%7IM0M;>26.
M:4(T,7G/D'A.><]^G:LM-$N5U,7)>+8+][K&3G:8MF.G7-2Z]HSZI-:O%(D8
M4^7/NS\\)(+*/<E1^9H`MMK%BDJ1M,07V\[&VJ6^Z&.,*3V!P:AM]=M)A=%E
MFC%O-Y/S1/EV_P!D8Y/7@9/YU5N]$N96O((FA%K?3)+([$[X\!<A1C!SMZY&
M/>HKC0;J625MT>%O3=1;9WC+`KM*DJ,K]030!IR:UI\444C3DK*I9=D;,<#@
MD@`D`=R<8IVJ:I#ING_;'5Y4+*JB-2V=Q`!X[<_Y.*Q[CPW*]I;I%%;"5/,;
M>L\J/&S'.0^6+>X(Y//'2M'4--N+K05LA.)+A1$3))P'9&5CG'3./UH`G.K6
M0N5MS*PD9@O,;`!B,A2V,!L=B<U!I^NVUXA\PB&4&4E,EL*C%2Q.,`<=_P!:
MH76AW]UJ"W$K6[JMW%<*7D8M&J@91>,`9!.>_<"H;?PK/#'=H)HU%\LR7&&)
MZL3&1D=1G!''6@#:.MZ>+=YVN"L:,JL6C8$;CA3@C.#V/2K%I>V]X)/(<L8G
MV.K*5*GT((!K!/AVX>VD!$*S,T'S&XEE)5'W');I[`#CU-:VGV,MK?:C/(R%
M;J99$"DY`"!>?Q%`#TU:Q>X,"SY?+*#M.UB.H#8P2,'(!SQ266L6%^Z);3ES
M)'YB91EW+TR,@9QW]*S8="N46VMG>'[-:SR3QNI.]RV[`(Q@8W]<G.*?IFBW
M%G)I+2/$19VKPR;2>6.WD<=.#0!NT444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4R5_+B>3:S;5)PHR3CTI]-=0Z,A)
M`88)4D'\".E`'.Q>+$ET^>[6WB?RC'\B7`)^=@N&!`*D9],>AJW=Z\+:YN[?
M[/NDADABC^?`D>3IGCY0/7FE?P[:2K/]HDFG>9!&9'*[E4'<`"`,X/.3DTO_
M``CULQN6DGN));AHY&E9EW*Z?=88&`?PQ[4`5[O4]3CU;3;=;94:99]\)D!1
MBH4JV_&0.3V!]JM+K2R>&SK*0DJ(#+Y1;!X[9_"I(](C6[M[J2YN9IH/,PTC
M@[MX`.1C`^Z,`8%12Z,(_#,ND6;G!@:*-I3ZYZD#W]*`*]SXADM(KDW%EB6*
MW6X1$EW;T)QUQP0>W/UJ:?6+F%YHQ8I)+;1>=.JS?=0DXVG;\S84G'`]Z/\`
MA'X);>5+F>>226)(2Y8915.=J\=,^N34]]I$-[*\AEFA:6,12^40/-3GY3D'
MU/(P>>M`%.;Q"R&ZDBM!):VT4<SRF7!*.">%QU`[9I\FOA6EE6V+6<,ZP23;
M\-N;;R%QR!N&3G\*8WA_S=1OGDE*6=Q'%&(8CC<J`@JV1P.1T.:M/H=JUP[[
MI!%)(LSP`CRW<8PQXSV'`..*`*UGXB2ZU6:R\E$,3.I#3`2#;W*$#@]B"??%
M4[GQ+++:W*0HL,R1QS1R(_F*4:0+U*@9Z],CWK3DT*WFNA-<37$ZJ6*12,"J
M%@0<'&[H3P20,_2HE\-6HC9&N;I\PI!EF7(1&W*/N]NE``GB!'UQM-\J-2KE
M#NF"R=,[@A'*_0D^U;59TNCPS7L=S+--((Y/-2)R"JOZ@D;A],X]JMVL'V:V
M2'S99MO\<K;F/U-`$U%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%5TO;9Y+A%E!:VQYHP?EXS^/X4MK>07?F>1)O\L@-P
M1@E0PZ^S`T`3T50M]8L[B1$C:8>8<(SV\B*Q]F*@'\ZOT`%%%,CD65-RA@,D
M?,I4\''0_P"30`^BBB@`HHHH`**8)%,K1@-N4`DE2!SGH>AZ=NGXT^@`HHJ*
MVN(KJ'S8'WIN9<X(Y4E3U]P:`):**;O'F%,-D#.=IQ^?3\*`'4444`%%12W$
M4,T,4CX>=BL8P?F(!8_H#4M`!144L\4+1+(X5I6VH/[QP3C\@?RHMKB*[MHK
MB!M\4JAT;!&0>G6@"6BBB@`HHJ**XBFEFCC?<\#!)!@C:2`V/R(H`EHHIKN$
M*@AOF.!A2?SQT^M`#J***`"BD)P,U';7$5W;17$#;XI5#HV",@].M`$M%%%`
M!1427$3W,MNKYEB56=<'@-G'/_`3^52T`%%%1)<1/<RVZOF6)59UP>`V<<_\
M!/Y4`2T444`%%%%`!1423QR2RQJV7B(#C'0D9'Z&I:`"BHEN(FNGM@_[Y$5V
M7!X4D@'/_`3^51W=]!9[/.\TF0D*L<3R$X]E!-`%FBJ]I>07L;/`S'8VUE9"
MC*?0JP!'4=?6K%`!1138W$B!U#`$9&Y2I_(\T`.HJ..>.5Y4C<,T3;'']TX!
MQ^1'YTZ1UBC:21@J("S$]@*`'4566^MVM4N2S)$[!5,D;(22VT<$`\DCM4EO
M<174;/"^Y5=D)P1\RD@CGW!H`EHHJM'?VLLUS"DP,EKCSEP<ID9'Z4`6:*9'
M(LL:R(<HX#*?4&F1W,4K;8R6^9E)"G`*G!!/04`34444`%%0W5S#9P--.Q6-
M2!D*222<``#DDD@8%1S7]M!);1S2%'NFVQ!E(+'&<=./QH`M4576]MWOI+)9
M,W$:"1DP>%/0YZ58H`**AFNH87$;L=Y1I`BJ68JN,X`&3U''O4HY&:`%HHHH
M`**@@NX;B6:.(L3"VUR48+GT#$8/OC.*ABU6SFDV)(V2"5)C8*X')VL1AOP)
MH`NT5';SQW-O%<0MNBE0.C8QD$9!YJ2@`HI&8*I9C@`9-,MYX[FWBN(6W12H
M'1L8R",@\T`245%-<1020I(^UIGV1C!.6P3C\@:#<1"Z6U+_`+YT,@7!Y4$`
MG/3JPH`EHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`J.:3RH7DV,^Q2VU1DG'8"I*9+(D,3RR,%1%+,Q[`=30!SPL-
M1LW6:5HYQ/%)%*D$)!4MEPQ)8YPV1P!]ZK?AZ&6$WOFQ/'NDC*[E(SB&,''X
M@C\*;>ZZ\=HYALYEN"%:))0OSJ6"[L;N@+#@D'D=*LWE_<6;:=&8/.>YD\N0
MJ`H7Y&8D`M[>IX!ZG&0"MI6F2BPM6N;FZ;RU#"W=454;MT4-Q[FLZPTZ&VL-
M,^V:<[P?9/WL:P%CYWR8+(!G.`0"1Q[5H:=XB2:PAFO8)('>U^T9VC;(!C=L
M`)/!(X///&:T;.^6Z=XVAEMYD`9HI=NX*<X/RDCG![]J`,B"UN1]C,L$VR.-
M!<JQR9#GY!WW%>I.?SK+-C=[1Y\)\K]]Y2M9/,R.9Y#N&&782"I#'CW'?H8K
MK4;H-<VRP"W61D$+J=\@5BI.[.%Z<#!_PE;5H5N"ABE\H2>4;C"^7YF<;>N<
MYXSC&>,T`92VLD6NI*(9)IRZ;WFMV!"[0"5E4X"]3L.><T_68[>36'%Q:2W+
M?9`(MD9?:^YL'C[I]&.,>HJU#XABF@69;*\VO")T!5,LG<CYNV1G./;-.&LV
MOVR0+:SD(Z0R7(1=J[@"N3G./G';COCK0!E2Z;<M%J4OD?Z49X<RF+<7C"1;
MP.02#@Y`/.,4Z&&ZM+%[RT@DD:&?=%!';&`,I4*P5&8D#.&[<J3CUV'U=([D
M12VMS&K;Q'(ZJ%D*@D@#.[H#U`SBFQ:U"Z!FM[F,%4==ZCE&(&[`/`&><\CT
MH`QGTZ:WO]LL,L]FB6XN<1EO.`$V>`/F^9E)`]>E36\<EK?6UR+6X6TVSQPH
ML3$QAC&5!4<J#M;K@#C.*Z""Y2>2=$#?N7V,Q'!.`>/7K^=9&J:W<65Y/#':
MEDB%NV_@Y\R3:1C.<XZ>X.>V0#+M;*2.+2F:UE:X2WA79);.=I&,[9%(\LCG
M(;@U(EM/#;10")T?4)IK>0'*D+YSMN_[X+X/NM;0UJ,H0+6Y-R)?)-MA=X;;
MNZ[MN-I!SG'X\4V[O(1I5SJ]M#&UQ!!)M:1/F4KG*'OC<.1GM0`:S#&PM/M%
ML]Q9HY\V)(S(/NG:2@Y8`]L'G![9K%TRTF>QDD@AD4HCR09R,LMQ(ZKGW&,^
MQJS+J=M,DGV^73M6M8HFF<6\(;RL>H+,.<G'3I6B=7BMU*M8W,20INE^5-L"
M\X)PWH,X7)`ZXH`R+FUNI8[6ZN(?W<XDEEBDLVGVNQ78"BD'(48SVP>E1S:=
M<-:7TDEO--<PV$!MWDCRXE7?R.3\P^7H2??FNA?585>2-8II)8PQ,:@9*A<[
MADX(.0`?4X['$\-Y%//Y41+'REEW#IALX_/!H`I:Q"LESI[26[SPQRN9`J%L
M#RV'('4<XQ[UF/#<6UO`H5D>^>2T"]&2,NS(?^`INX]ZNKJUP;\0EK96,QC^
MR.-DI7=C>&+8;CYL`=.^:+74S.ANGTF>2X22:)3&B$A%?!^8M@=!QGD@X!`S
M0`_6;2-Y=*8VWFQP7/.(]^P>6P!P!TW;>>V`>U8MOI=S;Z;9K9VLD,\NF.LY
M5"K,_P"[P&Z?-]X#)!Z]*V$\0QO<N1#(;4V\,L4@`RYD8A5QG.20`..QSVS,
MVMQ*4C^RW/VAY3%Y&%WAMF_KNVXQWSB@"OX=@>)[AE7R[<J@6-;-K9`PSDA6
M8G/(R<`=.O-9RQ7&+2U^RW&^"YNGD;RFV@.LI4AL8.=PZ?2M@:]:X#21SQ(T
M+3*S)]X+@,``<Y!([<]LTXZU&I5)+6Y2X+*OD$*7^8':>&Q@[3W[<T`93Z:8
M(85@M9!$UO";E44YDVNNX'N6VYXZD<55>S)^T&"R>.P-Z'\J2R=U*^2H!\H%
M25W=NQQQQQO1:NT]W:116LH2;S1)OV@QLA`(/S>OIGMBK]S-]GA,GER28(`2
M-=S$DX_R>@H`Y^STUI/+-W#+-Y=O(8V:'8R$N2NT$G:0.F3D#KCFH+&TF29%
MM[8J@G1O-%L\'.UQ\R'@D9&7'!XK7&NQ$B/[)<BX,QA\C";@X3?C.[;RO.<T
MDFN1M:B2WMYI7,;.R`*3%M)!W<^H(P,G@T`<[>6^8O)MK.=+W^S)Q/\`NF#2
M2?N^<X^<YSR,YK0O["6*XOHK2W$=F3!(Z"`NDGW]_P`H(+GA,@')]^]YI8]-
MTZWNK+38O,NGB$BP(B9W8R>2/H.>II=/UT3*!>0M#NDF59L`1ML9N!R3G:N>
MF.#0!G06>P1->V\MQ9?O/*B2T9%C8[-N(\L5'#8)QC/:K<,<D/@ZRBDM))76
M&)9(2&!'3.5')QW7OTK2LM12[D\LP30,4\Q!*`-Z?WA@GU'!P>>E0O<ZA<27
M#6(MUC@8H%E4DRL!SR"-HSQT-`&%8Z>\UU#%/8XLS?,XB^SE(@A@./E/0;O7
MOV!.*L:7:7,>KHS*R2B:1IF%FREU.[&Z4OAEY7``R,#@8-:[ZO$DI1H)BJ.L
M<LJ@%(W.,`\Y/WAR`0.]1QZY'*<16=V^XNL9"KB1D)#`?-QT[X%`&;K5@\US
MK%RMHTDR6D1M7\O<1(#(?D_VAQT]?>AK2Y.N.Y&)OM&X2+9LS&+^[YNX*%QQ
MC&?8]:T!XBM'7?'%</$(4G>4*-L:-G!.3GL>@-69-26*Y6)[:X$;/L$Y4;"W
MIUS^.,>]`'.+IDD.D:0#:(D(@_TJ-[)ILR;5VEHU()(PPSSC^4ALIA#=![>X
MDNGM(EMYFC(VR#?M[G:1D<D_C6K#XBMI85F:WN8HW@^T(TBJ-R#&XC#'IN&<
MX]LU:EOR+AUB`\JV.;ER,X&PM@8.<_=/3H:`*,43?VY]BQ^YB/VTD8`W-D!<
M?[V]ORJ/4["6YU+4988?WPL46WE*_=?,F=I/0\C\ZT=,N8;DS216<EL7(=F9
M%`ER.&W*2#T]<CN.E07%_>6-POVK[.\4@D81Q*0T:JI;<6)Y'`'08)%`&3;V
MLT4-Q=6\+9MO+E2*.R:`,RD[@%9B2Q4E20.<CDU*;,IY;ZE:27"RPEU18VE\
MN=F+-T'R]0`W&,=15N35+VTCQ<FV>26-&AV(RA2SJF&Y.<%ASQ]*D>[OXH+O
MSKFSB:T.YY3`Q5DVY^[O&#U'4]*`*-C:ZC#>Q37@>4`Q+*NW(+^4!YF<<X;C
MT&2>U4[.PO\`R)D`9;TV[K,T=JT1D<CO*6PYST(''M74Z>UT]C$]\(Q<,,L(
MU*@>V"3V]ZSX=<"P7EQ=(!#%']HB,8R7A.0#R<$_*3]"*`(-*2WM]7NYK:RG
MMK9X(4`^S.@+[WSQCW&3^/3FK^I6\UQ=V?DS30;2Y,D2J2..^X$4TZU$ID62
MVN4E21$\HJI8[\[6&#T.#UZ8.<5+;:G%<21Q>5+'(Y<%'`RA3&0<$CN.F:`,
M&:RO%MWCF5Y9%O-]U));F9;A=A"ML7&0/E!4="._=5M`(K;^T+2ZNK;9+Y2)
M`P,;%P5PNXE./NDD;1_=K7EUR*.T%T+2[>#R_-=U08C7GDY(ST/"Y-3VUV\T
M5VY"_N9&5<#J``1G\Z`,.2TN3KCOL=)3<1LD@M&=_+&W($N_:J\$%>O7@Y%4
MEMD,CQ7%C/+<#3HA"%C):.3=+@Y_@/HQQCUK5T[6Y;F2S'V_3KLSXWP6Z$/%
ME<DD[VX!X.0*L_VU9I'->FUF5/):19MB_OT3)^4YSW)`;'7B@`TBV-O?ZJ6@
M\N:65'\SR\!QY:C[V,'Y@W'O[UE)8L]AY7V&7[6+61;UVA.)GV<<D8<[N1C.
M/:MD:W%\RO;7*3?+Y<+*NZ4-G!7G'8]2,8YQ2_VS&S1QQVMS).S,K0KLW1E0
M"0V6QT8'K0!7U:QC;P_!`+0/'%)`QA6+=A0Z[L*!_=W<`>M4+?3I(6M[BWM6
MBN7O[D/)Y9#>6?-VY_V<[2.V<5J#59/^$?FU&6%H&C1VVLH?IGG`;G\Q5B+4
MTFO6MD@G(5BAF"@H&'4'!R/J0![T`9'ANUFAND)1H@L)69?L;0[I,CEF9SO;
M@_,,CD\]*)K*YCN-5O[:!VG6<[4Y'GQF*,$#UY&1[C'<U=N=::TU*ZAF@=[:
M"**1I(P/W88L"6R1P-HZ#/6K/]J1?:C#Y,WEB3RO/P/+W_W>N<]LXQGC-`&(
M+24!Q-:RO>MY7V.41$^4H101NQA,,&R"1G/>E-C.CW*6-LT$Y^UX<1%1N;&P
MYQ@]N?;VK4CUM)8HFCLKIVFR8HQL#.HZL,M@`9'7'6HSKH%U-MADEM8[:.?,
M:?,H+.&)!/;:.!SUZT`9]S:J]G"+*RE@@653<I+:NZO\C#_5Y!;G&2.IP><5
M=@M[H>%YXH?-\YED\H;#"P!)P%!8E>.F3D<=*OIJ4+[`%?<\QA"\9R`3GKTP
M,_0BFZAJ:Z>'9[6YDCC3S))(U&U%YY))&>AX&3[4`85[I\-TKBTTUUM?,MR8
MWMRH+B7YB%(_NDY;'(/4UJ:Y9R73VRP1Y:-)&C)7*HX`*9].0*FDU9?-FBAM
MYW$8(,P3,8<+NVGG/3'.,=LYIL6M1-9QS>5)+N*1YB4$%V[#GL>I[?@<`&-+
M:7\\$]U'`\5Q=Q^9(#&<A?,7Y".,MY8QC([]*0V5P;-?*0"T%P&>'^SG6/;L
M(_U)?<1N()Z<\X-;G]LQE45+6X>X8L/LP"[QMQNSEMO&1W[BF2:_9QPF7$I`
M,8("\_.2`<$]B&S]#0!@7FG2M8J[6DLSFRO(XC]E(*%B"BA<L5&-P&3WQQG%
M6S8RB6>Y6U?[2NI0^7(8R6$96,,1_LXW9_'TK4DUF..ZE#`^1&I&<?,SAPN!
MSZG'UIYUA`H7['=?:2^S[-A=_3.<[MN,=]WMUXH`R])CCAU/3XY+>1+\02?:
M9"A42.-F3G^+D]1GKCCI3]6MI'NKW-O))=N%^P3+$6$1VC^+&$^;).<9'K1I
M>H6L-J;F+2PL\K2M*+2%5*HLC*&;)&>G3DYS@5H_VU`7&V&=HP$\R4`;8BP!
M`;G/0CH#C/-`":/:+:P786V6)GN)6P$V[QN.#TZ8K,@CD#VL5O#>*D8(>VN(
M=R6XV$#9(1UZ*-I/!Z5?DUEFOK2&WMW\F:X:%IG4;6VJ^=O.<Y7J1@\XK2N%
MG:(BVDCCD[-)&7'Y`C^=`'+6ED]A:6ACT^3$FE@7**C*7D!CP&P,Y`+\=<9%
M-@L#/>PQOIX6S-VK^6+5HXMODR`G:??`.0.W'/.C_:>HPZ;'>3-;3;[A(1'%
M`RG!EV'DN<G'3WJPVNP(IDE62%8A*9HW0%D*!3U5B.C`\9SGM0!E6]E=)J)W
MJPF$LK,R6;`M&=VT&7=M*X*X4#(XXXS4<&FW%O9626EJ\+2::OVG:FTNRM'E
M6/\`>VF0#//6NGLKO[7&7-O-`0?NR@<^X*D@CZ&K-`'*&TE:_@?3;62WLA,I
MC3R3&$?RI0S;2`5&2@SQDU`+)C)_Q+K&XMI!8.DS/"R[GWQY!/&YB`W(//K7
M944`<C!IIFFM%:W#V1N@3"+%H(U_=2`G8Q)P25!R`,^N:MZ7:FVUMS#;N0S2
M>9)+;LCJ"21^\'RR#H`.H%='10`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!45S`EU;2V\HS'*A1AZ@C!J6HYR1!(0<$*<
M'\*`,MM%EGPUU=K))&@CB98MNU0ZL<C<<D[!SQ]*N7]FUT]JZ2B-[>;S!E=P
M/RLI'4=F//\`.L'3II%ET[$6HPRO%YLCW-T9$E4+\VU=[<Y(/0$5/:Z[?7$!
MF2U9PT!G5?LTB;,8.S<WRN2"<$$<CH10!8_X1Y&L[2VDN-RV]F]J3Y8^;=L^
M;!R.-G3GK5G2=*73C*V+4-(`"+:U6%>,]ADD\]SCT`J#^U+F[G$5CY*I)(5C
MFD4L,*H9C@$9Y..HZ&F0:I?7TGDVB6R30[_-\T,5<JY3"D'C.TG/...#0!8.
MF7"^9!!>^59R,S,@C/F+N)+!7W<#)/8D=O9&T=C(4%P!9F?[1Y7E_-YF[=][
M/3=SC&?>HKG5)HM12(2V[Q-,(C&D;EER.I?.T'/;'XUEOJ&H1>$XVDF!,VFF
M1)59A*KA0<EL\YSG/&".]`&S;Z-Y%I!!]HW>59FUW;,9SCYNOMTJM;:/=_:+
MM))Q'://&^T("T@1(QD'/R@E2"",\<8IPUFX;4VB2%V@$_D%5M92>N"_F?<`
M![>G?M2ZMO?5;>+R;V=/(=BEK<>5SN7D_.N>OO0`P^'6:]CN7ND9HVD*L8<N
M0ZLI!8MVW=L#CI5J?3]EN3L:YVVGV?RE`!?ISDD`53CNM1T^$).R%((9;AQ)
MF20H&.U-P/WMN!GGD=ZF_M&^A?RIS;-(]NURA52JJJE=RDDGLPPW'TH`LZ9:
MW-C:VL#LLC89[F0]6D/)(Y]2>WY5'?Z0UW>-.MP(U<0AE,>3^[DWC!R,9R1^
M7XL&L,EO%?3A$LY5D8<$,F!D`^^%;(['`J:>ZO8M/M'V0K=3/&C@@E5+=<<Y
M.*`*]YH"74L\IDA=I+@3*L]N)$'[L(05)YZ9R"/\;!TE?["FTQ71!+$Z;TB5
M%7=GD*,#`S_B>]5(]5ODFMQ<BUV23RV[%0R\H&._))P#MZ<XSUIL>L76^8%K
M><1Q+.6CA=`%W88`DG<<9P1^5`&IJ5E]OTNXLO,\OSHS'OQG&1UQ5>^TJ2ZD
MN`ET(X+N/R[A#'N)&",J<C:<''(/X4Z.\>ZM+Z5"HB1G2%D)R=HP3G_>##CT
MK/DUBZTZSC^TJDKR6Z/'L5F()9$(;NW+@\`$\\4`:2:>8;HW:R%I?ND`<&,#
MY4'/8\Y]2?6H]#LI+2VD,RE'ED+!"0?+3HB<<<#'3WY-/TF\GNDE%PC9C8`2
M?9WA#@CLK\C'3J:S/[:OA!9[S$);M&D4QVDDHC5<#!53DDEASP!_,`ORZ7<3
M$12WHDM1,)0KQ9D!#;@-^<8[=,X[U7DT"1\I]K0P^9*WER0EAB1MQR-V"0<X
M)&,'IZAUJX5$62`133QH8$96R7+;6!4X.!E3VX--DU2[$$<TOE"&[9XHEC!#
MQD*Y!+9YSL[`8SWH`!X:7[,D#7"O&+>*$AX0<F-B5."<8Y.1W]14UIH0MI;:
M0/`AAG:8I;VRQ(<QE,``Y[YR2?\`"K#K<_\`922JI#EHX5#Q.[@E02[*.3D<
M@#\3Z36^JWMU+%:I&L4[>8QEFMW175-G*HQ##.\#J<8/6@"2XT%+B.&.2?Y8
MX98C\@YWE3GGCC;TYS26>@K;.DFZU1ED5R+:T6%3M##L2<_-W)''`%1K/<_\
M(I;S&1OM!$66WG))<`_-4YU"YMYS'=>04295DD4%0%<':<$GG=@=><Y]J`'K
MILD,ZSQ3J6625]K1YR'.<=1R"!S4UW:SWNFK"\HAG(5F*@E<@@D8!!*GIC/2
MJEQ<W<_AXW4;I#+)AT.P\(6XR,@YVD9YZU%;W=]#<R-+)%)`;SR2NUMW('(.
M<`9[8/UH`=8^'_LEU'/]H0E;@W!5(=H),10@<\=<]SZYZTL>ARV\9%M>+')(
M)%D<P[LJSLXQSP07///TINC:S<:C+$S0MY$Z%U_T:1/*[C+M\K9'IC\:L7.I
M2P_;=JQ_N)8D7(/(;;G//^T:`)I[!Y-/AMHI@DD)C979-PRA!Y&1QQZU6&A+
MY%M#)/N2&:>1ODQO$@<8Z\8\SK[54.N7D*BYG2%K8W%Q`$C1MX\OS"#G/.0F
M,8[YSVI+G4KZQD-Q<F.7=;J42%6P&:15&5R2<;AR.3Z4`7M)T6/396D"VN[9
ML!@M5B)&?XB,DG@>@]JDEL+H2S&SO1!'.=SJ8M[*<8)0Y&.G<'FJ`U;4'-O"
MBQK)+<^5YTMI+&I7RV;(1B#D%<=3_A%>:O>PP7ZW2QQ,L,S11F.1"VT'!$@.
M&R!G`((H`OMH[@O$EVPM99%DD1UW.2NWHY/0[1G()Y/(J6RTO[(L`\[?Y4DS
M_=QGS&+8Z]LU634;R21)8_(%J;G[.49&W\'!;.<=0>,>^:@&MWD%FEW<QP21
MR6TDRI$K!@4QQDDYSGVQ[T`);>'[B*.6S^U8M7M(K:1BG,@`8';\WRGGJ<U8
MDT%Y+Y;AKI"$F$J`PY<#^[N+=,=,`=LYJ*/6+YV$'E#S)71(YGM)8D4G<2"K
M8)P%Z@\Y'2KNF2SB"\:YD1I(YW&<D*``/7.!_*@"*'2/L<-D=S7/V.T>W\M5
M`,N=OJ<#[G0GOUJ;2;&6TTH0RR-]H<%G?@D,>G;!P,#\*S)M4O9H;B&.X@WB
M)9$EC@=0OS`$<M\WU!'TK6U&YEM;>+;/;QR.VTO*K$="?E0')/'3/3//%`$>
MEZ5]@GGF+PEIL96"'RE.,_,1DY8YY/'TID.FW@GG:YO()XY]ROFW(?8<X4-O
MP`,^G/UYJC:ZU?WHBC@%O'(8IW9Y(GP3'($^[D$9ST)R*L0:U+/%!M2-9;HP
MO`IS]QUW-GU("O\`D*`'MHT\T+"YO(Y)5C5(76#:$VL&!(W')RJ^G2I#I<\L
M$RW%VK2SS1R.R1;5VJ5^0#)/(!YR>I^E4_$5U=VUR6AE41+I]S*T9##<5V8Y
M5@0>>HZ<^O$@U'46F4(+41-<FW4,K%A\F0Q.>>1T[^HH`U[F(SVTD2N8RZE=
MP'(S63?>&K.:%H[%(;$O$\+F*$?.K#N`1G!`//H?6JW]O7;I&B1J)E$GF%+6
M68.5D9,`)RN=I.23CWK1O;B>2RL9H5:&266(E')4@'DAO\*`%ETKS-2>[\[&
M\PG9MZ>66/7/?=^E(VERK/Y]O<JDHE=P6BW##``C&1S\HY_2J,^MW44JV>%^
MTAW5Y4M9)4PH0Y"*=W/F+WP.>:AFU"\^VPW;Y0>3&$MV#H!)))LRPR,COROY
M'F@"6Y\,-/9K:M>AHOLXA/F1;B",X9?FP#SSP>@QBM>VLO(AGC,F[SG+9VXQ
MD`>OM6;-J6H1745CNM3</.(S-Y3;-I1V!V[LYRF.M%EK-U<WR)Y#-"TSQ$"V
MD&P*6&_S/N$$KT[9ZG&*`+@TS8MB8YMDMJHC+A?]8F,%2,]._L:RY?#(MM-O
M(K1+9F-K)%"$ME21B5P-TA//UX]\U+JUS>#56M[6982/LQW,&8'=(X(P&`[#
MW(X/;%[5+JXM[B(6L/G2F&5ECW$;F`7`ZX[]Z`(6T>>5UN)[Q6NHMODN(L*F
MW=U7/)(8YY'MBI;72C!=K=23AYBSO*0FT,S!1P,G``0<<T[2;Z2Z29;AT:6(
MC(6%XF`([HV2._()!JCIFLWFH[6CBPD\1>,M:RJL7&1N<_*^?;'XT`7)=*>;
M1+C37N%Q*KHL@C^Z&SC(SR1GV_"D.DEM62^>6(["2I6`+*001M+@\KSTQ^-5
M'UZ5[2">&,!;F7RXR(VF*`*26*IRW(XQVP<TZWU6^N+FWA\M(,QRRR&2%P65
M'5?E4D$;@V><X]Z`+-]H_P!L_M+]_L^W6Z0?<SLV[N>O/WNG'2H_[`A&IF["
MVI!E\[+6JM+NZ\2'H,\],^AJO_:%])IMG>RB#RKJ6V,:QEU9`[KD'!YX(]CT
M(Q48\07=O;S&]B1+D!2MOY+JREG"\=1(`6&2OY<T`6KCP_'-:V<9-O)+:H44
MW%N)4(.,Y7(YX'.:4:&Z>8(+M8EEMDMV"P*,`%B2`,`'YSCC`]ZCAU2^F\NW
M5$$TDNQ9Y;:2)"NPL3L8@D\8Z^^>U1+<70\(ZI-),_VB/[5AU8Y4JSXP>HQC
MCTH`NVUBXUN6Z,;1P)$(XU+`[VZ%^/\`9"CGG@\>L>LZ$VJO*&N56*6+RRCQ
ME]IYPR_,`#SZ'H.E*]_>6TK),L+HHCD+(""$8[6SD]1USW&>*E.I.FD7NH-&
M"D(E>)<8+*N<$\]\$_0B@!%TRX2298[T+;S$L\?E`G<5VG#9^[QG&,Y[TV#1
M5MQ&D4P2%&B?RQ'@;D&"1SQD!>/;WJNTEPLEW;K,WFPV,4RRL['+Y<\C.,97
ML!D<=,8LZEJCVUM:-"AWW3!0?*:78-I;.U>3TQQ0`/I,B7)NK:Y6.XW2$,\6
M]=K[<@C<,\J.<U#-X<AF,`>8F..*1)%*_P"M+`C<?IO?C_:H_M>Z6UMY)(%5
MII&A`=6C^;.%?#8(4@9(ZCWI%UBY;4C$(6>%9_(*I:RD]<%_,^Z`#V].]`"M
MX=CDLDMIIO,VPA&9HP=[AP^XC/=AR/>G0:&]LBO;2VD%PKE@8;,)'@C!!4')
M]<[NOMQ35U'4/L1OBML;>0KY:X8.F7"\\X/!)[8/K2WEY=OJ*00RQQ+'=HA^
M0DLIC+$'D?YQ0!5DTN]L(52QWSSRK(DLPC0`AG9QG+@@@N>0&[\5/_PC<7VE
M)L6I)$?F&2U61\JH'R,?N\`=C^%51K-^EI+)"+?9;6273B0.S/DOE02W'"]3
MG\>URXU.^5_.B%N+87<5ML=6+G<R@MG.!]XX&/?/:@"4:1*MU;L+M?LUO.TZ
M1>5\V6#`@MGI\YQQ^=:<0D$2B5E:0#YF5=H)]ADX_,UG:Q?36@403V\;;&;$
MD3RLV.P52#^/Z54CUF\GM_M<:0)`L,$S(RDLP<9(!S@8]>:`+K:5NL(;7SO]
M5<K/NV=<2;\8S^&:C&C,MY<7"76UI7D<?NP=NY$7OP<;,].]57O;V>]TZ4R1
MQVTE[)&(TR&(59!\QS@YVYQCCCK3M?O+T6VIQV;QPK;6AD9SG>20WW2"-N-N
M<\T`7M*TW^S_`#F+1;IB"5@B\J,8[A<GDYY.>:T*P1K-U]N,:P/)$DJ0[5MI
M6)SC+^8/E`&>GH.M5[+4[B*1RW[Q(XXFD9G8G:TLBD\G`P`#G&<#OQ@`Z:BN
M?FUNZ+QB&,*DGF.K?9I)LHK;5X3INY.3T&.#2R:G>SP32^6D$4<,;M"ZN)-S
M#ID,,8^GY4`;]%8C:K>12>=(L!MA<R0%%4[\*&(;.<?PXQC\>U26-]?OJ-O!
M=_9BEQ;/<#RE8%""@"Y)Y^]UP,^@H`UZ***`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`IK`,A#?=(P:=4-V@DM)D.[#(P^4D'I
MV(Y%`$8L[2:WM@J*\<&UH2K'Y<#`(/T_,5'!I]C93B2-`CL"B!I"0HZE4!.%
MZ9P,=/:N;AN8X],'E7TPFCLU-C&)V(DDP<@#/SG=\I4YV@#@5L:XJM/H\EPS
M1A;KYB)"H!,;XS@]VP/QQWH`LQ:9ILFG00V\:BV0^9"T,A7;G)RK*<\Y/0]Z
M=+H]A-''&\'R1@@!79<@G)#8/S`GJ#D&N:LFN;+2;'['-.7GTMY"I=G`9?+P
M5'.,!CT'/H:V/#L\DSW`6>*:V54V;+E[C#<Y_>,H]N,G'MF@":2UT9=15)9(
MENV<2I"UP0=W]Y4W<9YZ#GFI5T/3EMS;BW_=&'R-I=CA.X'/&<#..M9\%S8V
MUI/9WH#WC32,UOD&68ER5*C//&,'MCMBHY+J07C?Z1(-1^UA!;>:<>1NQG9G
M&-G.['7OVH`VCIMJ;O[28V\S(;&]MN[^]MSMS[XS4YAC-P)RO[P*4#9[$@D?
MH*Y:Q65]-MG:\O"TVF^>Y-P^2Z[<$<\=3D#KWS1'=E[VY+7T_P!L6X@$$`E.
M&4I'N^3.".3GCCKQ0!U#6\33&5D!<IY9)[KUQBJT6DV42L%B8AL`[I6;`!R%
M&3PO^R./:N>DU$_VK%]GFF_>-.DH>Z+$81RH\L?*G*C'0_7DU=B2X1%6&YN)
M)&LTN/GE)W.I!_`'H0./:@#2O=+2["Q[E6$S":5-I)<@@C!SA>0,\<\^N:N2
MPQS;/,7=L8.O.,$=#6?IMTUQIUQJ+-,8YRTD2CDK&!A=H]P-V/5JHZ#>+/J;
MI#,\D+VXD^:Y,^6W8)R>`>>0IQTX%`&J;"QG&/+601RNY&XG#L"&SSZ,>/>H
M5TNV@\T63!+LQ;-\SO,0A/&06R1P<<^OO67=W44#312O*GFW,NW%P8$)`7`+
MCG//`'7G@XJA#/<B.2Z260WLEA;??E8$KYC"0X]0.^,C.<9/(!UMI8PVFG16
M,8)ACC$?)Y(QBHTTJRCC>-8!L=`A4L2`HZ`9/RCV&/6L"VDEN;BS@%V6M9;I
ME_T>]DER!$S$>:0I/(!ZG'Z5HZE-,OD#4G6RLS*0\D-RPR-IV[GVJ5Y]^N!G
MG!`-&P@M8(F-HV]68[G,ID+$<'+$DG&,=>,5&VG64L"6P4A;?A?+E963(_O`
MY&1[UR\5Y%%H\<:SS^9_I+Q8N3#O/G/@_+\SM[8/7I5AIG2*ZFCG(DF:W>8M
M<M&!&8QELC.T$\;@/Y<`'2?V=:;K4^0N;0DP]?DR,'Z\>M5Q9:7$CWG[M86#
M,7,Q\M=WWF`SM7.3DC'6LBWN9&%N+V\":>6DV2Q7+D$C9L4RD*6ZOCJ#@#)J
MU!D^#(?+?)\E=K.ON.2/Z4`6X(M(U!)!:RPSC8D;&&?.T+G;RIX(R>>M3_V5
M9^2L7EN`K%@PE8.2>I+9R<]\GFL[4K2[2&2[N+P&8*D*FWC,6U6D7/\`$Q)X
M]?7UJO<2&WN;F(W4Z744B+8PF=CYJ[5SP3\_)8$G.,=J`-P:?:BP6Q\D?9E`
M`CR<8!R!^E5[K2(IK&6TB(CBN&S.7W.SKW`8G(/3GG`Z"J:&YN9;F*.YE52K
M_8G)/S$'G)S\P!P!GMGKUJSI-Z+I7O)9/+2YD\N"-R5^Z.0`>^0YX[`>E`%V
MZCMGMC!<%5B<;<%MO;/!Z]!GCTJ*.&P(5$=&/FB0#S227QD'KSP,_K4%^Q&H
M\LPVV<K1@?WLKD_4#'YFL]9G>QN&DE<NCVQC)8Y#%4X'U)_')H`V;?3;2VG,
MT,;!^0`9&*KGKM4G"Y]@*CNK#3I[AI;@+Y@V,P\TJ#@_*2H."<C@D55U^ZB@
M,$4KRIYH;;BX,"$C&`7'.>>`.O/!Q7/@)<1-/>SS"5[*U=B9W0D+*P<G!'3C
M)QQG/&:`.N&FV@$8$(Q'*TR@L3AVW;CU[[FXZ<U''HUA&'`A)#IY9WR,WRYS
M@9/`';'3M6,MS='6]@GC$GV@*J-=N28?:(*0<CG=GKW'2F+)=0V-K-%=7323
MVDADRY?H5Y53GD`G&!SWS0!M1V>FP2HFX&:*02#S)V9]S`J"222<C<!G\.E.
M;1K!_.#0L5F#*R&5]HW?>PN<+G)Y&.M8-G+`-8N#I]Y)/"S6B^9YQDS\TN1N
M))(_'VI\<EW#8VT]O<7,D\]G*S!W+Y8;2"%/&1D].O?-`&HVC;]46Z:5!$KB
M18D1P=P&`3ERN?<*#[U96TT_$4`6-A&CQHA?/R\!AC//;-9^C30OK-W':7DE
MS;+;Q,-TS2`,6DS@DGT'\NU4[:TAFU-8/.G!$]T9`EPX8<J0,YR.,'C&:`-I
M='L5CD01.?,QEFE<N,=`&)RH';!&*<(+#3[8P.8XHKA]N)9/]8[=LL>2:Y>2
M_O2D):[59?LJ&!I;EX]S\Y(14/FG.,C]!G-;'B>V^V1:;`3M9[K`8?PMY4F"
M/H<&@"RNEZ7'*;?_`);2PE,/<.TC1Y]2V<`]#V[8JW<V,%U%'',)"(SE&65E
M8'&/O`@]/>N7EN+FZD_M2*-H[E[>6.,8^9`@7/8\[B_0'H.M.6\N?L4Q@N87
MM`T09UOI)`@.[<3,4RN?ESC)'MF@#H(M.T^R962-(B$D49<_=8AGZGU`-,MM
M,ACN[>YC9##;V_DVR*#\JG&<L2=WW1C\>N:QD<M';3SW(PKS+;O'=2,I&S(&
M\A=YR#SSQW-2!YVAFN3=7`>%[;8!*=O(3=D=#G)SG^=`&Y>Z=:W^/M,9?"/'
MP[+E6&&!P1D'C\A3UL;=2"(_NR>:/F/WL8S^58"7.=4L5:\F^V/>R+/;^:<!
M`LFWY,X`P%(/?KS2>*;[R&N$BFG2YCM_,A`N#&N?F.54<N>.0<CITY-`&R^C
MV+HJ>4Z@,[?)*ZD[B68$@\@D]#Q4T]O:2I%;3*F%(:././N]"![<?3BL>-IO
M-^U"YG9_MPC"F4[-I`XV]/?UJ+295EU+3FDN9)+TP2&YB9RPC?Y,C'\./0=N
M?>@#9;2;-H$AV.`A+*RRNKY/4[P=W/?GFE;3K)8F#0H(_*$9R2`$!R/R/.>M
M4+J:X3618(TNVX9;A6W'Y53[R^P)"<?[9K,65KG3]@N9Y;N6TD^W0^:Q\MMA
M_AS\AW<`#&1ZT`;]OI]@K+Y0WO#)YNYI6=@Y4@%B22?E;OVIZZ99K=BY$1\P
M,6`WMM#'JP7.T'D\XSR:P%D,UQ:V\-W.;9[F-`8YV^9/L['&[.>HSU]^M,2Z
M)A=+Z^GABA\];>03LK.ZRN`"1]\A0O!SG)X-`'0W=A93.TEPN'EV)N\QD)VD
ME0"",')/3FIKBSM[H@SQA\*R<D]&QD?H*I22R#3]-;S'#/)"&.3ELCG-4](,
MJRZ;(US/(;FWD,@DD+`D%<'!Z$9/3\<T`;%I906:L(0^6ZM)(TC'TY8DU"ND
M62,[+$WS@KCS6PH/4*,X7/MBLF]N%75KQ?MLRW221BV@$I`;*KG"=&]^#CKQ
MUJ""[O#J;+)<(D_G2AX_M+EO+&[;^ZVX4?=.[//KSB@#H9M.M9@P>(C<0V48
MJ00,`@@C!QQD4EOIMI:R1O#%M>-&16W$G#$,V<GDD@')YKF7D>'2-,G?4)0\
MULLKK+>21L[E0<HW()]$(P<]*MO=N;EV6XG&H_:(UCM6<@>22N3LZ$;2Q+8X
M/?C%`&NFC6"=(#@,K@&1B%*MN4#)X`/.!Q21:+I\2NJP$JR;-K2,P5<YPH)^
M49`X&.@]!6=I;O"VGSRW4S">WD:;S92R_+M(//`QD\C\:OZS-ML$<3/%`TB"
M66,X*QD\G(Z#W[#G(ZT`2#2;,0&+9(06W[S,YDW8QG?G=TXZTOV"Q@T][$H$
MMIMZLC.?FW9+<DYYR:Q[1GNM4C@6YG>P5Y#`ZSM^\4)&>6!RP#%N<_G6C?,_
M]KVX)81BVF=<#C>-@SGUP6_,T`->WL9+:6.RN;>-[M5C+EO,W*5)"J"W]TD@
M=.^*O006XL([>$*UL(@B@'(*XQ_*N:TN\NI/[*WW,S;Y(`^7)W9M2QSZY//U
MYK4CDECT74#9EF:.280X^8C#'@>N#D`>V*`)I=/@2U99IPLDT:6SS,=I=<D!
M>O#'<1D=S^%6KRWM9;8+<X6-""&#E"AZ`A@01^!KFGNU%^R:?J$\UN'LQG[0
MS@%IF##)/<8!'X>U3-<W9CNX#+,O]G(8B^\_O"S`H2>I(0#/NU`&Y'IEG''Y
M:P#;L9.23D,<MDGJ2>IZFC^S+3[2+CRV\P$-@R-MR.`VW.,^^,U@PRW4;6]Q
M'<3R32W]S!L>5BA4>:5&TG`P5'/7MTXJ;1KB.35[=+>^GN`UF[7"R2LP63='
MU!^ZW)^7C'H*`-7^QK#=*Q@SYH(8%V(`)R=HSA<G!XQR*3^S+"WB9F4HOF+*
MTC3-NW#@$L3GIQUYK&U:_NK+4I0))6BM&%XX5B,Q':NT^O/F$#_9%.1;F.UO
MY9KFX^T1+&,><VU2RJ6P,XZDT`:ZZ=IICDA5%*S1?9F7S#\R#/R]>VYO?FH)
MM#6;4UN6D18E=)/+57!9EQ@GY]I/`YVYP,9K-AC@BO4*S.)DN[@*K7#??/*@
MC/<`''>JEM=W<EJ0E[UC7SBEU)+(LAD09.4`C/+#;^G!H`ZJZT^VNW5YT8LH
M*_+(RY!['!&1['BFQZ79Q6QMTAQ$42,KN8_*HPHSGM46F!HKJ_M_-EDCCE79
MYCERN4!(R><9S6,\EW!81W%O<7,EQ-'.""Y?IDC:IXR,<<<]\T`;;Z;81W27
M;IMD63>I,K!0[9&0N<9.[TYS1=:?8:JK-*/-4AHG,<K*&`)!5MI&<'/!Z&L#
M46MY895@O)I[&.2V>20W#,(V\X;OGSD?+R1GY<`\4Z.Z+^6M[?3PVADNP)EF
M*G>LN$7.>>,X7G..AH`WVTJR:Z^T&$^9E6(WMM+#HQ7.TD8')&>!Z4JZ79*L
MJB`;9HO*D!8G<F6..OJS?G6"UW=?VTR+<JLOGQJB27$@8Q';G$(3!R,_-V/4
MC&*T=6EB34(4O;N6UMC$2A24QAI,CC(QDXZ+GGG@XH`L36.F2/;V;;4EACQ%
M'',8W"<`CY2"5X'MQ4XTZT$3Q+"JQNJH54D#"]`,=,>U8WAY)I-5N+B[$BW3
MV5L9%+M@,=^?ES@=/PY]371T`5OL-O@`1CB4S#)/WSG)Z^YXJEI>BBPNFN&D
M1VV&.-45U5$)!P`SM@<#@8`]*UJ*`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`*1B%4LQ``&23VI:BND:2UF1!EF1@![XH
M`A_M33]BO]OM=C/Y8;SEP6_N]>OM4YGB`),J`!@A.X?>]/KR.*P;O3;L"U:)
M;C`M!;LD!A^4]\^8",'VYXZ&GQZ3=1WT,:DBT\I9)'W@L9E38,],Y&#G`Y2@
M#8BN[:9Y$BN(I'B_UBJX)3Z^E,_M*Q%L;G[;;>0&VF7S5V@^F<XS6&^E7MSI
M\=H+9;5X+)[?S=ZD.Q4`;<<[<C/.#TXJW,MZRQRP:6('$GS8\II?NXR,G:/3
MJ3CMVH`MS:U8QL56>.1O(,X"RH-R>H)('X]/>K(N[8W1MA<1?:`-QBWC>!ZX
MZUS(TK4ET2>T:V9YI;>XC!WI]XR,RYY'4$=!^57X[&[5EMC;DA;M[G[5N7!!
M8MC&=V[!V],8[]J`-:WOK2Z9EMKJ"9E`9A'(&(!Z'CUJM#>Z;#<Z@%GBC>-U
M>Y+2``$J`"<GC@`=NE4M)TVYM6T<R0A/L]B\4V".')C...O1J==V=W_:;7"6
M[2QQW"3A0RCS!Y93`R1R#@\X'O0!K&Z@^R&Z$T9MPA?S`P*[>N<],5FIK6E:
MDIMFN0BS1QLI,P3?O)`52&SN!4@@58L+>5;2Y\R/R6GD>019!V9'0XXSW..Y
MK&_LN_DT[4!]E:.:33X8(@77)=-X."#QU4Y]Q^`!T,4]I',+**:%9408@5QN
M51_L]<4LUW;02QQ37$4<DOW$=P"_T!ZUB6VF7D>IXE-R\0NGN`^Z(1@$DCMY
MF<'&.GOCBI-;L[N6[,ME;2-*\2IY@>,QM@DA9$?^'G.5R>3Z"@#8%W;&Z-J+
MB(W`&XQ;QO`]<=:8=0L@)2;NW`B(63,@^0GH#SP:QK?2[R/4<2FY>(73W`<-
M$(QDDCL9,X.,=/?'%,&G7ATJ"R:P4R6[0JUP77,H6568CG.,`DYQSV-`&XE_
M9N\:)=P,\J[HU$@)<>HYY%00ZWILUI]J%[;I#O,>]Y5`R#TSGZ'Z$5FW.EW;
M:G.0+AX9[B.;*/$(UVA?O;E+@C;QM_3DT&WU*.....S(VM,AE7RB^&?((+'A
M2#SP3D=/4`V7O[-)5B>[@61AE4,@!(]AFIA(C2-&'4NH!90>0#TR/P-8.EZ:
M;729HM2"P1FTBB=RX&W:A!Y!XQZU<T6.>;3I+FX^6XNR6/)X&-JX].`#^-`%
MBXU:PM[>YG>[A*VPS*%<$K[$>IZ`4R36+2'3X+VX=88IV55WNG\73D$CISP>
ME8\^F7LVEBU6Q6*2WL);<,'7$K,H`"\_=R,_-CMQ6SJ44S64/DQ&5XI8W,:D
M`D*P)QD@9_&@!UCJMG?DI#,@F!<&%F&\!6*D[0>F1_*I[>[MKK?]FN(IO+.U
M_+<-M/H<=*PDTF\^S6<83RG%Q=-(P8?*KB7:>#S]Y/\`(J?1+&Y@N1)<"Z7R
MX/)`E:':>1]T1J..."3GGI0!:O=1BQ/"+>[GCC!$\EOQY?&>NX,3@_PY-2HV
MGQFUM5EA1E`:&'?AL8QD#.3P:KYO;&6Y2"R-R)I#)$XD554D#A\G/7N`>*JR
M6-Z?M$#VJ2-<W$<QN58!5VA,Y!.[(VG&,]N10!I27NFM)N>\MMUOER?.`V=5
M)//3MS3IKFP::%)KF#S-P:)3*`22#@@9Y[XK/TW3981:&:!0T<UR['(.`[L5
M/X@BLFST^\6UN-/-IF>33H;=I-Z_N6P_)YZ#K\N>10!U1O+477V4W,/V@C/E
M>8-^/IUIJ:A92,RQW=NQ4`D+(IP"<`]?6LB:VU*34(A]G(ABNUD++Y85UZ;N
MI8MZ]._7I2#3!'8V:WB)!%%:S1SN6"[-VWOGVSGVH`WA(C2-&'4NH!90>0#T
MR/P-/K)T0W!LUNKB)FFNY-S[3PB@84\XXPHX'.6^IK6H`*:ZAT*G.",<$@_F
M*=10!7M;*"TW>2'+/C<\DC2,<=/F8D]ZL444`%%%%`!1110`4444`55L+=;K
M[3B1I<DC?*[!3T^52<+^`%6J**`"BBB@`HHHH`*K7=C!>%?/\TA1C:DSHK#T
M(4@'\<U9HH`0`*````.`!2T44`1I#'')+(BX>4@N<]2!C^0J2BB@`HHHH`:Z
MAT9&Z,,'G%*JA5"J,`#`%+10`5')$DC1LZY:-MRG/0XQ_(FI**`$J-((X[<0
M("L87:`&(./KUS[U+10!7M;*"TW>2'+/C<\DC2,<=/F8D]ZL444`(>1BJ]M8
MP6LC21^8SL,%I97D./0%B<#V%6:*`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"H[C_CWE_W#_*I*9(RI&S2?
M<`);(SQ0!R]EI3BPM;I+*QLA';EFDMV)>8&,C#?(O&2#U/(_&EM]2OP5$:NL
M4#0Q`$Q"-E94SN+,'R=QQCCIUKI8O*DMD\I5\ED&U0N!MQQQZ8J":'3XKFVD
ME@@$^?+@<QC<,*3@'''`-`&'<ZM=Q7D?D7C,D_GA6N$2.!"J,00?OX!7DDD=
M>G%._M.^BMY+9FNFNO,C!W+#O57S\RL"$.=I`SC'?-;%I;Z;<QI>VUM;D3@2
MK*(@"V1UZ9S@G\ZDCTZQAMI(([.W2"3EXUB4*WU&,&@"G9WEV-*NY9HG>:W+
MA%=HR[X7(W;"5!SQCC\*SWGE@NED?4FD>6V3:XB5F4M(!A0`!ST&<XZG-;U@
MUJ]C"]BJ+;.@:,(FT;3R,#M3!IE@J.@L;8+)G>HB7#9YYXYH`YU+NZNKNW1[
MFX_T;46C4LL8=QY#-AMHQUR.,<'L>EW0]1O[J>V-R'"7,!E(D,0`(V_ZL*VX
MKR0=PSTZ=*UUL+-8Q&MI`$5E8*(Q@%>AQCJ.U-LHK(@W=G#"IN!N:1(PI?Z\
M9/XT`8UW%,U_=;+J0$WL`4%5(3Y1TX_GFF27=VM\(A/$TL45RJSS*BDX:+!)
MQQ][M@'CBMZ=+2*59IHHA)(RH'*98G^$9Q]:22.S%RD;PQ>=*KXS&"6'&[G'
M?Y<^N!0!7T6>>6.:.Z:8S1N,K,J!U!`."4^5OJ`.*RM&TUS;V=REC8VVT!S<
MQ-F60>A&P=>_)KH;:UM[2+RK6"*"/.=D:!1GZ"I$C2.,1QHJH!@*HP`/I0!S
MNFW-]=0:>DVI.C75H;EI/+CSD;?E7Y<8Y)/4^XJ6WU.YF-B#,FVYC1I'5>(^
M>".O#]!G\,UKR6-I+;I;R6L#PQXV1M&"JXZ8'05)Y$1##RDPV-PVCG'3-`&9
M97ES-J(LGD!>VWFX(Q\P)_=\8XR#GC'(JIJ>ISV]Z&@N965;J*!HQ$@C`8KD
M%C\Q.&S\OMQP36U;6B6\DTN]Y))FW,[XS@=!P!P*C%MI]S<RS?9H))T81O(8
M@6R,$#)'T-`&)'JE_%%!=-,UQYTMU$(-J@?N_,*X(&<_(!UQS5S3O,_M=&EO
M/M1>S#Y*J-N6'3`''IW]S6HT-M"J,($`C<LFR/)5FSD@`<$[CD^YH@LK6V9F
MM[:&%FSDQQA2<_2@#%N+V[COI1+,QMW,D:!5C>(D*2%/\2L,<YR.HJ$W]Y]C
M6=+OR?*GMX!`L:896\O)Y&<D,<8XP/QK?^Q6AN&N#:P^>R[6D\L;B/0GKBJ%
M[IM@=0M9[IR"76."/RDQN7+`;@NX#Y<XW8XH`JV%_>-<6,DURTB75Q<0&+8H
M50AD*D8&<_)CKCFH]4\R;5[B%9V@"O9D/&B;CEW')*G/8C/]3G9LVLKE0UM"
MNV&1MI,)4!CG<5R!G.3R.N33[BWM)&*3VR2_:,(VZ'<&"Y(#'&,#G&>Y]Z`*
M&L7=W'?6UK;+.%DC>1F@\K?E2N!^\(&.3GO44.HW<C6*O+&/M,:-*R881'V(
MR,.>!R?8FM>YM;>\C\NZMXITSG;*@89^AI'2!6"&$'S3CB/(.!D9(&!T[_2@
M#".JW$>JVPCGGGBN&F7:T2)'\JL1M_C)RN,DD<GIQ0IN+FWL))-7,C3/#+LC
M2,%<YZ<?=],C/'4UMI86:3&9+2!92V\N(P&W8(SGUP3^=(NG6*HZ+9VX61@[
MJ(EPS`Y!/')SWH`P+*]GL=.&QQBXDN(H%(&!-Y[[?<YS_P".UL:G+)##!$MS
M-'(YQF&)6=\#)QN&T?B*F?3H&F@<91(&:1(D`";SGYB`,YY/?'.>M2W%M;W2
M!+F"*9`<A9$#`'UYH`YJ/5=1GTR"Z$[@(KF0QB)G&V1EW.IZKA>=A'.<5J:M
MNDO-&,<\D:M='.T#YAY3GG(/IC\?7!%N>RTY8=\]I;>7`3("T2D(>I8<<'O4
MA^S7A\MU27RRKX=<[3U4\]Z`.;@N[W3-)@E2Y\U9+21UC=%"QE=N"#P<<G.3
M^5:VC7-W)//!=>:1&B.K3M%YAW;LY$9(`X&#QWZXK1%O`H0"&,!`54!1\H/4
M#TI+:TMK.,QVMO%`A.2L2!1GZ"@#!MM2NT-K<7%V3'/-<Q,A1=J!/,(;@9)P
MGKWJ-M3O$:>)+J9F\J.17FBC!4M(%X4<[<'^+GW-=$+6W`0""(!&9E&P?*3G
M)'H3DY^IJ.+3K&%=L-E;QJ.RQ*!U!]/4`_A0!DI<WT5Q(K7LDJVUZEN0R(/-
M5U4_-A1R-_&,=.<TFB:C?W<UO)<+*L=S&SE9#"%0CLFT[SCH=P_+I6Y]GARQ
M\F/+.'8[1RPQ@_7@<^U-BL[:&>2>&VACFD^_(J`,WU/>@#&U;4IH+HFWN9?W
M4\43QK$GEC<5R&+<DX/&T]QP>:ACU"]"&X:_W[KJXMQ`47`"E\$8&<@*.IQC
MMWK>DL;.6?SY+6!YB-OF-&"V/3-06^D6=NLVR)?,F,A:4J-_SL6(SCIECB@#
M&DU2^M+))%N#>M/;)+O"(!&6=%XZ#&&)&X_PG)Q4Z7MX(S;SSW,4AF"H3'"\
M[#86(PA*+TSDCIV[UJVMK8P"6V@AB!P!*!&!NR/XN.>*7^S+#[+]E^PVWV?.
M[RO*79GUQC&:`,/3=0O[Z-6:\,7E1S,2RQX<I(5&\@$`8'.W\#6AHMS<O-/!
M>23-(JJX618^ASRK)P5..,@$<]:TH[:"(DQP1H3D':@'4Y/ZTVVM+:T#"UMX
MH`YW,(T"[CZG%`&(VHW8A2[^U@F6>6'[/L7"[=^,<9W#:"<DCKP*N:7-=?:(
MH[FY,_G6JS<HJ[6X!Q@=.>^?K5N*&QFGFGC@A,P)BDD\L!CZ@G'(J8K%"!((
MP"H"`HF2!GIP,XH`Q[_4KNUFGMH\23H6N$`QEH0F<8Q_>&WZ'.<U#/J%W:;%
M^V&X$T*SF0J@$?[Q!@8'W2&.,Y/'6MI;5(KN6\9Y))&7:,@'8HYPH`]>>YH@
ML[..)Q#:0QI-RZB(+OS_`'AC^=`&1=WUU)J@M(+MHD-XL)9%4E5\@N1R#SD`
MU9UJ:]B>W6TE;&UVD2(Q^:V,8(#\%1DYQ@],5<M;:Q\J-[6W@6-3N39&%P1E
M<CCCC(I=0@LIH,W\$,T2'.)8PX!Z9P10!B)=RL\ES!?,$NS;JKLB@(''W@".
M">@R3R>]2B\O)+QM.^VM&$F9/M>Q-S8C5L8(VYRQSQ_">E;+V=K(7,EM"Q=/
M+<L@.Y?[I]1[4UM/LGM1:O:6[6Z](C&I0?AC%`&-9W<PUAD\U'@F>/=<QCY9
M&\H$`#G`."<Y]!WJ[J4TYOX[>*^6R40/,7**VX@@<[OX1GG&#TY%:'V>#G]S
M'R0Q^4=1T/X8&/I27%I;7007-O%,$;<OF(&VGU&>AH`Q$U&_?4BRK*T(N1!C
M,*Q;>F>6W[NX_D>M0I]JF@L;N>_F=GBE<H4CV?=Z8VYQ^-=`;.V-U]J-O#]H
MQCS=@WX],]:CNX[&"S,MS#$+>V4R#,8(C`!R0,>F>E`&!!%C4DNV8/(?LT8W
M1)\BD9(4[<CD>M6XK^9;0W<^J!#.#M@\I6:,[PH"@8)ZA3G/)'3H=>**V<;D
M@0;2.3'CITQD=NQI#I]D3,3:6^9QB4^6/WG^]QS^-`&!%<75U<)%)=7/^CZ@
MJ`NL8<CRRV&VC'7V!YYYJ?1-1O[N:WDN%E6.YC9RLAA"H1V3:=YQT.X?ETK8
M6PLTB$2VD"Q@@A1&,9'3C';M2I8VD<LLJ6L"R3#$C",`N/<]Z`*?B'_CQA_Z
M_+?_`-&K5?3+79:ZI*)7\^::53-M0.-I('(7G';.:UIDA$($D0:-2I"A-V""
M,$`#L<?2GI&B`A$50Q+$`8R3U-`''QFZM(9[FWO9`]MI$,V2B'S,>80IXZ=N
M,'WK134M0?4=P2;R?M(@V$PB(+ZY)W[N_OZ=ZV4L+..-XTM(%C==C*L8`9<D
MX([C+'CW/K3OL=K]I%S]FA^T`;1+L&\#TSUH`S-<NKRWE#6\SI%''O?RA&S+
MR?F96P2G'\)!ZU!;R3Q7,EPERWDR7^PP[!M(8#DG&<Y]_P`*VKBSM;ID:YMH
M9C&<H9$#;3ZC/2G^1%_SR3[V_P"Z/O>OU]Z`.6N=9NXTFDM[N61)+&:>-WBC
M5<J`5*#[V.?XLCWZU/>WVI6TTL44L\GD6ZS^8?(5226^_N*X08'W>?4UJP0:
M3([1PVMMF96=@(0-X)VL3QSGI5J>SM;AHVGMH93&<H70-M/J,]*`,F"]O/[6
MC$\S>1+(T:B,1O%G!.W(^=7&.<Y'6F>(M1GLTN7MKJ97MH!+Y<<2%<DG&]F[
M''1<'COD5LBSM1=&Z%M"+@C!E"#>1Z9ZTD]C:7,JRW%K!+(H*AGC#$`]1DT`
M8L][?K%-,D\S;[D6Z1QK'^['!R-V,MVY..>AJ[97%S+I=V;E6#Q%T!D,;,P"
MY^8(2H/.,>W2K[6MNT+PM!$8I/OH4&UOJ.],>SB^PM:0?Z-&5*CR54;1[`@C
M]*`,2._NS;33K<>4+/RE6W"+MEW(IYXSR6(&".G>H[6ZO)IVMH;G[,I%Y(3%
M$F<I,`.HQWY]?KS6^+"T#PR&VB:2!0L<C("RCV/44];6W1MR01*V&&0@!^8Y
M;\SR?6@#F[:66\:&\DF?-P]K)Y?R[4++GCC/YFM/3;VXNKS[.\F3:1E;GY`-
M\A;`^G"EL#^\*OBSLXBL@MH%,:A581@;57H![#M4>FV\,4+30R/,;D^<TK@!
MGR!CH!V`'3M0!F0O<V]W-,EPWE/?F,P[5VD$#G.,YS[X]JS)]1O[O0[J2X65
M8[FRF<K(80J$*>$VG><=#N'Y=*Z@/:,Y18PS";#;8B0),;LDXXXQS^'6E&GV
M0:9A:6X:<;93Y:YD'HW'/XT`8%_)-/Y;O=X2+4;>(6P5<??0Y)QG<<YZXQV[
MUU%5GL+.2=9Y+2!YEQMD:,%A@Y'/7@\U);P);0B*,84$G\223^IH`EHHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"H;L%K.=
M5!),;``=^*FI"<#)Z4`<L;20QQ?9K.XCB6*(7D94AI2&3C/\9"A@<9STYZ4K
M64;7-M-'I\BV27H:-&@/R`Q$;@F,JN_;V'(S[ULQZWI\L;R1SE@F.!&V6!Z%
M1C+`X.",YI'US3T6,F60F3=M18'+_*0&RH&01D<$4`96@:>UE)I+):M"7L&%
MR=A&7'E[0_N/FQGWI\ULR>(6FB@DEE>0$F2!OE7:`2DH.-O^P>IS6I+K-A"$
M+3EE=5<.D;.H4]"S`$*#ZG%.DU6T2Y>V\W]\H/!5@I(&2-V,9QSCKCM0!SMC
M826-E8M%82;WTUUN4560N_[O`8CG/WL=^H%):V+2W-Q$;`)922V["-+5HHR,
MN&RI^BYR!VX]=ZUUF"XN&A*NC!D16V/M8LF[@E0/\CU%7H9HYPQB;<$8H3CN
M."*`.;2QGCUOY4$;K<`HZ63$B$?PB7<%"XXVX_`U$NERP6-LUK:21W$EK()S
M&"CORIP3QSC(&>G:M]M7L4O&M6F(E5Q&W[MMJL0"`6Q@9R,<\]*AAURV:V26
M<-$SO(H15:0@(Y4L=HX'&<G@9ZT`9T=L3=*VGVDEO8[X-L9@,>'#-N;80"!@
MKDXYJJME<&&-+>VGBU$6<R3S^65#2D+SN/#$G.#70OJUE'<"!ICN+*FX(Q0,
MV,`L!M!.1@$]Q0NKV#/(OG[?+5G9G1E4JO#$,1A@.^,XH`P+?3VE)0VY-LTL
M(>(6301D@G<2K,23@\G&#QR:M06@M_$*-!:MC>P):W9#&N#TD!VLG0!#TXZ8
MK;M+V"]5C`S?+C*O&R,,]/E8`\U7;6K$3F!9B9,LJYC?:S*"6`;&#C:<XSCI
MUH`S-8T\W.H:A,;9I&6SB\APA)#AI#\I_O#CISS[TV>U-CJ\<\5K*+2&Y\QA
M#$6^]"RE@H&3\Q&<?C6U'J-L\/F&0##(C``\,P&`.,G.X<XHM]2M;J=H89"7
M&2,HP#8X.TD8;'MF@#EWLY#81-):3&8/,4BDMF<9,SD892#&W(._IC%;VD6Z
M076I8M?(EDF#LPCP'!48PV,-SN^F?>KCWUM&)"\F/*D6)N#D,V,#WSN'YU!_
M;5AME8SD)$C2,QC8`JO4J<8;'^SF@#GK6TEBCE@M[29D(0O));-%)N$B\.?N
MRG&X[AZ=>:=);H+ZT7['*M_YLYGE,9_>#RY`#NZ,.1@`G`XXZ5T5QJMG;.R2
MRD.JHQ58V8X8D+@`<Y*G@55O)K73/*N;/3HS<WD@0$0LA8GGYRJ$C\1_6@"/
M3;5=/FB=+=XT-FOFE4)+.".O<MC/O5G5X7EN-+VQLZI=[GPN0%\N09/MR!^-
M+>:Q;V^G/=QGS?W#SQIRN\*,GG'':IK:]$\4\AC*B%RI`^8G`!Z`>_2@"A:6
M*Q>&9;9()(-Z296!0C\D\@<<XQ63%:7>^W6QMA$JRR&.5;9X%#&"0`F-ONX.
MWD8!)K3C\30/;03>1)B5(6V+'(SKO)'0)T^4X(Z_B,V8];M6A)N0R$RRQ[%1
MI.$<J6.!P..IX&>M`&*;:WD,D-G8S0L8(_.0Q,A9O-7)QU)X.6[XZG%37-A)
M#J6RVM76W%P[J$0[1FV8$CL,M^I]:VT33]*MC)!!#;Q.0<01??)Z8"C)/TIC
M:U8+&CF5SO+`*(7+#;][*XR,9&<@8R*`,A].E@MT2SMW0/;1&X"J<R;77<">
M[%=P]:O:#]F%QJ(LX&AA$J`(4*8^13PI^[UZ8%7KR:S^Q;KH++;RX`7RS)YF
M>@"@'/Y5'8W.FI;*EB(XX0C2!(X]@`!PW&.#G.1US0!SL5M+<7+.MA/:+):R
MQS>3"RR[CC`+L0'/7!Z>AYQ6QX>C,,5PBVZQP[@4*V[6^XXY_=MTZ#D<&KC:
MK9)-%$TQW2A2OR-CYONY.,+GMG&:CTS6;;41&J[DF9"^QE8`@<'#$`-C(SCI
M0!SRVLMU-(RZ881):31RKY#@ER!@.[??/H<$>AYJPUG$)-T>GLL#>2TRK:L"
M\04@KC'.&VY7K@=*ZJB@#F[/3Q-?PF2S/V%9)7MXY(L"-=L>,J1\OS!B`:K_
M`-F3Q:=;FTMY(KF2SE25E4AB?E(!Y'/7&2/;%=910!REM`;6SN;U5\N&U"3Q
MQK9FV0%=V_"NQ.2I()X'(Z\UM:6PA@ABFW"ZN%:X92">202,].-P%79H8IU"
MS1)(H(8!U!`(Z'GO3MJ[P^T;@,`XYQ0!S6H6ET^N2NPY:2,VTBV;2,B@#($@
M8!.=V<]0>_2GW5K=,+XP0RJDB2"U5<@HW\9QQ@L<XY_$;JZ2B@#DH;206<^V
M"1K,O#OMXK)K=2H8[\(S%F.,9XP0.,\U;PEOAK6QNTMY+:2.)/*8D-NR!CJ@
M/;.`.G'2NBHH`Y5K$(X+6+%2(&N0L!)DC"$%>!\V&VDKR<#I4UGIXFOX3)9G
M["LDKV\<D6!&NV/&5(^7Y@Q`-=)10!2NYA/I5Q)!&\^4=1&"R,Q&01GJ.1VK
MFH+63[5<,+%DTYO):2&.T=%D`+AOD/+'.TGCD#H>I[!55%"JH4#L!BG4`<Q;
M:;#<W$:26#_9/,G81S1$*`0FW@]N#@'T]JBBL9ULK1Q:RB>:TA-P?+.YI!)&
M?F]P-W7H,UUE%`'*0V$L4=K,EHZSO/=I,_EG<8SYI4$^F0F/P]:1+5XM3MI%
MM)99F\E6$MLWRKM4$K*#A0.24;J<\<BNLHH`YFPTZ%'1O[-_X]X)-J&+8/,#
M\;3CKCHP_"JB6GG)=8TS9;O;*QC6T=0SJX)R&Y9L=\9/;-=C10!S*VS?:E\N
MUD6^^U!UG\D@"WW`[=V,`;.-O7/;O6AH<4-AIUK&T/DSSCYOW9!9@"?F..N!
MWK6II52P8J"1T..E`'->*(D\K47NK:28-9E;5UC+B-\-NY'W3RO)QD<>U3`2
MK*+?[-.7^W++N$9V[,#G=T_#K6U+96L\Z3S6T,DL?W)'C!9?H>U3T`<3/;W$
M\=R\.FO`TEC/'(JP/O9R!@,Y_P!8?0@'V/.*M:SIL,=K>QC3GDWV>VU$,!8)
M)AMW0?*22,D]>E=910!R]S$X5HIM.,Z23R$-+`\J*<+C*#KGG!.`,'D9JF-,
MGETZY:>SE:XBTN,0ED)995,GW?\`:''3GGWKM**`((9UF61$)\R(['W*1AMH
M/?KP1TKE9;.4Z1)'#9SK?"RE6\?RF'G.4(`W8_>$MR,9Q[=*Z]552Q50"QR<
M#J:=0!EWMHL6C""UMPHWQG9&G^VI)P/Q)K-L[!X;FSN5M72=M1N!+)L(;RB9
M2,G^Z3M([9P:Z:B@#E_%,,MPUPD5@99OL_[B;RGE(;YC\N/E1AQSD$Y'7`%3
MQV'[W[4;9OM!O@=Y0[MA`!_X#Z]JZ&B@##T>-VU"5'7]UIRFVB.>N2&_1?+'
MUS5>YMF>]F"VLIU!KI&2X,9*^3N7(W]`-NX;<]>W.:Z"&"*WC$<$21("2%10
MHR>3P*DH`Y6VTF"1-C:>56*VE4*82H$F_@@8P3P,$?A3'M+U[]7G#>:WDF"3
M[&TCH`J[@)`P"<[L@]<]^E=;10!DZ!9K;PW,K6XCGDN9BS%,,R^:Q7GKC!R/
MK6-)ICQ6&G'[+&L)1S<H]FT^Z0XVED4@G`W#/./Y=?10!QDELK7,L5U;7%U<
MC3XA"1$=R/NDVGJ=AZ88GC'6K%QITS0:G,UMNG:[0,YA+EXML>X``@LN0<@'
MG!'/2NH$:"5I0BB1@%+8Y(&<#/XG\Z?0!QLMBQMT>2.5HUD<PQ_V:QA7*IQY
M08NO(.#QC+=,C,C6M]+?+)<PF*9_),.+5YGA&U=RB7<`OS;LYZ^_2NNHH`Y1
M-+.(9/L3>;+?72RL8^6B;S<!O]@G:>>,D>M5+VV+:1'!;:2RRK9@1,;:0E9!
MNW;1@"-L\[N"<@\\9[:B@#E3IJ27WEFQ91+?%YF$!`9&@<9+8P>2WT)YZ\H]
MMJ%SI\LMU$V])$@=7B:021QYRWE@@D,QS@'D`=>E=710!F:!#)#8NKD[#(3&
MOD&$(N!P$))`SD\XZ]*TZ**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`*9*@EB>,G`92N?K3Z*`,5;76%T]+</:H80B+Y
M<C*9%'!);:=F>.`#TZU3M]/U.RU6!HTBF8K<,6>1]H#&+`+$$YX/UQV[=-10
M!S5_H6HSZ:UA'<QM&;<1@F1HP'P<G:HY!/J>/0UH+9WT;W$,9MOLTS.Y=BQ?
M+#[N,8Z]\GCC'>M6B@#`GL[FSL+K""5V6)H/*#,WFHH`!&.F5'.>A.<5I6$<
MEI'!:%-P$1:27U?//&.Y)/6KM%`&`ME>SW^I1A(TMI;N-S(^=Q"I&3M&,'.,
M9SP0>M1?V!<HB%2CN3*K`74L(`:1G!RGWN&Y!_.NDHH`YVXT2_D\J!9H_LT,
MD+Q#S7`54*_+MQS]TG+,>OXASZ)<RFZC!BMXIE<'RII"KL>A\LX">^T\UT%%
M`&7I&GRVDLT\Z(LDBJG%S+.<#/\`$_;GH!QSR<\9BV]W/>062QCR+1Y6$K1R
M)N#(ZC.Y0/XOX2V>O%=/10!CII$RW]G*95\B*%1+&"?FD4$*1QTPQ_):BT?1
M9=/FA#[6CMT*1N;F5RW;[A.U./3/MBMVB@#'N+9[GQ!'M$BV\:;YLJ0K.,A`
M">#]YB<?W5JN=#NYM.33I9(4A@MW@BD0EF?*%`6&`!@'H"<^U=!10!A)IE_+
MJ`N[G[,AQ`-D<C-]QG)Y*CKN'^>:T[VV>X>U9"H$,PD;/<;2./SJU10!SDVB
M7\UE]D+VP2.UFMXVW-ERX`!/'&,<CFM>PM7MDG60J?,E+C;Z$`?TJY10!S=M
MH=_!%&<VS20PVT2CS&PYB=CR=O&01V.#FE.@7*LTBE'9WERHNI80%:1G!RGW
MOO<@_G71T4`9]Q:7,>F06U@Z(T01<%R@90,8#88CZ\UF'1+P08*6\TGFR.&-
MQ+&Z!L8Q(,MP1R._'3I71T4`9MS8SS:3#;R&*ZF0+O:4M'O(&"0R\J?<9JHF
MF:E'&I$L4LC0O"_FRLVP$Y&&QE\=.<9K=HH`R;:ROK.=?(-L8Y%C$K.6RNT`
M':`.<@=R,=>>E%MIUS;1V)7RG>UAD0J6(#,<8YQTXZX_`UK44`(,X&>#WI:*
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`***CN/^/>7_`'#_`"H`DHKG;:TL[*STB:T@A@N9#&"8U"&0%?FW
M8^]QD\]Z99W$QU=;J:TF2WORT1D?:R,/^66,-D`J&Z@<O^8!TM%8-MI>GPW^
MHO%8VL;1!?+985!3*<XXXJ+1]/$5C!.=(TV`BVR)XFS)RG7_`%8ZYYY_.@#H
MZ*YVUL[2SL](EM+>*"YE,8)B4(9`5^;=C[W&3SWKHJ`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***CG)$$A!P0IP?PH`
MDHKF;:&ZOIHB?,E06T!9O[0FA(R#D[4&&/U(K2U6":>Y@2*0LBJQ>!+EH';I
MA@5Y..1C('/TH`U**YZSO+Z74B+-/.C^QQ$I=SE"K;Y`3\JL">,$^PZU7_M2
M9+.P):Z>2&%9Y?*BDEWD\;6*CTW]>^TT`=317(WK7<L^I3Q/((EN%C2X%[*H
M@!C0[O*`VLH+9YZYYXYJ_#;7<^ISR;6DC2XQO.H31X`"](U&T_3/-`&_16%;
M"2&]BFFDFE6:5E6>*Z+QN#G`,9X7ICY1VZ\FEUK46@O(DB^TG[.HF=889'#Y
M.-I*@@?+N//?::`-RBN1O6NY9]2GB>01+<+&EP+V51`#&AW>4!M906SSUSSQ
MS5^&VNY]3GDVM)&EQC>=0FCP`%Z1J-I^F>:`-^BL[5+Q$AEA24I.GEL0,CAG
MP.??!%9\K,]A>Z@]W/'=P/*$02,$4J2$4QYPV1CJ,G/':@#H:*Y\RWCW41BE
MD#I-,QBW<.`%^0_F<>AJ"Z9;VS%U'<W0W7\<0,=Q(GR-(H*X!'8D>HH`Z>BJ
M%@I2ZNX`\C1QE`N^1F(&T=R2:CM1<->FVDE8Q6F&#;CNDW?=#'V&<^IP:`-.
MBL>XGU!;^]6UBAEC6)#^]N&3:<-T`5OZ5F:7'>WUQ*Y\R9$,(W-J,T6W,,9.
M%4$'DD\]2:`.KHK,663^S=0?S&W(\P4YY7&<8J*VB%G=V*PSSN;A#YJ2SO+P
M%SN&XG'.!QZT`;%%96N)/*UE%!DEYB"HN7@W`(QY9`3VJE:--/)!874TT4>Z
M8-LG8EF5EVH)>&(P3Z$X]C0!T5%<Y/%YEM=K]INF2UG6.&1;B13@[,@D,-V"
M2,G/YBI4-[:ZO=VUBHGA2WB;%S=R94EI.02K$YQ[=!^`!O45A6[SW'AC3,7`
M\^:*+/F3F-ICMR5WC)!/)R.>#3$GN8YX8+197E2=E>&ZN3@#RP<;P&)'0\Y.
M30!T%%<W)?W(AG@G:6*>6[*_Z-OF,2!5)VX7..@Z?Q4RYN+K4#'/!;RS%;7>
M\"WDML0X8@@!1R<@CG'2@#IZ*Y2)+N\OHTCE:Z1;&)\_;YK<99I.?D!W'``R
M>>*GEN-2B&MI;I&\<.`&DNG#1_N$)V_*<\\YR,DT`=)16&@6Z%U+<WT\+V^`
MNR8H(QM!W$9PV>3SD=J?X=NKFZ%W)=[A)OB)0GA"8(R0!VY)_.@#9HKF=-S#
MI.DW0N[EKBZ1=ZRW#R"3*$GAB<8Z\8Z55A2^B\*R7SF17;3S()_[1FD8L4SG
M81M4]^#QVH`["BN9BCO(;NYA>?[#BW.WS+V2=7)(`8,X&W'3C^\/:M'2@T%S
M+;2+<1R;%?;)<F=#R1E6;YNW0X'3CK0!JT5Q-SJ%Y'HE[:"[G^TN)+B.4.=Z
M1`,3SZ!DV\=`PK9ENG_LG5")V\V-RJX8[E)5<`>G7]:`-VBL&7>EV]S)-+)"
M9PBRV]T2%^8+L:/[O7@D9/7I5C3[*./4[HB6[80LH19+N5U&5YR"Q!Z]Z`-:
MBL&[$L5[<7DDLTT*.N#;W1!A&`"IC^Z>YYR>>G`I$EEN+I;6::98'EN/F24H
MS,K@*@8$$<$G@CI0!OT5S4%S<27,<-J]VCVLL@:&X=6+853L+!FSPW!)R#UZ
M5K:1<B[AGE60NAG8+D]!Z>V/2@"_1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4A`(((R#U!I:*`*EOIEA:EC
M;6-M"6&&,<2KD>AP*G>&*1%1XT95((4J"`0<@_@14E%`#!&@9V"+E_O''WOK
MZU5AT?3+>42P:=:1R+T9(%!';J!5VB@"G#I=E;"3[%:P6DCJ5\R")%8>_3'Y
MYJ/^SKK_`*#-]_WQ!_\`&ZT**`,_^SKK_H,WW_?$'_QNC^SKK_H,WW_?$'_Q
MNM"B@#/_`+.NO^@S??\`?$'_`,;H_LZZ_P"@S??]\0?_`!NM"B@#/_LZZ_Z#
M-]_WQ!_\;H_LZZ_Z#-]_WQ!_\;K0HH`S_P"SKK_H,WW_`'Q!_P#&Z/[.NO\`
MH,WW_?$'_P`;K0HH`S_[.NO^@S??]\0?_&Z/[.NO^@S??]\0?_&ZT**`,_\`
MLZZ_Z#-]_P!\0?\`QNC^SKK_`*#-]_WQ!_\`&ZT**`,_^SKK_H,WW_?$'_QN
MC^SKK_H,WW_?$'_QNM"B@#/_`+.NO^@S??\`?$'_`,;H_LZZ_P"@S??]\0?_
M`!NM"B@#/_LZZ_Z#-]_WQ!_\;IT=A<I(K-JUY(%()1DAPWL<1@_D:O44`%%%
M%`!1110`4A`(((R#U!I:*`&1Q1Q?ZN-$X"_*H'`Z#\*CNK*UO45;NVAN%4Y`
MEC#`'\:GHH`C2&*-]Z1(K;0F0H!VC.!]!D\>]$4$4*E8HDC!ZA5`SQC^5244
M`0QVEM%"T,5O$D3##(J`*>`.1]`!]!4#:3IKS><^GVC2Y!WF%2V1TYQ5VB@"
MO'86<5RUS':0)<-]Z58P'/U/6I@B*S%54%SEB!UXQS^%.HH`ACM+:*%H8K>)
M(F&&14`4\`<CZ`#Z"H&TG37F\Y]/M&ER#O,*ELCISBKM%`$,MK;S31S2P122
MQ?ZMV0%D^A[4U[&TDNENGM8&N$X64Q@N/H>M6**`(Q#$K[Q&@;).0HSD]:3[
M/`5V^3'MW^9C:,;LYW?7/.:EHH`JRZ;8SW`N)K*WDG7&)'B4L,=.2,U8"*'9
MPH#-C)`Y..E.HH`9Y:;F;8N7&&..OUJI+HVES/OETVSD?`&YH%)P!@=O0`5>
MHH`J'2]/-P;@V-J9SG,GDKN.1@\XSTIHTFP2VG@@M(($G0H_E1*N01CTJ[10
M!!<V=K>1K'=6T,Z*<A94#`'UYI&L;1[46K6L#6XZ0F,%!^'2K%%`$2V\"0+`
MD,:PK@+&%`48Z<4X11B1I`BAW`5FQR0,X!/MD_F:?10!"UK;O;"V:WB:W"A1
M$4!7`[8Z8HAM;>!$2&WBC6/.Q40`+GKC'2IJ*`(UAB21I%B17;JP4`GIW_`?
ME0L,2.SI&BNW5@H!-244`4I=(TR8@RZ=:2$9P6@4XR23V]23^)J>.TMHHFBC
MMXDC<89%0`$8`P1]`!]!4U%`%>6QM)Y(Y)K6"1X_N,\8)7Z$]*9)IEA+=?:I
M+&V>XR&\UHE+Y'0YQGC`JW10!5MM-L+-F:ULK:!F&"8HE4D?@*CCT;2XB3'I
MMFA92IVP*,@]1TZ5>HH`CDABE(,D2.0"`64'`/4?C3+6SM;)&2TMH;=6.2(D
M"@G\*GHH`@:RM6&&MH2-C1\QC[K=5^A[BD>QM)+A+A[6!ID^[(T8++]#U%6*
M*`*YL;0W0NC:P&X'_+7RQO\`SZU,$569E4!F^\0.3]:=10!7>PLY+I;J2T@>
MX7[LK1@N/H>M.DM+:6%H9;>)XG)9D9`5)/4D5-10!##:V\"HL,$4:H"$"(`%
MSZ8Z4](TC!$:*@8ECM&,D]33Z*`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHJO=O>)L^QP02YSN\V8QX]
M,85L]_2@"Q16?YVL?\^-C_X&/_\`&J/.UC_GQL?_``,?_P"-4`:%%9_G:Q_S
MXV/_`(&/_P#&J/.UC_GQL?\`P,?_`.-4`:%%9_G:Q_SXV/\`X&/_`/&J/.UC
M_GQL?_`Q_P#XU0!H45G^=K'_`#XV/_@8_P#\:H\[6/\`GQL?_`Q__C5`&A16
M?YVL?\^-C_X&/_\`&J/.UC_GQL?_``,?_P"-4`:%%9_G:Q_SXV/_`(&/_P#&
MJ/.UC_GQL?\`P,?_`.-4`:%%9_G:Q_SXV/\`X&/_`/&J/.UC_GQL?_`Q_P#X
MU0!H45G^=K'_`#XV/_@8_P#\:H\[6/\`GQL?_`Q__C5`&A16?YVL?\^-C_X&
M/_\`&J/.UC_GQL?_``,?_P"-4`:%%9_G:Q_SXV/_`(&/_P#&J/.UC_GQL?\`
MP,?_`.-4`:%%9_G:Q_SXV/\`X&/_`/&J/.UC_GQL?_`Q_P#XU0!H45G^=K'_
M`#XV/_@8_P#\:H\[6/\`GQL?_`Q__C5`&A16?YVL?\^-C_X&/_\`&J/.UC_G
MQL?_``,?_P"-4`:%%9_G:Q_SXV/_`(&/_P#&J/.UC_GQL?\`P,?_`.-4`:%%
M9_G:Q_SXV/\`X&/_`/&J/.UC_GQL?_`Q_P#XU0!H45G^=K'_`#XV/_@8_P#\
M:H\[6/\`GQL?_`Q__C5`&A16?YVL?\^-C_X&/_\`&J/.UC_GQL?_``,?_P"-
M4`:%%9_G:Q_SXV/_`(&/_P#&J/.UC_GQL?\`P,?_`.-4`:%%9_G:Q_SXV/\`
MX&/_`/&J/.UC_GQL?_`Q_P#XU0!H45G^=K'_`#XV/_@8_P#\:H\[6/\`GQL?
M_`Q__C5`&A16?YVL?\^-C_X&/_\`&J/.UC_GQL?_``,?_P"-4`:%%9_G:Q_S
MXV/_`(&/_P#&J/.UC_GQL?\`P,?_`.-4`:%%9_G:Q_SXV/\`X&/_`/&J/.UC
M_GQL?_`Q_P#XU0!H45G^=K'_`#XV/_@8_P#\:H\[6/\`GQL?_`Q__C5`&A16
M?YVL?\^-C_X&/_\`&J/.UC_GQL?_``,?_P"-4`:%%9_G:Q_SXV/_`(&/_P#&
MJ/.UC_GQL?\`P,?_`.-4`:%%9_G:Q_SXV/\`X&/_`/&J/.UC_GQL?_`Q_P#X
MU0!H45G^=K'_`#XV/_@8_P#\:H\[6/\`GQL?_`Q__C5`&A16?YVL?\^-C_X&
M/_\`&J/.UC_GQL?_``,?_P"-4`:%%9_G:Q_SXV/_`(&/_P#&J/.UC_GQL?\`
MP,?_`.-4`:%%9_G:Q_SXV/\`X&/_`/&J/.UC_GQL?_`Q_P#XU0!H45G^=K'_
M`#XV/_@8_P#\:H\[6/\`GQL?_`Q__C5`&A16?YVL?\^-C_X&/_\`&J/.UC_G
MQL?_``,?_P"-4`:%%9_G:Q_SXV/_`(&/_P#&J/.UC_GQL?\`P,?_`.-4`:%%
M9_G:Q_SXV/\`X&/_`/&J/.UC_GQL?_`Q_P#XU0!H45G^=K'_`#XV/_@8_P#\
M:H\[6/\`GQL?_`Q__C5`&A16?YVL?\^-C_X&/_\`&J/.UC_GQL?_``,?_P"-
M4`:%%9_G:Q_SXV/_`(&/_P#&J/.UC_GQL?\`P,?_`.-4`:%%9_G:Q_SXV/\`
MX&/_`/&J/.UC_GQL?_`Q_P#XU0!H44V,N8U,BJKD#<%;(![X.!G\A3J`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`J.X9DMY'09
M=4)4>IQ4E%`'+W,=B!:M+<6<A-LI6.]7"NQR=Z-V8DG.,GIT[J'\QF>6)XK1
MIHC<QR9)5/(&`W_`MN?UKI(HDAC$<8VH.@STI]`')I]GNI_LMG%#!;>?&\<M
MG-NCW?/TPH`8;02!D<C-6)+N:5[R#[/(]Q+)'#)%'@$@+ER"2!@KT.>X[\5T
ME%`'.30PWNB%;^R0W%K(L6)U5W4;EQSSU4J3@U,TMAI-S>0-Y-I&\*^2@`16
M^]D*.A.>PYY]ZW:*`..ETV9X)I?LUE(\$,*NLUMOE4!!NV-G@@9P,=::G]F/
MJ][+/>Z/M\R(HU[$KR.ODQX*L7&`?H>:[.B@"C:$KJ%[&O\`J\HXYX#$<C]`
M?QJ]3(XDC+E%P7;<Q]33Z`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"H[AF2WD=!EU0E1ZG%244`<O<QV(%JTMQ9
MR$VRE8[U<*[')WHW9B2<XR>G3NH?S&9Y8GBM&FB-S')DE4\@8#?\"VY_6NDB
MB2&,1QC:@Z#/2GT`<FGV>ZG^RV<4,%MY\;QRV<VZ/=\_3"@!AM!(&1R,U8DN
MYI7O(/L\CW$LD<,D4>`2`N7()(&"O0Y[COQ7244`<Y-##>Z(5O[)#<6LBQ8G
M57=1N7'//52I.#4S2V&DW-Y`WDVD;PKY*`!%;[V0HZ$Y[#GGWK=HH`XZ739G
M@FE^S64CP0PJZS6V^50$&[8V>"!G`QUIJ?V8^KWLL][H^WS(BC7L2O(Z^3'@
MJQ<8!^AYKLZ*`*-H2NH7L:_ZO*..>`Q'(_0'\:O4R.)(RY1<%VW,?4T^@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`JO=WD5IL\U)VWYQY4#R]/7:#C\:L5'.Q2"1E."
M%)!_"@"G_;-K_P`\K[_P`G_^(H_MFU_YY7W_`(`3_P#Q%8Z7][]@::"ZOYC]
MG+NT]JL81L#&PE%![^HJ6*]OD:[4S70\E%W)=K#O#%A@KY8P5(W<GN..]`&G
M_;-K_P`\K[_P`G_^(H_MFU_YY7W_`(`3_P#Q%4GU&ZB2\$LBX,S+;N%'&&`*
MGU..1^/I4MHMW_;MS`^I7,D,,44@1DB`)8N""0@./E'>@"Q_;-K_`,\K[_P`
MG_\`B*/[9M?^>5]_X`3_`/Q%5Y[^XM[V]#NOV95"QG;S&^W(R>X/3GOCUJ&7
M7$AO;2&2ZA7Y8Q+&Q&YVDX&!UX."?8T`7O[9M?\`GE??^`$__P`11_;-K_SR
MOO\`P`G_`/B*Q8M7U`VNI1&<&Y:X=+1RB_(N]EZ8YVA">:DM+O4KN\F'F:@T
M:-$`;<6X09B1CG>-W5B>/PH`UO[9M?\`GE??^`$__P`11_;-K_SROO\`P`G_
M`/B*T**`,_\`MFU_YY7W_@!/_P#$4?VS:_\`/*^_\`)__B*T**`,_P#MFU_Y
MY7W_`(`3_P#Q%']LVO\`SROO_`"?_P"(K0HH`S_[9M?^>5]_X`3_`/Q%']LV
MO_/*^_\``"?_`.(K0HH`S_[9M?\`GE??^`$__P`11_;-K_SROO\`P`G_`/B*
MT**`,_\`MFU_YY7W_@!/_P#$4?VS:_\`/*^_\`)__B*T**`,_P#MFU_YY7W_
M`(`3_P#Q%']LVO\`SROO_`"?_P"(K0HH`S_[9M?^>5]_X`3_`/Q%']LVO_/*
M^_\``"?_`.(K0HH`S_[9M?\`GE??^`$__P`11_;-K_SROO\`P`G_`/B*T**`
M,_\`MFU_YY7W_@!/_P#$4?VS:_\`/*^_\`)__B*T**`,_P#MFU_YY7W_`(`3
M_P#Q%']LVO\`SROO_`"?_P"(K0HH`S_[9M?^>5]_X`3_`/Q%']LVO_/*^_\`
M`"?_`.(K0HH`S_[9M?\`GE??^`$__P`11_;-K_SROO\`P`G_`/B*T**`,_\`
MMFU_YY7W_@!/_P#$4?VS:_\`/*^_\`)__B*T*CG8I!(RG!"D@_A0!3_MFU_Y
MY7W_`(`3_P#Q%']LVO\`SROO_`"?_P"(K'2_O?L#3075_,?LY=VGM5C"-@8V
M$HH/?U%2Q7M\C7:F:Z'DHNY+M8=X8L,%?+&"I&[D]QQWH`T_[9M?^>5]_P"`
M$_\`\11_;-K_`,\K[_P`G_\`B*I/J-U$EX)9%P9F6W<*.,,`5/J<<C\?2I;1
M;O\`MVY@?4KF2&&**0(R1`$L7!!(0''RCO0!8_MFU_YY7W_@!/\`_$4?VS:_
M\\K[_P``)_\`XBJ\]_<6][>AW7[,JA8SMYC?;D9/<'ISWQZU#+KB0WMI#)=0
MK\L8EC8C<[2<#`Z\'!/L:`+W]LVO_/*^_P#`"?\`^(H_MFU_YY7W_@!/_P#$
M5BQ:OJ!M=2B,X-RUPZ6CE%^1=[+TQSM"$\U):7>I7=Y,/,U!HT:(`VXMP@S$
MC'.\;NK$\?A0!K?VS:_\\K[_`,`)_P#XBC^V;7_GE??^`$__`,16A10!G_VS
M:_\`/*^_\`)__B*/[9M?^>5]_P"`$_\`\16A10!G_P!LVO\`SROO_`"?_P"(
MH_MFU_YY7W_@!/\`_$5H44`9_P#;-K_SROO_```G_P#B*/[9M?\`GE??^`$_
M_P`16A10!G_VS:_\\K[_`,`)_P#XBC^V;7_GE??^`$__`,16A10!G_VS:_\`
M/*^_\`)__B*/[9M?^>5]_P"`$_\`\16A10!G_P!LVO\`SROO_`"?_P"(H_MF
MU_YY7W_@!/\`_$5H44`9_P#;-K_SROO_```G_P#B*/[9M?\`GE??^`$__P`1
M6A10!G_VS:_\\K[_`,`)_P#XBC^V;7_GE??^`$__`,16A10!G_VS:_\`/*^_
M\`)__B*/[9M?^>5]_P"`$_\`\16A10!G_P!LVO\`SROO_`"?_P"(H_MFU_YY
M7W_@!/\`_$5H44`9_P#;-K_SROO_```G_P#B*/[9M?\`GE??^`$__P`16A10
M!G_VS:_\\K[_`,`)_P#XBC^V;7_GE??^`$__`,16A10!G_VS:_\`/*^_\`)_
M_B*/[9M?^>5]_P"`$_\`\16A10!G_P!LVO\`SROO_`"?_P"(H_MFU_YY7W_@
M!/\`_$5H44`9_P#;-K_SROO_```G_P#B*/[9M?\`GE??^`$__P`16A10!G_V
MS:_\\K[_`,`)_P#XBC^V;7_GE??^`$__`,16A10`V-Q)&LBA@&`(#*5//J#R
M/H:=110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%-90ZE6&01@BG44`0M;0M:_9F3,.T+MR>@]Z;/8V]Q*))8RS["F0Q&1D'!P
M>>0*L44`5I;"UFA:&2$-&TGFD$G[V<Y_.I%MXDN9+A5Q+(JHS9/(7./_`$(_
MG4M%`%>6RMYDN$EB#K<#$H).&&,?RH6QMEMY8!$/+E!#C)^;C'7KT`JQ10!0
M71[!98Y1;CS(C(48L209#E^_?)_I33HEEYC.GVF,OMW>5=2H#A0HX5@.@`_"
MM&B@!*6BB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`IK*'4JPR",$4ZB@"%K:%K7[,R9AVA=N3T'O39[&WN)1)+
M&6?84R&(R,@X.#SR!5BB@"M+86LT+0R0AHVD\T@D_>SG/YU(MO$ES)<*N)9%
M5&;)Y"YQ_P"A'\ZEHH`KRV5O,EPDL0=;@8E!)PPQC^5"V-LMO+`(AY<H(<9/
MS<8Z]>@%6**`*"Z/8++'*+<>9$9"C%B2#(<OW[Y/]*:=$LO,9T^TQE]N[RKJ
M5`<*%'"L!T`'X5HT4`)2T44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%5[NSBN]GFO.
MNS./*G>+KZ[2,_C5BHYO,\E_)V^;M.S=TSVS0!BF/3O)NY5?4G%J2&47TV6Q
M_=S)ZY';D&HV%G$LGGPZO#*J[EA>_<M(,@94B4CJ1U(ZU(VAW,,#)!>/<%H?
M*(N-JCCD'*IGKGKGJ:ENK"_O29YH[:.:.,I%&DS,IRRL2S;1C[@'0T`5)39P
M12-/;ZQ%*I0"%K^0L^Y@H((E*]2._%#?94+)):ZRDX*XA-^Y9MQP"")=O4=R
M*L7VEW>J(QNTM4.8U$2N74J)5=LDJ,Y"XQBF7&@B,3165I9&UE=)3;R#8I93
MR.%/!&.W!'OP`(\-O%$AEM=82623RXX3J#EG."<@B7:!@'J1TI'CM5,2+;:R
M\\@8^0+V0,H7`)),H7J1T)SGBK`TZ46)A32=*C7S-Y@5CL;C[V0@VL/]T].U
M-.FW0MT5K:SN<.SB.:9_W.>R2;2<=>PZ^G%`%B'2K66)9`^HKN&=KWLX(^HW
MT_\`L:U_YZWW_@?/_P#%U8L8'MK.*&20R,@P6+%C],GDXZ9-6*`,_P#L:U_Y
MZWW_`('S_P#Q=']C6O\`SUOO_`^?_P"+K0HH`S_[&M?^>M]_X'S_`/Q=']C6
MO_/6^_\``^?_`.+K0HH`S_[&M?\`GK??^!\__P`71_8UK_SUOO\`P/G_`/BZ
MT**`,_\`L:U_YZWW_@?/_P#%T?V-:_\`/6^_\#Y__BZT**`,_P#L:U_YZWW_
M`('S_P#Q=']C6O\`SUOO_`^?_P"+K0HH`S_[&M?^>M]_X'S_`/Q=']C6O_/6
M^_\``^?_`.+K0HH`S_[&M?\`GK??^!\__P`71_8UK_SUOO\`P/G_`/BZT**`
M,_\`L:U_YZWW_@?/_P#%T?V-:_\`/6^_\#Y__BZT**`,_P#L:U_YZWW_`('S
M_P#Q=']C6O\`SUOO_`^?_P"+K0HH`S_[&M?^>M]_X'S_`/Q=']C6O_/6^_\`
M`^?_`.+K0HH`S_[&M?\`GK??^!\__P`71_8UK_SUOO\`P/G_`/BZT**`,_\`
ML:U_YZWW_@?/_P#%T?V-:_\`/6^_\#Y__BZT**`,_P#L:U_YZWW_`('S_P#Q
M=']C6O\`SUOO_`^?_P"+K0HH`S_[&M?^>M]_X'S_`/Q=']C6O_/6^_\``^?_
M`.+K0J.;S/)?R=OF[3LW=,]LT`8ICT[R;N57U)Q:DAE%]-EL?W<R>N1VY!J-
MA9Q+)Y\.KPRJNY87OW+2#(&5(E(ZD=2.M2-H=S#`R07CW!:'RB+C:HXY!RJ9
MZYZYZFI;JPO[TF>:.VCFCC*11I,S*<LK$LVT8^X!T-`%24V<$4C3V^L12J4`
MA:_D+/N8*"")2O4COQ22-9PJXFMM8CF4Q@0F_<L^]MJX(E(Z^I%6;[2[O5$8
MW:6J',:B)7+J5$JNV25&<A<8Q4=WX?VQSP6%O9BVFDBF,#C8I97!93A3\I`]
M./QH`'BMXHT,MIK*2R/LCA.H.6<X).")=H&`>I%(\=JIB1;;67GD#'R!>R!E
M"X!))E"]2.A.<\5.NG2BS:%-(TF-=X8P*YV/[Y$8VD<<X/X4ATVZ%NBM;6=S
MAV<1S3/^YSV23:3CKV'7TXH`L0Z5:RQ+('U%=PSM>]G!'U&^G_V-:_\`/6^_
M\#Y__BZL6,#VUG%#)(9&08+%BQ^F3R<=,FK%`&?_`&-:_P#/6^_\#Y__`(NC
M^QK7_GK??^!\_P#\76A10!G_`-C6O_/6^_\``^?_`.+H_L:U_P">M]_X'S__
M`!=:%%`&?_8UK_SUOO\`P/G_`/BZ/[&M?^>M]_X'S_\`Q=:%%`&?_8UK_P`]
M;[_P/G_^+H_L:U_YZWW_`('S_P#Q=:%%`&?_`&-:_P#/6^_\#Y__`(NC^QK7
M_GK??^!\_P#\76A10!G_`-C6O_/6^_\``^?_`.+H_L:U_P">M]_X'S__`!=:
M%%`&?_8UK_SUOO\`P/G_`/BZ/[&M?^>M]_X'S_\`Q=:%%`&?_8UK_P`];[_P
M/G_^+H_L:U_YZWW_`('S_P#Q=:%%`&?_`&-:_P#/6^_\#Y__`(NC^QK7_GK?
M?^!\_P#\76A10!G_`-C6O_/6^_\``^?_`.+H_L:U_P">M]_X'S__`!=:%%`&
M?_8UK_SUOO\`P/G_`/BZ/[&M?^>M]_X'S_\`Q=:%%`&?_8UK_P`];[_P/G_^
M+H_L:U_YZWW_`('S_P#Q=:%%`&?_`&-:_P#/6^_\#Y__`(NC^QK7_GK??^!\
M_P#\76A10!G_`-C6O_/6^_\``^?_`.+H_L:U_P">M]_X'S__`!=:%%`&?_8U
MK_SUOO\`P/G_`/BZ/[&M?^>M]_X'S_\`Q=:%%`&?_8UK_P`];[_P/G_^+H_L
M:U_YZWW_`('S_P#Q=:%%`&?_`&-:_P#/6^_\#Y__`(NC^QK7_GK??^!\_P#\
M76A10`V-!'&L:EB%``+,6/'J3R?J:=110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%,D8I&S*C2%02$7&6]AD@?F:`'T52M=12YM(;CR)HQ-G:C`%L`$YPI/
MI4;ZO"+2VGC@GE:Y8K%"J@.Q`)/#$`<*3R:`-&BLW^V%:*">&TN9K>9483+L
M"C<>!AF![CH#UJ:'4$GN)XHXI&2'(:52K+N'5<`[L_AVH`N451&H^99PW-M:
M7,XEZ(H56`]3N8`?3.::FK1R/;)'!*\DZ"38&C#1J?XB"W(_W<]*`-"BJE_?
MK81^;+#*T2C,DB`8C7U.2./IDU:H`6BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`IDC%(V94:0J"0BXRWL,D#\S3Z
M*`,O1H;B.S@%S;O"\,.P(S*23GGH2.PQS5.6TNIM&MHGLIP4D)=(Y$65>N"K
M;MO<9YZ9%=!10!0AAN&M[&.=$4Q@-*$P%!`X&/K@\<<4)$\FIF[^S/#LB:,Y
M*YER00>">!@XSS\U7Z*`,RS2Z&B>48'@N"&4*S*2N3UX)'?/7M3[NV,QM[>.
MV95A='2?*X0*02!SNR0,=,<UH44`9NHRSRP^1_9EQ-%)N60*T7*@XQRXX;^7
MH>FB,X&1@^GI2T4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110!_
"_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>sigx1x1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sigx1x1.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#`!`+#`X,"A`.#0X2$1`3&"@:&!86
M&#$C)1TH.C,]/#DS.#=`2%Q.0$1713<X4&U15U]B9VAG/DUQ>7!D>%QE9V/_
MVP!#`1$2$A@5&"\:&B]C0CA"8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C
M8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V/_P``1"``K`/4#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#OI'2-"\C!
M549))X%99U6XNW>/3+4N%_Y;S?+'^'<U2N8;_7GBNK6:.&TBDS''(I(EQ_$?
M;TJXE[?V4D":A!"89'$7FPMT8\#(/;/%`#HK75I`#<:@D9[K#$/YFJT\U[9:
MI9P1WXNO.D"O"R#<JXY;(Z8J234KC4Y9;72"%5#MDNV&54]POJ:M6=C:Z3#)
M,SY=OFEGD/S,?<_TH`O].M%<UXCDU"]T:66V62&V4@LH_P!9*F1GZ#&35[_A
M(-+CMX_L\IF^4!8XE+,!VXH`V**P[_4-1_LR:ZA@2T1(R^ZX.6P!GH/ZU?T:
M6YGTBTFO`!<21!GP,<F@"[2$@`DG`'>EILB+)&T;C*L""/8T`9TVM0!MEK')
M=R>D(R!]3TI!_;%Q)DF"TB[`#>_^%0V5MJ&D0"VBBCNK=#B/!V.%[`]CCUJ3
M^WH(G*WL$]ICJTJ?+_WUTH`G.GS.<R7]P>/X3M_E4$FE>4ID_M.]3;SEIB0/
MP-20ZI_:&_\`LQ4F1&VF9C\F?0>M.33?,*O?3-<.K;@.B#Z"@#,T;7+F6"2.
M:"6ZD29DCD1,;T[,>PJS)J>H)JUK:FVAVS-\ZJY9D7'WCVK2N[B'3[*2>3"Q
MQ+G`'7V%5M)LY($EN;LAKNY;=(1_".RCV`H`T:***`"BBB@`HHHH`****`"B
MBB@`HK(U)KJ]ODL+*X^SB-1+/(!D@$_*H^N#6M0`M%%%`!1110!F>';J"\T.
MSDMR-JQ*A']U@,$55\02)?F'2('S/+(KOMZQHIW;CZ<@#\:63PVJW,LEEJ%S
M91S-NDBA(VENY&1P35A8;'P_9O(B.6D8`G[\L[GH/<F@"OX=N+6T\,6C,RQ+
M&OER9Z^8#AA]<YJS!#+J$GVB\0QP`_NK=O8_>8>OMVK-CT.^>Z.H1S16DDCF
M3[*R&2-&(QNZCY_<<=?K5ZUTO4([Q+BYUB6<*>8A$J(>.GK0!K5'#;00%C##
M'&6Y;8H&:EHH`Q/%0::RM;)?^7RZCB;_`'<[F_1:VNE9.M?\A#1B=V!=GE1G
M_EF^/PK7H`****`(KBXCMHC)(<#H`.I/H/4U2BM9;Y3+J*D(_P!VVSPH_P!K
MU/Z5!?,4\2V+7)VVHB<1L3A?.)``/OMSC\:UI)(XD+RNJ(.K,<`4`8U[$FAR
MPWEFHCMGF6.XA7[IWD*&'H02*W*YO4+V+7[FWT[3F\^%)DEN+A.40*<A<]R2
M!724`9%SC4-:2T.&MK-1-,/60_<!^F"?RJ#^T[B76+`QMMM+EY$12OWPJ$[O
MQ/3V'O4!TW5'U/4X5`AM;R19&N@XW;`H!15ZYX(SVJ;Q-ML8=-OE0^597*%P
MH^ZA!4_S%`&\3@9-<?-XCN-2662UG^P6L1.7\LR2,!WVCH/K756<TEQ;)-+$
M8BXW!#U`[9]\=J+RU2[LYK9R5652I*]1GO0!6T63?I,,K3S3!@6\R9=K'GT[
M54N_$20O&8+2:X@:18S,HPN2<8&?O?A53=?W6IG0;J99H4C6:6YC^5F3IL8=
MB3Z=J/%5W'8WNCO(N8(I))/+'\3*GR`>^30!MW]_%8QC<#),_$<*<M(?0"LR
MWNM1@U^"+4)(Q%>0L8H4_P"6;+@X)[\$_E2QZ9J#0O>&:*/5)L?,Z[U@3^XO
M^/<U+IFBR6]W]MU"]>^NPI5&90JQ@]=JC^=`%J;4HTU6#3T4R2R`N^WI&H'4
M_4\4LFJV:7T=EYP>YD/$:?,1[G'05EC0+TWU]+_:/DQ7<H=FB3][M`P%W'H!
M]*2;2CHVH0ZAI=D;A1$T,L2L`YR0=^3U/'-`'15'YT?DF8.#&%W;@>,5D?:-
M:U!#''9KIR.,>=+('=?H@XS]36@;%5TEK&)BJ^28@QY/3&30!0\,KY]K-JCY
MWZA(90#_``H.$'Y#]:VJYO2]2ETK3[>QOM,O4:WC$9DBB\Q&QQD%?6K?_"4Z
M,,;[T1GTDC9?YB@#9HK-B\0:/,<)J=H3Z&4"K\<B2KNC=77U4Y%`#Z***`,W
M4]62RD2UA3S[Z8'RH%[^Y/8>])I^FR)+]LU"03WC<@_P1#^Z@[#WZFHK:V@?
MQ)?3M$AF18PKD<@;:V*`"BBB@`HHHH`2EHHH`****`&2Q1SQF.:-9$/56&0:
MIG1=+)R=/M3CUB6K]%`$<4,4";(8TC7^ZHP*DHHH`*0@$8(S2T4`)4=S.MM;
M2SN"5B0N0!DG`S4M(>1@T`8OA>VF6SEO[Q"MW?2&:16'*#HJ_@/YU=U#2K?4
M;BSFN,DVDOFH!T)]_P!#^%7:6@`HHHH`****`"BBB@!*1D5AAE!'N*=10!6D
MT^RF7;+:0./1HP:HS^&]*E1A':K;.>DEO^[8'U!%:]%`%33K+[!:K!]HFGV_
..QS-N;J3U_&BK=%`'_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>5
<FILENAME>v102090_ex10-1.htm
<TEXT>
<html>
  <head>
    <title>
      </title>
</head>
  <body bgcolor="#ffffff">
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">May
      18,
      2007</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mr.
      Richard M. Shepperd</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1664
      Rockcrest Hills Ave.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Henderson,
      NV 89052</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dear
      Richard:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      Board
      of Directors of Bioanalytical Systems, Inc. (the "</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Company</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">")
      has
      approved the grant of non-qualified stock options to you. This letter will
      serve
      as notice of the grant, effective as of the date of this letter (the
      "</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Date
      of Grant</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"),
      and
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>subject
      to and conditioned in all respects on the approval of the shareholders of the
      Company</em></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>,
      </strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">of
      an
      option to purchase (the "</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Option</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">")
      275,000 of the Common Shares of the Company (the "</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Option
      Shares</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">")
      on the
      terms and conditions set forth herein, and upon your execution and delivery
      to
      the Company of the copy of this letter included herein will constitute our
      agreement as to those terms. </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>This
      Option has not been granted under the terms of the Company&#8217;s employee stock
      option plans, and is not a "qualified" stock option as defined by the Internal
      Revenue Service.</em></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      You are
      urged to consult with your tax advisors concerning the tax effect of the grant
      and exercise of this Option.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>OPTION
      PRICE</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      The
      purchase price of the Option Shares is $7.10 per share (the "</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Option
      Price</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">").</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>MEDIUM
      AND TIME OF PAYMENT</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      You
      must pay the Option Price with respect to the Option Shares being purchased
      at
      the time you exercise the Option. The Option Price may be paid either (a) in
      cash; (b) by certified check or by bank cashier's check; (c) if you can do
      so
      without violating Section 16(b) of the Securities Exchange Act of 1934, through
      the tender to the Company of outstanding Common Shares, which shall be valued,
      for purposes of determining the extent to which the purchase price has been
      paid, at the fair market value of the Common Shares on the date of exercise
      of
      the Option; (d) by surrendering a sufficient portion of the vested Option based
      on the difference between the exercise price of the Option and the fair market
      value at the time of exercise of the Shares subject to the Option, or (e) by
      any
      combination of (a), (b), (c) and (d).</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>TERM
      AND EXERCISABILITY OF OPTIONS</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      The
      Option is effective immediately upon your acceptance of this letter subject
      only
      to approval of the Company's shareholders. Unless the Option is terminated
      or
      vesting of the Option or any portion thereof is accelerated (in each case as
      provided in this letter), the Option shall vest and become exercisable in three
      installments, as follows: (a) as to the first installment of 75,000 shares,
      at
      5:00 p.m., West Lafayette, Indiana time, on the day the shareholders of the
      Company approve the Option, (b) as to the second installment of 100,000 shares,
      on December&#160;1, 2008, and (c) as to the third installment of 100,000 shares,
      on December&#160;1, 2009. The Option shall also vest and become exercisable as
      to all unvested Option Shares upon the occurrence of a "Change in Control"
      as
      defined in your Employment Agreement with the Company of even date herewith,
      as
      the same may be amended from time to time. The Option will be considered to
      have
      been effectively exercised only upon delivery to the Company, with a copy to
      the
      Chair of the Compensation Committee of the Board of Directors of the Company,
      of
      the Option Price and a "</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Notice
      of Exercise</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
      in the
      form attached hereto, and the satisfaction of all other conditions described
      in
      this letter. The Option shall expire as to all unexercised Option Shares at
      the
      close of business on the tenth anniversary of the date of this letter (or on
      the
      next business day if that date is a Saturday, Sunday or holiday).</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>APPROVAL
      BY SHAREHOLDERS</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      The
      Option granted hereby is conditioned upon and subject to approval by the
      shareholders of the Company. In the event that the shareholders of the Company
      fail to approve the grant of the Option within twelve (12) months of the date
      of
      this letter, the Option shall be null and void and of no effect, and neither
      you
      nor the Company shall have any continuing rights or obligations hereunder.
      The
      Company will submit the Option to its shareholders for approval at the first
      annual or special meeting of its shareholders occurring after the date hereof,
      and in any event prior to the expiration of twelve (12) months from the date
      hereof.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>CESSATION
      OF SERVICE WITH THE COMPANY</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      In the
      event you cease to serve as an employee of the Company or any of its
      subsidiaries, this Option shall terminate immediately upon termination of
      employment as to any unexercised Option Shares; provided, however, that if
      termination of employment is due to retirement with the consent of the Company,
      the expiration of the term of your employment with the Company set forth in
      your
      employment agreement, or is due to a permanent and total disability, you shall
      have the right to exercise the Option with respect to the Common Shares for
      which it could have been exercised on the effective date of termination of
      employment at any time within three (3) months after the termination date.
      In
      the event of your death while serving as an employee of the Company or any
      of
      its subsidiaries, your personal representative shall have the right to exercise
      this Option with respect to the Common Shares for which it could have been
      exercised on the date of your death at any time within six (6) months of your
      death. Whether termination is a retirement with the consent of the Company
      or
      due to permanent and total disability, and whether an authorized leave of
      absence on military or government service shall be deemed to constitute
      termination of employment for the purposes of this Option, shall be determined
      by the Board of Directors in its sole discretion, which determination shall
      be
      final and conclusive.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>RECAPITALIZATION</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      The
      number of Option Shares and the Option Price each shall be proportionally
      adjusted for any increase or decrease in the number of issued Common Shares
      resulting from a subdivision or consolidation of shares of the Company, the
      payment of a share dividend, a share split or other increase or decrease in
      the
      outstanding Common Shares effected without receipt of consideration by the
      Company (including an increase or decrease effected as a part of the
      Recapitalization of the Company, as defined herein). In the event that there
      shall be a recapitalization or reorganization of the Company or a
      reclassification of its outstanding shares (each a "</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Recapitalization</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">")
      as a
      result of which other shares (the "</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>New
      Shares</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">")
      are
      issued in exchange for Common Shares, then there shall be substituted for the
      Option Shares then issuable hereunder that number of New Shares into which
      those
      Option Shares have been converted had they been outstanding at the effective
      date of the Recapitalization.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>MERGER,
      DISSOLUTION</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      If the
      Company shall enter into any agreement of merger or consolidation (whether
      or
      not it shall be the surviving entity thereunder), the Company shall have the
      right to terminate this Option as of any date specified in a written notice
      given to you not less than 30 days prior to the termination date. If the merger
      or consolidation described in that notice is not consummated within 180 days
      following the termination date of this Option specified in the notice, this
      Option thereafter shall be deemed to have been continuously in effect since
      the
      date hereof. In the event of the sale of all or substantially all of the assets
      of the Company and the distribution of the proceeds thereof to shareholders
      in
      liquidation of the company, the Company shall give you 30 days prior written
      notice specifying record date for the purpose of determining the shareholders
      entitled to participate in that distribution and this Option shall expire as
      to
      all Option Shares that remain unexercised as of the date of that
      distribution.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>NONASSIGNABILITY</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      This
      Option is not assignable or transferable except by will or under the laws of
      descent and distribution. During your lifetime, this Option shall be exercisable
      only by you (or if you become incapacitated, by your legal guardian or
      attorney-in-fact).</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>ISSUANCE
      OF SHARES AND COMPLIANCE WITH SECURITIES LAWS</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      The
      Company may postpone the issuance and delivery of certificates representing
      Common Shares until (a) the admission of such shares to listing on any exchange
      on which shares of the Company of the same class are then listed and (b) the
      completion of any requirements for registration or other qualification of the
      shares under any state or Federal law, rule or regulation or the rules and
      regulations of any exchange upon which the Common shares are traded as the
      Company shall determine to be necessary or advisable. The Company shall use
      its
      reasonable commercial efforts to complete any required registration or other
      qualification. You have no right to require the Company to register the Common
      Shares acquired upon the exercise of this Option under federal or state
      securities laws. As a condition to the effective exercise of this Option you
      may
      be required to make such representations and furnish such information as may,
      in
      the opinion of counsel for the Company, be appropriate to permit the Company
      to
      determine whether registration or qualification of those shares is required
      in
      connection with that transaction.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>RIGHTS
      AS A SHAREHOLDER</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      You
      shall have no rights as a shareholder with respect to Common Shares subject
      to
      this Option until the date of issuance of a certificate to you. A certificate
      will not be issued until you have exercised the Option, fully paid for the
      Common Shares acquired thereby and satisfied all other details described in
      this
      letter. No adjustment will be made for dividends or other rights for which
      the
      record date is prior to the date a certificate is issued.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">2</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">11.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>NO
      OBLIGATION TO EXERCISE OPTION</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      The
      grant of this Option imposes no obligation upon you to exercise the
      Option.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">12.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>NO
      OBLIGATION TO CONTINUE EMPLOYMENT</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      The
      grant of this Option to you does not constitute any contract of employment
      between you and the Company, and does not impose any obligation of the Company
      to continue your employment.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">13.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>WITHHOLDINGS</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      As a
      condition to the effective exercise of this Option, the Company shall have
      the
      right to require you to remit to the Company amounts sufficient to satisfy
      any
      applicable withholding requirements set forth in the Internal Revenue Code
      of
      1986, as amended, or under state or local law relating to the Option. The
      Company shall have the right, to the extent permitted by law, to deduct from
      any
      payment of any kind otherwise due to you any federal, state or local taxes
      of
      any kind required by law to be withheld with respect to the exercise of the
      Option.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">14.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>POWER
      AND AUTHORITY</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      The
      Board of Directors shall have the full power and authority to take all actions
      and make all determinations required or provided for under the terms of this
      Option; to interpret and construe the provisions of this letter, which
      interpretation or construction shall be final, conclusive and binding on the
      Company and you; and to take any and all other actions and make any and all
      other determinations not consistent with the specific terms and provisions
      of
      this letter which the Board of Directors deems necessary or
      appropriate.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Please
      acknowledge your receipt of this letter and your agreement to the terms set
      forth herein by signing and returning the copy enclosed for that
      purpose.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div align="left">
      <table border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr bgcolor="#ffffff">
            <td align="left" valign="top" width="50%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="3%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="47%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr bgcolor="#ffffff">
            <td align="left" valign="top" width="50%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="2" valign="top" width="50%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Very
                truly yours,</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BIOANALYTICAL
                SYSTEMS, INC.</font></div>
            </td>
          </tr>
          <tr bgcolor="#ffffff">
            <td align="left" valign="top" width="50%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="3%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="47%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr bgcolor="#ffffff">
            <td align="left" valign="top" width="50%" style="border-bottom: #ffffff solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="3%" style="border-bottom: #ffffff solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">By:&#160;&#160;</font></div>
            </td>
            <td align="left" valign="top" width="47%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">/s/&#160;Michael
                R. Cox</font></div>
            </td>
          </tr>
          <tr bgcolor="#ffffff">
            <td align="left" valign="top" width="50%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="3%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="47%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Michael
                R. Cox, Vice President-Finance and </font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Chief
                Financial Officer</font></div>
            </td>
          </tr>
          <tr bgcolor="#ffffff">
            <td align="left" valign="top" width="50%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="3%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="47%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr bgcolor="#ffffff">
            <td align="left" valign="top" width="50%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="2" valign="top" width="50%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Accepted
                and agreed to:&#160;&#160; </font></div>
            </td>
          </tr>
          <tr bgcolor="#ffffff">
            <td align="left" valign="top" width="50%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="2" valign="top" width="50%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr bgcolor="#ffffff">
            <td align="left" valign="top" width="50%" style="border-bottom: #ffffff solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="2" valign="top" width="50%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">/s/
                Richard M. Shepperd</font></div>
            </td>
          </tr>
          <tr bgcolor="#ffffff">
            <td align="left" valign="top" width="50%">&#160;</td>
            <td align="left" colspan="2" valign="top" width="50%"><font size="2">Richard
              M.
              Shepperd</font></td>
          </tr>

      </table>
    </div>
    <div>&#160;</div>
    <div align="left">
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td align="left" valign="top" width="50%" style="border-bottom: #ffffff solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="5%" style="border-bottom: #ffffff solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Date:</font></div>
            </td>
            <td align="left" colspan="4" valign="top" width="68%" style="border-bottom: black thin solid;"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">May&#160;18,
              2007</font></td>
          </tr>

      </table>
    </div>
    <div align="left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">3</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>EXHIBIT
      A</u></strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>BIOANALYTICAL
      SYSTEMS, INC.</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>NOTICE
      OF EXERCISE</u></strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Date:
      __________</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mr.
      Michael R. Cox</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Chief
      Financial Officer</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BIOANALYTICAL
      SYSTEMS, INC.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2701
      Kent
      Avenue</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">West
      Lafayette, Indiana 47906</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dear
      Mr.
      Cox:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant
      to the agreement dated May&#160;18, 2007 granting me an option ("</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Option</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">")
      with
      respect to the purchase of Common Shares of Bioanalytical Systems,&#160;Inc.,
      please accept this letter as notice of exercise of the Option with respect
      to
      ___________ Common Shares. I am tendering full payment to the Company for the
      Common Shares and all applicable withholdings in one or more of the following
      forms:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td align="left" valign="top" width="6%">&#160;</td>
            <td align="left" valign="top" width="6%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.</font></div>
            </td>
            <td align="left" valign="top" width="66%" style="border-bottom: #ffffff thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Cash
                in the amount of $__________</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td align="left" valign="top" width="6%">&#160;</td>
            <td align="left" valign="top" width="6%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.</font></div>
            </td>
            <td align="left" valign="top" width="66%" style="border-bottom: #ffffff thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Certified
                or bank cashier's check in the amount of $__________</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td align="left" valign="top" width="6%">&#160;</td>
            <td align="left" valign="top" width="6%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.</font></div>
            </td>
            <td align="left" valign="top" width="66%" style="border-bottom: #ffffff thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Tender
                to the Company of </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">__________
                </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">outstanding
                Common Shares.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td align="left" valign="top" width="6%">&#160;</td>
            <td align="left" valign="top" width="6%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.</font></div>
            </td>
            <td align="left" valign="top" width="66%" style="border-bottom: #ffffff thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Surrender
                of vested Options to purchase</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                __________ Common Shares that are subject to the
                Option.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Unless
      I
      have delivered herewith sufficient funds to pay in full all required
      withholdings under applicable law, I authorize the Company to withhold from
      the
      Common Shares otherwise issuable to me as a result of this exercise of the
      Option to pay in full all such required withholdings.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr bgcolor="#ffffff">
            <td align="left" valign="top" width="35%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="4%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="4%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="35%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr bgcolor="#ffffff">
            <td align="left" valign="top" width="35%" style="border-bottom: #ffffff solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="4%" style="border-bottom: #ffffff solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="4%" style="border-bottom: #ffffff solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="35%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr bgcolor="#ffffff">
            <td align="left" valign="top" width="35%">&#160;</td>
            <td align="left" valign="top" width="4%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="4%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="35%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Signature</font></div>
            </td>
          </tr>
          <tr bgcolor="#ffffff">
            <td align="left" valign="top" width="35%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="4%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="4%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="35%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr bgcolor="#ffffff">
            <td align="left" valign="top" width="35%" style="border-bottom: #ffffff solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="4%" style="border-bottom: #ffffff solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="4%" style="border-bottom: #ffffff solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="35%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr bgcolor="#ffffff">
            <td align="left" valign="top" width="35%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="4%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="4%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="35%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Printed
                Name</font></div>
            </td>
          </tr>
          <tr bgcolor="#ffffff">
            <td align="left" valign="top" width="35%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="4%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="4%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="35%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr bgcolor="#ffffff">
            <td align="left" valign="top" width="35%" style="border-bottom: #ffffff solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="4%" style="border-bottom: #ffffff solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="4%" style="border-bottom: #ffffff solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="35%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr bgcolor="#ffffff">
            <td align="left" valign="top" width="35%" style="border-bottom: #ffffff solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="4%" style="border-bottom: #ffffff solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="4%" style="border-bottom: #ffffff solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="35%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr bgcolor="#ffffff">
            <td align="left" valign="top" width="35%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="4%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="4%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="35%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Address</font></div>
            </td>
          </tr>
          <tr bgcolor="#ffffff">
            <td align="left" valign="top" width="35%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="4%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="4%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="35%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">4</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>6
<FILENAME>v102090_ex10-2.htm
<TEXT>
<html>
  <head>
    <title>
      </title>
</head>
  <body bgcolor="#ffffff">
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">November
      6, 2007</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mr.
      Michael R. Cox</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2701
      Kent
      Avenue</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">West
      Lafayette, IN 47906</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dear
      Michael:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      Board
      of Directors of Bioanalytical Systems, Inc. (the "</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Company</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">")
      has
      approved the grant of non-qualified stock options to you. This letter will
      serve
      as notice of the grant, effective as of the date of this letter (the
      "</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Date
      of Grant</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"),
      and
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>subject
      to and conditioned in all respects on the approval of the shareholders of the
      Company</em></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>,
      </strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">of
      an
      option to purchase (the "</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Option</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">")
      45,000
      of the Common Shares of the Company (the "</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Option
      Shares</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">")
      on the
      terms and conditions set forth herein, and upon your execution and delivery
      to
      the Company of the copy of this letter included herein will constitute our
      agreement as to those terms. </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>This
      Option has not been granted under the terms of the Company&#8217;s employee stock
      option plans, and is not a "qualified" stock option as defined by the Internal
      Revenue Service.</em></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      You are
      urged to consult with your tax advisors concerning the tax effect of the grant
      and exercise of this Option.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>OPTION
      PRICE</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      The
      purchase price of the Option Shares is $8.60 per share (the "</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Option
      Price</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">").</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>MEDIUM
      AND TIME OF PAYMENT</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      You
      must pay the Option Price with respect to the Option Shares being purchased
      at
      the time you exercise the Option. The Option Price may be paid either (a) in
      cash; (b) by certified check or by bank cashier's check; (c) if you can do
      so
      without violating Section 16(b) of the Securities Exchange Act of 1934, through
      the tender to the Company of outstanding Common Shares, which shall be valued,
      for purposes of determining the extent to which the purchase price has been
      paid, at the fair market value of the Common Shares on the date of exercise
      of
      the Option; (d) by surrendering a sufficient portion of the vested Option based
      on the difference between the exercise price of the Option and the fair market
      value at the time of exercise of the Shares subject to the Option, or (e) by
      any
      combination of (a), (b), (c) and (d).</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>TERM
      AND EXERCISABILITY OF OPTIONS</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      The
      Option is effective immediately upon your acceptance of this letter subject
      only
      to approval of the Company's shareholders. Unless the Option is terminated
      or
      vesting of the Option or any portion thereof is accelerated (in each case as
      provided in this letter), the Option shall vest and become exercisable in three
      equal installments on November 30, 2008, 2009 and 2010. The Option shall also
      vest and become exercisable as to all unvested Option Shares upon the occurrence
      of a "Change in Control" as defined in your Employment Agreement with the
      Company of even date herewith, as the same may be amended from time to time.
      The
      Option will be considered to have been effectively exercised only upon delivery
      to the Company, with a copy to the Chair of the Compensation Committee of the
      Board of Directors of the Company, of the Option Price and a "</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Notice
      of Exercise</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
      in the
      form attached hereto, and the satisfaction of all other conditions described
      in
      this letter. The Option shall expire as to all unexercised Option Shares at
      the
      close of business on the tenth anniversary of the date of this letter (or on
      the
      next business day if that date is a Saturday, Sunday or holiday).</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>APPROVAL
      BY SHAREHOLDERS</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      The
      Option granted hereby is conditioned upon and subject to approval by the
      shareholders of the Company. In the event that the shareholders of the Company
      fail to approve the grant of the Option within twelve (12) months of the date
      of
      this letter, the Option shall be null and void and of no effect, and neither
      you
      nor the Company shall have any continuing rights or obligations hereunder.
      The
      Company will submit the Option to its shareholders for approval at the first
      annual or special meeting of its shareholders occurring after the date hereof,
      and in any event prior to the expiration of twelve (12) months from the date
      hereof.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>CESSATION
      OF SERVICE WITH THE COMPANY</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      In the
      event you cease to serve as an employee of the Company or any of its
      subsidiaries, this Option shall terminate 30 days after your termination of
      employment as to any unexercised Option Shares; provided, however, that if
      termination of employment is due to retirement with the consent of the Company,
      the expiration of the term of your employment with the Company set forth in
      your
      employment agreement, or is due to a permanent and total disability, you shall
      have the right to exercise the Option with respect to the Common Shares for
      which it could have been exercised on the effective date of termination of
      employment at any time within three (3) months after the termination date.
      In
      the event of your death while serving as an employee of the Company or any
      of
      its subsidiaries, your personal representative shall have the right to exercise
      this Option with respect to the Common Shares for which it could have been
      exercised on the date of your death at any time within six (6) months of your
      death. Whether termination is a retirement with the consent of the Company
      or
      due to permanent and total disability, and whether an authorized leave of
      absence on military or government service shall be deemed to constitute
      termination of employment for the purposes of this Option, shall be determined
      by the Board of Directors in its sole discretion, which determination shall
      be
      final and conclusive.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>RECAPITALIZATION</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      The
      number of Option Shares and the Option Price each shall be proportionally
      adjusted for any increase or decrease in the number of issued Common Shares
      resulting from a subdivision or consolidation of shares of the Company, the
      payment of a share dividend, a share split or other increase or decrease in
      the
      outstanding Common Shares effected without receipt of consideration by the
      Company (including an increase or decrease effected as a part of the
      Recapitalization of the Company, as defined herein). In the event that there
      shall be a recapitalization or reorganization of the Company or a
      reclassification of its outstanding shares (each a "</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Recapitalization</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">")
      as a
      result of which other shares (the "</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>New
      Shares</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">")
      are
      issued in exchange for Common Shares, then there shall be substituted for the
      Option Shares then issuable hereunder that number of New Shares into which
      those
      Option Shares have been converted had they been outstanding at the effective
      date of the Recapitalization.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>MERGER,
      DISSOLUTION</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      If the
      Company shall enter into any agreement of merger or consolidation (whether
      or
      not it shall be the surviving entity thereunder), the Company shall have the
      right to terminate this Option as of any date specified in a written notice
      given to you not less than 30 days prior to the termination date. If the merger
      or consolidation described in that notice is not consummated within 180 days
      following the termination date of this Option specified in the notice, this
      Option thereafter shall be deemed to have been continuously in effect since
      the
      date hereof. In the event of the sale of all or substantially all of the assets
      of the Company and the distribution of the proceeds thereof to shareholders
      in
      liquidation of the company, the Company shall give you 30 days prior written
      notice specifying record date for the purpose of determining the shareholders
      entitled to participate in that distribution and this Option shall expire as
      to
      all Option Shares that remain unexercised as of the date of that
      distribution.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>NONASSIGNABILITY</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      This
      Option is not assignable or transferable except by will or under the laws of
      descent and distribution. During your lifetime, this Option shall be exercisable
      only by you (or if you become incapacitated, by your legal guardian or
      attorney-in-fact).</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>ISSUANCE
      OF SHARES AND COMPLIANCE WITH SECURITIES LAWS</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      The
      Company may postpone the issuance and delivery of certificates representing
      Common Shares until (a) the admission of such shares to listing on any exchange
      on which shares of the Company of the same class are then listed and (b) the
      completion of any requirements for registration or other qualification of the
      shares under any state or Federal law, rule or regulation or the rules and
      regulations of any exchange upon which the Common shares are traded as the
      Company shall determine to be necessary or advisable. The Company shall use
      its
      reasonable commercial efforts to complete any required registration or other
      qualification. You have no right to require the Company to register the Common
      Shares acquired upon the exercise of this Option under federal or state
      securities laws. As a condition to the effective exercise of this Option you
      may
      be required to make such representations and furnish such information as may,
      in
      the opinion of counsel for the Company, be appropriate to permit the Company
      to
      determine whether registration or qualification of those shares is required
      in
      connection with that transaction.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>RIGHTS
      AS A SHAREHOLDER</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      You
      shall have no rights as a shareholder with respect to Common Shares subject
      to
      this Option until the date of issuance of a certificate to you. A certificate
      will not be issued until you have exercised the Option, fully paid for the
      Common Shares acquired thereby and satisfied all other details described in
      this
      letter. No adjustment will be made for dividends or other rights for which
      the
      record date is prior to the date a certificate is issued.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">2</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">11.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>NO
      OBLIGATION TO EXERCISE OPTION</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      The
      grant of this Option imposes no obligation upon you to exercise the
      Option.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">12.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>NO
      OBLIGATION TO CONTINUE EMPLOYMENT</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      The
      grant of this Option to you does not constitute any contract of employment
      between you and the Company, and does not impose any obligation of the Company
      to continue your employment.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">13.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>WITHHOLDINGS</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      As a
      condition to the effective exercise of this Option, the Company shall have
      the
      right to require you to remit to the Company amounts sufficient to satisfy
      any
      applicable withholding requirements set forth in the Internal Revenue Code
      of
      1986, as amended, or under state or local law relating to the Option. The
      Company shall have the right, to the extent permitted by law, to deduct from
      any
      payment of any kind otherwise due to you any federal, state or local taxes
      of
      any kind required by law to be withheld with respect to the exercise of the
      Option.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">14.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>POWER
      AND AUTHORITY</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      The
      Board of Directors shall have the full power and authority to take all actions
      and make all determinations required or provided for under the terms of this
      Option; to interpret and construe the provisions of this letter, which
      interpretation or construction shall be final, conclusive and binding on the
      Company and you; and to take any and all other actions and make any and all
      other determinations not consistent with the specific terms and provisions
      of
      this letter which the Board of Directors deems necessary or
      appropriate.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Please
      acknowledge your receipt of this letter and your agreement to the terms set
      forth herein by signing and returning the copy enclosed for that
      purpose.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="3" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Very
                truly yours,</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="3" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="3" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BIOANALYTICAL
                SYSTEMS, INC.</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="3" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="3" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="3%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">By:</font></div>
            </td>
            <td align="left" colspan="2" valign="top" width="36%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">/s/
                Richard M. Shepperd</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="3%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="2" valign="top" width="36%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Richard
                M. Shepperd, President</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="3" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="3" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Accepted
                and agreed to:</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="3" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="3" valign="top" width="39%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">/s/
                Michael R. Cox</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="3" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Michael
                R. Cox</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="3" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%" style="border-bottom: #ffffff solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="2" valign="top" width="4%" style="border-bottom: #ffffff solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Date:</font></div>
            </td>
            <td align="left" valign="top" width="35%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">November
                6, 2007</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">3</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>EXHIBIT
      A</u></strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>BIOANALYTICAL
      SYSTEMS, INC.</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>NOTICE
      OF EXERCISE</u></strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Date:
      __________</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mr.
      Michael R. Cox</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Chief
      Financial Officer</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BIOANALYTICAL
      SYSTEMS, INC.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2701
      Kent
      Avenue</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">West
      Lafayette, Indiana 47906</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dear
      Mr.
      Cox:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant
      to the agreement dated May&#160;18, 2007 granting me an option ("</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Option</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">")
      with
      respect to the purchase of Common Shares of Bioanalytical Systems,&#160;Inc.,
      please accept this letter as notice of exercise of the Option with respect
      to
      ___________ Common Shares. I am tendering full payment to the Company for the
      Common Shares and all applicable withholdings in one or more of the following
      forms:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div>
        <table cellpadding="0" cellspacing="0" width="100%">

            <tr>
              <td align="left" valign="top" width="6%">&#160;</td>
              <td align="left" valign="top" width="6%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.</font></div>
              </td>
              <td align="left" valign="top" width="66%" style="border-bottom: #ffffff thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Cash
                  in the amount of $__________</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div>
        <table cellpadding="0" cellspacing="0" width="100%">

            <tr>
              <td align="left" valign="top" width="6%">&#160;</td>
              <td align="left" valign="top" width="6%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.</font></div>
              </td>
              <td align="left" valign="top" width="66%" style="border-bottom: #ffffff thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Certified
                  or bank cashier's check in the amount of $__________</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div>
        <table cellpadding="0" cellspacing="0" width="100%">

            <tr>
              <td align="left" valign="top" width="6%">&#160;</td>
              <td align="left" valign="top" width="6%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.</font></div>
              </td>
              <td align="left" valign="top" width="66%" style="border-bottom: #ffffff thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Tender
                  to the Company of </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">__________
                  </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">outstanding
                  Common Shares.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div>
        <table cellpadding="0" cellspacing="0" width="100%">

            <tr>
              <td align="left" valign="top" width="6%">&#160;</td>
              <td align="left" valign="top" width="6%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.</font></div>
              </td>
              <td align="left" valign="top" width="66%" style="border-bottom: #ffffff thin solid;">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Surrender
                  of vested Options to purchase</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                  __________ Common Shares that are subject to the
                  Option.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Unless
      I
      have delivered herewith sufficient funds to pay in full all required
      withholdings under applicable law, I authorize the Company to withhold from
      the
      Common Shares otherwise issuable to me as a result of this exercise of the
      Option to pay in full all such required withholdings.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td align="left" valign="top" width="42%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="36%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="42%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="36%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Signature</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="42%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="36%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="42%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="36%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="42%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="36%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="42%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="36%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Printed
                Name</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="42%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="36%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="42%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="36%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="42%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="36%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="42%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="36%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="42%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="36%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Address</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Cc:
      Compensation Committee Chairman</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">4</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>7
<FILENAME>v102090_ex10-3.htm
<TEXT>
<html>
  <head>
    <title>
      </title>
</head>
  <body bgcolor="#ffffff">
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">November
      6, 2007</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mr.
      Edward M. Chait</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2701
      Kent
      Avenue</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">West
      Lafayette, IN 47906</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dear
      Edward:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      Board
      of Directors of Bioanalytical Systems, Inc. (the "</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Company</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">")
      has
      approved the grant of non-qualified stock options to you. This letter will
      serve
      as notice of the grant, effective as of the date of this letter (the
      "</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Date
      of Grant</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"),
      and
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>subject
      to and conditioned in all respects on the approval of the shareholders of the
      Company</em></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>,
      </strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">of
      an
      option to purchase (the "</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Option</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">")
      45,000
      of the Common Shares of the Company (the "</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Option
      Shares</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">")
      on the
      terms and conditions set forth herein, and upon your execution and delivery
      to
      the Company of the copy of this letter included herein will constitute our
      agreement as to those terms. </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em>This
      Option has not been granted under the terms of the Company&#8217;s employee stock
      option plans, and is not a "qualified" stock option as defined by the Internal
      Revenue Service.</em></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      You are
      urged to consult with your tax advisors concerning the tax effect of the grant
      and exercise of this Option.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>OPTION
      PRICE</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      The
      purchase price of the Option Shares is $8.60 per share (the "</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Option
      Price</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">").</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>MEDIUM
      AND TIME OF PAYMENT</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      You
      must pay the Option Price with respect to the Option Shares being purchased
      at
      the time you exercise the Option. The Option Price may be paid either (a) in
      cash; (b) by certified check or by bank cashier's check; (c) if you can do
      so
      without violating Section 16(b) of the Securities Exchange Act of 1934, through
      the tender to the Company of outstanding Common Shares, which shall be valued,
      for purposes of determining the extent to which the purchase price has been
      paid, at the fair market value of the Common Shares on the date of exercise
      of
      the Option; (d) by surrendering a sufficient portion of the vested Option based
      on the difference between the exercise price of the Option and the fair market
      value at the time of exercise of the Shares subject to the Option, or (e) by
      any
      combination of (a), (b), (c) and (d).</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>TERM
      AND EXERCISABILITY OF OPTIONS</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      The
      Option is effective immediately upon your acceptance of this letter subject
      only
      to approval of the Company's shareholders. Unless the Option is terminated
      or
      vesting of the Option or any portion thereof is accelerated (in each case as
      provided in this letter), the Option shall vest and become exercisable in three
      equal installments on November 30, 2008, 2009 and 2010. The Option shall also
      vest and become exercisable as to all unvested Option Shares upon the occurrence
      of a "Change in Control" as defined in your Employment Agreement with the
      Company of even date herewith, as the same may be amended from time to time.
      The
      Option will be considered to have been effectively exercised only upon delivery
      to the Company, with a copy to the Chair of the Compensation Committee of the
      Board of Directors of the Company, of the Option Price and a "</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Notice
      of Exercise</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"
      in the
      form attached hereto, and the satisfaction of all other conditions described
      in
      this letter. The Option shall expire as to all unexercised Option Shares at
      the
      close of business on the tenth anniversary of the date of this letter (or on
      the
      next business day if that date is a Saturday, Sunday or holiday).</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>APPROVAL
      BY SHAREHOLDERS</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      The
      Option granted hereby is conditioned upon and subject to approval by the
      shareholders of the Company. In the event that the shareholders of the Company
      fail to approve the grant of the Option within twelve (12) months of the date
      of
      this letter, the Option shall be null and void and of no effect, and neither
      you
      nor the Company shall have any continuing rights or obligations hereunder.
      The
      Company will submit the Option to its shareholders for approval at the first
      annual or special meeting of its shareholders occurring after the date hereof,
      and in any event prior to the expiration of twelve (12) months from the date
      hereof.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>CESSATION
      OF SERVICE WITH THE COMPANY</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      In the
      event you cease to serve as an employee of the Company or any of its
      subsidiaries, this Option shall terminate 30 days after your termination of
      employment as to any unexercised Option Shares; provided, however, that if
      termination of employment is due to retirement with the consent of the Company,
      the expiration of the term of your employment with the Company set forth in
      your
      employment agreement, or is due to a permanent and total disability, you shall
      have the right to exercise the Option with respect to the Common Shares for
      which it could have been exercised on the effective date of termination of
      employment at any time within three (3) months after the termination date.
      In
      the event of your death while serving as an employee of the Company or any
      of
      its subsidiaries, your personal representative shall have the right to exercise
      this Option with respect to the Common Shares for which it could have been
      exercised on the date of your death at any time within six (6) months of your
      death. Whether termination is a retirement with the consent of the Company
      or
      due to permanent and total disability, and whether an authorized leave of
      absence on military or government service shall be deemed to constitute
      termination of employment for the purposes of this Option, shall be determined
      by the Board of Directors in its sole discretion, which determination shall
      be
      final and conclusive.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>RECAPITALIZATION</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      The
      number of Option Shares and the Option Price each shall be proportionally
      adjusted for any increase or decrease in the number of issued Common Shares
      resulting from a subdivision or consolidation of shares of the Company, the
      payment of a share dividend, a share split or other increase or decrease in
      the
      outstanding Common Shares effected without receipt of consideration by the
      Company (including an increase or decrease effected as a part of the
      Recapitalization of the Company, as defined herein). In the event that there
      shall be a recapitalization or reorganization of the Company or a
      reclassification of its outstanding shares (each a "</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Recapitalization</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">")
      as a
      result of which other shares (the "</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>New
      Shares</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">")
      are
      issued in exchange for Common Shares, then there shall be substituted for the
      Option Shares then issuable hereunder that number of New Shares into which
      those
      Option Shares have been converted had they been outstanding at the effective
      date of the Recapitalization.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>MERGER,
      DISSOLUTION</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      If the
      Company shall enter into any agreement of merger or consolidation (whether
      or
      not it shall be the surviving entity thereunder), the Company shall have the
      right to terminate this Option as of any date specified in a written notice
      given to you not less than 30 days prior to the termination date. If the merger
      or consolidation described in that notice is not consummated within 180 days
      following the termination date of this Option specified in the notice, this
      Option thereafter shall be deemed to have been continuously in effect since
      the
      date hereof. In the event of the sale of all or substantially all of the assets
      of the Company and the distribution of the proceeds thereof to shareholders
      in
      liquidation of the company, the Company shall give you 30 days prior written
      notice specifying record date for the purpose of determining the shareholders
      entitled to participate in that distribution and this Option shall expire as
      to
      all Option Shares that remain unexercised as of the date of that
      distribution.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>NONASSIGNABILITY</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      This
      Option is not assignable or transferable except by will or under the laws of
      descent and distribution. During your lifetime, this Option shall be exercisable
      only by you (or if you become incapacitated, by your legal guardian or
      attorney-in-fact).</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>ISSUANCE
      OF SHARES AND COMPLIANCE WITH SECURITIES LAWS</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      The
      Company may postpone the issuance and delivery of certificates representing
      Common Shares until (a) the admission of such shares to listing on any exchange
      on which shares of the Company of the same class are then listed and (b) the
      completion of any requirements for registration or other qualification of the
      shares under any state or Federal law, rule or regulation or the rules and
      regulations of any exchange upon which the Common shares are traded as the
      Company shall determine to be necessary or advisable. The Company shall use
      its
      reasonable commercial efforts to complete any required registration or other
      qualification. You have no right to require the Company to register the Common
      Shares acquired upon the exercise of this Option under federal or state
      securities laws. As a condition to the effective exercise of this Option you
      may
      be required to make such representations and furnish such information as may,
      in
      the opinion of counsel for the Company, be appropriate to permit the Company
      to
      determine whether registration or qualification of those shares is required
      in
      connection with that transaction.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>RIGHTS
      AS A SHAREHOLDER</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      You
      shall have no rights as a shareholder with respect to Common Shares subject
      to
      this Option until the date of issuance of a certificate to you. A certificate
      will not be issued until you have exercised the Option, fully paid for the
      Common Shares acquired thereby and satisfied all other details described in
      this
      letter. No adjustment will be made for dividends or other rights for which
      the
      record date is prior to the date a certificate is issued.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">2</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">11.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>NO
      OBLIGATION TO EXERCISE OPTION</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      The
      grant of this Option imposes no obligation upon you to exercise the
      Option.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">12.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>NO
      OBLIGATION TO CONTINUE EMPLOYMENT</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      The
      grant of this Option to you does not constitute any contract of employment
      between you and the Company, and does not impose any obligation of the Company
      to continue your employment.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">13.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>WITHHOLDINGS</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      As a
      condition to the effective exercise of this Option, the Company shall have
      the
      right to require you to remit to the Company amounts sufficient to satisfy
      any
      applicable withholding requirements set forth in the Internal Revenue Code
      of
      1986, as amended, or under state or local law relating to the Option. The
      Company shall have the right, to the extent permitted by law, to deduct from
      any
      payment of any kind otherwise due to you any federal, state or local taxes
      of
      any kind required by law to be withheld with respect to the exercise of the
      Option.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">14.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>POWER
      AND AUTHORITY</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      The
      Board of Directors shall have the full power and authority to take all actions
      and make all determinations required or provided for under the terms of this
      Option; to interpret and construe the provisions of this letter, which
      interpretation or construction shall be final, conclusive and binding on the
      Company and you; and to take any and all other actions and make any and all
      other determinations not consistent with the specific terms and provisions
      of
      this letter which the Board of Directors deems necessary or
      appropriate.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Please
      acknowledge your receipt of this letter and your agreement to the terms set
      forth herein by signing and returning the copy enclosed for that
      purpose.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="3" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Very
                truly yours,</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="3" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="3" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BIOANALYTICAL
                SYSTEMS, INC.</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="3" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="3" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="3%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">By:</font></div>
            </td>
            <td align="left" colspan="2" valign="top" width="36%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">/s/
                Richard M. Shepperd</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="3%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="2" valign="top" width="36%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Richard
                M. Shepperd, President</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="3" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="3" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Accepted
                and agreed to:</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="3" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="3" valign="top" width="39%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">/s/
                Edward M. Chait</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="3" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Edward
                M. Chait</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="3" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" colspan="2" valign="top" width="4%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Date:</font></div>
            </td>
            <td align="left" valign="top" width="35%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">November
                6, 2007</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">3</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>EXHIBIT
      A</u></strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>BIOANALYTICAL
      SYSTEMS, INC.</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><u>NOTICE
      OF EXERCISE</u></strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Date:
      __________</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mr.
      Michael R. Cox</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Chief
      Financial Officer</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BIOANALYTICAL
      SYSTEMS, INC.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2701
      Kent
      Avenue</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">West
      Lafayette, Indiana 47906</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dear
      Mr.
      Cox:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant
      to the agreement dated May&#160;18, 2007 granting me an option ("</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>Option</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">")
      with
      respect to the purchase of Common Shares of Bioanalytical Systems,&#160;Inc.,
      please accept this letter as notice of exercise of the Option with respect
      to
      ___________ Common Shares. I am tendering full payment to the Company for the
      Common Shares and all applicable withholdings in one or more of the following
      forms:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div>
          <table cellpadding="0" cellspacing="0" width="100%">

              <tr>
                <td align="left" valign="top" width="6%">&#160;</td>
                <td align="left" valign="top" width="6%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.</font></div>
                </td>
                <td align="left" valign="top" width="66%" style="border-bottom: #ffffff thin solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Cash
                    in the amount of $__________</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div>
          <table cellpadding="0" cellspacing="0" width="100%">

              <tr>
                <td align="left" valign="top" width="6%">&#160;</td>
                <td align="left" valign="top" width="6%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.</font></div>
                </td>
                <td align="left" valign="top" width="66%" style="border-bottom: #ffffff thin solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Certified
                    or bank cashier's check in the amount of $__________</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div>
          <table cellpadding="0" cellspacing="0" width="100%">

              <tr>
                <td align="left" valign="top" width="6%">&#160;</td>
                <td align="left" valign="top" width="6%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.</font></div>
                </td>
                <td align="left" valign="top" width="66%" style="border-bottom: #ffffff thin solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Tender
                    to the Company of </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">__________
                    </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">outstanding
                    Common Shares.</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div>
          <table cellpadding="0" cellspacing="0" width="100%">

              <tr>
                <td align="left" valign="top" width="6%">&#160;</td>
                <td align="left" valign="top" width="6%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.</font></div>
                </td>
                <td align="left" valign="top" width="66%" style="border-bottom: #ffffff thin solid;">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Surrender
                    of vested Options to purchase</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                    __________ Common Shares that are subject to the
                    Option.</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Unless
      I
      have delivered herewith sufficient funds to pay in full all required
      withholdings under applicable law, I authorize the Company to withhold from
      the
      Common Shares otherwise issuable to me as a result of this exercise of the
      Option to pay in full all such required withholdings.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td align="left" valign="top" width="42%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="36%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="42%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="36%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Signature</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="42%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="36%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="42%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="36%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="42%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="36%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="42%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="36%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Printed
                Name</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="42%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="36%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="42%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="36%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="42%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="36%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="42%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="36%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="42%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
            <td align="left" valign="top" width="36%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Address</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Cc:
      Compensation Committee Chairman</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">4</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
